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Abstract 
Some 78 years after its discovery the Diels-Alder reaction is still one of the most useful 
and powerful transformations in synthetic organic chemistry. Nevertheless, there are 
many unexplored possibilities and aspects of the Diels-Alder reaction that are poorly 
understood. This thesis explores the development of new, efficient and stereocontrolled 
synthetic strategies using the Diels-Alder reaction as a key element. In order to gain a 
deeper understanding of the stereochemical outcome of both the intermolecular and 
intramolecular Diels-Alder reactions detailed synthetic and computational investigations 
have been carried out. 
 
There are five chapters of results and discussion in this thesis, each of them dealing with 
aspects of the Diels-Alder reaction. New methods of controlling the stereochemical 
outcome of the Diels-Alder reaction are presented in chapters two and three. The 
development and application of powerful cascade Diels-Alder strategies for natural 
product synthesis are explored in chapters four, five and six. 
 
The stereochemical outcome of the intramolecular Diels–Alder reaction of ester-linked 
1,3,8-nonatrienes has been controlled by substituents about a stereogenic centre 
attached to C1 (Scheme 1). The scope and limitations of this approach have been 
investigated, with variation in substrate structure about the allylic stereocentre and the 
dienophile. Silyloxy groups are much superior to hydroxy, alkoxy and ester groups in 
their stereocontrolling ability. Computational modelling carried out by Prof. Michael 
Paddon-Row is used to explain the experimental results. 
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Scheme 1 
 
 
 
 vi 
Moderately stereoselective cycloaddition reactions have been rendered completely 
stereoselective simply by the replacement of a hydrogen in the precursor by a bromine 
(Scheme 2). Taken together with the ability to select for either cis or trans-bicyclic 
lactone acids from simple dienols and maleic anhydride, operationally simple 
stereocontrolled approaches to enantiomerically pure bicyclic building blocks with 
complimentary stereochemistries are now in hand. 
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Scheme 2 
Dendralenes are acyclic cross-conjugated oligo-alkenes with much synthetic potential. 
They are particularly attractive precursors for Diels-Alder reactions, since they function 
as multi-dienes, thereby allowing rapid access to polycyclic frameworks. A short and 
general synthetic route to substituted dendralenes has been developed. The 
cycloaddition chemistry of chiral [3]dendralenes is controlled, allowing the assembly of 
tetracyclic systems common to numerous biologically interesting terpenoid natural 
products (Scheme 3). 
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 vii 
The new methods developed have been applied to the synthesis of natural products. A 
concise formal total synthesis of triptolide, a biologically active natural product, was 
completed (Scheme 4). A sequence involving two intermolecular Diels-Alder reactions 
was used to form the tetracyclic core. 
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 viii 
Finally, an intramolecular/intramolecular diene-transmissive Diels-Alder sequence has 
been used to synthesise fused tetracyclic frameworks, such as those found in 
cycloamphilectane natural products (Scheme 5). 
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rt room temperature 
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T temperature 
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 xi 
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 1 
1 Introduction 
 
There is much demand for efficient and practical syntheses of complex organic 
molecules. It is for this reason that cascade sequences are increasingly being applied to 
the total synthesis of natural products and other target molecules.1,2 Cascade or domino 
sequences are defined as two or more reactions carried out in one-pot in which 
subsequent reactions only occur as a result of functionality that is formed in the 
previous step.3 Cascade sequences are attractive to organic chemists as they often result 
in a dramatic increase in molecular complexity, with several new bonds and 
stereocentres being formed at once. 
 
While the value of cascade sequences has long been known there is a continuing interest 
in developing new and more impressive cascade events. One recent example is the 
organocatalysed Michael/Michael/aldol condensation sequence in which four new 
stereocentres were generated in a single step with a high level of diastereoselectivity 
and complete enantioselectivity (Scheme 1.1).4  
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Scheme 1.1 Reagents and conditions: (a) Toluene, 0 oC, RT, 25-58%. 
As with conventional synthesis the reactions incorporated into a cascade sequence 
should be versatile, high yielding and selective. Thus both the intermolecular and 
intramolecular Diels-Alder reactions are ideally suited for use in cascade sequences. 
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1.1 The Intermolecular Diels-Alder Reaction 
1.1.1 Introduction 
Since the first report of the Diels-Alder reaction in 19285 it has become one of the most 
useful and powerful transformations in organic synthesis.2,6-10  
 
The Diels-Alder reaction involves the concerted [4+2] cycloaddition of a conjugated 
diene to a dienophile to form a six membered ring containing a double bond (Scheme 
1.2). The thermodynamic driving force of the reaction is the formation of two σ-bonds 
at the expense of two π-bonds.  The reaction often proceeds under mild conditions to 
give up to four new stereocentres, allowing the rapid assembly of structurally complex 
molecules. 
 
 
Scheme 1.2 The Diels-Alder reaction 
1.1.2 The Diene and Dienophile. 
For a Diels-Alder reaction to occur the diene must be able to adopt the s-cis 
conformation (Figure 1.1). The preferred conformation of 1,3-butadiene is the s-trans 
form, where the steric hindrance between the ‘inside’ hydrogens is reduced. The more 
populated the s-cis conformation is in the ground state, the more reactive the diene will 
be, thus a bis-exo-methylene diene will be more reactive than a semicylic or acyclic 
diene. Examples of dienes capable of undergoing the Diels-Alder reaction are illustrated 
in Figure 1.2. 
 
H
H
H
H
s-trans s-cis  
Figure 1.1The preferred conformation of 1,3-butadiene 
 
 
 3 
acyclic bis-exo-
methylene
semicylic linked rings cyclic
 
Figure 1.2 Dienes capable of undergoing the Diels-Alder reaction 
 
The dienophile may be acyclic, cyclic or alkynic. An electron-withdrawing group 
(EWG) is usually attached to the dienophile, reducing the amount of energy required for 
the Diels-Alder reaction to occur.11 Examples of EWGs used include aldehydes, esters 
and ketones. 
 
1.1.3 Regioselectivity 
If both diene and dienophile are unsymmetrically substituted, two regioisomeric 
products may be formed by a Diels-Alder reaction. If the diene is substituted at a 
terminal position, ortho- and meta-adducts are produced (Scheme 1.3). If the diene 
bears a substituent at an internal position, meta- and para-adducts may be formed 
(Scheme 1.4). For electronic reasons the ortho- and para-adducts are usually 
favoured.11,12  
 
 
+
R1 R1
R2 R2
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R2
+
ortho-adduct meta-adduct  
Scheme 1.3 Diels-Alder reaction of a terminally substituted diene 
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Scheme 1.4 Diels-Alder reaction of an internally substituted diene 
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1.1.4 Cis-stereospecificity 
Concerted Diels-Alder reactions are suprafacial with respect to both reactants, which 
means that both σ-bonds are formed on the same π-face of the diene and dienophile. As 
a result, the relative stereochemistries of both the diene and dienophile are conserved 
(Scheme 1.5). 
MeO2C
CO2Me
CO2Me
CO2Me
+
+
CO2Me
CO2Me
CO2Me
CO2Me
CO2Me
CO2Me
+
6 E,E 7 Z
6 E,E 9 E
8
10 11  
Scheme 1.5 Cis-stereospecificity in Diels-Alder reactions 
 
1.1.5 Endo/exo-stereoselectivity 
The endo/exo cycloaddition modes of the Diels-Alder reaction are defined by the 
orientation of the dienophile with respect to the diene. The endo-mode is the transition 
state spatial arrangement in which the larger dienophile substituents are closer to C2 and 
C3 of the diene (Scheme 1.6). The exo-mode is the arrangement where the dienophile 
substituents lie away from the diene.  
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Scheme 1.6 endo- and exo-cycloaddition modes of the Diels-Alder reaction between 
maleic anhydride and cyclopentadiene 
 
The endo/exo selectivity of the intermolecular Diels-Alder reaction can, in general, be 
explained by the Alder endo rule.13 According to this rule the endo-transition state is 
favoured because of maximum orbital overlap between the diene and the unsaturated 
substituents of the dienophile.14 The stabilizing overlap between the lobes of the atomic 
orbitals that do not participate in the formation of σ bonds are known as secondary 
orbital interactions (SOI) (Figure 1.3).15 However, the existence of this orbital overlap 
has not been unequivocally proven and there are many exceptions to the rule.16  
O
SOI
O
dienophile
diene
 
Figure 1.3 An example of secondary orbital interactions between acrolein and  
penta-1,3-diene. 
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1.1.6 π-Diastereofacial Selectivity 
If the diene or dienophile is unsymmetrically substituted, different stereoisomers may 
be formed as a result of cycloadditions involving different combinations of the diene 
and dienophile π-faces. Generally, the cycloaddition mode that minimises steric 
hinderance between the diene and dienophile will be favoured (Scheme 1.7).17  
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Scheme 1.7 π-Diastereofacial selectivity in the Diels-Alder reaction between 
cyclopentadiene and a chiral maleic anhydride analogue. 
 
1.2 The Intramolecular Diels-Alder Reaction 
1.2.1 Introduction 
The intramolecular Diels-Alder (IMDA) reaction differs from the intermolecular Diels-
Alder reaction in that a tether links the diene and dienophile, thereby producing two 
rings in one step (Scheme 1.8).  
 
tether
 
Scheme 1.8 The intramolecular Diels-Alder reaction 
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The first IMDA reaction was reported in 1953,18 but it was not until the 1960s that more 
detailed reports were made.19-21 The IMDA reaction often has entropic, regiochemical 
and stereochemical advantages over the intermolecular Diels-Alder reaction, but the 
reaction outcome is usually less predictable.  Despite this, the IMDA reaction has been 
featured in the total synthesis of many natural products.1,2,8,22-25  
 
1.2.2  The Tether and Regioselectivity 
The nature of the tether in the IMDA reaction precursor will influence both the regio- 
and stereochemistry of the product. Tethers are often made up entirely of carbon atoms, 
including unsaturated carbons that are part of carbonyl, olefinic or aromatic groups. A 
number of other functional groups have been incorporated into the tether, such as 
amines, amides, esters and ethers. 
 
There are two general ways in which the diene and dienophile may be connected by the 
tether (Figure 1.4). Reactions where the tether is attached to the terminal carbon of the 
diene are referred to as Type 1 (a and b, Figure 1.4). The diene may be E- (a) or Z-
substituted (b). Type 2 reactions occur when the tether is attached to the internal carbon 
of the diene (c, Figure 1.4). 
 
a
d
b
e
c
f
Type 1 Type 2  
Figure 1.4 Tether connections for IMDA reactions 
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The length of the tether will influence the regiochemical outcome of the IMDA 
reaction. For each tether connection in a, b and c, the dienophile may approach the 
diene with the opposite regioselectivity, as shown in d, e and f respectively (Figure 1.4). 
Until recently it was thought that no reaction would occur if the tether contained less 
than three atoms due to strain in the transition state.26 In 2005, however, Houk reported 
examples of IMDA reactions with just one atom in the tether.27 For Type 1 IMDA 
reactions, the most common tether length is three to five atoms, there are a number of 
examples of longer tethers.27-30  
 
This study will deal mainly with E-dienes connected to a dienophile through a three-
atom ester tether (Figure 1.5). The ester tether is easily prepared it also allows complete 
regiochemical control as all precursors cyclise via arrangement a, not d (Figure 1.4). 
 
O
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3
4
5
6
78
9
1
18  
Figure 1.5 E-diene system with a three-atom ester tether (1,3,8-nonatriene) 
 
1.2.3 Endo/exo-Stereoselectivity 
The endo/exo cyclisation modes of the ester tethered IMDA reaction are defined by the 
orientation of the tether carbonyl group with respect to the diene. If the carbonyl group 
is proximal to the diene the reaction proceeds via the endo-transition state, resulting in 
the formation of the cis-fused cycloadducts. If the carbonyl group is distant from the 
diene the reaction proceeds via the exo-transition state and trans-fused cycloadducts are 
formed. The terms endo and exo will not be used to describe transition states and 
products as they are ambiguous terms when describing some dienophile patterns, such 
as E-1,2-disubstituted dienophiles. The terms cis and trans will be used in their place.  
 
As the diene and dienophile moieties in IMDA precursors are generally 
unsymmetrically substituted, there are two distinct π-faces of both diene and dienophile. 
Thus, two trans-mode cyclisations are possible, with the dienophile si π-face reacting 
with the si π-face of the diene, or the dienophile re π-face reacting with the re π-face of 
the diene. For the cis-mode of addition the dienophile may approach such that its si π-
 9 
face reacts with the re π-face of the diene or so its re π-face reacts with the si π-face of 
the diene (Scheme 1.9). With an achiral precursor such as 18, in the absence of any 
external chiral influence, the racemate of any cis or trans adducts would be obtained. 
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Scheme 1.9 The four possible cyclisation modes for an ester-tethered IMDA reaction 
 
1.2.4 π-Diastereofacial Selectivity 
Any IMDA precursor can naturally be divided into three components: the diene, tether 
and dienophile. Reported methods for obtaining π-diastereofacial selectivity from 
IMDA reactions involve the placement of suitable substituents on the tether,31-39 
attaching an auxiliary to the dienophile terminus40-42 and through enantioselective 
cycloaddition of achiral trienes with chiral Lewis acids,43-50 or organocatalysts.6,10 
Methods for controlling the π-diastereofacial outcome of IMDA reactions involving 
substituents on the diene have remained fairly unexplored. 
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1.3 Mechanism and Theoretical Aspects of the Diels-Alder 
Reaction 
 
The mechanism of the Diels-Alder reaction may be concerted with partial formation of 
the two new σ–bonds at the transition state. The transition state of a concerted 
mechanism may be synchronous, with both bonds forming to the same extent, or 
asynchronous, with one bond forming advanced of the other. The other possibility is a 
non-concerted, stepwise mechanism through an intermediate with a single σ–bond 
formed between the diene and dienophile followed by formation of the second bond. 
The stepwise mechanism may be of a zwitterionic or diradical nature (Figure 1.6). 
 
Pericyclic
Ionic
Radical
concerted synchronous process
concerted asynchronous process
stepwise process
stepwise process
 
Figure 1.6 Possible mechanisms of the Diels-Alder reaction 
 
The mechanism most widely accepted for a Diels-Alder reaction between a symmetrical 
diene and symmetrical dienophile is a concerted synchronous process.51,52 If either the 
diene or dienophile is unsymmetrical, the Diels-Alder reaction is thought to proceed via 
a concerted asynchronous process.51,52 This asynchronicity is due to advanced bond 
formation between the reactant termini with the largest MO coefficients (Figure 1.7).53-
56  
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Figure 1.7 Asynchronicity in Diels-Alder reactions 
 
Several groups have proposed models based on asynchronicity to explain the cis/trans 
selectivities of the Diels-Alder reaction.53-57 White56 and Roush54 both proposed that 
during IMDA reactions of C9 EWG-substituted 1,3,8-nonatrienes (see Figure 1.5), 
formation of the internal bond is advanced of the peripheral bond in the transition state. 
This would lead to a pseudo-5-membered transition state. The major product would 
have a trans-ring fusion because the trans-1,2-disubstituted 5-membered ring suffers 
less steric strain than the  cis-fused isomer (Scheme 1.10).54 
OBz OBz OBz
H H
+
a
MeO2C
Me
CO2Me CO2Me
30:70
23 24 25
 
Scheme 1.10 Reagents and conditions: (a) PhMe, BSA, 240 oC, 11 h, 87% 
 
It was also proposed that 1,3,8-nonatrienes carrying a C8 EWG substituent would 
preferentially cyclise via a pseudo-9-membered transition state, where the formation of 
the peripheral bond was advanced. This would lead to the major product possessing a 
cis-ring fusion (Scheme 1.11), since a skewed cis-fused transition state will minimise 
non-bonding interactions between the diene and dienophile.54  
OBz
OHC
OBz OBz
H
OHCOHC
H
+
a
77:23
26 27 28
 
Scheme 1.11 Reagents and conditions: (a) CCl4, BHT, 150 
oC, 18 h, 87% 
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Whilst a detailed review of computational aspects of the Diels-Alder reaction is out of 
the scope of this thesis, some key findings are presented below. Paddon-Row and 
Sherburn recently reported models based on combined synthetic-computational 
studies.58 It was found that for C9 substituted 1,3,8-nonatrienes (see Figure 1.5), the 
IMDA reaction cis/trans selectivity is strongly dependant on the dienophile E/Z 
configuration. C1 substituents, however, have no effect on the cis/trans selectivity. In 
all cases the forming internal bond in the transition state was advanced of the forming 
peripheral bond, irrespective of C9/C1 substitution. Despite this, some IMDA reactions 
of C9 substituted 1,3,8-nonatrienes are cis-selective while others are trans-selective. 
The origin of this selectivity is not precisely known, but it is suspected to be a result of 
secondary orbital interactions, steric and electrostatic effects.15  
 
1.4 Dendralenes and Diene-Transmissive Diels-Alder Sequences 
 
Dendralenes are acyclic cross-conjugated oligo-alkenes with much synthetic potential 
(Figure 1.8).59-62 The parent [3]dendralene was first synthesised in 195563-65 but it was 
not until 2000 that a general route to this class of compounds was developed.60,66 
 
[3]dendralene [4]dendralene [5]dendralene
29 30 31
 
Figure 1.8 The parent dendralenes 
 
Diene-transmissive Diels-Alder (DTDA) sequences involve the addition of a dienophile 
to a dendralene, forming a new diene unit that may participate in a second Diels-Alder 
reaction with a different dienophile (Figure 1.9). DTDA sequences were reported along 
with the first syntheses of the dendralenes.63-65,67 
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32 33  
Figure 1.9 A diene-transmissive Diels-Alder reaction 
 
The parent (unsubstituted) [3]dendralene contains two equivalent diene units. If the 
[3]dendralene bears a substituent at any one of the four possible positions, the two diene 
units are no longer equivalent (Figure 1.10). 
 
R
R
R
unsubstituted [3]dendralene
2 equivalent dienes
The four possible substitued [3]dendralenes
2 inequivalent dienes
R
29 34 35 36 37
 
Figure 1.10 Mono-substituted [3]dendralenes 
 
In addition to regiochemistry associated with diene/dienophile orientation, endo/exo 
selectivity and π-diastereofacial selectivity, site selectivity of the dienophile addition 
between the two diene units must also be considered for DTDA sequences of substituted 
dendralenes. 
 
1.5 Aims 
 
We aim to explore the development of new, efficient and stereocontrolled synthetic 
strategies using the Diels-Alder reaction as a key element.  
 
The first aim of this project is to gain a better understanding of stereochemical outcome 
of both the intermolecular and intramolecular Diels-Alder reactions through combined 
experimental and computational studies. These results will then be applied to the 
synthesis of biologically active natural products. 
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There have been many reports describing methods to control the π-diastereofacial 
selectivity of IMDA reactions (see section 1.2.3). The possibility of controlling the π-
diastereofacial selectivity of IMDA reactions by placing a stereogenic centre allylic to 
the diene but remote to the tether has remained unexplored. This method of π-
diastereofacial control will be investigated in chapter two (Figure 1.11). Computational 
modelling carried out by Prof. Michael Paddon-Row will be used to explain the 
experimental results. 
 
R
*R O R O
+ MLn
*
*R
tether
substituents
dienophile
auxiliary
enantioselective
catalysis
diene
controller
*
previous methods of obtaining !-diastereofacial control
a new method for obtaining !-diastereofacial control?  
Figure 1.11 Obtaining π-diastereofacial selectivity in IMDA reactions 
 
The Diels–Alder reaction is by no means fully optimised since it commonly delivers 
more than one stereoisomeric product and, furthermore, methods to effect a switch in 
stereoselectivity are rare. It has previously been shown that IMDA precursors 38Z and 
38E cyclise to give mixtures of all four possible cycloadducts. Chapter three will 
explore the use of a removable bromine substituent to enhance the stereoselectivity of 
both inter- and intramolecular Diels-Alder reactions (Scheme 1.12).  
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+
trans, lk cis, lk
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38Z  (maleate: E = H; Z = CO2Me)
38E (fumarate: E = CO2Me; Z = H)
39
++
Z
41
40
42
E
1
4
8
9
Z Z
Z Z
E E
E E
5
PhMe, 110 °C
3
O
O
Z
E
1
4
8
9
53
Br
enhanced stereoselectivity?
43  
 
Scheme 1.12 Enhanced stereoselectivity through the use of a removable bromine 
substituent? 
 
Dendralenes are acyclic cross-conjugated oligo-alkenes with much synthetic potential. 
They are particularly attractive precursors for Diels-Alder reactions, since they function 
as multi-dienes, thereby allowing rapid access to polycyclic frameworks. We aim to 
develop a short and general synthetic route to substituted dendralenes. It will be 
demonstrated that DTDA sequences can be used for the rapid assembly of 
enantiomerically pure polycyclic compounds (Scheme 1.13). 
 
OH
diene-transmissive Diels-Alder
sequence
O
H
H O
CO2Me
H
H
O
O
44 45  
Scheme 1.13 A diene-transmissive Diels-Alder sequence to give fused tetracycles 
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The new methods developed in earlier chapters will be applied to the synthesis of 
natural products. A formal total synthesis of triptolide, a biologically active natural 
product, will be undertaken (Scheme 1.14). A sequence involving two intermolecular 
Diels-Alder reactions will be used to form the tetracyclic core. 
 
O
O
H
H
O
O
O
O
OH
HO O
O
(-)-triptolide 46
O
O
OMe
47
OH
8 steps
O
O
O
FGI
Diels-Alder
O
H
H
H
H
CO2Me
Diels-Alder
4849
50
51
52  
Scheme 1.14 Retrosynthetic analysis of triptolide 
 
Having shown that internally-substituted dendralenes are useful for the rapid 
construction of steroid like frameworks, we aim to demonstrate that a terminally-
substituted dendralene may be used for the construction of cycloamphilectane or 
kempane carbon skeletons, depending on the regioselectivity of the IMDA additions 
(Scheme 1.15). 
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O
H
H OH
H
H
a kempane
natural product
NCHH
H H
a cycloamphilectane
natural product
H
bond
rotation
first 
IMDA
reaction
first 
IMDA
reaction
second
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reaction
second
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reaction
53
53
54 55
56 57
 
Scheme 1.15 Diene-transmissive Diels-Alder pathways to different tetracycles.  
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2 Allylic Stereocontrol of the Intramolecular Diels-Alder 
Reaction 
2.1 Introduction 
 
Despite the popularity of the IMDA reaction in synthesis, accurate predictions of the 
stereochemical outcome of the reaction are rare. As the diene and dienophile moieties in 
IMDA precursors are generally unsymmetrically substituted there are two distinct π-
faces of both diene and dienophile. This leads to four stereoisomeric products (see 
Scheme 1.9). In order to accurately predict the stereochemical outcome of an IMDA 
reaction, the origin of π-diastereofacial selectivity must be elucidated. π-Diastereofacial 
selectivity may be governed by steric or electronic interactions between the diene and 
dienophile or by conformational effects in the tether.  
 
Reported methods for achieving π-diastereofacial selectivity during IMDA reactions 
involve the placement of suitable substituents on the tether,31-35,37-39 attaching an 
auxiliary to the dienophile terminus40-42 and through enantioselective cycloaddition of 
achiral trienes with chiral Lewis acids43,44,46-50 or organocatalysts.6,10 The possibility of 
controlling the stereochemical outcome of IMDA reactions by placing a stereogenic 
centre allylic to the diene but remote from the tether has remained unexplored (Figure 
2.1). 
 
R
*R O R O
+ MLn
*
*R
tether
substituents
dienophile
auxiliary
enantioselective
catalysis
diene
controller
*
previous methods of obtaining !-diastereofacial control
this study  
Figure 2.1 Obtaining π-diastereofacial selectivity in IMDA reactions 
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2.2 Reported Methods of π-Diastereofacial Control 
2.2.1 Tether Substituents 
There are many reported methods for the stereochemical control of an IMDA reaction 
through the use of a substituent on the tether. For example, the total synthesis of (±)-
dendrobine involved the cyclisation of an IMDA precursor bearing a stereocentre allylic 
to the diene as the key step.68,69 In an earlier study of related IMDA reactions, Roush 
reported the cyclisation of trienes 58a/b to give the trans adducts 59 and 60 in 
preference to the cis adducts 61 and 62 (Table 2.1).37 The preference for trans-fused 
products was thought to be due to the conformational preference of the tether and the π-
diastereofacial selectivities were a result of 1,3A-strain between the vinylic hydrogen at 
C3 and the substituent at C5. This example highlights the interdependence of endo/exo 
selectivity and π-diastereofacial selectivity. 
 
Table 2.1  
E
Z
OBn
OBnOBn
OBn OBn
Z
Z
H H
H
H
H
E
E
H
H
H
E
Z
Z
E
PhMe, 115 oC
58
59 60
61 62  
 
Triene 
substrate 58 E/Z 
Reaction time 
(h) 
Isolated 
yield (%) 
Adduct ratio[c,d,e] 
59:60:61:62 
a H/CO2Me 110 64 53:30:13:4 
b CO2Me/H 44 92 29:37:0:34 
 
2.2.2 Chiral Auxiliaries at the Dienophile Terminus 
The use of chiral auxiliaries attached to the dienophile terminus to control the π-
diastereofacial selectivity of IMDA reactions was first reported in 1982 by Roush.42 
Evans obtained much higher yields and selectivities in 1984 through the use of chiral 
triene-N-acyloxazolidones (Table 2.2).40 
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Table 2.2  
!"
O
H
H
H
H
!" !"O O
+
Me2AlCl, CH2Cl2,
-30 oC
63 64 65  
 
Chiral Auxiliary Triene 63 Ratio (64:65) 
Isolated Yield of major 
isomer (%) 
O
NO R1
 
R1 = iPr 
R1 = CH2Ph 
a 
b 
83:17 
95:5 
60 
73 
O
N
O
Ph  
c 15:85 70 
O
N
O
 
d 3:97 65 
 
The high levels of π-diastereofacial selectivity observed in these reactions are thought to 
be due to the in situ formation of the s-cis bidentate chelated dienophile 66. Lewis 
Acids accelerate Diels-Alder reactions by lowering the LUMO of the dienophile, 
making it closer in energy to the HOMO of the diene. 
 
N
O
O
Al
R1 Me2AlCl2
s-cis enone
66  
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2.2.3 Enantioselective Catalysis 
Enantioselective catalysis of the IMDA reaction may be used to obtain enantiomerically 
pure cycloadducts from achiral, acyclic substrates. The boron catalysts A and B have 
been used by Yamamoto to successfully control the enantioselectivity of IMDA 
reactions of achiral trienes 67a/b (Table 2.3 entry 1-3).45,47,50 More recently Corey 
reported the use of the N-protonated oxazaborolidine catalyst C in the IMDA reactions 
of trienes 67b/c to give excellent yields and enantioselectivities (Table 2.3, entry 4-5).43 
 
Table 2.3 
OHC
R CHO
R
H
CHO
R
H
H
H
+
catalyst, 
CH2Cl2
67 68 69  
 
Entry Triene 67 R Catalyst Temp (oC) Ratio 
68:69 
Yield (%) 
1 a H A - 40 4:96 84 
2 a H B - 40 90:10 95 
3 b Me A - 20 27:73 74 
4 b Me C - 78 95:5 93 
5 c Br C - 78 97:3 - 
 
O
O
OH
B
CF3
Ph
CF3
OMe
OMe
O
O
CO2H
CO2H
OH
B
H3C
ON
Ph
Ph
H
H
BH3.THF
A B C
Tf2N
 
 
MacMillan recently reported the use an organocatalyst to control the enantioselectivity 
of IMDA reactions. IMDA reaction of 70 in the presence of imidazolidinone catalyst 72 
resulted in the formation of 71 with >20:1 endo/exo selectivity and 93% ee (Scheme 
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2.1). The catalyst lowers the LUMO of the dienophile via the reversible formation of an 
iminuim ion. 
CHO
H
Ph
H
OHC
Ph
N
H
N
O
Ph
TFA
a
70 71
72  
Scheme 2.1 Reagents and conditions: (a) 20 mol% 72, CH3CN (2% H2O), -20 
oC, 20 h, 
84%, 93% ee. 
 
2.2.4 Diene Auxiliaries 
Previous reports of IMDA reactions of substrates with diene auxiliaries employ either 
conformationally restricted semicylic dienes70-73 or are complicated by the presence of 
additional tether substituents and dienophile auxiliaries.74-76 
 
In his total synthesis of (+)-himbacine Hart employed the IMDA reaction of a precursor 
bearing a stereocentre allylic to the diene terminus (Scheme 2.2).71 In this example the 
diene is semicylic and the stereogenic centre is located in the lactone ring, allylic to the 
diene. Dienophile approach is favoured from the top face, away from the methyl 
substituent. 
 
O
O
COSEt
HH
H
O
O
EtS
O
O
O
COSEt
HH
H
+
20 : 1
a
(COSEt endo) (COSEt exo)
73 74 75
 
Scheme 2.2 Reagents and conditions: (a) SiO2-EtAlCl, PhMe, 40 
oC, 96 h, 75% 
 
The total synthesis of (+)-lepicidin A involved the IMDA reaction of 76 (Scheme 2.3).76 
In addition to the stereocentre allylic to the terminus of the diene, this precursor has 
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several other stereocentres that could influence the stereochemical outcome of the 
IMDA reaction. 
O O
N
O
O
O Bn
Et
H
OTBS
PO P'O
OTBS
H
H
H
O
O
Et
H
PO
P'O
H
N
O
O
O
Bn
10:1 diastereoselection
a
76 77
 
Scheme 2.3 Reagents and conditions: (a) Me2AlCl, CH2Cl2, 0 
oC to rt, 71%. 
 
An initial study into the effect of placing a stereogenic centre allylic to the diene but 
remote from the tether in an IMDA precursor carried out by Sherburn and Lilly 
demonstrated that high levels of stereoselectivity could be obtained.77 It was reported 
that the ester-linked 1,3,8-nonatriene 78 cyclised under thermal conditions to give a 
mixture of the two exo-cycloadducts in good yields (Table 2.4). The reasons for the 
stereochemical outcome of the IMDA reactions were not known. 
 
Table 2.4 
 
O
O
O
OP O
Z
H
H
H O
O
O
OP O
Z
H
H
H+
PhMe or 
PhCl
reflux
79 trans, unlike 80 trans, like
E E
78
OP
O
O
O
O
CO2R
 
 
Triene 
substrate 78 P/E/Z 
Solvent/ 
Reaction time[a] 
(h) 
Isolated 
yield[b] (%) 
Adduct ratio[c] 
79:80 
a H/H/CO2Me PhMe/5 86 66:34 
b TMS/H/CO2Me PhMe/12 67 82:12 
c TBS/H/CO2Me PhMe/15 80 91:9 
d TIPS/H/CO2Me PhMe/18 68 96:4 
[a] Time required for >95% conversion, as judged by 1H NMR. [b] Combined isolated 
yield for the two adducts after chromatography. [c] Determined from 1H NMR spectra 
of crude reaction mixtures. 
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The Seebach–Prelog descriptors like and unlike are used to describe the cycloadducts 
arising from IMDA reactions of this type.78 The term like describes a cycloadduct 
resulting from the approach of the dienophile to the re face of the diene with an allylic 
stereocentre of R configuration. The term unlike refers to si/R and re/S combinations. 
For consistent use of this convention, the priorities of the groups about the allylic 
stereocenter are assigned such that the sp2 carbon has a higher priority than the sp3 
carbon.79,80 
 
2.3 Aims 
 
The scope and limitations of the allylic stereocontrol method for IMDA reactions will 
be explored. IMDA reactions of ester-linked 1,3,8-nonatriene 78 will be carried out, 
along with cycloaddition reactions of three additional groups of substrates; namely, 
triene esters 81, 82 and 83 (Figure 2.2). Series 81, diastereomeric with 78, will be 
prepared to investigate the dependence of stereoselectivity upon the relative 
configurations at the allylic and homoallylic stereocentres. Chiral trienes 82 and 83 
would uncouple the effects of the allylic and homoallylic stereocentres, allowing a more 
general assessment of the applicability of this approach. To shed light upon 
stereoselectivities, these reactions will be examined computationally by Prof. Michael 
Paddon-Row (UNSW), using the hybrid B3LYP functional together with the 6-31G(d) 
basis set. It is generally accepted that B3LYP/6-31G(d) models give reliable geometries 
of transition structures (TSs) and activation energies for pericyclic reactions.58,81-86  
 
OP
O
O
78 81
82 83
O
E
Z
O OP
O
O
O
E
Z
O
O
O
O
E
Z
O OP
O
E
Z
O
 
Figure 2.2 Chiral trienes under investigation. The effect of the groups P, E, and Z upon 
IMDA stereoselectivity will be examined. 
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2.4 Experimental Results  
2.4.1 Synthesis of the Chiral Dienols 
Chiral dienols 86, 89, 92 and 94 were prepared from the inexpensive and readily 
available chiral precursors L-ascorbic acid, D-isoascorbic acid, L-malic acid and L-
lactic acid respectively, as shown in Scheme 2.3. The syntheses of these dienols follow 
the same general pathway, involving the chain extension of a chiral ester into the 
corresponding conjugated diene. 
 
Thus, ascorbic and isoascorbic acids were smoothly converted into monoacetonides87 
before oxidative cleavage with potassium carbonate and hydrogen peroxide in water. 
The resulting potassium carboxylates were treated with ethyl iodide to give α-hydroxy 
esters 84 and 87.88,89 Regioselective reduction of diethyl malate with borane-dimethyl 
sulfide complex, followed by treatment of the resulting diol with 2,2-
dimethoxypropane90 produced acetonide 90 in 70% yield after distillation. Silylation of 
the α-hydroxy esters followed by reduction with DIBALH at low temperature produced 
aldehydes 85, 88 and 9391 cleanly. Chain extensions were carried out by Horner–
Wadsworth–Emmons reaction with phosphonate 95 to selectively give the E,E-dienes (J 
= 15.4-15.1 Hz).92 The diene esters were reduced cleanly to the dienols with DIBALH. 
In the malate series, a two step reduction-oxidation93 sequence was necessary for 
conversion of ester 90 into aldehyde 91. Wadsworth–Horner–Emmons reaction between 
aldehyde 91 and the lithium salt of phosphonate 9592 gave the E,E-dienoate ester in a 
disappointing yield. DIBALH reduction gave dienol 92 in 93% yield as a colourless oil.  
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Scheme 2.4 Reagents and conditions: (a) TBSCl, imidazole, DMF, rt, ascorbate 68%; 
isoascorbate 91%. (b) DIBALH, CH2Cl2, –100 °C to –78 °C, ascorbate 86%; 
isoascorbate 58%. (c) LiN(Si(CH3)3)2, (CH3O)2P(=O)CH2CH=CHCO2Me (95), THF, –
78 °C, ascorbate 49%; isoascorbate 70%; malate 21%; lactate 42%. (d) DIBALH, Et2O, 
0 °C, isoascorbate 80%; lactate 88%; ascorbate 74%; malate 93%. (e) LiAlH4, THF, 0 
°C, 92%; (f) (COCl)2, DMSO, NEt3, CH2Cl2, 100%. 
 
2.4.2 Triene Synthesis and IMDA Reactions 
2.4.2.1 The ascorbate series 
Ascorbic acid-derived dienol 86 was converted into precursors for IMDA reaction 
differing in both the stereocentre oxygen substituent P and the nature of the dienophile. 
Seven triene derivatives were prepared (Scheme 2.5, 78a–g). 
 
Reaction of dienol 86 with maleic anhydride furnished a near quantitative yield of 
carboxylic acid 96, which was treated with diazomethane to give diester 78c. 
Desilylation of diester 78c gave an unacceptably low yield (26%) of secondary alcohol 
78a. A much better result (85% yield) was, however, obtained by deprotection of acid 
96. The resulting hydroxy acid 97 was converted to methyl ester 78a, which was used to 
prepare trimethylsilyl derivative 78b and triisopropylsilyl derivative 78d by exposure to 
the appropriate trialkylsilyl triflate. Reaction of alcohol 78a with para-nitrobenzoyl 
chloride gave ester 78e. Fumarate ester 78f and propynoate ester 78g were prepared by 
Steglich esterification of dienol 86 with the requisite carboxylic acid. 
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OTBSO
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O
E
hg
78g78f   E = CO2Me
OP
O
O
O
O
CO2R
86
a
96     
78c  
97   
78a 
78b  
78d
78e
P = TBS,
P = TBS,
P = H,
P = H,
P = TMS,
P = TIPS,
P = p-NO2C6H4C(O),
b
e
c
b
d
f
96
R = H    
R = Me
R = H   
R = Me 
R = Me 
R = Me
R = Me
 
Scheme 2.5 Reagents and conditions: (a) maleic anhydride, Et3N, DMAP, CH2Cl2, rt, 
99%. (b) CH2N2, Et2O, 96 → 78c, 74%; 97 → 78a, 80%. (c) n-Bu4NF, THF, rt, 85%. 
(d) TMSOTf, Et3N, DMAP, CH2Cl2, rt, 51%. (e) TIPSOTf, 2,6-lutidine, CH2Cl2, rt, 
91%. (f) p-NO2C6H4COCl, pyridine, DMAP, 25 °C, 82%; (g) (E)-
HO2CCH=CHCO2Me, DCC, DMAP, Et2O, rt, 96%. (h) HO2CC≡CH, DCC, DMAP, 
Et2O, rt, 65%. 
 
Precursors 78a–e underwent IMDA reactions at high dilution in boiling toluene 
producing mixtures of the four possible cycloadducts (Table 2.5). In all five cases, two 
of the four adducts were formed in significantly larger amounts than the other two. 
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Table 2.5 IMDA reactions of ascorbic acid-derived trienes 78a–f. 
 
O
O
O
OP O
Z
H
H
H O
O
O
OP O
Z
H
H
H
O
O
O
OP O
Z
H
H
H O
O
O
OP O
Z
H
H
H
+
PhMe or 
PhCl
reflux
++
79 trans, unlike 80 trans, like
98 cis, unlike 99 cis, like
78
E
E E
E
 
 
Triene 
substrate 78 P/E/Z 
Solvent/ 
Reaction time[a] 
(h) 
Isolated 
yield[b] (%) 
Adduct ratio[c,d,e] 
79:80:98:99 
a H/H/CO2Me PhMe/5 86 56:32:8:4 
b TMS/H/CO2Me PhMe/12 67 80:14:4:2 
c TBS/H/CO2Me PhMe/15 80 86:9:4:1 
d TIPS/H/CO2Me PhMe/18 68 92:7:1:0 
e PNB/H/CO2Me PhMe/12 95 49:39:6:6 
f TBS/CO2Me/H PhCl/53 62 12:3:82:3 
[a] Time required for >95% conversion, as judged by 1H NMR. [b] Combined isolated 
yield for the four adducts after chromatography. [c] Determined from 1H NMR spectra 
and HPLC analyses of crude reaction mixtures. Differences +/– 3%. [d] Kinetic product 
ratios are reported: control experiments confirmed that all cycloadducts were stable to 
the reaction conditions. [e] The two minor adducts were not fully characterized. 
 
The stereochemistry of each the two major cycloadducts from the three silyl ether 
substrates 78b–d were elucidated using 2D NMR experiments.∗ Finally, the identities of 
cycloadducts 79e and 80e were confirmed by esterification of the alcohols 79a and 80a 
with para-nitrobenzoyl chloride in the usual manner. Insufficient quantities of the two 
minor cycloadducts were obtained from these experiments for full characterization. 
 
The stereoselectivities observed for maleate derivatives 78a–e (Table 1) are intriguing 
in that the level of π-diastereofacial selectivity varies considerably with group P. The 
                                                
∗ These 2D NMR experiments were carried out and analysed by M. Lilly 
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alcohol substrate 78a exhibits only modest unlike78-80 π-diastereofacial preference 
between the two trans-cycloadducts but this improves considerably after the installation 
of common silyl protecting groups.94 A progressive improvement in unlike selectivity is 
observed as the size of the silyl group is increased (cf. 78b → 78c → 78d). The TIPS 
derivative 78d, the most sterically demanding protecting group examined, instigates a 
remarkably high level of stereocontrol. Conversely – and unexpectedly – the para-
nitrobenzoate derivative 78e exhibits the lowest π-diastereofacial selectivity of the five 
substrates. 
 
As expected, the fumarate precursor 78f was significantly less reactive than the 
corresponding maleate 78c.56 The same isolated yields and stereochemical outcomes 
were obtained when 78f was heated in toluene and chlorobenzene, although the former 
required prolonged reaction times for complete conversion. Fumarate 78f underwent 
cycloaddition with virtually complete unlike-selectivity and high cis-selectivity, the 
latter feature being in stark contrast to previous findings with pentadienyl fumarates, 
which generally furnish mildly trans-selective IMDA reactions.56,58,84,86,95-104  
 
The last precursor derived from ascorbic acid, the alkynic dienophile 78g, underwent a 
smooth IMDA reaction at 110 °C (Scheme 2.6).56 Lacking questions of cis/trans-
stereoselectivity, this substrate perhaps best exemplifies the unlike π-diastereofacial 
preference found in this series. The IMDA reaction of the corresponding 2-butynoate 
ester was thwarted by aromatisation of the cycloadducts under the reaction conditions.  
 
O
O
O
TBSO O
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H O
O
O
TBSO O
H
H+
PhMe, 110 °C,
43 h, 92%
100 unlike 101 like
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O
O
O
O
78g
64:36  
Scheme 2.6 IMDA reaction of ascorbic acid-derived alkynoate 78g. 
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2.4.2.2 Isoascorbate and malate series. 
To determine if the outcomes of these reactions were dependent upon the relative 
stereochemistry of this starting material or if the allylic stereocentre is necessary for 
stereoselectivity the IMDA reactions of two more series of substrates were performed. 
The isoascorbic acid-derived dienol 89 was converted into maleate and fumarate 
derivatives 81a and 81b in the same manner as described previously (Scheme 2.7) while 
the malic acid-derived dienol 92 was transformed into corresponding trienes 82x and 
82y. 
 
X
O
O
O
O
E
Z
X
O
O
OH
a or b
81a   X = OTBS  E = H   Z = CO2Me
81b   X = OTBS  E = CO2Me,  Z = H
82x   X = H  E = H   Z = CO2Me
82y   X = H  E = CO2Me  Z = H
89  X = OTBS 
92  X = H
 
Scheme 2.7 Reagents and conditions: (a) maleic anhydride, Et3N, DMAP, CH2Cl2, rt, 
then CH2N2, Et2O, 0 °C, 89 → 81a, 74%; 92 → 82x, 56%. (b) (E)-
HO2CCH=CHCO2Me, DCC, DMAP, Et2O, rt, 89 → 81b, 78%; 92→ 82y, 74%. 
 
The isoascorbic acid-derived precursors underwent IMDA reactions with approximately 
the same ease as the ascorbic acid series, whereas the malic acid derived precursors 
cyclized somewhat more rapidly (Table 2.6).  
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Table 2.6 IMDA reactions of isoascorbic acid and malic acid derived precursors 81a,b 
and 82x,y. 
O
O
O
X O
Z
H
H
H E O
O
O
X O
Z
H
H
H E
O
O
O
X O
Z
H
H
H E O
O
O
X O
Z
H
H
H E
+
PhMe
reflux
++
102 trans, unlike 103 trans, like
104 cis, unlike 105 cis, like
81a,b
82x,y
 
Triene 
substrate X/E/Z 
Solvent/ 
Reaction time[a] 
(h) 
Isolated 
yield[b] (%) 
Adduct ratio[c,d,e] 
102:103:104:105 
81a OTBS/H/CO2Me PhMe/9.5 86 78:16:4:2 
81b OTBS/CO2Me/H PhCl/72 89 9:6:66:19 
82x H/H/CO2Me PhMe/3.5 89 41:39:11:9 
82y H/CO2Me/H PhCl/43 89 32:33:18:17 
[a] Time required for >95% conversion, as judged by 1H NMR. [b] Combined isolated 
yield for the four adducts after chromatography. [c] Determined from 1H NMR spectra 
and HPLC analyses of crude reaction mixtures. [d] Kinetic product ratios are reported: 
control experiments confirmed that all cycloadducts were stable to the reaction 
conditions. [e] The stereochemical identities of the two minor adducts were not 
elucidated. 
 
Product stereochemistries in the isoascorbate series were determined through NMR 
experiments and comparison to the data for the other series. The stereochemical identity 
of the major product from fumarate precursor 81b was established by selective acetal 
deprotection/lactonization to 106 (Scheme 2.8). It was thought that exposure of 104b to 
triflouroacetic acid would result in removal of the silyl protecting group. However 1H 
NMR revealed that the silyl group was still present but the acetal protecting group had 
instead been selectively removed. The stereochemistry of the bis-lactone 106 was 
determined through 2D NMR experiments. A NOESY cross peak between H-4 and H-8 
(highlighted in yellow) is an indicator of the product stereochemistry (Figure 2.3).  
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HO
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CF3CO2H, H2O,
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H H
OH
CO2Me
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HO
H
 
Scheme 2.8 Acetonide deprotection/lactonization of 104b. 
 
Figure 2.3 NOESY spectrum for 106. 
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In the malic acid products, the ring junction stereochemistry was clearly evident from 
NMR coupling constants. The ring junction geometry of cycloadducts 102x, 103x, 102y 
and 103y was evident from the large trans-diaxial coupling constants (3J = 14.2-13.6 
Hz) between the ring junction hydrogens.  
 
The major diastereomer obtained from intramolecular cycloadditions of isoascorbic 
acid-derived substrates 81a and 81b (Table 2.6) correlates with those obtained in the 
ascorbic acid series 78c and 78f (Table 2.5). Thus, a Z-dienophile precursor (i.e. 81a or 
78c) gives the trans, unlike adduct whereas the E-dienophile precursor (i.e. 81b or 78f) 
gives the cis, unlike adduct. The adduct ratios are similar but not identical, indicating a 
contribution to the overall stereochemical outcome by the configuration at the 
homoallylic site. No π-diastereofacial selectivity was witnessed in cyclisation of either 
maleate 82x or fumarate 82y, however, indicating that a lone homoallylic stereocentre is 
insufficient to invoke stereoselection. It is noteworthy that the E-dienophile precursor 
82x undergoes a trans-selective IMDA reaction, a result which is consistent with 
previous findings56,58,84,86,95-104 but in contrast to those of the other three fumarate 
precursors in the present study. 
 
2.4.2.3 Lactate series 
In the research described so far, it has been demonstrated that stereogenic elements at 
the diene terminus can induce high levels of stereoselectivity upon IMDA reactions. 
Ascorbate and isoascorbate-derived systems 78 and 81 are complicated by the presence 
of two stereocentres and an acetal functional group. To determine if precursors lacking 
these structural features would also give rise to stereoselective IMDA reactions and, 
furthermore, to minimize the assumptions made in the computational modelling of this 
reaction, we elected to carry out a synthetic study on dienol 94. Thus, lactic acid-
derived dienol 94 was converted into the four maleate esters 83a–d, and the fumarate 
ester 83e using similar procedures to those described previously (Scheme 2.9). 
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PO
O
O
CO2R
94
O
O
MeO2C
TBSO
a
107  
83c   
108    
83a  
83b
83d
P = TBS,
P = TBS,
P = H,
P = H,
P = TMS,
P = TIPS,
c
e
b
c
d
f
83eR = H    
R = Me
R = H  
R = Me 
R = Me
R = Me  
Scheme 2.9 Reagents and conditions: (a) maleic anhydride, Et3N, DMAP, CH2Cl2, rt, 
75%. (b) n-Bu4NF, THF, rt, 44%. (c) CH2N2, Et2O, 0 °C, 107 →  83c; 87%, 107–83a, 
44%. (d) TMSOTf, Et3N, DMAP, CH2Cl2, rt, 88%. (e) TIPSOTf, Et3N, CH2Cl2, rt, 
78%. (f) (E)-HO2CCH=CHCO2Me, DCC, DMAP, Et2O, rt, 89%. 
 
The five triene precursors underwent IMDA reactions in refluxing toluene (Table 2.7) 
over slightly shorter reaction times than those of the corresponding ascorbic and 
isoascorbic acid-derived precursors (Table 2.5 and Table 2.6). Furthermore, mixtures of 
the four possible cycloadducts were produced in all cases.  
 
The four cycloadducts obtained from IMDA reaction of the maleate TBS ether 83c were 
separated by HPLC. The ring junction geometry of cycloadducts 109c and 110c was 
evident from the large trans-diaxial coupling constants (3J = 13.5 Hz) between the ring 
junction hydrogens. On the basis of 2D NMR experiments it was possible only to 
elucidate the relative stereochemistry at the four new stereocentres; the lack of 
conformational preference about the C1'–C5 bond precluded the correlation of new with 
existing stereochemistry in this set of cycloadducts. Thus, whereas the endo/exo-
stereoselectivity of these IMDA reactions could be ascertained readily, the π-
diastereofacial selectivity was more elusive. 
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Table 2.7 IMDA reactions of lactic acid derived trienes 83a–e 
O
PO O
Z
H
H
H EO
PO O
Z
H
H
H E
O
PO O
Z
H
H
H EO
PO O
Z
H
H
H E
+
++
109 trans, unlike 110 trans, like
111 cis, unlike 112 cis, like
PhMe
reflux
83
 
Triene 
substrate 83 P/E/Z 
Solvent/ 
Reaction time[a] 
(h) 
Isolated 
yield[b] (%) 
Adduct ratio[c,d] 
109:110:111:112 
a H/H/CO2Me PhMe/4.5 88 41:36:5:18
[e] 
b TMS/H/CO2Me PhMe/6.5 83 56:30:6:8 
c TBS/H/CO2Me PhMe/7.25 96 61:27:5:7 
d TIPS/H/CO2Me PhMe/8.25 85 63:26:5:6 
e TBS/CO2Me/H PhCl/43 73 8:28:40:24 
[a] Time required for >95% conversion, as judged by 1H NMR. [b] Combined isolated 
yield for the four adducts after chromatography. [c] Determined from 1H NMR spectra 
and HPLC analyses of crude reaction mixtures. Differences +/– 3%. [d] Kinetic product 
ratios are reported: control experiments confirmed that all cycloadducts were stable to 
the reaction conditions. [e] Tricyclic bis-lactones 113 and 114 were isolated instead of 
cis-adducts 111a and 112a in this series. See main text for an explanation. 
 
The identities of the four sets of products from each of the reactions of 83a, 83b and 
83d were correlated with the four derived from 83c by interconversions. Thus, crude 
reaction mixtures obtained by heating 83b and 83c were treated with trifluoroacetic 
acid. NMR and GC analyses of these reaction mixtures linked the TMS and TBS 
cycloadducts with those derived from the alcohol precursor 83a. Attempts to deprotect 
TIPS-protected cycloadducts were unsuccessful, so two trans-alcohols 109a and 110a 
were converted to TIPS ethers 109d and 110d, respectively. Cis-adducts 111a and 112a 
in this series rapidly form tricyclic bis-lactones 113 and 114 respectively (Figure 2.4) 
under the reaction conditions. Crystal structures were obtained of compounds 110a, 
113, 114 (Figure 2.4). Treatment of compound 110e with trifluoroacetic acid generated 
the alcohol which spontaneously lactonized to bislactone 115. Similar treatment of 111e 
with TFA gave alcohol 116. The structures of 115 and 116 were also confirmed by 
single crystal X-ray analyses (Figure 2.4).  
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81%
111e
CF3CO2H,
CDCl3, 5h, RT
85%
 
 
 
Figure 2.4 Thermal ellipsoid diagrams of 110a, 113, 114, 115 and 116. Ellipsoids show 
30% probability levels. 
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The main features of the lactate series can be summarized as follows. The Z-dienophile 
precursors 83a–d, once again, undergo strongly trans-selective IMDA reactions. The 
alcohol substrate 83a exhibits a very small π-diastereofacial selectivity during 
cycloaddition. The corresponding silyl ethers undergo more stereoselective IMDA 
reactions, with higher levels of π-diastereofacial selectivity being obtained with larger 
silyl groups. Nevertheless, the highest level of π-facial selectivity delivered by a lactate-
derived precursor (83d, unlike:like = 68:32) is considerably lower than that witnessed in 
the ascorbate series (78d, unlike:like = 93:7). The E-dienophile precursor 83e undergoes 
a reaction with considerably lower stereoselectivity than the corresponding ascorbate 
and isoascorbate trienes, 78f and 81b respectively. Once again, however, the cis,unlike 
diastereomer is the major adduct. 
 
2.5 Discussion  
 
Whilst the stereoselectivity of IMDA reactions of precursors 78, 81, 82 and 83 varies 
considerably, the following generalizations can be made: (1) Maleate esters of dienols 
86, 89, 92 and 94 undergo trans-selective IMDA reactions, whereas the corresponding 
fumarate esters are generally cis-selective. The exception is fumarate 82y, which 
undergoes a trans-selective IMDA reaction. These selectivities are more pronounced the 
larger the substituents attached to the allylic stereocentre; (2) Chiral allylic alcohols 
(78a and 83a) give poor to moderate levels of π-diastereofacial selectivity in IMDA 
reactions. Silyl ether derivatives of these allylic alcohol precursors give moderate to 
high levels of π-facial stereoselectivity, with an increase in the size of the silyl 
protecting group leading to an increase in stereoselection. An allylic benzoyloxy 
derivative gave essentially no π-facial discrimination in these reactions; (3) An increase 
in the size of the alkyl group leads to an increase in π-facial stereoselectivity (compare 
results of substrates 78 and 81 with those of 83); (4) The two diastereomeric dienols 86 
and 89 gave similar but non-identical stereoisomer ratios, a result which demonstrates 
that the allylic stereocentre controls the outcome of these reactions to a large extent; (5) 
An allylic stereocentre appears to be necessary for π-facial stereoselectivity, since 
substrates carrying an allylic methylene and homoallylic stereocentre (82x,y) gave no 
stereocontrol. 
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These experimental results clearly demonstrate that the presence of an allylic 
stereocentre can indeed give rise to high levels of stereoselectivity in IMDA reactions. 
Inspection of molecular models and literature searches gave no clear reasons for the 
observed experimental stereoselectivities. The C* substituents would be expected to 
adopt an approximately staggered arrangement with respect to the developing C1–C9 
bond,105,106 with allylic alkyl, silyloxy, and hydrogen substituents distributed among the 
inside (in), anti (an), and outside (ou) positions in TSs, as depicted by 117 (Figure 2.5). 
The facial selectivity is determined by the positional preferences of the C* substituents 
for the in, an and ou sites in the TS. What are these preferences? This question was 
answered by model computational studies. 
O
O
E
H
H
H
Z
anin
ou
H
117
Z
H
E
an
ou
in
* 1
9
*
1
(behind)
9
 
Figure 2.5 A representation of one of the trans-TSs. The Newman projection formula 
on the right depicts a view along the C*–C1 bond of the structure on the left. 
 
2.6 Computational Results and DiscussionΨ 
2.6.1 Computational Modelling 
 B3LYP/6-31G(d) density functional theory calculations were conducted on maleate 
and fumarate IMDA precursors 83b, 83f and 83g (Figure 2.5). The computational 
modelling of these reactions is complicated by the large number of possible reactive 
orientations of each precursor. Thus, in addition to the three conformations about the 
C*–C1 bond, three conformations about the allylic C*−O bond and s-cis/s-trans 
orientations of the C9−CO2CH3 bond are feasible (Figure 2.5). In principle, therefore, a 
total of 72 diastereomeric TSs can be envisioned for each IMDA precursor, with 18 
diastereomeric TSs leading to each of the four cycloadducts, 109, 110, 111 and 112. It 
was impractical to calculate all 72 TSs at this level of theory for each IMDA precursor 
                                                
Ψ Calculations were carried out by Prof. Michael Paddon-Row (UNSW) and the results 
were interpreted by Assoc. Prof. Michael Sherburn and Prof. Michael Paddon-Row. 
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and, consequently, relaxed potential energy scans were carried out on model TSs to 
locate the lowest energy conformation about the allylic C*−O bond. IMDA TSs for 83f 
in which the ester adopts the s-cis conformation were found to be slightly (2.5 – 6.0 kJ 
mol–1) lower in energy than the corresponding s-trans TSs. In all other respects, the two 
sets of TSs, one with s-cis and the other with s-trans ester conformations showed very 
similar trends, particularly with respect to facial selectivity; hence discussion here will 
be limited to the s-cis TSs. 
3 orientations
O
O
H
H
H
H
OCH3O
O
H3C
H
83b: trans, like TSs
Me3Si
3 orientations
2 orientations 110
83b: P = OSiMe3, E = H, Z = CO2Me
83f:  P = OSiH3, E = H, Z = CO2Me
83g: P = OSiH3, E = CO2Me, Z = H
OP
O
E
Z
O
*
*
 
Figure 2.6 Structures of the three precursors under scrutiny by DFT and the 18 possible 
diastereomeric TSs for the trans, like IMDA cycloaddition mode of 83b. 
These considerations led to a more manageable three TSs leading to each of the four 
diastereomeric adducts. These three TSs, corresponding to three low energy 
conformations about the C*–C1 bond; cf. Figure 2.4, were located for each of the four 
cycloaddition modes (cis/trans; like/unlike combinations) and their relative energies 
(including zero-point energies) were used to construct a predicted Boltzmann 
distribution of stereoisomeric cycloadducts. The structures and relative energies of 12 
diastereomeric TSs for the IMDA reaction of C*–OSiH3 Z-dienophile precursor 83f are 
depicted in Figure 2.6. 
 
For both C*–OSiH3 triene 83f and C*–OSiMe3 triene 83b, theory correctly predicts the 
major – minor product sequence: the predicted Boltzmann populations of IMDA 
adducts from the reaction of 83b at 383K in the gas phase (109b:110b:111b:112b = 
81.9:15.3:1.2:1.6) compares favourably with the experimentally determined ratio in 
refluxing toluene (Table 3, entry 2; 109b:110b:111b:112b = 56:30:6:8). Considering 
the complexity and multiplicity of TSs examined and the omission of solvent effects in 
the calculations – which are expected to be small, considering the low polarity of the 
toluene and chlorobenzene solvents used in the experiments – the close correlation 
between theory and experiment is remarkable, providing compelling evidence in 
support of the reliability of our theoretical model. 
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(a) 54.8% (b) 14.6% (c) 0.6%
(d) 13.0% (e) 10.2% (f) 1.6%
(g) 0.9% (h) 1.2% (i) 0.2%
(j) 0.9% (k) 1.9% (l) 0.1%
trans,
unlike
trans,
like
cis,
unlike
cis,
like
OSiH3 inside H inside CH3 inside
109
110
111
112
69.9%
24.9%
2.4%
2.9%
 
Figure 2.7 TSs and calculated Boltzmann populations (blue for individual TSs, red is 
the total for each diastereomeric adduct) at 383K for the IMDA reaction of 83f. The 
twelve TSs are viewed down the C1–C* axis and the developing C1–C9 bond is 
depicted as a vertical grey line. C*–H is coloured green, C*–CH3 is coloured black and 
some atoms are omitted for clarity. Structures (a)–(c) lead to the trans, unlike adduct 
109f; (d)–(f) lead to trans, like adduct 110f; (g)–(i) lead to cis, unlike adduct 111f; and 
(j)–(l) lead to the cis, like adduct 112f. Structures on the left have the –OSiMe3 group 
inside, those in the centre column have the –H inside, and those on the right have the –
CH3 inside. To facilitate comparisons between TSs, dienophile approach from below is 
depicted throughout, hence the configuration at the allylic stereocentre is inverted in the 
unlike TSs. 
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For the E-dienophile series, the predicted IMDA adduct ratio from the reaction of 
OSiH3 substrate 83g is 109:110:111:112 = 25:20:50:5 at 405K in the gas phase. 
Experimentally, in refluxing chlorobenzene solution (405K), the ratio of products for 
the –OTBS substrate 83e is 8:28:40:24. Thus, theory correctly predicts: (1) a less 
stereoselective IMDA reaction for a fumarate ester than the corresponding maleate 
ester; (2) the identity of the major product, the cis, unlike diastereoisomer, (3) the 
cis/trans-selectivity of the reaction and (4) in a qualitative manner, the π-diastereofacial 
selectivity within the cis-adduct manifold. There is a discrepancy between theory and 
experiment, however, in the π-diastereofacial selectivity of the trans-adducts (expt: 
unlike:like = 22:78; theory unlike:like = 57:43) Nevertheless, once again, overall there is 
a very good correlation between experiment and theory, which demonstrates the validity 
of the computational model. Extensive CPU times were necessary to carry out these 
calculations and it was not feasible to carry out a similar computational analysis on TBS 
fumarate precursor 83e. 
 
2.6.2 TS Geometries and Relative Energies. 
For all three trienes examined computationally, the lowest energy IMDA TSs have 
unlike stereochemistry and exhibit a conformation in which the C*–silyloxy group 
adopts the inside position, the C*–methyl group is in the anti position, and the C9-
CO2Me group adopts the exo orientation (cf. Figure 2.5). The preferences of the methyl 
and silyloxy groups for the anti and the inside positions, respectively, in the lowest 
energy TSs are a consequence of their respective innate tendencies to adopt these 
positions in both the transition state and the ground state, irrespective of the presence of 
the other substituent. 
 
For all TSs located, the forming internal (C4–C8) bond is considerably shorter than the 
developing peripheral (C1–C9) bond, giving rise to significant bond-forming 
asynchronicity (see Figure 1.7). This is exemplified in Figure 2.8 with the most stable 
TSs for each of the three series of precursors, 83f, 83b and 83g. The two 9-Z-CO2Me 
TSs, trans, unlike-83fTS-(a) and trans, unlike-83bTS-(a) have large bond-forming 
asynchronicities of 0.75 and 0.77 Å, respectively, whereas the 9-E-CO2Me TS 
cis, unlike-83gTS-(g) exhibits slightly lower levels of bond-forming asynchronicity of 
0.56 Å. Similar bond-forming asynchronicities and trends are found in the other TSs. 
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These geometric features are consistent with findings on related systems.58,84,86 
Inspection of the profiles of the 36 IMDA TSs located for trienes 83b, 83f and 83g 
reveals that the allylic substituents show little staggering about the forming peripheral 
bond (r2) that is normally characteristic of additions to allylic systems.
105,106Indeed, the 
C1−C* conformations in these TSs are essentially the same as those for isolated allylic 
ethers, with one substituent eclipsing the double bond.107,108 This is hardly a surprising 
finding, given the highly extended length of the developing peripheral bond.58,84,86 
 
2.730 1.976 2.744 1.978
2.582 2.025
trans, unlike 
83fTS-(a)
trans, unlike 
83bTS-(a)
cis, unlike 
83gTS-(g)
a b c  
Figure 2.8 Most stable TSs for each of the three series of precursors. a: trans, unlike-
83fTS-(a) (Figure 5a); b: trans, unlike83-(a) (see Figure S1a[28]); c: cis, unlike-83gTS-
(g) (see Figure S2g[28]). Upper: front views (forming bond lengths in Å). Lower: 
Newman projections down the O–C* bond. Most H atoms and C3 – C8 have been 
omitted for clarity. 
 
Our model for the favoured TS for IMDA reactions, in which the silyloxy group adopts 
the inside position and the alkyl group the anti position, is reminiscent of that proposed 
for intermolecular 1,3-dipolar cycloadditions of nitrile oxides to chiral allylic 
ethers.106,109  
2.6.3 Origin of unlike π-Diastereofacial Selectivities. 
The considerably lower π-facial selectivities observed experimentally in IMDA 
reactions of alcohol substrates 78a and 83a and the p-nitrobenzoate ester 78e vs. the 
corresponding silyl ethers (Tables 2.5 and 2.7) may be explained by an attractive 
electrostatic interaction between the oxygen atom and the hydrogen atom at C2. 
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Calculations show that the charge on oxygen is significantly higher for silyl alkyl ethers 
than for alcohols, dialkyl ethers or p-nitrobenzoate esters, which supports an 
electrostatic argument. Further evidence for the effect being electrostatic in nature was 
obtained by examining the preferred conformations of allylic alcohol derivatives. 
Increased stabilization of the –OR inside conformation in IMDA reactions should lead 
to even higher levels of facial stereocontrol than those witnessed in Tables 2.5-2.7. This 
might be achieved using the alkoxide anion group (–O–). Attempts to examine the 
IMDA reactions of metal alkoxides derived from alcohol 83a were thwarted by the 
instability of the ester groups in the presence of the alkoxide. 
 
2.6.4 Magnitude of π-Diastereofacial Selectivities. 
Theory predicts an IMDA reaction for the maleate SiMe3 substrate which is 
considerably more π-diastereofacially selective than that of the SiH3 substrate 
[unlike:like = 5.9:1 (SiMe3); 2.8:1 (SiH3)]. This result is in qualitative agreement with 
the experimental findings, which demonstrate that the larger the silyl protecting group, 
the higher the π-diastereofacial selectivity.  
 
2.6.5 Anomalous Fumarate cis Stereoselectivities. 
In the maleate series, for both SiH3 (Figure 2.6) and SiMe3 substrates, TSs leading to 
the trans-fused bicyclic products are considerably more stable than those leading to the 
cis-fused adducts. These results are consistent with the experimental findings, and are in 
agreement with computational and synthetic investigations of smaller achiral 
pentadienyl maleate substrates.84  
 
In the case of fumarate systems, TSs leading to trans- and cis-fused adducts are 
generally quite similar in energy, with a slight trans IMDA selectivity generally 
witnessed in the laboratory with small achiral substrates. In stark contrast, substrates 
78f, 81b and 83e undergo IMDA reactions with anomalously high (up to 85:15) cis-
selectivities. The origin of this unprecedented preference for the cis-cycloadduct can be 
traced, once again, to preferred inside location of the C*–OSiR3 substituent (Figure 
2.8). In the fumarate trans-TSs, the E-CO2Me group must reside directly beneath the 
inside silyloxy group, which necessitates a destabilizing gauche conformation between 
the SiH3 and C*–CH3 groups about the C*–O bond (highlighted in the dashed box in 
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Figure 2.8). In the corresponding cis-TS, the E-CO2Me group is located in the exo-
position, hence the inside silyl group is free to adopt a lower energy conformation about 
the C*–O bond in which it avoids the C*–methyl group [note the positioning of the 
SiH3 group in the endo region in cis, unlike-TS-(g)]. The destabilization of 
trans, unlike-83gTS-(a), relative to cis, unlike-83gTS-(g), will be amplified by the 
presence of larger silyl groups, which will result in a higher selectivity for the cis fused 
adduct. 
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C* C*
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Si–O–C*–C(H3) = 73.8° Si–O–C*–C(H3) = 136.5°
view down C*–O bond view down C*–O bond
CH3 CH3
view down C9–C8 bond view down C9–C8 bond
 
Figure 2.9 The two most stable (–OSiH3 inside, –CH3 anti) fumarate TSs leading to the 
trans, unlike (left) and cis, unlike (right) adducts. TS (g) is energetically favored over 
TS (a). Top: views down the C9–C8 axis (C3 – C8 are omitted for clarity); bottom: 
views down the C*–O bond. The gauche interaction between the SiH3 and CH3 groups 
is highlighted in the dashed box. This conformation is brought about by the steric (and 
possibly electronic) destabilization in the endo region in TS (a) indicated in the top left 
depiction. The CO2CH3 group is coloured green throughout. 
 
2.7 Conclusions 
 
The synthetic scope and limitations of the IMDA allylic stereocontrol method have been 
investigated with respect to allylic substituents and dienophile geometry, and theoretical 
models have been devised to explain these findings. The computational results offer 
unprecedented insights into the subtle stereocontrolling influences at play in these 
synthetically important reactions, and point the way forward for future investigations 
into additions to chiral allylic systems. The unlike π-diastereofacial selectivity observed 
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in these reactions comes about through the preference for a reactive conformation about 
the bond connecting the diene and the stereocentre in which the silyloxy group adopts 
an inside orientation, as summarized in Figure 2.10. The dienophile reacts at the more 
accessible π-face of the diene; in the absence of overriding electronic effects, this will 
be on the side of the diene in which the smaller substituent resides.  
 
A particularly important finding from both experimental and computational studies is 
the requirement for the C*–oxygen atom to be electron rich, thereby strengthening its 
preference for the inside position by stabilizing electrostatic interactions with the diene 
C2H group. Thus, the silyloxy group is much superior to hydroxy, alkoxy and ester 
groups in its stereocontrolling ability. 
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Figure 2.10 Theoretical model for π-diastereofacial selectivity in addition reactions to 
chiral allylic silyloxy systems. 
 
The enantiomerically pure cycloadducts formed in these reactions are rich in 
functionality, which invites further transformation into structures common with natural 
products. 
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3 Enhanced Stereocontrol in Diels–Alder Reactions of 
Chiral Dienols 
3.1 Background 
 
The Diels–Alder reaction is by no means fully understood and fully optimised since it 
commonly delivers more than one stereoisomeric product and, furthermore, methods to 
effect a switch in stereoselectivity are rare.110 
 
It was recently reported that reactions between conjugated dienols 118 and maleic 
anhydride 12 (Scheme 3.1) provide either cis-fused 121 or trans-fused 122 bicyclic 
products as major products, depending upon how the reaction is carried out.111 When 
mixtures of the two reactants are heated, an endo-selective intermolecular Diels–Alder 
reaction gives putative hydroxy anhydride intermediate 119, which rapidly undergoes 
intramolecular esterification to furnish cis-fused lactone acids 121. Alternatively, the 
pre-formed maleate half-ester derivative 120 affords trans-fused lactone acids 122 in 
high selectivity by way of an exo-selective intramolecular Diels–Alder (IMDA) 
reaction. 
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Scheme 3.1 Diels-Alder reactions of dienols and maleic anhydride. 
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In a separate study the stereocontrolling influence of a removable bromine substituent 
upon the outcome of IMDA reactions of pentadienyl acrylates (Scheme 3.2; Table 3.1) 
was demonstrated.85 Thus, compared with nonbrominated precursor 123, the C3-
bromine substituent in precursor 124 induces a dramatic improvement in both trans/cis 
stereoselectivity and π-diastereofacial selectivity. Detailed computational investigations 
identified destabilising torsional and steric strain operating in the transition structures 
(TSs) leading to cycloadducts 130, 131 and 132. The TS leading to the major 
cycloadduct 129 lacked such unfavourable interactions. 
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Scheme 3.2 Reagents and conditions: (a) X = H, 1,2-dichlorobenzene, 180 oC, 146 h, 
59%; (b) X = Br, PhCl, 156 h, 83%. 
 
Several groups have used a “steric directing group” strategy to control the outcome of 
IMDA reactions.37,68,104 An investigation carried out in the Sherburn group focussed on 
the stereochemical outcome of IMDA reactions of C9-CO2Me substituted trienes 
carrying a C5-dioxolanyl substituent and a C1-CH2OTBS group (Scheme 3.3; Table 
3.1).58 The C9-Z-CO2Me substrate, maleate 133Z, gave two of the four possible 
cycloadducts, namely trans,lk-134Z and cis,lk-135Z (86:14, respectively) in quantitative 
yield. The C9-E-CO2Me substrate, fumarate 133E, gave three of the four possible 
adducts, trans,lk-134E, cis,lk-135E, and cis,ul-137E in a ratio of 72:17:11, respectively, 
in 90% yield. DFT calculations carried out on truncated maleate and fumarate model 
systems lacking the C1 substituent, and with the C5-dioxolane group replaced by a 
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methyl group, correctly predicted the trans,lk-adduct 39 as the major product with both 
E- and Z-dienophile geometries.  
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Scheme 3.3 
Table 3.1 Synthetic and computeda product ratios for Schemes 3.2 and 3.3 
Entry Triene Time 
(h) 
Yield 
(%) 
Product ratio 
trans,lk:cis,lk:trans,ul:cis,ul 
1 123 146 59 125:126:127:128 
synthetic 
computed 
 
28:30:12:30 
45:25:8:22 
2 124 156 83 129:130:131:132 
synthetic 
computed 
 
81:19:0:0 
91:8:0:1 
3 133Z 
 
38Z 
19 100 134Z:135Z:136Z:137Z 
synthetic 
39Z:40Z:41Z:42Z 
computed 
 
86:14:0:0 
 
85:2:12:1 
4 133E 
 
38E 
39 90 134E:135E:136E:137E 
synthetic 
39E:40E:41E:42E 
computed 
 
72:17:0:11 
 
62:14:10:14 
aPopulations at B3LYP/6-31+G(d) level. 
 
Nevertheless, significant differences exist between experiment and theory in the 
distribution of the minor cycloadducts. In the maleate case, cis,lk-135Z is the only 
minor product observed in appreciable amounts from experiments, whereas theory 
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predicts that trans,ul-136Z should be the second most prevalent product. In the fumarate 
case, theory predicts a roughly even distribution of the three minor stereoisomeric 
cycloadducts, whereas experiments furnish only two. This unsatisfactory correlation 
could reflect unmodelled influences stemming from differences between the 
experimental and computed structures, or discrepancies in the theory (i.e. neglect of 
solvent effects). In order to identify the origin of the disagreement between theory and 
experiment, summarised in Scheme 3.3, the IMDA reactions of maleate 38Z and 
fumarate 38E were investigated. 
 
In a study conducted by Cayzer112 kinetically controlled intramolecular Diels–Alder 
reactions of the two triene precursors 38Z and 38E were carried out in dilute solutions 
of refluxing toluene. (Scheme 3.4; Table 3.2). Four cycloadducts were formed in both 
cases.  
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Scheme 3.4 Reagents and conditions: (a) PhMe, 110 oC. 
Table 3.2 Synthetic and computeda product ratios for Scheme 3.4 
Triene Entry Time 
(h) 
Yield 
(%) 
Product ratio 
trans,lk:cis,lk:trans,ul:cis,ul 
38Z 1 3 94 39Z:40Z:41Z:42Z 
syntheticb 
computedd 
 
68:9c:19:4 
85:2:12:1 
38E 2 57 71 39E:40E:41E:42E 
syntheticb 
computedd 
 
55:13:16:16 
62:14:10:14 
aPopulations at B3LYP/6-31+G(d) level. 
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The IMDA reaction of maleate 38Z exhibited strong trans-selectivity (87:13, trans:cis) 
and like π-diastereofacial preference (77:23, like:unlike). Fumarate 38E also underwent 
a trans-selective (71:29, trans:cis) IMDA reaction with a like π-diastereofacial 
preference (68:32, like:unlike). The isolation of the trans,like-cycloadduct as the major 
product from both reactions is consistent with other reports with C5-substituted 
pentadienyl maleates and fumarates.58,104 Arseniyadis and co-workers employed the 
IMDA reaction of the C5-Et counterpart of fumarate 38Z as a key step in their synthesis 
of A-seco mevinic acid.104 Compared to the C5-Me triene 38Z in the present study, the 
C5-Et triene gave slightly higher trans-selectivity and slightly higher like π-
diastereofacial selectivity (trans,lk:cis,lk:trans,ul:cis,ul = 74:4:7:15 [Et]104 vs. 
62:14:10:14 [Me]). Evidently, the smaller methyl group has a slightly weaker 
stereocontrolling influence upon the IMDA reaction. 
 
The identities of the four products from the IMDA reactions of 38Z and 38E were 
correctly predicted by theory with an impressive level of accuracy. Indeed, the 
experimental ratios of the three minor cycloadducts are in close agreement with 
calculated DFT Boltzmann distributions. 
 
The order of product abundance in the IMDA reaction of maleate 38Z, namely trans,lk 
> trans,ul > cis,lk > cis,ul, can be rationalised by consideration of interactions in the 
C3–C5 region of the TSs (Figure 3.1). Two destabilising interactions can be identified, 
namely 1,3-allylic strain between C3-H and C5-CH3 in the two unlike TSs, and an 
eclipsed C4–C5 bond in the two cis-TSs. These two interactions are absent in the 
trans,lk-TS, which leads to the major product from the reaction. They are both present 
in the cis,ul-TS, which leads to the least abundant product from the reaction. Of the two 
products formed in intermediate amount, the trans,ul cycloadduct is more abundant than 
the cis,lk product, which presumably indicates that the eclipsing interaction is more 
costly than allylic strain. It is noteworthy that the C5-des-methyl analogue of 38Z 
undergoes a much less trans-selective reaction (58:42, trans:cis).86 The enhanced trans-
selectivity in the IMDA reaction of 38Z can be ascribed to the destabilising interactions 
in TSs leading to the cis-isomers. 
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Figure 3.1 IMDA TSs from 38Z with destabilising interactions identified. 
 
With the fumarate precursor 38E, both experiments and calculations showed that the 
trans,lk-cycloadduct is the dominant product, with the remaining three isomers being 
formed in roughly equal amounts. The destabilising interactions are the same as those 
identified in the Z-TSs. In the case of the E-triene, there are negligible differences in the 
energies of the TS leading to the three minor products. Evidently, allylic strain and 
eclipsing interactions are finely balanced in this case. 
 
Whilst these results confirmed the validity of the theoretical model, we were interested 
in developing a way to carry out these reactions in a more synthetically useful (i.e. a 
more stereoselective) manner.  
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3.2 Aims 
 
The aim of this study is to enhance the stereoselectivity of maleate and fumarate IMDA 
reactions through incorporation of a C3-Br substituent and to investigate the influence 
of the bromine substituent upon the π-diastereofacial selectivity of intermolecular 
Diels–Alder reactions (Figure 3.2).  
 
O
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Br Br
3 3
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43Z 43E 138  
Figure 3.2 Enhanced stereocontrol through removable Br substituent? 
 
3.3 Results and Discussion 
3.3.1 Synthesis of the IMDA Precursors 
The maleate and fumarate IMDA precursors 43Z and 43E were synthesised according 
to Scheme 3.5. Corey-Fuchs dibromomethylenation113 of aldehyde 93 gave 139. 
Selective Stille reaction with tributyl(vinyl)tin using modified Farina conditions114 gave 
the diene 140 in good yield. Removal of the silyl protecting group yielded the chiral 
dienol 138.85 Esterification with maleic anhydride followed by treatment with 
diazomethane gave the maleate IMDA precursor 43Z. Alternatively Steglich 
esterification of dienol 138 with E-methoxycarbonylacrylic acid gave the fumarate 
precursor 43E. 
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43E  
Scheme 3.5 Reagents and conditions: (a) PPh3 (4.0 equiv), CBr4 (2.0 equiv), CH2Cl2, 4 
h, 76 %; (b) CH2=CHSnBu3 (1.05 equiv), Pd2dba3, AsPh3, 50 
oC, 83%; (c) TBAF, THF, 
2.5 h, 84%; (d) Maleic anhydride, Et3N, DMAP, CH2Cl2, 0 
oC; (e) CH2N2, Et2O, -78 
oC; 
40% over 2 steps; (f) E-methoxycarbonylacrylic acid, DCC, DMAP, Et2O, RT, 63%. 
 
3.3.2 IMDA Reactions of Maleate and Fumarate Precursors 43Z and 43E. 
The IMDA reactions of trienes 43Z and 43E were carried out in dilute solutions of 
refluxing toluene (Scheme 3.6). To our delight, a single isomer was generated from both 
reactions with complete stereoselectivity, within the limits of detection (Table 3.3). The 
products were tentatively assigned as the trans,lk-stereoisomer 142 on the basis of the 
large trans-diaxial coupling constants (J = 19.1-18.4 Hz). 
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Scheme 3.6  Reagents and conditions: (a) PhMe, 100 oC. 
Table 3.3 Synthetic and computed product ratios for Scheme 3.6 
Entry Triene Time 
(h) 
Yield 
(%) 
Product ratio 
trans,lk:cis,lk:trans,ul:cis,ul 
1 43Z 0.6 84 142Z:143Z:144Z:145Z 
synthetic 
computed 
 
>98:0:0:0 
  99:1:0:0 
2 43E 10 77 142E:143E:144E:145E 
synthetic 
computed 
 
>98:0:0:0 
  96:4:0:0 
 
The bromine-containing cycloadducts 142Z and 142E were reductively debrominated 
under radical conditions to give samples which were identical to those obtained from 
the IMDA reactions of the non-brominated precursors 38Z and 38E (Scheme 3.7), 
whose structures had previously been determined by 2D NMR experiments. 
 
O
O
H
H
MeO2C
trans,lk-142Z
Br
O
O
H
H
MeO2C
trans,lk-39Z
a
trans,lk-142E
O
O
H
H
MeO2C
Br
trans,lk-39E
O
O
H
H
MeO2C
a
 
Scheme 3.7 Reagents and conditions: (a) HSnBu3, AIBN, PhMe, 80 
oC , 3 h, 59 %. 
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The C3-Br IMDA precursors were also analysed computationally by Prof. Michael 
Paddon-Row (UNSW) (Table 3.3). Very high levels of stereoselectivity in favour of the 
trans,lk-adduct 142 were predicted in each case. The most obvious effect of the bromine 
in these TSs (Figure 3.3) is to enhance the magnitude of the destabilising 1,3A-strain 
between the C3-substituent and the C5-methyl group. The unlike-TSs become 
prohibitively high in energy relative to the like-TSs and are, therefore, not populated to 
any significant extent. The H4•••CH3 eclipsing interaction still destabilises the two cis-
TSs. Indeed, the presence of the bromine has surprisingly little effect on the overall 
geometries of the TSs. 
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Figure 3.3  IMDA TSs from 43Z with destabilising interactions identified. Distances 
between interacting atoms, and forming bond lengths are given in Angstroms (Å). The 
enantiomeric lk-TSs are depicted for ease of comparison. 
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3.3.3 Intermolecular Diels-Alder Reactions of Dienol 138 
The dramatic improvement in stereoselectivity in these IMDA reactions brought about 
by the cis-C3-Br substituent led us to investigate the possibility of stereocontrol in 
intermolecular Diels–Alder reactions. The reaction between maleic anhydride and chiral 
dienol 146 (Scheme 3.8) as reported by Franck and coworkers80 gave exclusively cis-
adducts, with modest π-diastereofacial selectivity (cis,lk-40Z:cis,ul-42Z = 73:27; Table 
3.4, entry 1). When carried out by Cayzer this reaction furnished a mixture of four 
stereoisomeric cycloadducts (Table 3.4, entry 2). The cis-fused isomers – resulting from 
the intermolecular Diels–Alder pathway – are the dominant products but the trans-fused 
bicycles, accounting for about 10% of the product mixture, result from the competing 
esterification/IMDA pathway.111 Nevertheless, a level of π-diastereofacial selectivity 
between the two cis-isomers that is consistent with the earlier report was observed. 
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Scheme 3.8 Reagents and conditions: (a) PhMe, 110 oC; (b) P = H, CH2N2, Et2O; P = 
TBS, i) CF3CO2H, CH2Cl2; ii) CH2N2, Et2O. 
 
 58 
Table 3.4 Experimental product ratios for Scheme 3.8 
Entry Diene Time 
(h) 
Yield 
(%) 
Synthetic product ratio 
trans,lk:cis,lk:trans,ul:cis,ul 
1a 146 72 83 39Z:40Z:41Z:42Z 0:73:0:27 
      
2b 146 2 71 39Z:40Z:41Z:42Z 10:57:1:32 
      
3 138 5.5 58 142Z:143Z:144Z:145Z 13:87:0:0 
      
4c 138 74 58 142Z:143Z:144Z:145Z 0:>98:0:0 
a As reported by Franck et al. Reaction carried out at room temperature for 3 days.12 bAs 
reported by Cayzer. c Reaction conducted on 140, the TBS ether of 138. 
 
Chiral bromodienol 138 reacts with maleic anhydride to give two of the four possible 
cycloadducts, cis,lk-143Z and translk-142Z, in an 87:13 ratio (Scheme 3.8). Thus, 
complete π-diastereofacial selectivity is witnessed in this cycloaddition. That the minor, 
trans-isomer is the result of the esterification-IMDA pathway111 is demonstrated by the 
reaction of the TBS ether derivative 140. This protected alcohol undergoes 
intermolecular Diels–Alder reaction to give a single isomeric product, within the limits 
of detection. This product furnishes material identical in all respects to cis,lk-adduct 
40Z, after silyl ether hydrolysis with concomitant lactonisation, methyl ester formation 
with diazomethane, and reductive debromination (Scheme 3.9). The very high level of 
like π-diastereofacial stereoselectivity witnessed here with a removable bromine 
substituent is comparable to that seen in Prein’s investigations with methyl-substituted 
dienes.79 
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Scheme 3.9 Reagents and conditions: (a) PhMe, 110 oC, 74 h;  (b)  CF3CO2H, CH2Cl2, 
RT, 23h; (c) CH2N2, THF, -78 
oC; 58% over 3 steps;   (d) HSnBu3, AIBN, PhMe, 80 
oC, 
3 h, 68 % 
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3.4 Conclusions 
 
In summary, this work confirms the validity of the DFT model for pentadienyl maleate 
and fumarate IMDA reactions. The stereodirecting ability of a cis-bromine substituent 
in both intramolecular and intermolecular cycloaddition reactions of chiral dienols has 
been demonstrated. Thus, moderately stereoselective cycloaddition reactions are 
rendered completely stereoselective simply by the replacement of a hydrogen in the 
precursor by a bromine. Taken together with the ability to select either cis or trans-
bicyclic lactone acids from simple dienols and maleic anhydride, operationally simple 
stereocontrolled approaches to enantiomerically pure bicyclic building blocks with 
complementary stereochemistries are now in hand. The use of a vinyl substituent in 
place of the bromine will be examined in the next chapter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 61 
4 Chiral Dendralenes For Rapid Access To 
Enantiomerically Pure Polycycles 
4.1 Background 
 
The main classes of hydrocarbons that can be constructed using C=C bonds are 
illustrated in Scheme 4.1.61 Diene 148 and triene 149 are the first two members of the 
linearly conjugated acyclic polyenes. Next are the cyclic conjugated polyenes also 
known as annulenes, of which 150 and 151 are the first two members. Compounds 152 
and 153 are members of the radialene family of hydrocarbons, characterised by 
conjugated exocyclic double bonds. The dendralenes 29 and 30 are acyclic cross-
conjugated oligo-alkenes. 
linear cojugated cyclic cojugated
annulenes
radialenesdendralenes
148
149
150
151
152
153
29
30
 
Scheme 4.1 The 4 main classes of hydrocarbon constructed from C=C bonds (modified 
from H. Hopf)61 
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Of the classes of hydrocarbons identified in Scheme 4.1, the linear acyclic conjugated 
polyenes and the annulenes have been extensively studied, while the dendralenes have 
remained somewhat neglected until recently. The preferred conformation of these 
hydrocarbons has caused much discussion in the literature. It is well established that the 
linear polyenes exist in a coplanar form to maximise overlap of the p-orbitals.115 Their 
coplanar conformation is evident upon inspection of the UV absorption data for these 
compounds. The lower members of the annulenes, that is cycobutadiene 150 and 
benzene 151, are also known to exist in planar form, while higher members of this class 
of hydrocarbons prefer a non-planar conformation for steric reasons.61 Spectral data 
suggest that [3]radialenes (152) adopt planar conformations, as do [4]radialenes (153), 
provided there is no steric hinderance between the substituents.116 For all known [5]- 
and [6]radialenes, steric hinderance between the substituents prevent them from 
adopting a planar conformation. The preferred conformation of the dendralenes is of 
particular interest.60-62,117,118 Analysis of UV spectra show an absorption maximum in 
the same region as in simple 1,3-dienes, suggesting that they do not exist in a coplanar 
form. Further experimental studies and calculations show that there is in fact a dihedral 
angle of 40 o between the plane of the s-trans-1,3-butadiene and the remaining vinyl 
group in [3]dendralene 29 (Figure 4.1).119 
 
40 o out of plane
in plane s-trans diene                           
Figure 4.1 The preferred conformation of [3]dendralene. 
 
The dendralenes are particularly attractive precursors for cycloaddition reactions with 
dienophiles, since they function as multi-dienes, thereby allowing rapid access to a 
variety of polycyclic frameworks. For this reason there has been much effort directed 
toward the synthesis of this class of compounds. 
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4.1.1 Previous Syntheses of Dendralenes 
The first synthesis of the parent [3]dendralene 29 was reported in 1955 by Blomquist 
and Verdol.65 Pyrolysis of 3-methylene-1,5-pentanediol diacetate 154 at 485 oC yielded 
[3]dendralene 29 (Scheme 4.2). It was reported that 29 was volatile and prone to 
dimerisation and polymerisation.65 
 
AcO OAc OAc
a
154 155 29  
Scheme 4.2 Reagents and conditions: (a) 485 oC, 30%. 
Bailey and Economy also reported a synthesis of the parent [3]dendralene 29 in 1955.63 
Thermal ring opening/elimination of 1,2-di(acetoxymethyl)cyclobutane 156 gave 
[3]dendralene 29 (Scheme 4.3). 
 
OCO2CH3
OCO2CH3
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Scheme 4.3 Reagents and conditions: (a) 500 oC, 50%. 
A more effective preparation of [3]dendralene 29 was reported by Cadogan in 1991 
through cheleotropic elimination of sulphur dioxide from the sulfolene 158.120 
However, six synthetic steps are involved, one of which is an oxidation that requires 46 
days to go to completion (Scheme 4.4). 
 
O2S
a
158 29  
Scheme 4.4 Reagents and conditions: (a) 550 oC, 87%. 
In 2000 Sherburn and Fielder reported a general route to the synthesis of the dendralene 
family.66 The precursors to [3], [4], [5], [6] and [8]dendralene were synthesised from 
organotin and alkenyl halide building blocks. The key building block stannane 163 was 
synthesised in 3 steps from sulfolene 159 (Scheme 4.5). 
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Scheme 4.5 Reagents and conditions: (a) Br2, CHCl3, 63 
oC, 2 h, 80%; (b) TolSO2Na, 
NaOH, MeOH, reflux, 5 h, 63%; (c) HSnBu3, AIBN, PhH, 80 
oC, 85%. 
 
Stannane 163 was converted to iodide 165 which was coupled with vinyl tributyltin to 
give [3]dendralene precursor 158 (Scheme 4.6). Coupling of the stannane 163 with 1,1-
dibromoethylene gave the [5]dendralene precursor 166 while the [4]dendralene 
precursor 167 was obtained through coupling of the stannane 163 and the iodide 165. 
Finally, [6]dendralene precursor 169 and [8]dendralene precursor 170 were obtained 
through coupling of iodide 165 with 2,3-bis-trimethylstannyl-1,3-butadiene 168. 
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Scheme 4.6 Reagents and conditions: (a) CH2Cl2, I2, 1 h, 80%; (b) Bu3SnCH=CH2, 
[PdCl2(CH3CN)2] (0.05 equiv), DMF, rt, 2 h, 92%; (c) CH2=CBr2 (0.5 equiv), 
[PdCl2(CH3CN)2] (0.05 equiv), DMF, 40 
oC, 36 h, 11%; (d) 163, [PdCl2(CH3CN)2] 
(0.05 equiv), DMF, rt, 18 h, 95%; (e) [PdCl2(CH3CN)2] (0.10 equiv), DMF, 60 
oC, 72 h, 
43% of 169 and 30% of 170. 
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The [3], [4], [5], [6] and [8]dendralenes were then unmasked from the precursors 158, 
166, 167, 169 and 170 respectively through capillary pyrolysis (Scheme 4.7). 
S
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a
n = 0,1,2,4  
Scheme 4.7 Reagents and conditions: (a) capillary pyrolysis at 450 oC, 52-89%. 
 
More recently, the Sherburn group has developed a highly efficient synthesis of the 
parent [4], [5], and [6]dendralenes.121 The Grignard reagent derived from chloroprene 
undergoes oxidative coupling to give [4]dendralene 30 in 26% yield. This reaction has 
been carried out on large scale and 10 g batches of the dendralene can be readily 
synthesised. The Grignard reagent can also be used in a nickel catalysed Kumada 
coupling with vinylidene chloride to give [5]dendralene 31 in good yield. 
 
Cl
a b
30 171 31  
Scheme 4.8 Reagents and conditions: (a) i) Mg, ZnBr2, (BrCH2)2, THF; ii) CuCl, -78 
oC; iii) CuCl2.2LiCl, -78 
oC, 26% overall; (b) i) Mg, ZnBr2, (BrCH2)2, THF; ii) 
vinylidene chloride, Ni(dppe)Cl2, THF, 65%. 
 
There have been several syntheses of substituted [3]dendralenes reported in the 
literature. The most general method developed thus far for internally substituted trienes 
is the indium-mediated γ-pentadienylation of aldehydes and ketones reported by 
Fallis.122 The reagent generated from the treatment of 5-bromo-1,3-pentadiene 172 with 
indium adds to aldehydes and ketones in a regioselective manner to give non-
conjugated compounds of the type 174. Dehydration of the diene 174 under Mitsunobu 
conditions generated the dendralene 175. 
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Scheme 4.9 Reagents and conditions: (a) In, H2O, 16 h, 65%; (b) Ph3P, DEAD, PhH, 80 
oC, no yield reported.  
 
4.1.2 Diene-Transmissive Diels-Alder Sequences 
Diene-transmissive Diels-Alder (DTDA) sequences involve the addition of a dienophile 
to a dendralene, forming a new diene unit that may participate in a Diels-Alder reaction 
with a second dienophile (Scheme 4.10). This strikingly efficient process forms four C–
C bonds and as many as eight stereocentres, yet it involves only two bond-forming 
events. 
 
29 32 33  
Scheme 4.10 Diene-transmissive Diels-Alder sequence. 
 
As for all Diels-Alder reactions the issues of stereoselectivity, π-diastereofacial 
selectivity and regioselectivity must be considered (Section 1.1). In addition to this, if 
the [3]dendralene bears a substituent then the two diene units are no longer equivalent, 
raising the issue of site selectivity. If we consider an internally substituted [3]dendralene 
we can see that the s-cis conformation of one of the diene units is disfavoured due to 
steric interactions (Figure 4.2). This would result in the initial Diels-Alder reaction 
occurring at the diene more able to adopt the s-cis conformation. 
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Figure 4.2 The preferred conformation of an internally-substituted [3]dendralene. 
 
Ideally it would also be possible to control the selective formation of either the mono-
adduct (ie. semicyclic diene 32) or the bis-adduct (decalin 33). If the DTDA sequence 
can be interrupted after the first cycloaddition a different dienophile could be used in 
the second Diels-Alder reaction giving access to a wider range of polycyclic skeletons. 
 
There have been several examples of DTDA sequences reported in the literature. Both 
inter and intramolecular Diels-Alder reactions have been utilised as well as acyclic and 
cyclic dendralenes and dienophiles. The examples most relevant to this study are 
reviewed below. 
 
4.1.2.1 Inter/Intermolecular DTDA sequences of acyclic dendralenes. 
The first DTDA sequence was reported in 1955 along with the first synthesis of the 
parent [3]dendralene (Scheme 4.11).65 The structure of [3]dendralene 29 was confirmed 
through a DTDA sequence with two equivalents of maleic anhydride. Only the bis-
adduct 177 was isolated and no stereochemistry was given. 
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29 176 177  
Scheme 4.11 Reagents and conditions: (a) maleic anhydride (2.1 equiv), PhH, 100 oC, 
2h, 82% 
 
The Cadogan group also provided examples of DTDA sequences involving the parent 
[3]dendralene 29 (Scheme 4.12).120 They showed that a different dienophile may be 
used for the second Diels-Alder reaction in the sequence, resulting in the formation of 
mixed bis-adducts. Again, no stereochemistry was reported. 
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Scheme 4.12 Reagents and conditions: (a) p-benzoquinone, PhMe, 40 oC, 36 h, 90%; 
(b) N-phenyl-1,2,4-triazoline-3,5-dione, acetone, 40 oC, 2.5 h, 63%. 
 
The Tsuge group have made a significant contribution to the area of DTDA chemistry. 
They have carried out a number of studies on inter/intermolecular DTDA sequences of 
substituted [3]dendralenes.123-125 The [3]dendralene 182 was synthesised in two steps 
from benzaldehyde and 2,4-pentanedione (Scheme 4.13).123 A phenyl substituent on the 
central C=C unit of the bis(trimethylsilyloxy)[3]dendralene 182 provides site selectivity 
for the first cycloaddition by disfavouring the s-cis conformation of one of the diene 
units. The phenyl group also influences π-diastereofacial selectivity in the second 
cycloaddition, with the dienophile approaching from the opposite π-diastereoface to that 
possessing the substituent.  
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Scheme 4.13 Reagents and conditions: (a) benzaldehyde, piperidine, PhH, 80 oC; (b) 
TMSCl, NEt3, DMF, 90-95 
oC, 48 h, 55%; (c) N-methylmaleimide (3 equiv), PhH, 80 
oC, 72 h; (d) MeOH, rt, 18 h, 60% over 2 steps. 
 
In the same study, dendralene 182 is also reacted with the unsymmetrical dienophile 
methyl propiolate, raising the issue of regioselectivity whilst removing the concern of 
stereoselectivity. When 182 was treated with an excess of methyl propiolate followed 
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by work up with methanol, the bicyclic product 188 was isolated in 47% yield (Scheme 
4.14). The assignment of the product was based on spectral data. As only one product 
was formed, each Diels-Alder reaction has occurred in a highly regioselective manner. 
The regioselectivity is explained by the ortho-, para-orientation rule implied by the 
Woodward-Hoffman rules.11,14 
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Scheme 4.14 Reagents and conditions: (a) methyl propiolate, PhH, 80 oC; (b) methanol, 
47% over 2 steps. 
 
The methoxy substituted [3]dendralene 189 was synthesised in a similar manner to 
182.126 The methoxy substituent at the central position of 189 also invokes site 
selectivity. The DTDA sequence can be interrupted after the first cycloaddition, 
allowing a different dienophile to be used for the second cycloaddition (Scheme 4.15). 
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Scheme 4.15 Reagents and conditions: (a) N-methylmaleimide (1.0 equiv), PhH, rt, 24 
h; (b) dimethyl acetylenedicarboxylate (1.0 equiv), PhH, 80 oC, 20 h; (c) methanol, 41% 
3 steps. 
 
A DTDA sequence was also carried out using the 2-ethoxy substituted [3]dendralene 
196, synthesised from the Grignard reagent derived from chloroprene and 1-ethoxy-1,2-
dibromoethane 194 (Scheme 4.16).127 The authors had expected reaction to first occur at 
the more substituted diene. When 196 was reacted with N-methylmaleimide, however, 
the only product obtained was the bis-adduct 198, resulting from the intermediate 
mono-adduct 197. This result was explained on the basis of steric effects (Figure 4.3).  
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Figure 4.3 Preferred conformation of substituted [3]dendralene 196 
 71 
OEt
N
O
O
OEt
H
H
N
O
O
H
H
OEt
a
N
O
O
H
H
H
OEt
Br
Br
OEt
BrMgCl
+
b
c
193 194 195 196
197198  
Scheme 4.16 Reagents and conditions: (a) THF, 0 oC, 6 h, 14%; (b) DBU, 100-110 oC, 
2666 Pa, 82%; (c) N-methylmaleimide (2.4 equiv), PhH, rt, 2 h, 66%. 
 
All DTDA sequences reviewed thus far exhibited near complete site and 
stereoselectivity. In contrast, the Diels-Alder reactions of terminally substituted 
[3]dendralene 201, synthesised from Grignard reagent derived from chloroprene and 
methyl oxirane 199, were less selective.128 Reaction of 201 with N-phenylmaleimide 
results in the formation of the two cycloadducts 204 and 205 in a ratio of 5:1 
respectively (Scheme 4.17).  
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Scheme 4.17 Reagents and conditions: (a) 50-60 oC, THF, 2 h, 42%; (b) TsCl, pyridine, 
36 h, 80%; (c) DBU, 110 oC, 20 mm/Hg, 30 min, 64%; (d) N-phenylmaleimide (1.1 
equiv), PhH, rt, 20 h, 92%. 
 
DTDA sequences have also been used as part of a larger domino sequence. de Meijere 
has reported a novel sequence involving a Heck reaction to form the substituted 
[3]dendralene 207 followed by a DTDA sequence to give the bis-adduct 208 as a 
mixture of diastereoisomers (Scheme 4.18).129   
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Scheme 4.18 Reagents and conditions: (a) vinyl iodide, dimethyl maleate, Pd(OAc)2, 
PPh3, NEt3, DMF, 75 
oC, 20 h, 49%. 
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 More recently, Fallis reported DTDA sequences involving the internally substituted 
[3]dendralene 175 (Scheme 4.19).122 The bis-adducts 209 and 211, arising from the 
addition of p-benzoquinone or N-phenylmaleimide, were synthesised with complete site 
and π-diastereofacial selectivity. Once again the site selectivity is a result of the 
substituent disfavouring the s-cis conformation of one of the diene units. The bis-adduct 
209 was reacted further with an excess of cylopentadiene to give the octacyclic skeleton 
210 as a mixture of diastereoisomers. 
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Scheme 4.19 Reagents and conditions: (a) p-benzoquinone, 21 oC, no yield reported; 
(b) cyclopentadiene, 21 oC, 16 h, 71%; (c) N-phenylmaleimide, 21 oC, 81%. 
 
Schreiber used Fallis’ method to synthesise 40 dendralenes from phenolic aldehyde-
loaded macrobeads.130 These dendralenes were used in the combinatorial synthesis of 
29400 discrete polycyclic compounds comprising 10 different ring skeletons. It was 
reported that disubstituted dienophiles, such as N-ethylmaleimide, underwent double 
cycloaddition to give the bis-adducts while tri- or tetrasubstituted dienophiles only 
underwent mono addition. The monoadducts were then reacted further with a second 
dienophile (Scheme 4.20). 
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Scheme 4.20 Reagents and conditions: (a) 2,5-diphenyl-p-benzoquinone, PhMe; (b) N-
ethylmaleimide, PhMe. 
 
4.1.2.2 Intra/Intermolecular DTDA sequences 
In addition to his work on inter/intermolecular DTDA sequences, Fallis has also 
reported an intra/intermolecular DTDA sequence.131 The [3]dendralene 216 was 
synthesised in eight steps from L-arabinose. Oxidation of the alcohol resulted in 
spontaneous IMDA reaction to give the semi-cyclic diene 218 in 78% yield. The cis-
fused isomer is formed through the endo-transition state which is favoured for steric 
reasons. Intermolecular Diels-Alder reaction with p-benzoquinone gave the nor-
triterpenoid 219 as a single product. Single crystal X-ray analysis confirmed that the 
dienophile had approached the diene from the more accessible convex face in an endo-
orientation. 
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Scheme 4.21  Reagents and conditions: (a) (COCl)2, DMSO, CH2Cl2, NEt3, -78 
oC, 
78%; (b) p-benzoquinone, PhH, 21 oC, 3 d, 85%. 
 
Recently a domino sequence involving a Rh-catalysed Alder-ene reaction followed by 
an inter/intramolecular DTDA transformation was reported.132 The best result obtained 
involved the one-pot conversion of dialkynylallene 220 into tetracycles 223 and 224 in a 
5:1 ratio respectively, when N-methylmaleimide was used as the dienophile. The 
intramolecular Diels-Alder reaction proceeds with complete site and stereoselectivity to 
give a single isomer, while the intermolecular Diels-Alder reaction gives the two endo-
products resulting from addition of the dienophile to either π-diastereoface of 222. The 
use of an unsymmetrical dienophile for the intermolecular Diels-Alder reaction resulted 
in the formation of the two diastereoisomers 225 and 226 in a 1:1 ratio. The reaction 
did, however, proceed with complete regioselectivity. 
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Scheme 4.22 Reagents and conditions: (a) [Rh(CO)2Cl]2 (0.05 equiv), DCE, rt, 1 h; (b) 
[Rh(dppe)Cl]2 (0.05 equiv), AgSbF6 (0.10 equiv), DCE, 30 min; (c) N-methyl 
maleimide, 24 h, 82%; (d) methyl vinyl ketone, 12 h, 75%. 
 
4.1.2.3 Sequential Diels-Alder reactions using [3]dendralene equivalents 
In order to address the issue of site selectivity, a number of groups have carried out 
Diels-Alder reactions on masked dendralenes. This involves a Diels-Alder reaction 
followed by a transformation, often an elimination, to unmask a second diene, followed 
by another Diels-Alder reaction. 
 
The Tsuge group have made contributions to this area also, firstly with examples of 
masked equivalents of the parent [3]dendralene.133 Thus, diene 227 readily reacts with a 
variety of dienophiles to give cycloadducts of the type 228 (Scheme 4.23). Thermal 
elimination followed by Diels-Alder reaction with the newly formed diene gives the bis-
adduct 230. This example was published before Cadogan’s work120 (Scheme 4.12) and 
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was the first example of the parent dendralene or an equivalent being reacted with two 
different dienophiles to give mixed bis-adducts. 
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Scheme 4.23 Reagents and conditions: (a) DMAD, EtAlCl2 (2.0 equiv), CH2Cl2, rt, 24 
h, 52%; (b) PhMe, 110 oC, 22 h; (c) N-phenylmaleimide, 76%. 
 
The Hosomi group reported the use of 2-trimethylsilylethyl-1,3-butadiene 232 as a 
synthetic equivalent to the parent [3]dendralene 29.134 Diels-Alder reaction between 232 
and dimethyl maleate give cycloadduct 233 in 85% yield. Elimination followed by 
Diels-Alder reaction gives the tetracycle 235 in 79% yield. Product stereochemistry was 
not reported in this publication. 
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Scheme 4.24 Reagents and conditions: (a) i) Mg, THF; ii) CH2=CHBr, Ni(dppp)Cl2, 
88%; (b) dimethyl maleate, 130 oC, 24 h, 85%; (c) i) Ph3C
+BF4
-, MeCN, rt, 5 h; ii) 
PhMe, 110 oC, 36 h, 79%. 
 
There are also examples of equivalents of substituted [3]dendralenes undergoing 
sequential Diels-Alder reactions. The Grignard reagent derived from chloroprene was 
reacted with acetone to give a mixture of the two alcohols 236 and 237 in a 3:1 ratio 
(Scheme 4.25).135 This mixture was heated with dimethyl maleate to give the 
cycloadduct 238. Dehydration and the second Diels-Alder reaction could be achieved in 
one pot by adding molecular sieves and an excess of dimethyl acetylenedicarboxylate to 
238. The bis-adduct 240 was obtained in 63% yield.  
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Scheme 4.25 Reagents and conditions: (a) Acetone in THF, no yield given; (b) 
dimethyl maleate, PhMe, 110 oC, 95%; (c) 5Å molecular sieves, dimethyl 
acetylenedicarboxylate (3 equiv), PhH, 80 oC. 
 
Reaction of [3]dendralene 201 with the unsymmetrical dienophile methyl vinyl ketone 
at room temperature gave a mixture of the three mono-adducts 241, 242 and 243 in a 
ratio of 48:21:31 respectively (Scheme 4.26).128 The use of a Lewis acid improved the 
endo/exo selectivity while it had no effect on the site selectivity, resulting in a product 
ratio of 71:2:26. 
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Scheme 4.26 Reagents and conditions: (a) methyl vinyl ketone (2.2 equiv), PhH, rt, 2 h, 
76%; (b) methyl vinyl ketone, EtAlCl2, PhMe, -78 
oC, 0.5 h, 46%. 
 
Diels-Alder reaction was then carried out between tosylate 244, a synthetic equivalent 
of [3]dendralene 201 and methyl vinyl ketone in the presence of ethylaluminum 
dichloride to give 245 as a single product. Subsequent elimination gave the diene 243, 
previously obtained as the minor product in Scheme 4.25, thus illustrating the 
advantages of this method. 
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Scheme 4.27 Reagents and conditions: (a) methyl vinyl ketone, EtAlCl2, PhMe, -78 
oC, 
1h, 67%; (b) DBU, PhMe, 110 oC, 12 h, 66%. 
 
4.1.2.4 DTDA reactions involving heteroatom-containing equivalents of 
[3]dendralenes 
There are many examples of a heteroatom-containing equivalent of a dendralene being 
used in a DTDA sequence. An example of a nitrogen-containing [3]dendralene 
equivalent undergoing an intermolecular/intermolecular DTDA was reported in 1991.136 
A mixture of two bis-adducts 249 and 250 was obtained after 247 was treated with N-
phenylmaleimide followed by subsequent migration of the double bond to the more 
substituted position. 
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Scheme 4.28 Reagents and conditions: (a) KOH, isopropanol, 60 oC, 40 min, 79%; (b) 
N-phenylmaleimide, CH2Cl2, rt, 48 h, 31% of 249 and 43% of 250. 
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The Spino group have published several papers on a DTDA strategy involving an 
intermolecular hetero Diels-Alder followed by an intramolecular Diels-Alder reaction to 
synthesise the quassinoid skeleton.137-140 They recently reported the synthesis of an 
advanced intermediate to the quassinoids in 14 steps from tetrahydrofuran (Scheme 
4.26).141 Hetero-Diels-Alder reaction between [3]dendralene equivalent 251 and 
ethylvinyl ether proceeds via an endo-transition state with the dienophile approaching 
the less hindered π-diastereoface of 251 to give 252. The intramolecular Diels-Alder 
reaction also proceeds through an endo-transition state to give pentacycle 253 as a 
single isomer. 
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Scheme 4.29  Reagents and conditions: (a) ethylvinyl ether, Yb(fod)3, 76%; (b) PhMe, 
250 oC, 50%. 
 
The Saito group have reported examples of heteroatom containing dendralene 
equivalents undergoing both intra/intermolecular DTDA sequences and 
intramolecular/intramolecular DTDA sequences.142 When ketone 254 was treated with 
Lawesson’s reagent the resulting thioketone underwent rapid IMDA reaction to give the 
cycloadducts 255 and 256 in a ratio of 52:48.  Intermolecular Diels-Alder reaction 
between each of the mono-adducts 257 and 258 and N-phenyl maleimide proceeded 
with a high level of endo- and π-diastereofacial selectivity to give a single product in 
each case.  
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Scheme 4.30 Reagents and conditions: (a) Lawesson’s reagent, PhH, 80 oC, 0.5 h, 80%; 
(b) N-phenylmaleimide, xylene, 140 oC, 3 h, 88% for 257, 28 h, 84% for 258. 
 
Similarly, when ketone 259 was treated with Lawesson’s reagent, the intermediate 
thioketone underwent rapid IMDA reaction to give the cycloadducts 260 and 261 in a 
ratio of 67:33 (Scheme 4.31). After separation each of the mono-adducts 260 and 261 
were heated in xylene to effect the second IMDA cyclisation with a high level of exo-
selectivity to give 262 and 263 respectively. 
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Scheme 4.31 Reagents and conditions: (a) Lawesson’s reagent, PhH, 80 oC, 1 h, 94%; 
(b) xylene, 140 oC, 7 h, 81% for 262, 14 h, 54% for 263. 
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4.2 Aims 
 
While several examples of the DTDA sequence have been reported in the literature, 
until now the control of chemo-, regio- and stereoselectivity during intermolecular 
“diene-transmissive” cycloaddition sequences has not been reported. Furthermore, no 
general synthetic approach to substituted cross-conjugated systems has been reported.  
 
We aim to develop a straightforward method for the preparation of substituted chiral 
dendralenes (Figure 4.4). This new approach will demonstrate that substitution can be 
tolerated at all available positions of the triene-framework. 
OH
R
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R  
Figure 4.4 Chiral dendralenes where R = H or alkyl groups. 
 
We will also demonstrate the involvement of one of the simplest chiral [3]dendralenes 
in highly chemo-, regio- and stereoselective diene-transmissive Diels–Alder (DA) 
sequences to form enantiomerically pure polycyclic frameworks (Scheme 4.32). 
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Scheme 4.32 The rapid construction of fused polycycles. 
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4.3 Results and Discussion 
4.3.1 Synthesis of Substituted Chiral Dendralenes 
4.3.1.1 Synthesis of a simple chiral [3]dendralene 44 
Applying Fallis’ indium-mediated coupling protocol to simple chiral aldehyde 93 gave  
the alcohol 264 as a 1:1 mixture of diastereoisomers. Elimination under Mitsunobu 
conditions furnished triene silyl ether 265 in 25% overall yield (Scheme 4.33). A 
slightly higher yield was obtained using mesylation of the alcohols followed by 
elimination. The modest yield for this transformation led us to develop an alternative 
route. Thus, Corey-Fuchs dibromomethylenation113 of aldehyde 93 gave 139,91 which 
underwent twofold Stille or Negishi couplings to furnish triene 265 in up to 51% overall 
yield from 93. Deprotection of the silyl ether gave alcohol 44. Trienes 265 and 44 are 
easily purified and stored and require no special handling techniques.  
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Scheme 4.33 Reagents and conditions: (a) CH2=CH-CH=CHCH2Br (172) (1.2 equiv), 
In (1.1 equiv), DMF, 25 °C, 16 h, 54%; (b) PPh3 (2.0 equiv), DEAD (2.0 equiv), THF, 
reflux, 3.25 h, 46%;  (c) PPh3 (4.0 equiv), CBr4 (2.0 equiv), CH2Cl2, 25 °C, 4 h, 76 %. 
(d) CH2=CHSnBu3 (2.5 equiv), Pd(OAc)2 (0.05 equiv), PPh3 (0.10 equiv), CH3CN, 60 
°C, 26 h, 61 % or CH2=CHMgBr (3.33 equiv), ZnBr2 (3.47 equiv), Pd(PPh3)4 (0.03 
equiv), THF, 25 °C, 48 h, 67 %. (e) TBAF (2.0 equiv), THF, 25 °C, 2.5 h, 86 %. 
 
4.3.1.2 Other chiral dendralenes 
In contrast to Fallis’ seminal nucleophilic addition–dehydration approach to 
[3]dendralenes, the route that we have developed is by no means limited to the synthesis 
of trienes substituted at the central methylene unit. In order to demonstrate the 
generality of this new approach, several other dendralenes with different substitution 
patterns were synthesised.  
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[3]dendralene 266 was synthesised to show that substitution can be tolerated at the 2 
position of the triene framework (Scheme 4.34). Thus dibromide 139 was reacted with 
an excess of isopropenyl zinc bromide in a Negishi coupling to give the dendralene 266 
in good yield. 
 
OTBSBr
Br
139
OTBS
a
266  
Scheme 4.34 Reagents and conditions: (a) H2C=C(CH3)ZnBr (5.0 equiv), Pd(PPh3)4 
(0.05 equiv), THF, RT, 18 h, 83% 
 
The route also lends itself to the highly stereoselective synthesis of both geometrical 
isomers of unsymmetrically–substituted systems. This was exemplified by the synthesis 
of the first chiral [4]dendralenes, 268 and 271 (Scheme 4.35). 
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Scheme 4.35 Reagents and conditions: (a) H2C=CHSnBu3 (1.05 equiv), Pd2(dba)3 
(0.025 equiv), AsPh3 (0.10 equiv), THF, 50 °C, 10 h, 85 %; (b) 3-(tributylstannyl)-3-
sulfolene (1.2 equiv), Pd(OAc)2 (0.05 equiv), PPh3 (0.10 equiv), CH3CN, 60 °C, 48 h, 
90%; (c) PhCl, 132 °C, 1.5 h, 90% for 268, 69% for 271; (d) 3-(tributylstannyl)-3-
sulfolene (1.0 equiv), tri(2-furyl)phosphine (0.15 equiv), Pd2(dba)3 (0.025 equiv), 
PhMe, 55 °C, 55%; (e) H2C=CHSnBu3 (2.0 equiv), Pd(OAc)2 (0.05 equiv), PPh3 (0.10 
equiv), CH3CN, 60 °C, 18 h, 92%.  
 
Stille couplings between gem-dibromoalkenes and one equivalent of a vinyl stannane 
have been shown to proceed with trans-selectivity.143 Thus, dibromide 139 was 
selectively coupled with tributyl(vinyl)tin following the procedure of Wong to give the 
Z-bromodiene 140 with greater than 20:1 selectivity.85 A second Stille coupling using a 
slight excess of 3-(tributylstannyl)-3-sulfolene 16366 resulted in clean inversion of 
configuration144 to give [4]dendralene precursor 267 as a single product. The 
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configuration of 267 was determined through 2D NMR experiments. A NOESY cross 
peak between H-2 and H-5 shows that inversion of configuration has occurred (Figure 
4.5). 
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Figure 4.5 NOESY spectrum of [4]dendralene precursor 267 
 
This unusual inversion of configuration has been seen in the coupling of organozinc 
compounds with 2-bromo-1,3-butadienes and is thought to proceed via the mechanism 
shown in Scheme 4.36.144 It is proposed that steric repulsion between Pd and the cis 
substituent in the Pd-complex 272 is reduced via the allene species 274 leading to the 
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trans-Pd species 277. The trans-Pd complex would then undergo transmetallation and 
reductive elimination to give the observed product. 
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Scheme 4.36 Proposed mechanism of inversion of configuration at the sp2 centre. 
 
The geometrical isomer of [4]dendralene precursor 267 could be synthesised by 
reversing the order of the two palladium catalysed coupling steps. Once again, reaction 
between bromide 269 and tributyl(vinyl)tin proceeded with clean inversion of 
configuration to give the [4]dendralene precursor 270. The configuration of the central 
alkene of 270 was also determined through 2D NMR experiments. NOESY cross-peaks 
between H-8 and H-2 confirm that inversion of configuration has occurred. 
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Figure 4.6 NOESY spectrum of [4]dendralene precursor 270. 
 
The [4]dendralene precursors 267 and 270 underwent cheleotropic extrusion of sulfur 
dioxide when heated to give the [4]dendralenes 268 and 271 respectively. 
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4.3.2 DTDA Reactions Involving Chiral [3]Dendralene 44 
In order to demonstrate that these chiral substituted dendralenes could be used in DTDA 
sequences to form enantiomerically pure polycyclic frameworks we elected to carry out 
reactions using the simplest chiral [3]dendralene 44. 
4.3.2.1 Double cycloadditions of chiral [3]dendralene and maleic anhydride 
A mixture of chiral [3]dendralene 44 and maleic anhydride (2 equiv) in acetonitrile at 
room temperature gave tetracyclic lactone acid 280 in high yield (Scheme 4.37). The 
transformation presumably proceeds111,112 by way of the short lived hydroxy anhydride 
278, which cyclizes rapidly to bicyclic lactone acid 279, which in turn reacts with 
maleic anhydride to form 280. Both cycloaddition steps are highly stereoselective, with 
280 being formed as a single diastereomer, the stereochemistry of which was 
determined after subsequent experiments. The intermediate mono-adduct 279 remains a 
minor component throughout the course of the transformation, demonstrating that the 
second cycloaddition is more facile than the first. There are traces of minor products 
resulting from the competing esterification/IMDA pathway (Scheme 3.1). 
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Scheme 4.37 Reagents and conditions: (a) maleic anhydride (2.0 equiv), CD3CN, 25°C, 
60 h, >90% 
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The cascade sequences depicted above are agreeably effective ways to form new fused 
ring systems in a stereocontrolled manner. Nevertheless, a sequence that could be 
interrupted after the cycloaddition would offer significantly greater synthetic versatility.  
 
Gratifyingly, this outcome was achieved in a very straightforward manner, by simply 
carrying out the reaction between alcohol 44 and maleic anhydride in benzene (Scheme 
4.38). The same highly stereoselective cycloaddition–lactonization sequence carried out 
in benzene gave lactone acid 279, which is insoluble in benzene and precipitates from 
solution as it forms; the product is isolated in pure form simply by filtration.  
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Scheme 4.38 Reagents and conditions: (a) maleic anhydride, (1.05 equiv), C6D6, 25°C, 
48 h, 83%; (b) CH2N2, Et2O/THF, –78°C, 15 min, 70%; (c) maleic anhydride (1.5 
equiv), C6D6, 80°C, 18 h, 67%. 
 
Esterification of 279 with diazomethane gave the corresponding methyl ester 281. 
Reaction of 281 with a second equivalent of maleic anhydride gave 282 as a single 
diastereomer. The clean conversion of bicycle 281 into the tetracycle 282 could be 
tracked by 1H NMR. Figure 4.7 shows 1H NMR spectra of the reaction between 281 and 
maleic anhydride at time = 0 h, 1 h, 4 h, 7 h and finally 18 h. The disappearance of the 
signal due to the C1-H in the starting material (highlighted in purple) and the formation 
of the corresponding peak in the product (highlighted in green) provide a good 
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indication of how far the reaction has progressed. As can be seen in the spectrum taken 
at 18 h, there is a single alkenic peak due to the product (highlighted in blue). 
 
   
 
 
  
 
 
 
Figure 4.7 NMR spectra for the conversion of 281 to 282. 
 
Attempts were made to determine the stereochemistry of tetracycle 282 using 2D NMR 
techniques. While a solvent was found that separated all of the peaks of interest, the 
stereochemistry at the three new stereocentres relative to the existing stereocentres 
could not be unequivocally proven. Thus, single crystal X-ray analysis was used to 
confirm the stereochemistry of the tetracyclic product (Figure 4.8). 
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Figure 4.8 Thermal ellipsoid diagram of 282. Ellipsoids show 30% probability levels. 
 
It was thought that the high level of stereoselectivity observed in the first cycloaddition 
reaction could be result of hydrogen bonding between the free alcohol and maleic 
anhydride.79 As a result of 1,3A strain, there are two likely preferred conformations 
about the C1-C2 bond as depicted in Figure 4.9. In the conformation on the left, the H is 
in the most sterically hindered inside position, the CH3 in the outside position and the 
OH in the anti position. If this is the preferred conformation, the maleic anhydride 
would be expected to approach the dendralene from the top face as drawn to maximise 
hydrogen bonding. In the conformation on the right, the H is still in the most sterically 
hindered inside position, while the CH3 in the anti position and the OH is in the outside 
position. If this is the preferred conformation, the maleic anhydride would approach the 
dendralene from above since the bottom face is blocked by the methyl group. 
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Figure 4.9 The preferred conformations about the C1-C2 bond 
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To determine if hydrogen bonding was the reason for the high level of stereoselectivity, 
the protected analogues of [3]dendralene 44, namely silyl ether 265 and MOM ether 
285, were reacted with maleic anhydride (2 equiv). It was envisaged that if hydrogen 
bonding was not possible, the maleic anhydride would approach the dendralene from 
both  π-diastereofaces and a mixture of products would be obtained. 
 
In the event, both the silyl ether 265 and MOM ether 285 underwent highly 
stereoselective domino cycloadditions to give tetracyclic bis-anhydrides 284 and 287 as 
sole products in high yields (Scheme 4.39 and Scheme 4.40). The second DA reaction 
in the diene-transmissive sequence occurred faster than the first. That the protected 
alcohols 265 and 285 give the same stereoisomeric double cycloadducts as alcohol 44 
was confirmed by the conversion of 284 into 282, and the X-ray crystal structures of 
282 and 287.  
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Scheme 4.39 Reagents and conditions: (a) maleic anhydride (2.0 equiv), C6D6, 25°C, 
48 h, 97%; (b) CF3CO2H, CH2Cl2, 25°C, 16 h then CH2N2, Et2O/THF, –78°C to 25°C, 
0.25 h, 81%. 
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Scheme 4.40 Reagents and conditions: (a) MOMCl, iPr2NEt, CH2Cl2, 18 h, 60%; (b) 
maleic anhydride (2.0 equiv), C6D6, 25°C, 72 h, 100% 
 
 
Figure 4.10 Thermal ellipsoid diagram of 287. Ellipsoids show 30% probability levels. 
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4.3.2.2 Cycloadditions with benzoquinones 
As the DTDA sequence with alcohol 44 is easily interrupted after the first cycloaddition 
(Scheme 4.38), different dienophiles could be used for the second Diels-Alder reaction 
in the sequence. Thus, methyl ester 281 underwent a highly selective cycloaddition with 
p-benzoquinone (Scheme 4.41). With the unsubstituted dienophile, attempts to purify 
the initial cycloadduct by column chromatography were met with aromatisation to 289. 
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Scheme 4.41 Reagents and conditions: (a) p-benzoquinone (1.0 equiv), C6D6, 80°C, 48 
h then SiO2, CH2Cl2, 70% overall. 
 
Aromatisation could be prevented by using 2,6-dimethyl-p-benzoquinone or 2,5-
dimethyl-p-benzoquinone. These dienophiles also incorporate angular methyl groups 
into the tetracyclic product, a feature common to many natural products. One major 
cycloadduct was formed in very high regio- and diastereoselectivity by reaction of diene 
281 with each of the dimethyl-p-benzoquinones (Scheme 4.42). In both cases, 
epimerisation occurred upon exposure of the initial cycloadducts 290/45 to flash silica, 
leading separately to 291 and 292, the stereochemistries of which were confirmed by 
single crystal X-ray analyses (Figure 4.11). 
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Scheme 4.42 Reagents and conditions: (a) 2,5- or 2,6-dimethyl-p-benzoquinone (1.2 
equiv), [D8]toluene, 110°C, 125 h, 78% (for 290), 76% (for 45); (b) SiO2, CH2Cl2, 8 h, 
100% (for 291), 4 h, 100% (for 292) 
 
 
 
Figure 4.11 Thermal ellipsoid diagram of 291 and 292. Ellipsoids show 30% 
probability levels. 
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Finally, semicyclic diene 281 participated in a highly selective double cycloaddition 
reaction with 2,6-dimethyl-p-benzoquinone to form heptacycle 293 in high yield 
(Scheme 4.43). The reaction proceeds via the tetracyclic intermediate 45, which acts as 
a dienophile in the second Diels-Alder reaction. The heptacyclic product has as axis of 
symmetry, as evident by the 1H and 13C NMR spectra. The structure of 293 was 
confirmed by single crystal X-ray analysis (Figure 4.12). This last example 
demonstrates the extraordinary ease by which enantiomerically pure fused polycyclic 
structures can be prepared: structure 293 was assembled in three synthetic steps from 
dendralene 44.  
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Scheme 4.43 Reagents and conditions: (a) 2,6-dimethyl-p-benzoquinone (0.5 equiv), 
CH2Cl2, 25°C, 19 kbar, 72 h, 85%. 
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Figure 4.12 Thermal ellipsoid diagram of 293. Ellipsoids show 30% probability levels. 
 
4.4 Conclusions 
 
A variety of substituted chiral dendralenes have been synthesised from a simple chiral 
dibromoalkene. Considering the functional group tolerance of both the Corey-Fuchs 
dibromomethylenation of aldehydes and metal–catalyzed cross couplings, the scope of 
this approach for the synthesis of cross–conjugated systems – and polycyclic systems 
derived therefrom – is vast.  
 
The next chapter builds upon these findings in a formal total synthesis of the 
biologically active natural product triptolide. 
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Scheme 4.44 A diene-transmissive Diels-Alder sequence to give tetracyclic frameworks 
common to natural products. 
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5 The Formal Total Synthesis of (±)-Triptolide  
5.1 Background 
5.1.1 Isolation and Biological Activity 
Extracts of the plant Tripterygium wilfordii Hook F have been used in traditional 
Chinese medicine for many years. In 1972 Kupchan reported the isolation of triptolide 
46 and triptonide 294 from the vine like plant (Figure 5.1).145 These compounds 
represent the first known diterpenoid triexpoxide natural products. 
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Figure 5.1 Diterpenoid triepoxide natural products 
Triptolide 46 and triptonide 294 and their derivatives have displayed potent 
antiluekemic and antitumour activity.145-149 They exhibit antiinflammatory146,150,151 and 
immunosuppressive150-155 properties as well as having a potential use as a male 
contraceptive.156 The number of papers published relating to the biological activity of 
triptolide has risen dramatically over the last decade (Figure 5.2).  
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Figure 5.2 Scifinder Scholar search results of papers on the synthesis and biological 
activity of triptolide. 
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5.1.2 Biosynthesis 
Electrophilic addition to the C14-C15 olefinic linkage in geranylgeraniol pyrophosphate 
(GGPP) 295 triggers a cyclisation leading to the bicyclic labdane type intermediate 296 
(Scheme 5.1).157 This cationic structure and the derived copalyl pyrophosphate 297 are 
involved in the biosynthesis of most terrestrial diterpenoids. Loss of pyrophospate ion 
and cyclisation gives pimarane type intermediate 298. A suggested link between the 
pimarane and abietane type structures is shown in Scheme 5.1. The abietane type 
diterpenoid 301 can be transformed into the triptolidane type 304, a precursor of 
triptolide 46, through introduction of a leaving group at C14 followed by loss of the 
leaving group and methyl migration.  
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Scheme 5.1 The biosynthesis of triptolide 
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5.1.3 Previous Syntheses 
Due to the significance of its biological activity and its unusual triepoxide skeleton, 
triptolide has been to focus of much synthetic effort. Berchtold reported initial studies 
on the synthesis of triptolide in 1977, three years before publishing a completed total 
synthesis in 1980. A revised total synthesis was published in 1982 (Scheme 5.2).158-160 
 
6-Methoxy-1-tetralone 305 was converted to the ketone 306 via a nine step procedure. 
The enolate of 306 was alkylated with 307 before the lactone was cleaved with Me2NH 
to give a 1:1 mixture of diastereomers 308. Oxidation to the aldehyde followed by 
Al2O3-catalysed aldol condensation gave a 1:1 mixture of 309 and 310. The mixture 
was heated with acid to effect dehydration of 309. Aldehyde reduction and acid 
catalysed lactonisation during work up gave 311 as a single isomer.  
 
It was originally reported that methoxide-catalysed isomerization of 311 gave 313 
directly. In a subsequent publication, however, it was reported that a mixture of the 
trans (40%) and cis (60%) isomers is obtained after 15 minutes, with the cis isomer 
being the sole product of the base-catalysed reaction after 48 h. To avoid this problem, 
an alternative route was developed. Thus, peracid epoxidation of 311 gave epoxides 
312, which were dehydrated to give the diene 47. Hydrogenation gave the trans-fused 
product 313 as the major product (60% after recrystallisation). 
 
Benzylic oxidation and ether cleavage lead to phenol 315. Subsequent reduction of the 
ketone gave 316 which underwent the Alder periodate reaction to give the epoxy 
dienone 317. Reaction of 317 with mCPBA followed by treatment with H2O2/OH
- gave 
triptonide 294. Sodium borahydride reduction of triptonide 294 gave triptolide 46 in 
21% yield along with 68% of C1 epitriptolide. 
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Scheme 5.2  Reagents and conditions: (a) NaH, DMF, 12 h; (b) Me2NH, 12 h; (c) 
CrO3.py, CH2Cl2, 15 min; (d) grade 3 neutral alumina, EtOAc, 48 h; (e) p-TsOH, C6H6, 
reflux, 2 h; (f) NaBH4, EtOH, 2 h; (g) aq. HCl (work-up); (h) m-CPBA, CH2Cl2, 18 h; 
(i) NEt3, CH2Cl2, 18 h; (j) 2,4,6-trimethylpyridine, MsCl, DMF; (k) Pd/C, 50 psi H2, 
EtOAc, 1.5 h; (l) CrO3, HOAc-H2O (9:1), 6 h; (m) BBr3, CH2Cl2, 10 h; (n) NaBH4, 
EtOH, 1h; (o) NaIO4, aq. MeOH, 5 h; (p) m-CPBA (3 equiv), CH2Cl2, reflux, 20 h then 
rt 18 h; (q) 30% H2O2 (1.75 equiv), 1 M aq. NaOH (1.3 equiv), MeOH, 20 h; (r) NaBH4, 
EtOH, 1 h. 
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van Tamelen reported the formal synthesis of the natural enantiomer of triptolide in 
1980.161 The trifluoroacetate 319, derived from dehydroabietic acid 318, was converted 
to 320 through a twelve-step sequence. Oxidation of 320 to the carboxylic acid followed 
by hydrogenolysis of the benzyloxy group led to spontaneous lactonisation to give 
butenolide 321 in quantitative yield. In a sequence similar to that used by Berchtold 
3221 was converted to the epoxy dienone 317. Nucleophilic epoxidation with H2O2-
KOH then peracid epoxidation gave l-triptonide 294 in 15% yield, thus completing the 
formal total synthesis of l-triptolide. 
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Scheme 5.3 Reagents and conditions: (a) NaClO2-HOSO2NH2, dioxane-H2O; (b) H2, 
Pd/C, EtOH; (c) CrO3, AcOH-H2O, 40 
oC; (d) KOH, MeOH-H2O; (e) NaBH4, EtOH; (f) 
NaIO4, MeOH-H2O; (g) H2O2-KOH, MeOH; (h) 3,5-(NO2)2C6H3CO3H-Na2HPO4, 
CH2Cl2. 
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In 1982, van Tamelen and co workers reported two further syntheses of racemic 
triptolide.162,163 The first of these had an overall yield 40 to 50 times greater than their 
earlier synthesis.162 The bicyclic diketone monoethylene ketal 326 was converted to the 
ketene dithioacetal 327 through a high yielding sequence. Treatment of 327 with 
dimethylsulfonium methylide followed by acid hydrolysis gave the unsaturated lactone 
328. 
 
Butenolide 328 was converted into the α-(tert-butyldimethylsilyl)furan 329, which then 
underwent a Diels-Alder reaction with methyl acrylate to give 330 after acid mediated 
aromatisation of the cycloadduct. Methylation of the phenol followed by the addition of 
methyl lithium formed the tertiary alcohol, which was deoxygentated to give 331, a key 
intermediate in the synthesis. 
 
Epoxidation followed by base-promoted ring opening gave the allylic alcohol 332. 
Thionyl chloride induced rearrangement of 332 gave the allylic chloride 333. 
Conversion to the alcohol 334 followed by Eschenmoser-Claisen rearrangement 
resulted in the formation of the allylic amide 335. 
 
Epoxidation of 335 followed by β-elimination gave the intermediate α,β-unsaturated 
amide, which underwent acid hydrolysis to give the butenolide 313. Finally, benzylic 
oxidation gave 314, an intermediate used in a Berchtold’s synthesis of (±)-triptonide 
(Scheme 5.2). 
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Scheme 5.4 Reagents and conditions: (a) Li/NH3, THF, 0.8 equiv t-BuOH, - 78 
oC 15 
min; diethyl chlorophosphate, THF, 0 oC, 30 min; Li, EtNH2, THF, t-BuOH, 0 
oC, 12h; 
(b) 3M H2SO4, THF, 25 
oC, 24 h; (c) CS2, lithium 4-methyl-2,6-di-tert-butylphenoxide, 
THF, 48 h then MeI, THF, 24 h; (d) dimethylsulfonium methylide, 1:1 DMSO/THF 
then 1:6 6M aq HCl/MeOH, 15 h; (e) LDA/HMPA, THF, 25 min then TBSCl, 1h; (f) 
methyl acrylate, C6H6, 65 – 70 
oC, 48 h then 5:1 MeOH/6M HCl, 25 oC, 1h; (g) MeI, 
NaH, THF, 25 oC, 48 h; MeLi, THF, -15 oC, 5 min; MsCl, NEt3, CH2Cl2, 0 – 25 
oC, 1 h; 
Li/NH3, THF, -78 
oC, 15 min; (h) m-CPBA, CH2Cl2, 25 
oC, 6 h; LDA, THF, 25 oC, 24 
h; (i) SOCl2, pyridine, EtO2, 0 
oC, 2 h; (j) KOAc, DMSO, 70 – 75 oC, 24 h; NaOMe, 
MeOH, 25 oC, 2 h; (k) dimethylformamide dimethylacetal, xylene, reflux, 4 Å sieves, 3 
days; (l) m-CPBA, CH2Cl2, 25 
oC, 30 h; (m) lithium hexamethyldisilazide, THF, 0 oC 
then 25 oC for 2 h; 1 M HCl, 10 min; (n) CrO3, 80% AcOH-H2O, 35 – 40 
oC, 2 – 3 h. 
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The second synthesis reported by van Tamelen in 1982 differed from previous 
approaches in that it uses a biomimetic strategy (Scheme 5.5).163 2-Isopropylphenol 336 
was converted to the benzyl bromide 337 through a three step sequence. Alkylation of 
the cyclopropyl β-ketoester 338 with bromide 337 gave 339 in near quantative yield. 
Hydrolysis and decarboxylation of the ester and reduction of the ketone gave the 
cyclopropyl carbinol 341, which was converted to the homoallylic bromide 342 in 70% 
yield. Ethyl acetoacetate was alkylated with bromide 342 to give the cyclisation 
precursor 343. 
 
Upon treatment with SnCl4, 343 underwent the biomimetic cationic bicyclization to give 
tricycle 344, which was converted to the unsaturated ester 345 without purification. The 
crude ester 345 was epoxidised before base-promoted elimination to form the tetracycle 
313, an intermediate used in Berchtold’s previous syntheses of (±)- triptolide (Scheme 
5.2). 
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Scheme 5.5 Reagents and conditions: (a) NaH, MeI, THF, rt; (b) n-BuLi, TMEDA, 
CHO; (c) PBr3, Et2O, 0 
oC; (d) NaH, THF, 0 oC; (e) Ba(OH)2, H2O/Et2O, 90 
oC 17 h; (f) 
LAH, Et2O, 0 
oC; (g) LiBr, PBr3, collidine in Et2O, then ZnBr2 in Et2O, 0 
oC; (h) ethyl 
acetoacetate, LiH, DMF, 75 oC; (i) SnCl4, CH2Cl2, 0 
oC; (j) MeSO2Cl, NEt3, CH2Cl2, 0 
oC;  (k) m-CPBA, CH2Cl2 then LDA, -78 
oC. 
 
In 1999 Yang reported a diastereoselective synthesis of (-)-triptolide, (-)-triptonide and 
the related natural products (+)-triptophenolide and (+)-triptoquinonide (Scheme 
5.6).164,165 A strategy similar to van Tamelen’s second synthesis was used, with the two 
central rings being formed through a biomimetic type bicyclisation, albeit via a radical 
intermediate. 2-Isopropylphenol 336 was converted into ketoester 346 through an eight 
step sequence. Transesterification with (+)-8-phenylmenthol 347 gave the acyclic chiral 
precursor 348. Yb(OTf)3/Mn(OAc)3-promoted radical bicyclisation of 348 gave the 
tricyclic product 349 as the major diastereomer (38:1 dr). 
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Scheme 5.6 Reagents and conditions: (a) DMAP, PhMe, reflux; (b) Mn(OAc)3.2H2O, 
Yb(OTf)3, CF3CH2OH, -5 
oC, 5 h; (c) KHMDS, THF, -78 to 20 oC, then PhNTf2, -78 
oC 
to rt; (d) DIBAL-H, CH2Cl2, -78 
oC to -30 oC, 20 h; (e) Bu3N, Pd(PPh3)4, LiCl, CO (1 
atm), CH3CN, 65 
oC, 12 h; (f) CrO3, aq. HOAc, rt; (g) BBr3 CH2Cl2, -78 
oC to rt; (h) 
NaBH4, CH3OH, 0 
oC, 2h; (i) NaIO4, 3:1 MeOH:H2O, 0 to 25 
oC, 1 h; (j) CF3COCH3, 
Oxone, NaHCO3, 3:2 CH3CN:aq Na2(EDTA), 25 
oC, 4 h; (k) H2O2, NaOH, MeOH, 25 
oC 3h; (l) Eu(fod)3, NaBH4, CH3OH.  
 
After preparation of vinyl triflate, the ester was reduced to the alcohol 350 using an 
excess of DIBAL-H. Carbonylation of 350 led to methyl ether 313, an intermediate 
common to earlier syntheses of (-)-triptolide. This was converted to (-)-triptolide though 
a sequence similar to that developed by Berchtold (Scheme 5.2). The overall yield, 
however, was greatly improved. 
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5.2 Aims 
 
The previous syntheses of triptolide have either been multistep approaches, where one 
ring is constructed at a time, or they have involved a biomimetic approach to form two 
rings in one step. In Chapter 4, we demonstrated that a DTDA sequence could be used 
for the rapid assembly of tetracyclic systems common to diterpenoid natural products. 
The aim of the work described herein is to synthesise the tetracyclic compound 47, a 
key intermediate from previous syntheses of (-)-triptolide,160 through a DTDA approach 
(Scheme 5.7). 
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Scheme 5.7 Proposed synthesis of triptolide 
 
The proposed synthesis requires the preparation of the unsymmetrically substituted 
dendralene 51 in synthetically useful amounts. Investigations will initially be carried out 
in order to optimise the synthesis of this dendralene. 
 
The first Diels-Alder reaction in the DTDA sequence could either be carried out with 
methyl acrylate to give the lactone 49 directly or with acrolein forming the lactol 351, 
which would then be oxidised to form the lactone 49. Both of these Diels-Alder 
reactions should proceed via an endo transition state to give the cis-fused cycloadducts. 
The initial reaction should also be site selective as one of the diene units in the 
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dendralene is more able to adopt the required s-cis conformation. It is envisaged that 
these Diels-Alder reactions could be carried in an enantioselective manner by using a 
chiral catalyst. The reactions are also predicted to give the desired regiochemical 
outcome by the ortho-, para-orientation rule implied by the Woodward-Hoffman 
rules.11,14 
 
The second Diels-Alder reaction in the sequence should also proceed via an endo 
transition state with the dienophile approaching the diene from the less hindered π-
diastereoface. According to literature precedent166 the Diels-Alder reaction should also 
proceed to give the desired regiochemical outcome. 
 
Once the tetracyclic core is in place, one of the ketones on the A ring (48 in Scheme 
5.7) must be converted to a methyl ether, while the other needs to be removed. The last 
step required is a dehydrogenation across the C/D ring junction to give the α,β-
unsaturated lactone.  
 
The possibility of carrying out a Diels-Alder reaction between semicyclic diene 49 and 
the substituted benzyne 354 to give tetracycle 355 directly was also considered (Scheme 
5.8).  
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Scheme 5.8 Benzyne approach to triptolide 
There are several methods available for the generation of benzynes, however, many of 
them involve the use of strong bases. Since the benzyne 354 would need to be generated 
in the presence of the lactone 49, non-nucleophilic conditions would be required. It was 
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therefore decided to investigate the synthesis of anthranilic acid precursors for the 
benzyne 354. For substituted benzynes such as 354, there are two possible 
regioisomeric anthranilic acid precursors, that is, with the amino group ortho (352) or 
meta (353) to the methoxy substituent. Paquette has shown that for benzyne generation 
to occur the amino group must be positioned meta to the methoxy substituent (Scheme 
5.9).167 
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Scheme 5.9 Reagents and conditions: (a) iC5H11ONO, 57%. 
 
A search of the literature also revealed that Diels-Alder reactions of similar substrates 
do not proceed with a high level of regioselectivity and the yield for such reactions is 
quite low (Scheme 5.10).168 
OCH3
CO2H
NH2
O
O
O
O
O
O
OMe
O
O
O
OMe
+
4:1
a
356 359
360
361
 
Scheme 5.10 Reagents and conditions: (a) pentyl nitrile, dioxane, 70 oC, 35%. 
 
The synthesis of the required regioisomer of the anthranilic acid precursor would take 
several steps to complete. In addition, the regiochemical outcome of the Diels-Alder 
reaction could not be predicted and the overall yield for the sequence was anticipated to 
be quite low. The benzyne approach was, therefore, abandoned in favour of the quinone 
route. 
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5.3 Results and Discussion 
5.3.1 Synthetic Approaches to Substituted [3]Dendralene 365 by Stille 
Coupling 
As observed earlier, palladium catalysed cross-couplings of 2-bromo-1,3-butadienes 
often proceed with clean inversion of configuration (Scheme 4.36). Thus, a Stille 
coupling between the known dibromoolefin 362,85,169 synthesised in three steps from 
ethyl glycolate, and tributyl(vinyl)tin was carried out to give 363 (Scheme 5.11).85 The 
Stille coupling between 363 and tributyl(prop-1-en-2-yl)stannane was expected to occur 
with clean inversion of configuration at the sp2 centre.144 After several attempts, 
however, the best result obtained was a 50:50 ratio of the products due to inversion and 
retention of configuration. 
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Scheme 5.11 Reagents and conditions: (a) tributyl(vinyl)tin (1.05 equiv), Pd2(dba)3 
(0.025 equiv), Ph3As (0.10 equiv), THF, 55 
0C, 18 h, 66%; (b) tributyl(prop-1-en-2-
yl)stannane (2.0 equiv), PPh3 (0.1 equiv), Pd(OAc)2 (0.05 equiv), CH3CN, 60 
oC, 48 h, 
49% of a 50:50 mixture of 364 and 365; or tributyl(prop-1-en-2-yl)stannane (2.0 equiv), 
CsF (2.0 equiv), CuI (0.08 equiv), PdCl2 (0.04 equiv), tBu3P (0.08 equiv), DMF, 45 
oC, 
24 h, 44% of 50:50 mixture of 364 and 365. 
 
While this study was being conducted, it was reported in the literature that certain 
conditions for coupling reactions resulted in the retention of configuration of the 
starting materials.170 Therefore, the bromodiene 366 was synthesized through a Negishi 
coupling between dibromoolefin 36285,169 and isopropenyl magnesium bromide 
(Scheme 5.12). Stille reaction between bromodiene 366 and tributyl(vinyl)tin under the 
conditions of Baldwin,171 using tBu3P as the ligand, proceeded cleanly to give two 
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dendralenes in a 91:9 ratio. 2D NMR experiments, however, showed that the major 
product resulted from inversion of configuration, not retention as expected.170 It was 
hoped that if these same conditions were applied to a coupling between 363 and 
tributyl(prop-1-en-2-yl)stannane, clean inversion would also occur. Unfortunately, this 
was not the case and once again a mixture products was obtained (Scheme 5.11). 
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Scheme 5.12 Reagents and conditions: a) isopropenyl magnesium bromide, ZnBr2, 
THF, rt, 45 min, 78%; (b) tributyl(vinyl)tin (2.0 equiv), CsF (2.0 equiv), CuI (0.08 
equiv), PdCl2 (0.04 equiv), tBu3P (0.08 equiv), DMF, 45 
oC, 24 h, 50% conversion, 
69% yield based on recovered s.m. (c) vinyl tributyltin(2.0 equiv), PPh3 (0.1 equiv), 
Pd(OAc)2 (0.05 equiv), CH3CN, 60 
oC, 18 h, 46% 
 
Finally, bromodiene 366 was coupled with an excess of tributyl(vinyl)tin under the 
conditions that gave complete inversion of configuration during the synthesis of the 
chiral [4]dendralene precursors (Scheme 4.35). To our surprise the two dendralenes 364 
and 365 were formed in a 72:28 ratio, with the major product resulting from retention of 
configuration (Scheme 5.12).  
 
The unexpected results obtained from the coupling reactions could be the result of 
finely balanced competing steric interactions (Scheme 5.13 cf  Scheme 4.36). Steric  
interactions include those between the Pd ligands and the substrate (368) and between 
the substituent X and other parts of the substrate (369, 372 and 373). A change in 
substitution or ligand will determine which of these steric interactions are dominant. 
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Scheme 5.13 Steric interactions during the palladium catalysed coupling reactions 
leading to retention or inversion of configuration. 
 
As a 72 :28 ratio of the dendralenes 365 and 364 was the best result obtained, this 
mixture was carried on to the next step of the synthesis. 
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5.3.2 Synthesis of the Bicyclic Intermediate 49 
5.3.2.1 A dendralene approach 
Deprotection of dendralene 365 gave the alcohol 51 (Scheme 5.14). When heated in a 
sealed tube with methyl acrylate, 51 underwent a stereoselective and regioselective 
Diels-Alder reaction through the transtion state 376 depicted in Scheme 5.14 to give the 
desired product. As the overall yield for this sequence was disappointingly low, 
however, an alternative route to the key intermediate 49 was sought. 
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Scheme 5.14 Reagents and conditions: (a) TBAF, THF, 2.5 h; (b) methyl acrylate, 
PhMe, 100 oC, 18 h, 30% for 2 steps. 
 
5.3.2.2 An IMDA approach  
As sufficient quantities of the desired [3]dendralene 51 could not be synthesised, an 
alternative route to the key bicyclic intermediate 49 was designed (Scheme 5.15). 
Treatment of bromodiene 366 with tetrabutyl ammonium fluoride resulted in removal of 
the silyl group to give alcohol 377. The alcohol 377 was esterified with acryloyl 
chloride to form the IMDA precursor 378. 
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Scheme 5.15 Reagents and conditions: (a) TBAF, THF, 1h, 80%; (b) acryloyl chloride, 
NEt3, CH2Cl2, 0 
oC, 1.5 h, 85%; (c) C6H4Cl2, 180 
oC, 72 h; (d) DBU, CH2Cl2, 40 
oC, 2.5 
h, 40% over 2 steps; (e) tributyl(vinyl)tin, PdCl2(CH3CN)2, DMF, 100 
oC, 6 d, 36%. 
 
Cyclisation of triene 378 occurred after prolonged heating at 180 oC to give a mixture of 
the cis and trans fused cycloadducts. After removal of the dichlorobenzene by 
distillation under reduced pressure, the crude product mixture was treated with DBU to 
give exclusively the cis fused bicyclic product 379. The low yield for this sequence 
(40%) has been attributed to the volatility of the cycloadducts, since GC analysis of the 
distilled dichlorobenzene showed the presence of the cycloadducts. 
 
Stille reaction between bromide 379 and tributyl(vinyl)tin under optimised conditions 
occurred in a disappointingly low yield of 36% after six days. As this route was very 
low yielding overall and sufficient quantities of material could not be made it was 
abandoned.  
 
5.3.2.3 An intermolecular approach    
Since Stille reactions are known to occur with iodides much more readily than they do 
with bromides, the bicyclic iodide 385 was synthesised (Scheme 5.16). Dehydration of 
2-methyl-3-butyn-2-ol 380 according to a literature procedure gave 2-methyl-1-buten-3-
yne 381 in 50% yield.172 Reaction of 381 with ethyl magnesium bromide and 
paraformaldehyde gave the alcohol 382.173 Treatment of 382 with lithium aluminium 
hydride followed by iodine gave the iodides 383 and 384.174 The mixture of isomers 
was then heated with methyl acrylate in a sealed tube at 100 oC for 18 h. The Z isomer 
underwent a regioselective Diels-Alder reaction followed by spontaneous lactonisation 
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to give the bicyclic lactone 385 in 61% yield. Finally, Stille reaction between 385 and 
tributyl(vinyl)tin gave the desired bicyclic intermediate 49 in very good yield. 
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Scheme 5.16  Reagents and conditions: (a) Acetic anhydride, pTsOH, 50%; (b) 
EtMgBr, (CH2O)n, THF, 56%; (c) LiAlH, I2, -78 - 0 
oC, 42% (E/Z 2.75:1); (d) methyl 
acrylate, PhMe, 100 oC, 18 h, 61%; (e) tributyl(vinyl)tin, Pd2(dba)3, tri(2-
furyl)phosphine, PhMe, 60 oC, 24 h, 86 %. 
 
5.3.2.4 A new dendralene approach 
As large amounts of the iodide 383 were now readily available, an alternative route to 
the dendralene 51 was considered. Protection of the butadiene as its sulfolene derivative 
would prevent inversion of configuration in subsequent palladium catalysed coupling 
reactions. Cheleotropic extrusion of sulphur dioxide would then give the dendralene. 
 
Thus, iodide 383 was reacted with an excess of sulphur dioxide in a sealed tube for six 
days to give 386 (Scheme 5.17). Stille coupling between 386 and tributyl(vinyl)tin gave 
the [3]dendralene precursor 387 in good yield.  
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Scheme 5.17 Reagents and conditions: (a) SO2, MeOH/Et2O, 1:1, rt, 6 d, 51%; (b) 
tributyl(vinyl)tin, PdCl2(CH3CN)2, DMF, 100 
oC, 75%; (c) 230 oC, 100 mm/Hg, 16%; 
(d) acrolein, MeOH/H2O 95:5, 24 h, 29%; (e) PCC, NaOAc, NaHCO3, CH2Cl2, 18 h, 
93%. 
 
Sulfolene 387 was expected to readily undergo cheleotroplic elimination of sulphur 
dioxide when heated, as is the case for most such substances.175,176 Intriguingly, no 
reaction was observed when solutions of 387 in chlorobenzene or dimethyl sulfoxide 
were heated to reflux. Finally, heating 387 to 230 oC at 100 mm/Hg resulted in the 
formation of the dendralene 51, albeit in low yield. It is thought that conjugation of the 
3,4-alkene slows the rate of cheleotropic elimination. 
 
Reaction of dendralene 51 and acrolein proceeded at room temperature to give the lactol 
351 and subsequent oxidation gave the lactone 49. Optimisation of this sequence was 
not carried out as we already had a shorter and higher yielding route available. 
 
5.3.2.5 Attempted enantioselective synthesis of the bicyclic intermediate 385 
In recent years there has been much interest in catalysed enantioselective Diels-Alder 
reactions. It was envisaged that a Diels-Alder reaction between dienol 383 and acrolein 
could be carried out using Corey’s chiral, cationic oxazaborolidine catalyst 3886  to 
enantioselectively give the lactol 389 (Scheme 5.18). The lactol 389 could then be 
oxidised to give the bicyclic lactone 385. 
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Scheme 5.18 Enantioselective route to 385. 
 
Before any enantioselective reactions were attempted, the uncatalysed Diels-Alder 
reaction between dienol 383 and acrolein was first carried out (Scheme 5.19). Reaction 
occurred at room temperature to give the lactol 389 in good yield. Oxidation was then 
accomplished using PCC. 
 
I
OH
O
I
OH
H
H
O
I
O
H
H
a b
383
389 385  
Scheme 5.19 Reagents and conditions: (a) acrolein, MeOH/H2O 95:5, rt, 6 d, 66 %; (b) 
PCC, NaOAc, NaHCO3, CH2Cl2, 18 h, 84%. 
  
Reactions between dienol 383 and acrolein, ethyl acrylate and triflouroethyl acrylate in 
the presence of 388 were attempted. At best, only trace amounts of the desired product 
were formed. Chiral HPLC analysis of the products showed little to no ee. In order to 
determine if the catalyst was being formed an example from Corey’s paper was carried 
out. As this reaction was successful, we conclude that even though the catalyst 388 is 
reported to be of broad applicability, it was not useful for our diene. 
 
Due to time constraints, exploration of alternative catalysts was postponed and the 
synthesis of racemic triptolide was investigated. 
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5.3.3 Completion of the Synthesis of (±)-Triptolide 
5.3.3.1 Formation of the dienophile 50 
The requisite dienophile 50 was synthesised according to literature procedures (Scheme 
5.20).177 Friedel-Crafts reaction of hydroquinone and one equivalent of isopropanol 
gave a mixture of starting material, the desired product 391 and 2,5-
diisopropylhydroquinone. 2-isopropylhydroquinone 391 was obtained after 
recrystallisation. Subsequent oxidation gave 2-isopropyl-p-benzoquinone 50. The yield 
for this sequence is very low (7%) but compares well with that reported in the literature 
(11%). Nevertheless, substantial amounts of the desired product could be obtained as 
the reactions can be carried out on large scale and inexpensive starting materials are 
used. 
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Scheme 5.20 Reagents and conditions: (a) i-PrOH, ZnCl2, HCl, H2O, 98 
oC, 18 h; (b) 
KBrO3, H2SO4, H2O, dioxane, 70 
oC, 5 min, 7% over 2 steps. 
 
5.3.3.2 Formation of the tetracyclic core 
As the diene 49 and dienophile 50 were now in hand, a Diels-Alder reaction could be 
carried out. A solution of diene 49 and a slight excess of dienophile 50 in 
dichloromethane was compressed at 19 kbar pressure for seven days to give two 
products in a 83:17 ratio (Scheme 5.21). Single crystal X-ray analysis confirmed that 
the major product was indeed the desired tetracycle 48 (Figure 5.3). Due to striking 
similarities between the 1H NMR and 13C NMR spectra for both isomers, it is thought 
that the minor product is the regioisomer where the isopropyl group is in the C3 
position, however, this is yet to be confirmed. 
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Scheme 5.21 Reagents and conditions: (a) 50 (1.2 equiv), 19 kbar, CH2Cl2, 7 d, 50% of 
48. 
 
 
Figure 5.3 Thermal ellipsoid diagram of 48. Ellipsoids show 30% probability levels. 
 
The Diels-Alder reaction proceeded with a high level of stereoselectivity and 
regioselectivity. The major product is a result of the dienophile approaching the convex 
face of the bicyclic diene 49 in an endo orientation as depicted in 392 (Scheme 5.21). 
The regioselectivity observed is presumably a result of steric forces.  
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5.3.3.3 Synthetic strategy I 
With the tetracyclic core now in place, some functional group interconversions were 
required to complete the synthesis (Scheme 5.22). We planned to carry out a 
regioselective reduction of the ketone at C4, followed by dehydration and aromatisation 
to give phenol 396. Methyl ether formation followed by dehydrogenation across the 
C/D ring junction (cf 396) would give 47, thus completing the formal total synthesis of 
triptolide. 
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Scheme 5.22 Synthetic strategy 
 
5.3.3.3.1 Reduction of diketone 48 
Treatment of the diketone 48 with 0.8 molar equivalents of sodium borohydride resulted 
in the formation of a single product in quantitative yield (Scheme 5.23). Single crystal 
X-ray analysis revealed that the ketone next to the isopropyl group had been reduced 
(C1) (Figure 5.4). This result was unexpected since the isopropyl group was expected to 
inhibit approach of the nucleophile to the adjacent C=O group. Analysis of the crystal 
structure of the diketone 48, however, reveals that the C4 ketone is in a significantly 
more hindered position than the C1 ketone. 
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Scheme 5.23 Reagents and conditions: (a) NaBH4 (0.8 equiv), THF, H2O, 0 
oC, 30 min, 
99%. 
 
Figure 5.4 Thermal ellipsoid diagram of 397. Ellipsoids show 30% probability levels. 
 
5.3.3.4 Synthetic strategy II 
As the reduction occurred at the C1 ketone in preference to the C4 ketone, a new 
strategy was required. We envisaged a five step sequence to convert 397 into 47 which 
involved methylation to give 398, formation the vinyl triflate 399 followed by careful 
aromatisation then palladium-catalysed reductive removal of the triflate group to give 
355. Finally, dehydrogenation would give 47 (Scheme 5.24). 
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Scheme 5.24  Revised strategy 
 
5.3.3.4.1 Methyl ether formation 
As there are epimerisable positions in 397, a strong base could not be used to form the 
methyl ether 398. Thus, methylation was first attempted using conditions reported to 
prevent epimerisation.178 Alcohol 397 was treated with 30 equivalents of 2,6-di-tert-
butylpyridine and 15 equivalents of methyl triflate. No reaction was observed under 
these conditions. A base could be avoided altogether by using methyl iodide and silver 
oxide, however only a trace amount of the desired methyl ether 398 was formed when a 
solution of alcohol 397 in dichloromethane was treated with methyl iodide and silver 
oxide.179 Gratifyingly when the reaction was carried out with 10 equivalents of silver 
oxide and using methyl iodide as the solvent, the desired product 398 was obtained in 
near quantitative yield (Scheme 5.25). Single crystal X-ray analysis confirmed that 
epimerisation had not occurred (Figure 5.5). 
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Scheme 5.25 Reagents and conditions: (a) MeI, Ag2O, 41 
oC, 18 h, 99%. 
 
Figure 5.5 Thermal ellipsoid diagram of 398. Ellipsoids show 30% probability levels. 
 
5.3.3.4.2 Unexpected results from reaction of 398 with triflic anhydride 
Treatment of ketone 398 with 1.2 equivalents of 2,6-di-tert-butyl-4-methylpyridine and 
1.1 equivalents of triflic anhydride180 did not give any on the expected vinyl triflate 399 
and instead two other products were obtained (Scheme 5.26). The products were 
separated by column chromatography. 1H NMR analysis suggested that one of the 
products was in fact the penultimate target 355. This was confirmed by single crystal X-
ray analysis (Figure 5.6). The identity of the other major product was more elusive. 1H 
NMR analysis showed no peak due to the methyl ether or the methyl group at the ring 
junction. 13C NMR spectroscopy showed that only one carbon atom had been lost. This 
was confirmed by high resolution mass spectrometry. Finally, single crystal  X-ray 
analysis showed that 398 had undergone extensive rearrangement under the reaction 
conditions to form a novel ring system 400 (Figure 5.6). 
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Scheme 5.26 Reagents and conditions: (a) Tf2O (1.1 equiv), 2,6-di-tert-butyl-4-
methylpyridine (1.2 equiv), CH2Cl2, -78 
oC-rt, 48 h. 
 
 
 
 
Figure 5.6 Thermal ellipsoid diagrams for 355 and 400. Ellipsoids show 30% 
probability levels. 
 
The mechanism for the formation of 355 possibly proceeds via the path shown in 
Scheme 5.27. Formation of the triflate followed by enolisation gives 402. Protonation 
and deprotonation gives 404, which is then able to undergo elimination of triflic acid to 
give the product 355.  
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Scheme 5.27 A possible mechanism for the formation of 355 
 
A proposed mechanism for the formation of the rearranged product 400 is drawn in 
Scheme 5.28. The generation of a new five membered ring from the common 
intermediate 403 results in the formation of a stable tertiary carbocation 405. A 1,2-shift 
gives the spirocyclic ring system 406 while forming a new tertiary carbocation. 
Elimination gives the exocyclic double bond and hydrolysis gives the rearranged 
product 400. 
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Scheme 5.28 A possible mechanism for the formation of 400 
 
5.3.3.4.3 Dehydrogentation of 355 
Several options were available for the dehydrogenation of 355 to form the α,β-
unsaturated lactone 47. Studies on the model compound 408 showed that treatment with 
an excess of potassium hexamethyldisilazide, diphenyl diselenide and HMPA gave the 
intermediate selenide 409.181 Elimination across the ring junction to give the more 
substituted double bond (410) was accomplished in good yield using aqueous hydrogen 
peroxide (Scheme 5.29). Unfortunately, these conditions led to decomposition of the 
starting material when applied to 355. 
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Scheme 5.29 Reagents and conditions: (a) PhSeSePh (3.25 equiv), KHMDS (3.25 
equiv), HMPA, THF, -78 oC, 2 h; (b) TIPSOTf (2.0 equiv), NEt3 (3.0 equiv), PhSeCl 
(3.0 equiv), CH2Cl2, rt, 10 min; (c) H2O2, CH2Cl2, 0 
oC, 2 h, 66%. 
 
Alternative conditions that did not require the use of a strong base were sought. 
Treatment of the model compound 408 with an excess of triisopropylsilyl triflate and 
triethylamine resulted clean conversion to the corresponding silyl ketene acetal. All 
attempts to isolate the silyl ketene acetal were met with hydrolysis back to 408. Thus, 
the silyl enol ether was formed in situ then treatment with phenylselenyl chloride gave 
selenide 409. Gratifyingly, when these conditions were applied to the real system 355, 
selenide 411 was generated. Treatment of a solution of the crude selenide in 
dichloromethane with aqueous hydrogen peroxide resulted in elimination across the ring 
junction to give 47, thus completing the formal total synthesis of (±)-triptolide (Scheme 
5.30). Unfortunately, due to time constraints, conditions for this reaction could not be 
optimised. 
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Scheme 5.30 Reagents and conditions: (a) TIPSOTf (6.0 equiv), NEt3 (8.0 equiv), 
PhSeCl (8.0 equiv), CH2Cl2, rt, 10 min; (b) H2O2, CH2Cl2, 0 
oC, 2 h, 50% by NMR. 
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5.4 Conclusions and Future Work 
 
A concise formal total synthesis of (±)-triptolide was completed (Scheme 5.31). The 
iodide 383 was formed in two steps from commercially available material, following 
literature procedures. Regioselective and stereoselective Diels-Alder reaction with 
methyl acrylate gave the bicylic iodide 385. This was converted to the semi-cyclic diene 
49 via a Stille coupling. A second Diels-Alder reaction gave the tetracyclic intermediate 
48. In just four more synthetic steps the tetracyclic target 47 was obtained. This 
intermediate has previously been converted to triptolide through an eight step sequence. 
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Scheme 5.31 Reagents and conditions: (a) EtMgBr, (CH2O)n, THF, 56%; (b) LiAlH, I2, 
-78 - 0 oC, 42% (E/Z 73:27); (c) methyl acrylate, PhMe, 100 oC, 18 h, 61%; (d) 
tributyl(vinyl)tin, Pd2(dba)3, tri(2-furyl)phosphine, PhMe, 60 
oC, 24 h, 86 %; (e) 50 (1.2 
equiv), 19 kbar, CH2Cl2, 7 d, 50%; (f) NaBH4 (0.8 equiv), THF, H2O, 0 
oC, 30 min, 
99%; (g) MeI, Ag2O, 41 
oC, 18 h, 99%; (h) Tf2O (1.1 equiv), 2,6-di-tert-butyl-4-
methylpyridine (1.2 equiv), CH2Cl2, -78 
0C-rt, 48 h; (i) TIPSOTf (6.0 equiv), NEt3 (8.0 
equiv), PhSeCl (8.0 equiv), CH2Cl2, rt, 10 min; then H2O2, CH2Cl2, 0 
oC, 2 h, 50% by 
NMR. 
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The possibility of carrying out the first Diels-Alder reaction in the presence of a suitable 
catalyst to selectively give either enantiomer of triptolide remains. The stereocentres 
formed during the first Diels-Alder reaction would be used to stereoselectively control 
the formation of the quaternary stereocentre present in the target compound. If 
successful, this would be the first catalytic enantioselective synthesis of the natural 
product. While the use of Corey’s catalyst does not look promising there are many other 
catalysts available, such as MacMillan’s organocatalyst. The methods developed could 
also be applied to the synthesis of related natural products such as wilforinide 413 
(Scheme 5.32). 
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Scheme 5.32 Possible synthesis of wilforonide 
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6 Diene-Transmissive Diels-Alder Approaches to 
Tetracyclic Natural Product Frameworks 
6.1 Introduction 
 
With the growing interest in cascade sequences, many groups have recognised the 
power of the intramolecular Diels-Alder (IMDA) reaction. There is only one previous 
example, however, of a diene-transmissive Diels-Alder (DTDA) sequence that involves 
two consecutive IMDA reactions (see Scheme 4.31).142  
 
There are several different ways in which two dienophiles can be connected to a 
[3]dendralene, to allow a sequence of two IMDA reactions. A DTDA sequence of 
precursor 53 could produce either the carbon skeletons 55 or 57, depending on the order 
of the cycloadditions (Scheme 6.1).  
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Scheme 6.1 Diene-transmissive sequences to give carbon skeletons 55 and 57. 
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6.1.1 Perhydropyrene Ring System 
Diisocyanoadociane, the first example of a diterpene containing a perhydropyrene ring 
system, was isolated from a marine sponge of the genus Amphimedon (ex. Adocia) in 
1976.182 The skeleton is unusual in that it contains no angular methyl substituents. It’s 
biosynthesis might involve a unique tetracyclisation along with a single methyl 
migration (Figure 6.1).157  
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Figure 6.1 Possible biosynthesis of 7,20-Diisocyanoadociane. 
 
Examples of related natural products isolated from marine sponges are illustrated in 
Figure 6.2. Many display significant and selective in vitro antimalarial activity.183 
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Figure 6.2 Tetracyclic diterpenes isolated from marine sponges Amphimedon sp. and 
Cymbastela hooperi. 
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Several studies have been carried out on the biosynthesis of 7,20-diisocyanoadociane 
417.184-188 Only one total synthesis189 and one formal total synthesis has been 
reported.190 In 1987, Corey reported a synthesis of a single enantiomer of the natural 
product, allowing the assignment of the absolute configuration of 417 (Scheme 6.2).189 
 
The vinyl ketone 427, synthesised in three steps from menthol and glutaric acid, was 
transformed into the ethylene ketal by a two step sequence. Reaction with LDA and 
methyl crotonate gave the Michael adduct 428 as a 8:1 mixture of diastereomers. After 
removal of the auxiliary by reduction with LiAlH4, the resulting alcohol was converted 
to the E-diene by a two step sequence. The triene 432 underwent IMDA reaction upon 
heating in toluene at 150 oC for 20 hours to give the trans-fused adduct 433 in 90% 
yield. The free enone corresponding to ketal 432 undergoes an IMDA reaction rapidly 
at or below room temperature to give the cis-fused adduct exclusively. It is thought that 
steric interactions involving the ketal unit in 432 disfavour the endo transition state. 
 
The bicyclic product 433 was converted to a second IMDA precursor through a five 
step sequence. Triene 438 was heated in toluene at 185 oC for 36 hours to give the 
desired adduct 439 in 54% yield along with 36% of a diastereomeric adduct. Removal 
of the benzyl group followed by oxidation gave aldehyde 440, which was converted to 
the all trans-fused ketone 441.  
 
Finally, the two isocyanide groups were installed through a single “biomimetic” 
operation. A mixture of four diastereomeric isocyanides was obtained. Separation of the 
mixture by HPLC gave 7,20-diisocyanoadociane 417.  
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Scheme 6.2 Reagents and conditions: (a) 1.1 equiv tributyl(vinyl)tin, 0.34 mol% 
Pd(PPh3)4, THF, 70 
oC, 2 h, 90%; (b) 1.3 equiv PhSeSiMe3, 5 equiv ethylene glycol, 
0.025 equiv I2, CHCl3, 65 
oC, 4h, 99%; (c) 1.5 equiv mCPBA, CH2Cl2, -20 
oC, 15 min 
then 0.8 equiv DMS, 3 equiv DIPA, 60 oC, 6.5 h, 90%; (d) LDA, 1.1 equiv methyl 
crotonate, - 78 oC, 1 h, 80% (threo/erythro 8:1, ca. 60%ee); (e) 2.3 equiv 
NaAl(CH3OCH2CH2O)2H2, Et2O, -40 
oC, 1.5 h; (f) 1.05 equiv TBSCl, 1.2 equiv NEt3, 
0.4 equiv DMAP, CH2Cl2, 30 min, 85% for 2 steps; (g) 0.4 M LiAlH4, Et2O, 1.5 h, 90 
%; (h) 3 equiv PDC, 4 Å molecular sieves, CH2Cl2, 30 min; (i) 1.2 equiv 
methylallyldiphenylphosphonium bromide, 1.1 equiv KO-t-Bu, THF, 0 oC, 45 min, 75% 
for 2 steps; (j) PhMe, 150 oC, 20 h, 90%; (k) Bu4NF, THF, 1.5 h; (l) PDC, 4 Å 
molecular sieves, CH2Cl2, 30 min, 82% 2 steps; (m) triethyl lithio-4-phosphono-E-
crotonate, THF -78 oC – rt, 1 h, 70%; (n) 2.2 equiv DIBAL-H, PhMe, -20 oC, 10 min; 
(o) 4 equiv NaH, 1.4 equiv BnBr, DMSO, 30 min, 89% 2 steps; (p) 0.04 M sol in PhMe, 
185 oC, 36 h, 54% desired adduct, 36% diastereomeric adduct; (q) 1 atm H2, Pd-C, 
ethanol, 4.5 h, 80 %; (r) PDC, 4 Å molecular sieves, CH2Cl2, 30 min, 80%; (s) 
pyrrolidine, pTsOH, C6H6, 10 h, 90%; (t) ruthenium tetroxide, CCl4, 0 
oC, 5 min; (u) 1 
M NaOMe in MeOH, 2 min, 75%; (v) 1.05 equiv LDA, 5 equiv MeI, -78 – 23 oC over 
20 min; (w) 0.5 M NaOMe in 1:1 THF/MeOH, 12 h, 90%; (x) 0.5 M HCl in 50% aq, 
acetone, 99%; (y) 4.8 equiv MeLi, 5 equiv CeCl3, THF, -78 - 0 
oC, 1.5 h, 92%; (z)  3 
equiv trifluoroacetic anhydride, 5 equiv pyridine, CH2Cl2, 0 
oC, 20 min, 95%; (aa) 15 
equiv TMSCN, 20 equiv TiCl4, CH2Cl2, 3.5 h, 70 % of 4 diastereomeric isocyanides. 
 
Recently, Mander reported a total formal synthesis of racemic 7,20-diisocyanoadociane 
417 (Scheme 6.3).190 Birch reduction of 2-methoxy-5-methylbenzoate 443 and in situ 
alkylation followed by Friedel-Crafts cyclisation gave 445. AlCl3-catalyzed acylation of 
the styrene double bond with propionyl chloride gave the key intermediate 446.  
 
A nine-step sequence involving reduction, protection, oxygenation and a retro-Claisen 
reaction led to 447. From this point, a ten-step sequence, including another Birch 
reduction, led to the next key intermediate 448. After another nine steps 449 was 
obtained. This compound has both quaternary centres in place and is the precursor for 
the final cyclisation.  
 
Following the intramolecular Michael reaction to give the tetracyclic intermediate 450, 
reduction gave the diol. Conversion to the dixanthate and subsequent Barton-McCombie 
deoxygenation gave the tetracycle 451. Demethylation of the ester groups preceeded 
preparation of the diacyl azide 452. Curtius rearrangement to 453 was achieved by 
heating in toluene at reflux. Finally, hydrolysis in concentrated HCl gave the diamine 
454, thus completing the formal total synthesis of 7,20-diisocyanoadociane 417.  
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Scheme 6.3 Reagents and conditions: (a) i) Li, NH3; ii) BF3.Et2O, 85%; (b) EtCOCl, 
AlCl3, 75%; (c) NEt3, HOCH2CH2OH, 70 
oC, 4 days, 71% (4:3 mixture R = 
CH2CH2OH to R = Me); (d) NaBH4, CeCl3; (e) NaHMDS, CS2, MeI; (f) n-Bu3SnH, 
AIBN, 47% 3 steps; (g) n-PrSNa, 87%; (h) (COCl)2; (i) NaN3; (j) PhMe, 110 
oC; (k) 
concd HCl, 39% 4 steps. 
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When the two previous syntheses are analysed retrosynthetically, it can be seen that 
they have little in common. In Corey’s synthesis, the key ring forming steps are two 
IMDA reactions where the double bond formed in the first IMDA acts as the dienophile 
in the second IMDA reaction (Scheme 6.4). While this approach is very elegant, several 
manipulations are carried out between the two Diels-Alder reactions.  
 
Diels-Alder Diels-Alder
455 456 457  
Scheme 6.4 Key disconnections in Corey’s synthesis 
 
In Mander’s synthesis, the key ring forming events are: (a) a Birch reduction with in 
situ alkylation and cyclisation and, (b) an intramolecular Michael reaction (Scheme 
6.5). 
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Scheme 6.5 Key disconnections in Mander’s synthesis 
 
Both of these elegant syntheses are landmark achievements. Nevertheless, they involve 
long linear sequences of either 26 steps (Corey) or 40 steps (Mander). A short synthetic 
route to a cycloamphilectane natural product would represent a significant new 
contribution to this area. 
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6.1.2 Cembrene-Derived Carbon Skeletons 
 
The defence secretions of soldier termites from the Nasutitermitinae subfamily have 
been found to contain a variety of structurally complex diterpenes.191 Many of these are 
based on the kempane 460 or rippertane 461 skeletons, which are formed from a 
common precursor, cembrene A 462 (Figure 6.3). 
 
kempane 460 rippertane 461 cembrene A 462  
Figure 6.3 The kempane and rippertane skeletons 
After the isolation of these unusual diterpenes, the defence secretions of other South 
American termites were investigated192 and several other related tetracyclic natural 
products were isolated (Figure 6.4). 
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Figure 6.4 Kempane and rippertane natural products 
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Several groups have attempted the synthesis of kempane diterpenes, with varying levels 
of success.193-203 In 1991, Dauben reported the total synthesis racemic kempene-2 465 
(Scheme 6.6). This remains the only successful synthesis of a natural product from this 
class.193 The first step of the synthesis involved a Lewis-acid catalysed Diels-Alder 
reaction between 2,6-dimethylbenzoquinone and isoprene to give a mixture of 
regioisomeric products. Reduction of the quinone double bond under equilibrating 
conditions gave 470 in 13% yield. The less hindered carbonyl group was reduced with 
L-Selectride to give the axial alcohol as a single isomer. After protection of the alcohol 
as the benzyl ether 471, the remaining carbonyl was converted into a vinyl group 473 by 
a 3 step sequence. Selective hydroboration followed by oxidative work-up gave the 
primary alcohol which was then converted into the benzyl ether 474. Hydroboration 
followed by oxidation gave ketone 475 as a mixture of diastereomers. The mixture was 
treated with pyridinium bromide perbromide, with the resulting bromides being 
subjected to elimination conditions to give 477, a key intermediate in the synthesis. 
 
A second Lewis-acid catalysed Diels-Alder reaction with isoprene gave 478 as the 
major cycloadduct. Dihydroxylation and removal of the benzyl protecting groups gave 
the tetrol 479 as a mixture of isomers. Glycol cleavage and treatment with acid yielded 
the dienol ether 481. Acetylation, hydrolysis of the enol ether and oxidation of the 
primary alcohol gave enone aldehyde 482.  
 
The final step of the synthesis was Ti0-induced McMurry coupling to form the 
tetracyclic skeleton, yielding (±)-kempene-2 465 in 24 steps and 0.04% overall yield. 
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Scheme 6.6  Reagents and conditions: (a) BF3.Et2O, isoprene, 96 h; (b) Zn, HOAc, 
reflux, 18 h, 13% over 2 steps; (c) L-Selectride, THF, -78 oC then 0 oC, NaOH, H2O2, 
82%; (d) NaH, BnBr, Bu4NI, THF, 72 h, 83%; (e) CH3OCH2TMS, sec-BuLi, THF, -60 
oC to -20 oC, 1 h, then 471, -40 oC, 30 min; (f) HCO2H, EtOH, 73% 2 steps; (g) 
CH3PPh3I, KOtBu, THF, 0 
oC, 1 h, then 472, rt, 18 h, 78%; (h) HB(sia)2, THF, 40 
oC, 
72 h then 0 oC, NaOH, H2O2, 82%; (i) NaH, BnBr, Bu4NI, THF, 48 h, 98%; (j) 
BH3.THF, 0 
oC, 6 h then NaOH, H2O2, 77%; (k) (COCl)2, DMSO, CH2Cl2, 90%; (l) 
py.HBr.Br2, THF, -78 
oC, 30 min; (m) LiBr, Li2CO3, DMF, 120 
oC, 16 h, 60% of 477 
and 23% of 476; (n) Bu3SnH, AIBN, C6H6, reflux, 24 h, 53%; (o) EtAlCl2, PhMe, 5 min 
then isoprene, 80 oC, sealed tube, 24 h, 66%; (p) HPLC; (q) Cat OsO4, (CH3)2CO/H2O, 
95%; (r) H2, 10% Pd/C, AcOEt, 88%; (s) NaIO4, dioxane/H2O, 81% (t) Cat TsOH.H2O, 
C6H6, 80 
oC, 2h, 61%; (u) Ac2O, pyridine, DMAP, 66%; (v) HCl, EtOH, 80 
oC, 68%; 
(w) PCC/Al2O3, hexane/CH2Cl2, 57%; (x) TiCl3(DME)1.5, Zn-Cu, DME, reflux, 4h, 
then 482 added over 12 h, 2 h reflux, 32%.  
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While other groups have successfully synthesised the tetracyclic kempane/rippertane 
framework194,195,203-206 the synthesis of most relevance to this study involves an IMDA 
reaction of a fulvene (Scheme 6.7).201 Selective reduction of 483 followed by oxidation 
with PCC gave aldehyde 485. Stereoselective Michael addition of 485 and methyl vinyl 
ketone gave 486 in 73% yield as a 3:1 diastereomer ratio. Horner-Wadsworth-Emmons 
Olefination, followed by condensation of the ketone with cyclopentadiene gave fulvene 
488. Heating 488 in toluene resulted in an IMDA reaction to give the tricyclic product 
489. Reduction of the methyl ester 489 to the alcohol, followed by oxidation gave the 
aldehyde 490. Finally, Prins reaction of 490 with TiCl2(i-OPr)2 gave the tetracyclic 
skeleton 491. 
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Scheme 6.7 Reagents and conditions: (a) BH3-SMe2, 84%; (b) PCC, 81%; (c) MVK, 
THF, HFIP, (R)-2-Benzhydryipyrolidine, 73%; (d) LDA, THF, 
(EtO)2P(O)CH2CH=CHCO2Et, 69%; (e) cyclopentadiene, pyrrolidine, MeOH, 85%; (f) 
PhMe, 110 oC, 71%; (g) i) DIBALH, THF; ii) DMP, CH2Cl2, 71%; (h) TiCl2(i-OPr)2, 
CH2Cl2, 82%. 
 
The tetracyclic framework 491 was synthesised though a concise and impressive 
sequence that involves just eight linear steps. 
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6.2 Aims 
 
We have demonstrated that diene-transmissive Diels-Alder (DTDA) sequences 
involving internally-substituted [3]dendralenes are useful for the rapid assembly of 
fused tetracyclic frameworks common to many natural products (Chapter 4). We now 
aim to synthesise the tetracyclic cycloamphilectane and kempane frameworks through 
DTDA sequences involving a terminally-substituted [3]dendralenes (Scheme 6.1). 
 
We aim to demonstrate that a DTDA sequence can be used for the rapid construction of 
the cycloamphilectane framework. It is envisaged that the all-trans stereochemistry in 
the target could be obtained via epimerisation of the tetracyclic adduct 493 (Scheme 
6.8). The use of internally activated dienophiles would result in carbonyl groups being 
in ideal locations for both the epimerisations and the other functional group 
interconversions. So, an efficient route to the DTDA precursor 494 is required. The 
[3]dendralene moiety will be installed through an olefination reaction while the 1,6-
dioxygenation of the DTDA precursor invokes ozonolysis of a cyclohexene as the first 
step.  
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Scheme 6.8 Retrosynthesis of a cycloamphilectane natural product 
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A reliable method for the synthesis of terminally-substituted [3]dendralenes must be 
developed. Since chiral aldehyde 93 was readily available from earlier studies (Chapter 
2, 3 and 4), model studies will be directed towards the synthesis of simple chiral 
[3]dendralene 499 (Scheme 6.9). 
 
OTBS
O
OTBS
93 499  
Scheme 6.9 A simple chiral terminally-substituted [3]dendralene 
 
6.3 Results and Discussion 
6.3.1 Synthesis of a Terminally-Substituted [3]Dendralene 
We initially attempted the synthesis of the terminally-substituted [3]dendralene 499 by 
applying a similar method to that developed by Fallis for the synthesis of internally 
substituted [3]dendralenes (Scheme 4.9).122 Thus, the known bromide 500, generated in 
three steps from isoprene,207 was used in an indium-mediated coupling208 with aldehyde 
93 (Scheme 6.10). The resulting mixture of diastereomeric alcohols 501 were 
dehydrated under Mitsunobu conditions to give the [3]dendralene 499 in a disappointing 
yield of 26%. The overall low yield for this sequence prompted us to investigate an 
alternative path. 
 
OTBS
O
Br +
OTBS OTBS
a b
OH
500 93
501 499  
Scheme 6.10 Reagents and conditions: a) In (1.1 equiv), DMF, rt, 18 h, 58%; b) PPh3 
(2.0 equiv), DEAD (2.0 equiv), THF, reflux, 5 h, 26%.  
 
The phosphonium salt 502,209 synthesised from the bromide 500, was used in a Wittig 
reaction with aldehyde 93 (Scheme 6.11). Several attempts were made to optimise this 
reaction by varying the solvent, temperature and time but the best result obtained was a 
37% yield of a mixture of E/Z isomers of 499 and 503. 
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OTBS
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PPh3Br +
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502 93 499 503  
Scheme 6.11 Reagents and conditions: a) n-BuLi (1.0 equiv), THF, -78 oC – rt, 1.5 h, 
37%. 
 
Yamamoto has reported that allyldiphenylphosphine oxide 504 undergoes highly E-
selective Horner-Emmons type couplings with several different aldehydes (Scheme 
6.12).210,211  
 
P(Ph)2
O O
+
a
504 505 506  
Scheme 6.12 Reagents and conditions: a) n-BuLi (1.0 equiv), HMPA (2.0 equiv), THF,  
-78 oC – rt, 4 h, 82% (E/Z 90:10). 
 
It was anticipated that a vinyl substituent (compare 504 Scheme 6.12 with 512 Scheme 
6.13) would not alter the reactivity of the phosphine oxide. Thus, the phosphine oxide 
512 was synthesised according to Scheme 6.13. Propargyl alcohol was reacted with 
diphenylphosphine chloride according to the procedure of Brandsma.212 The 
intermediate alkyne 509 undergoes a spontaneous rearrangement to give the allene 510. 
Reaction with sodium iodide in acetic acid gave the iodide 511.213 Stille reaction 
between iodide 511 and tributyl(vinyl)tin gave the desired phosphine oxide 512 in good 
yield. Negishi and Suzuki reactions were also attempted without success, presumably on 
account of the base sensitive nature of the substrate. 
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Scheme 6.13 Reagents and conditions: a) NEt3 (1.1 equiv), CH2Cl2, -80 
oC, 5 min, 
100%; b) LiI, AcOH, 100 oC, 18 h, 81%; c) tributyl(vinyl)tin (1.2 equiv), Pd(CH-
3CN)2Cl2 (0.05 equiv), DMF, rt, 3 h, 72%.  
 
Gratifyingly, reaction between phosphine oxide 512 and aldehyde 93 yielded the chiral 
[3]dendralene 499 as a single isomer in acceptable yield (Scheme 6.14). With a reliable 
method for the preparation of terminally-substituted dendralenes now available, we 
turned our attention to the synthesis of a DTDA precursor. 
 
+P(Ph)2
O
OTBS
O
OTBS
a
512 93 499  
Scheme 6.14 Reagents and conditions: a) nBuLi (1.2 equiv), HMPA (2.4 equiv), THF,   
-78 oC – rt, 4 h, 55%. 
 
6.3.2 Synthesis of the Tetracyclic Framework 
6.3.2.1 Synthetic Strategy 
The pseudo-symmetrical nature of the DTDA precursor lends itself to an efficient two 
directional214 synthesis (Scheme 6.15). Ozonolysis of (cyclohex-3-enyl)methyl benzoate 
498 with in situ reduction should give a 1,6-diol. Protection of the diol followed by ester 
cleavage and oxidation is expected to give the aldehyde. After the dendralene is 
installed through the Horner-Emmons-type Olefination, the two dienophile units can be 
constructed. We aim to do this through a four step sequence involving deprotection, 
oxidation, Grignard reaction and oxidation. 
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Scheme 6.15 Synthetic strategy 
It is anticipated that the first Diels-Alder reaction (516 to 517, Scheme 6.15) would 
occur via an endo transition state to give a cis ring junction,189 with the dienophile-
containing side chain in an equatorial position. The second Diels-Alder reaction is also 
expected to proceed via an endo transtion state, with the dienophile approaching the 
diene from the less hindered π-diasteroface, resulting in a trans fusion between the D 
and B rings (518, Scheme 6.15). Base-promoted epimerisation should give the most 
thermodynamically stable all trans ring system required for the natural product. 
 
6.3.2.2 Synthesis of aldehyde 497 
1,2,3,6-Tetrahydrobenzaldehyde 520 was reduced with lithium aluminium hydride and 
the subsequent alcohol was protected as the benzoate to give 498 in high yield (Scheme 
6.16). Ozonolysis and in situ reduction with sodium borahydride followed by protection 
of the resulting diol gave the differentially protected triol 513. Removal of the benzoate 
protecting group was achieved with sodium hydroxide in methanol. Finally, Swern 
oxidation gave the required aldehyde 497. 
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Scheme 6.16  Reagents and conditions: a) LiAlH4 (1.2 equiv), Et2O, 0 
oC, 1 h, 100%; 
b) NEt3 (1.2 equiv), BzCl (1.2 equiv), CH2Cl2, rt, 18 h, 84%; c) O3, NaHCO3, NaBH4, 
CH2Cl2, MeOH; d) imidazole (3.0 equiv), TBSCl (2.5 equiv), DMF, 1.5 h, 80% over 2 
steps; e) NaOH, MeOH, 18 h, rt, 77%; f) (COCl)2 (1.2 equiv), DMSO (2.0 equiv), NEt3 
(4.0 equiv), CH2Cl2, -78 
oC – rt, 1.5 h, 76%. 
 
6.3.2.3 DTDA sequence 
To our delight, the Horner-Emmons-type reaction between aldehyde 497 and phosphine 
oxide 512 resulted in an 86% yield of the terminally-substituted [3]dendralene 514 
(Scheme 6.17). The Z-isomer of the dendralene was not detected. Removal of the silyl 
protecting groups with tetrabutyl ammonium flouride gave the diol 522. Oxidation to 
the dialdehyde 515 occurred under Swern reaction conditions. The dialdehyde 515 was 
not purified as it was feared it would not be stable towards column chromatography. 
Instead, the crude dialdehyde 515 was treated with an excess of vinyl magnesium 
bromide to give the diol 523. The crude diol 523 was then oxidised under Swern 
conditions to give the DTDA precursor 516. This product was not isolated and instead, 
the reaction was worked up in the usual manner and a small amount of triflouroacetic 
acid was added. After 48 h at room temperature the reaction mixture was concentrated 
in vacuo. 1H NMR analysis of the crude product revealed that there was one major 
product from the reaction. High resolution mass spectrometry suggested that the desired 
product had in fact been formed.  
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Scheme 6.17 Reagents and conditions: a) 512 (1.1 equiv), n-BuLi (1.2 equiv), HMPA 
(2.4 equiv), THF,   -78 oC – rt, 86%; b) TBAF (3.0 equiv), THF, rt, 2 h, 76%; c) 
(COCl)2 (2.4 equiv), DMSO (4.0 equiv), NEt3 (8.0 equiv), CH2Cl2, -78 
oC – rt, 1.5 h; d) 
vinyl magnesiumbromide (1.0 M, 5.1 equiv), THF, 1 h; e) (COCl)2 (2.4 equiv), DMSO 
(4.0 equiv), NEt3 (8.0 equiv), CH2Cl2, -78 
oC – rt, 1.5 h; f) TFA (5 equiv), 48 h, 3% 
over 4 steps. 
 
The tetracycle 524 was purified by semi-preprative HPLC to give a small amount of 
pure material, representing a 3% yield from the diol 523. Optimisation of the yield was 
deferred until the stereochemistry of the product could be determined. The 800 MHz 1H 
NMR spectrum for 524 is very complicated, with 19 signals appearing between 1.2 and 
2.8 ppm and only one alkenic signal. Thus, NMR techniques could not be used to 
determine the stereochemistry. 
 
Single crystal X-ray analysis revealed the stereochemistry of the tetracycle 524 is as 
depicted in Figure 6.5.  
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Figure 6.5 Thermal ellipsoid diagram of 524. Ellipsoids show 30% probability levels. 
 
Disappointingly, this is not the stereochemistry required for the synthesis of the target 
natural product 414 (see Scheme 6.1). As predicted, the first Diels-Alder reaction 
proceeds via an endo transition state with the dienophile approaching the diene from 
below. The second Diels-Alder reaction also proceeds via an endo transition state with 
the dienophile once again approaching the diene from below (526, Scheme 6.18). This 
sequence results in a fixed cis fusion between rings B and D (524, Scheme 6.18). This 
result was unexpected due to the stereochemistry at C6 relative to that at the AB ring 
junction (517, Scheme 6.18). The side-chain containing the dienophile is pointing up, 
therefore it was expected to approach the diene from above. Inspection of a Drieding 
model of the bicyclic intermediate, however, suggests that the dienophile can only 
approach the diene from below. In order to get the required trans ring fusion, the second 
Diels-Alder reaction would have to proceed via an endo transition state with the 
dienophile approaching the diene from above. 
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Scheme 6.18 Stereoselectivity in the DTDA sequence 
 
6.4 Conclusions and Future Work 
 
The tetracycle 524, possessing the carbon skeleton common to several 
cycloamphilectane natural products, was obtained through a short synthetic sequence of 
11 steps. As the tetracycle with the required stereochemistry could not be obtained, an 
alternative approach must be devised. In his synthesis of 7,20-diisocyanoadociane 417, 
Corey noted that the intramolecular Diels-Alder reaction of ketone 527 proceeded 
rapidly at room temperature or below to give the cis fused adduct  528 resulting from an 
endo mode of cyclisation (Scheme 6.19).189 In contrast, the corresponding ketal 432 
undergoes a Diels-Alder reaction under more forcing conditions to give the trans fused 
adduct 433 resulting from the exo mode of cyclisation. The reversal in selectivity is 
thought to be brought about by the ketal unit, which disfavours the endo transition state 
relative to the exo transition state.  
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Scheme 6.19 Reagents and conditions: a) rt; b) PhMe, 185 oC, 36 h, 54%. 
 
It is envisaged that we could take advantage of this reversal of selectivity by 
synthesising the DTDA precursor 529 (Scheme 6.20). Cyclisation should lead first to 
the trans-fused bicylic intermediate 530. Models suggest that the second Diels-Alder 
reaction should proceed through an exo-transition state with the dienophile approaching  
the diene from above, as depicted in 531. This would give the tetracycle 532, possessing 
the same relative stereochemistry as that observed in the natural products of interest. 
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Scheme 6.20 Proposed synthesis of a tetracycle with the correct relative 
stereochemistry. 
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Once a tetracycle with the correct relative stereochemistry is synthesised, simple 
functional group interconversions would lead to natural products of the 
cycloamphilectane class. Studies into the possibility of controlling the order of the 
cycloadditions in the DTDA sequence, to gain access to the kempane class of natural 
products, are currently underway. 
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7 Experimental  
7.1 General Methods 
NMR spectra were recorded at 298K using a Varian Unity INOVA 500 MHz, Bruker 
DPX/DRX 400 Mhz or a Varian Unity INOVA 300 MHz spectrometer. Residual 
acetone (δ2.04 ppm), benzene (δ7.15 ppm), chloroform (δ7.26 ppm), and methanol 
(δ3.31 ppm) were used as internal references for 1H NMR spectra measured in these 
solvents. Residual acetone (δ29.8 ppm , 206.8   ppm), benzene (δ128.1 ppm), 
chloroform (δ77.1 ppm), and methanol (δ49.0 ppm) were used as internal references for 
13C NMR spectra. Assignment of proton signals was assisted by 1H–1H COSY and 
NOESY experiments when necessary. IR spectra were recorded on a Perkin–Elmer 
1600 F.T.I.R,, a  Perkin–Elmer Spectrum One spectrometer or a Perkin-Elmer Paragon 
1000 FT-IR spectometer as neat films on NaCl plates for oils or as KBr pellets for solid 
products. Low resolution mass spectra were recorded on a Finnigan PolarisQ ion trap 
mass spectrometer using electron impact (EI) ionisation mode at 40 or 70 eV. Low 
resolution electrospray ionisation spectra were recorded on a Finnigan LCQ ion trap 
mass spectrometer. High resolution mass spectra were recorded on a VG Autospec mass 
spectrometer operating at 70 eV. High resolution electrospray ionisation spectra were 
recorded on a Bruker BioApex FTICR with an Analytica ESI source, operating at 4.7 T. 
Melting points were measured on a Reichert melting point stage and are uncorrected. 
Optical rotations were measured with an Optical Activity Polaar 2001, Perkin Elmer 
241 optical polarimeter or an Optical Activity Limited AA-100 polarimeter. HPLC was 
performed using a Shimadzu LC-10ADVP pump with a Shimadzu SIL-10ADVP 
autoinjector or a Shimadzu LC-8A preprative pump monitored by a Shimadzu SPD-
PAVP UV detector at  λ = 254 nm  and a Shimadzu RID-10A refractive index detector 
or a Waters 510EF chromatograph pump and Waters U6K injector monitored by an 
Waters Lambda-Max 481 UV spectrophotometer at λ = 254 nm and an Erma ERC-7512 
refractive index detector or a Waters 510EF chromatograph pump and Waters U6K 
injector monitored by an ISCO 226 UV spectrophotometer at λ = 254 nm and a Waters 
R403 refractive index detector. GC measurements were recorded on an Agilent 6850 
gas chromatograph with a split/splitless capillary inlet and FID detector or GC 
measurements were recorded on a Hewlett Packard 5890A gas chromatograph with a 
split/splitless capillary inlet and FID detector. GC data was processed using Hewlett 
Packard ChemStation software. Analytical TLC was performed with Merck silica gel 
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plates, precoated with silica gel 60 F254 (0.2 mm). Flash chromatography employed 
Merck Kiesegel 60 (230–400 mesh) silica gel. 
 
Reactions were conducted under a positive pressure of dry argon or nitrogen. Benzene, 
diethyl ether, toluene and tetrahydrofuran were dried over sodium wire and distilled 
from sodium benzophenone ketyl. Dichloromethane was distilled from calcium hydride. 
Chlorobenzene was purified by the method of Perrin and Armarego.215 Commercially 
available chemicals were purified by standard procedures or used as purchased. 
 
7.2 Chapter 2 
7.2.1 Chiral Dienols 
Ethyl (2R, 3S)-3,4-O-isopropylidene-2,3,4-trihydroxybutanoate 84 
CO2Et
OH
O
O
84  
L-ascorbic acid (100g, 0.57 mol) was protected based on the method of Jung and 
Shaw87 to give 5,6-O-isopropylidene-L-ascorbic acid (93.6 g, 0.43 mol, 76%) as a white 
crystalline solid. Oxidative cleavage of 5,6-O-isopropylidene-L-ascorbic (93.6 g, 0.43 
mol) acid and esterification of the resulting potassium salt was based on the method of 
Abushanab et al88,89 to give ethyl (2R, 3S)-3,4-O-isopropylidene-2,3,4-
trihydroxybutanoate 84 (69.0 g, 0.33 mol, 78%) as a yellow oil. 1H NMR data for this 
compound was consistent with that previously reported.216,217 
 
(2R,3S)-3,4-O-Isopropylidene-2-((tert-butyldimethylsilyl)oxy)-3,4-dihydroxybutanal 85 
CHO
OTBS
O
O
85  
The TBS ether of ethyl (2R,3S)-3,4-O-isopropylidene-2,3,4-trihydroxybutanoate 84 
(10.2 g, 50 mmol) was synthesised according to the procedure of Lilly.216,217 Distillation 
gave ethyl (2R,3S)-3,4-O-isopropylidene-2-((tert-butyldimethylsilyl)oxy)-3,4-
dihydroxybutanoate (10.8 g, 30 mmol, 68%) as a colourless oil. 1H NMR data for this 
compound was consistent with that previously reported.216,217 
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Reduction of ethyl (2R,3S)-3,4-O-isopropylidene-2-((tert-butyldimethylsilyl)oxy)-3,4-
dihydroxybutanoate (10.8 g, 34 mmol) was carried out according to Lilly’s procedure  
Distillation gave (2R,3S)-3,4-O-Isopropylidene-2-((tert-butyldimethylsilyl)oxy)-3,4-
dihy-droxybutanal 85 (7.97 g, 29 mmol, 86%) as a colourless oil. 1H NMR data for this 
compound was consistent with that previously reported.216,217 
 
Triethyl phoshonocrotonate 95 
P(OEt)2
CO2Me
O
95  
This product was formed following literature procedure.92 Methyl 4-bromocrotonate 
(11.28 g, 63 mmol, 1.0 equiv) was added to triethyl phosphite at such a rate that the 
temperature remained at 130 oC. The mixture was stirred at this temperature for 1 h 25 
min. The mixture was cooled to RT and unreacted triethyl phosphite was removed 
under reduced pressure to give triethyl phoshonocrotonate 95 (14.88 g, 63 mmol, 100%) 
as a yellow oil. 1H NMR data for this compound was consistent with that reported in the 
literature.92 
 
(2S,3S,4E,6E)-1,2-O-Isopropylidene-3-((tert-butyldimethylsilyl)oxy)-4,6-octadien-
1,2,8-triol 86 
OH
OTBS
O
O
86  
To a stirred solution of lithium hexamethyldisilazide, prepared from 
hexamethyldisilazane (2.28 mL, 19.0 mmol, 1.8 equiv) and n-butyllithium (10.34 mL of 
a 1.66 M solution in hexanes, 15.5 mmol, 1.47 equiv) in tetrahydrofuran (20 mL) at –78 
°C under nitrogen, was added phosphonate 95 (3.49 g, 14.8 mmol, 1.4 equiv) in 
tetrahydrofuran(10 mL). The reaction mixture was warmed to –40 °C and a solution of 
(2R,3S)-3,4-O-isopropylidene-2-((tert-butyl-dimethylsilyl)oxy)-3,4-dihydroxybutanal 
85 (2.89g, 10.6 mmol, 1.0 equiv) in tetrahydrofuran (5 mL) was added dropwise. The 
reaction mixture was warmed to rt and stirring was continued for 1.5 h. The mixture 
was concentrated in vacuo and the residue was portioned between water (100 mL) and 
ether (3 x 20 mL). The combined organic layers were washed with 1 M HCl (40 mL), 
dried and concentrated in vacuo. Chromatography of the crude product on silica 
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(hexanes/ethyl acetate 93:7) gave ethyl (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)-oxy)-7,8-dihydroxy-2,4-octadienoate (2.60 g, 5.2 mmol, 49%) as a 
colourless oil.  
To a stirred solution of ethyl (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadienoate (853 mg, 2.4 mmol, 1.0 equiv) 
in diethyl ether (5 mL) at 0 °C under nitrogen was added DIBAL-H (1.0 M solution in 
hexanes, 5.10 mL, 5.10 mmol, 2.1 equiv). After 1 h 45 minutes the reaction mixture was 
added dropwise, via cannula, to a stirred solution of sodium potassium tartrate 
tetrahydrate in ice/water (50 mL) and dichloromethane (50 mL). The emulsion was 
stirred at room temperture for 2 h. After separation of the phases the aqueous layer was 
extracted with ether (3 x 20 mL). The combined organic extracts were washed with sat. 
NaHCO3 (20 mL), brine (20 mL), dried and concentrated in vacuo. Chromatography of 
the crude product on silica (hexanes/ethyl acetate 80:20) gave (2S,3S,4E,6E)-1,2-O-
isopropylidene-3-((tert-butyldimethylsilyl)oxy)-4,6-octadien-1,2,8-triol 86 (724 mg, 2.2 
mmol, 92%) as a colourless oil. 1H NMR data for this compound was consistent with 
that previously reported.216,217 
 
Ethyl (2R, 3R)-3,4-O-isopropylidene-2,3,4-trihydroxybutanoate 87 
CO2Et
OH
O
O
87  
Isoascorbic acid was converted into the monoacetonide before oxidative cleavage with 
potassium carbonate and hydrogen peroxide in water. The resulting potassium 
carboxylate was treated with ethyl iodide to give ethyl (2R, 3R)-3,4-O-isopropylidene-
2,3,4-trihydroxybutanoate 87 following the method of Abushanab et al.88,89  
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(2R,3R)-3,4-O-Isopropylidene-2-((tert-butyldimethylsilyl)oxy)-3,4-dihydroxybutanal 88 
CHO
OTBS
O
O
88  
To a stirred solution of 87 (4.5 g, 22.2 mmol, 1.0 equiv) in DMF (5mL) at 0oC under 
argon was added imidazole (1.82 g, 26.7 mmol, 1.2 equiv) and tert-butyldimethylsilyl 
chloride (3.69 g, 24.5 mmol, 1.1 equiv).  On completion of the addition the resulting 
solution was allowed to warm to rt and stirred for 30min.  The reaction mixture was 
partitioned between water (50mL) and ethyl acetate (3 x 50mL) and the combined 
extracts were dried, filtered and evaporated to give the crude product as a yellow oil.  
Column chromatography gave ethyl (2R,3R)-3,4-O-isopropylidene-2-((tert-
butyldimethylsilyl)oxy)-3,4-dihydroxybutanoate (6.44 g,  20.2 mmol, 91 %) as a 
colourless oil that was used directly in the next step.  
To a stirred solution of ethyl (2R,3R)-3,4-O-isopropylidene-2-((tert-
butyldimethylsilyl)oxy)-3,4-dihydroxybutanoate (5.86 g, 18.4 mmol, 1.0 equiv) in 
dichloromethane (50 mL) at -98 °C under nitrogen was added DIBAL-H (1.0 M in 
hexanes, 27.6 mmol, 27.6 mL, 1.5 equiv) dropwise over 45 minutes. The reaction 
mixture was stirred at this temperature for a further 15 minutes before being quenched 
with 2 % aqueous sodium hydroxide (15 mL). The reaction mixture was allowed to 
warm to room temperature and water (50 mL) and dichloromethane (50 mL) were 
added resulting in an emulsion, which was eliminated by the stepwise addition of sat. 
aqueous potassium sodium (+)-tartrate. The aqueous layer was extracted with ether (3 x 
50 mL). The combined organic layers were dried and concentrated in vacuo. 
Chromatography of the crude product on silica (hexanes/ethyl acetate 95:5) gave 
(2R,3R)-3,4-O-isopropylidene-2-((tert-butyldimethylsilyl)oxy)-3,4-dihy-droxybutanal 
88 (2.94 g, 10.7 mmol, 58%) as a colourless oil. [α]D
25 = +15.79  (c = 2.66, 
chloroform). 1H NMR (300 MHz, CDCl3): δ 9.64 (1H, d, J = 1.8 Hz,), 4.22 (1H, dd, J = 
6.1, 6.1 Hz), 4.04 (1H, dd, J = 6.3, 1.9 Hz), 4.00 (1H, dd, J = 8.3, 6.3 Hz), 3.90 (1H, dd, 
J = 8.3, 5.8 Hz), 1.41, 1.32 (6H, 2 x s), 0.89 (9H, s), 0.08, 0.07 (6H, 2 xs)  ppm. 13C 
NMR (75 MHz, CDCl3): δ 201.5, 109.9, 78.0, 75.9, 65.9, 26.6, 25.7, 25.3, 18.3, -4.5, -
4.9  ppm . IR (thin film): ν = 2955, 2931, 2858, 1737 cm-1. EIMS (70 eV) m/z (%): 259 
(10), 217 (40), 159 (80), 101 (95) 75 (100); HRMS: calcd for C12H23O4Si [M-CH3]: 
259.1366; found: 259.1363.  
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(2R,3S,4E,6E)-1,2-O-Isopropylidene-3-((tert-butyldimethylsilyl)oxy)-4,6-octadien-
1,2,8-triol 89 
OH
OTBS
O
O
89  
To a stirred solution of lithium hexamethyldisilazide, prepared from 
hexamethyldisilazane (3.05 mL, 14.0 mmol, 1.8 equiv) and n-butyllithium (6.92 mL of 
a 1.66 M solution in hexanes, 11.5 mmol, 1.47 equiv) in tetrahydrofuran (20 mL) at –78 
°C under nitrogen, was added phosphonate 95 (2.58 g, 10.9 mmol, 1.4 equiv) in 
tetrahydrofuran (10 mL). The reaction mixture was warmed to –40 °C and a solution of 
(2R,3R)-3,4-O-isopropylidene-2-((tert-butyldimethylsilyl)oxy)-3,4-dihydroxybutanal 88 
(2.14 g, 7.8 mmol, 1.0 equiv) in tetrahydrofuran (5 mL) was added dropwise. The 
reaction mixture was warmed to room temperature and stirring was continued for 1.5 h. 
The mixture was concentrated in vacuo and the residue was portioned between water 
(100 mL) and ether (3 x 20 mL). The combined organic layers were washed with 1 M 
HCl (40 mL), dried and concentrated in vacuo. Chromatography of the crude product on 
silica (hexanes/ethyl acetate 93:7) gave ethyl (2E,4E,6S,7R)-7,8-O-isopropylidene-6-
((tert-butyldimethylsilyl)-oxy)-7,8-dihydroxy-2,4-octadienoate (1.94 g, 5.4 mmol, 70%) 
as a colourless oil. [α]D
25 =  −8.13  (c= 0.16, chloroform). 1H NMR (300 MHz, CDCl3): 
δ 7.27 (1H, dd, J = 16.5, 11.8 Hz), 6.37 (1H, dd, J = 14.6, 11.3 Hz), 6.11 (1H, dd, J = 
15.1, 5.8 Hz), 5.88 (1H, d, J = 15.1 H), 4.21 (1H, dt, J = 5.7, 1.1 Hz), 4.01-3.81 (3H, 
m), 3.73 (3H, s), 1.40, 1.32 (6H, 2 x s), 0.89 (9H, s), 0.07, 0.01 (6H, 2 x s)   ppm. 13C 
NMR (75 MHz, CDCl3): δ  167.4, 143.9, 142.4, 128.8, 121.3, 109.6, 78.8, 73.2, 66.3, 
51.6, 26.7, 25.8, 25.4, 18.2, -4.2, -4.7 ppm. IR (thin film): ν = 2987, 2954, 2858, 1723, 
1649, 1619 cm-1. EIMS (70 eV) m/z (%): 356 (5), 341 (50), 299 (10), 241 (35), 101 
(100) ; HRMS: calcd for C18H32O5Si [M
+]: 356.2019; found: 356.2023.  
To a stirred solution of ethyl (2E,4E,6S,7R)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)-oxy)-7,8-dihydroxy-2,4-octadienoate (2.55 g, 7.1 mmol, 1.0 equiv) 
in diethyl ether (5 mL) at 0 °C under nitrogen was added DIBAL-H (1.0 M solution in 
hexanes, 15.2 mL, 15.2 mmol, 2.1 equiv). After 1 h 45 minutes the reaction mixture was 
added dropwise, via cannula, to a stirred solution of sodium potassium tartrate 
tetrahydrate (7.72 g, 27.4 mmol, 3.7 equiv) in ice/water (50 mL) and dichloromethane  
(50 mL). The emulsion was stirred at rt for 2 h. After separation of the phases the 
aqueous layer was extracted with ether (3 x 20 mL). The combined organic extracts 
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were washed with sat. NaHCO3 (20 mL), brine (20 mL), dried and concentrated in 
vacuo. Chromatography of the crude product on silica (hexanes/ethyl acetate 80:20) 
gave (2R,3S,4E,6E)-1,2-O-isopropylidene-3-((tert-butyldimethylsilyl)oxy)-4,6-
octadien-1,2,8-triol 89 (1.88 g, 5.72 mmol, 80%) as a colourless oil. [α]D
25 =  −2.88 (c= 
3.64, chloroform). 1H NMR (500 MHz, CDCl3): δ  6.25 (2H, m), 5.84 (1H, m), 5.67 
(1H, m), 4.19 (2H, d, J = 5.1 Hz), 4.15 (1H, t, J = 5.8 Hz), 3.96 (2H, m), 3.88 (1H, dt, J 
= 5.4, 1.9 Hz), 1.41 (3H, s), 1.33 (3H, s), 0.89 (9H, s), 0.08 (3H, s), 0.03 (3H, s) ppm. 
13C NMR (100 MHz, CDCl3): δ 133.6, 132.4, 130.8, 130.6, 109.4, 79.1, 73.5, 66.2, 
63.2, 26.7, 25.9, 25.8, 18.2, -4.1, -4.7 ppm . IR (thin film): ν = 3436, 2955, 2931, 2858 
cm-1. EIMS (70 eV) m/z (%): 328 (20), 313 (25), 275 (30), 101 (100), 75 (70), 73 (75); 
HRMS: calcd for C17H32O4Si [M
+]: 328.2070; found: 328.2075. 
 
Diethyl-L-malate  
CO2Et
CO2Et
HO
diethyl malate  
The title compound was synthesised from L-malic acid (27 g, 0.20 mol) according to 
the procedure of Seebach.  Distillation gave diethyl-L-malate (39 g, 0.20 mol, 100%) as 
a colourless oil.218 1H NMR data for this compound was consistent with that previously 
reported.216,217 
 
Ethyl (3S)-3,4-O-isopropylidene-3,4-dihydroxybutanoate 90 
CO2Et
O
O
90  
Regiochemical reduction of diethyl L-malate (18.0 g, 95 mmol, 1.0 equiv) and 
protection of the resulting diol was based on the method of Saito et al90 to give ethyl 
(3S)-3,4-O-isopropylidene-3,4-dihydroxybutanoate 90 (12.4 g, 66 mmol, 84%) as a 
colourless oil. 1H NMR data for this compound was consistent with that previously 
reported.216,217 
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(3S)-3,4-O-Isopropylidene-3,4-dihydroxybutanal 91 
CHO
O
O
91  
To a stirred solution of ethyl (3S)-3,4-O-isopropylidene-3,4-dihydroxybutanoate 91 
(12.4 g, 66 mmol, 1.0 equiv) in tetrahydrofuran (180 mL) at 0˚C under argon was added 
lithium aluminium hydride (6.25g, 160 mmol, 2.5 equiv.).  The solution was stirred at 
this temperature for 2 h.  The reaction mixture was diluted with dichloromethane (150 
mL) and the excess lithium aluminium hydride was quenched with 
tetrahydrofuran:water (1:1, 50 mL).  The reaction mixture was filtered through celite 
(20g) which was rinsed with dichloromethane (3 x 300mL), then the combined extracts 
were dried, filtered and evaporated to give (2S)-1,2-O-isopropylidene-1,2,4-butanetriol 
(8.34g, 57 mmol, 86%) as a colourless oil. 
To a stirred solution of oxalyl chloride (2.24 mL, 26 mmol, 1.5 equiv) in 
dichloromethane (230 mL) at -78 oC was added dimethyl sulfoxide (3.65 mL, 50 mmol, 
3.0 equiv). After 5 minutes a solution of (2S)-1,2-O-Isopropylidene-1,2,4-butanetriol 
(2.5 g, 17 mmol, 1.0 equiv) in dichloromethane (100 mL) was added. The resulting 
solution was stirred at -78 oC for 1.5 h before the addition of triethylamine (16 mL). The 
reaction mixture was then gradually warmed to rt. Sat. aq. NH4Cl (200 mL) was added. 
The aqueous layer was extracted with diethyl ether (2 x 100 mL) and ethyl acetate (100 
mL). The combined organic layers were dried and concentrated in vacuo to give (3S)-
3,4-O-isopropylidene-3,4-dihydroxybutanal 91 (2.46 g, 17 mmol, 100%) as a colourless 
oil. 1H NMR data for this compound was consistent with that previously reported.216,217 
 
(2S,4E,6E)-1,2-O-Isopropylidene-4,6-octdadiene-1,2,8-triol 92 
OH
O
O
92  
To a stirred solution of lithium hexamethyldisilazide, prepared from 
hexamethyldisilazane (3.93 mL, 19 mmol, 1.1 equiv) and n-butyllithium (7.3 mL of a 
2.46 M solution in hexanes, 18 mmol, 1.05 equiv) in tetrahydrofuran (30 mL) at –78 °C 
under nitrogen, was added phosphonate 95 (4.24 g, 18 mmol, 1.05 equiv) in 
tetrahydrofuran (10 mL). The reaction mixture was warmed to –40 °C and a solution of 
(3S)-3,4-O-isopropylidene-3,4-dihydroxybutanal 91 (2.46 g, 17 mmol, 1.0 equiv) in 
tetrahydrofuran (5 mL) was added dropwise. The reaction mixture was warmed to rt and 
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stirring was continued for 1.5 h. The mixture was concentrated in vacuo and the residue 
was portioned between water (100 mL) and ether (3 x 20 mL). The combined organic 
layers were washed with 1 M HCl (40 mL), dried and concentrated in vacuo. 
Chromatography of the crude product on silica (hexanes/ethyl acetate 85:15) gave  
(2E,4E,7S)-7,8-O-isopropylidene-7,8-dihydroxy-2,4-octadienoate (798 mg, 3.5 mmol, 
21%) as a colourless oil. 
To a stirred solution of ethyl (2E,4E,7S)-7,8-O-isopropylidene-7,8-dihydroxy-2,4-
octadienoate (610 mg, 2.7 mmol, 1.0 equiv) in dichloromethane (26 mL) at –78 °C was 
added DIBAL-H (1.0 M solution in hexanes, 5.93 mL, 5.93 mmol, 2.2 equiv). Stirring 
was continued at this temperature for 1.5 h before addition to stirred solution of sodium 
potassium tartrate tetrahydrate (2.86 g, 10.08 mmol, 3.75 equiv) in ice/water (100 mL) 
and dichloromethane (100 mL). The emulsion was stirred at rt for 1.5 h. The aqueous 
layer was extracted with ether (3 x 50 mL). The combined organic extracts were washed 
with sat. NaHCO3 (50 mL), brine (50 mL), dried and concentrated in vacuo to give 
(2S,4E,6E)-1,2-O-isopropylidene-4,6-octdadiene-1,2,8-triol 92 (498 mg, 2.5 mmol, 
93%) as a colourless oil. 1H NMR data for this compound was consistent with that 
previously reported.216,217 
 
(S)-2-[(tert-Butyldimethylsilyl)oxy]propanal 93 
CHO
OTBS
93  
Protection of (S)-ethyl lactate (11.5 mL, 101 mmol, 1.0 equiv) was carried out 
according to literature procedures91,169,219 to give ethyl (S)-2-[(tert-
butyldimethylsilyl)oxy]propanoate (20.02 g,  85 mmol, 85 %) as a colourless oil, 
distilling at 42-50 oC/ 1-1.5 mmHg. 1H NMR data for this compound was consistent 
with that reported in the literature.91 
Reduction of of ethyl (S)-2-[(tert-butyldimethylsilyl)oxy]propanoate (13.1 g, 57 mmol, 
1.0 equiv) was carried out according to literature procedures91,169,219 to give ethyl (S)-2-
[(tert-butyldimethylsilyl)oxy]propanoate 93 (6.93 g,  37 mmol, 65 %) as a colourless oil 
distilling at 78 oC /25 mmHg. 1H NMR data for this compound was consistent with that 
reported in the literature.91  
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(2E,4E,6S)-6-((tert-Butyldimethylsilyl)oxy)hepta-2,4-dien-1-ol 94 
OH
OTBS
94  
To a stirred solution of lithium hexamethyldisilazide, prepared from 
hexamethyldisilazane (6.55 g, 41 mmol, 1.29 equiv) and n-butyllithium (21.4 mL of 
1.58 M solution in hexanes, 34 mmol, 1.07 equiv) in tetrahydrofuran (56 mL) at  –78 ˚C 
under argon was added phosphonate 95 (7.51 g, 32 mmol, 1.0 equiv) in tetrahydrofuran 
(9.5 mL). The mixture was warmed to –40 ˚C and aldehyde 93 (5.94 g, 32 mmol, 1.0 
equiv) in tetrahydrofuran (6 mL) was added dropwise. The reaction mixture was 
warmed to rt and concentrated in vacuo. The residue was partitioned between water 
(100 mL) and ether (20 mL). The aqueous phase was extracted with ether (3 x 20 mL). 
The combined extracts were washed with 1M HCl (40 mL), dried (MgSO4) and 
concentrated in vacuo. Purification by column chromatography over silica gel 
(hexane/ethyl acetate 95:5) gave methyl (2E,4E,6S)-6-((tert-
butyldimethylsilyl)oxy)hepta-2,4-dienoate (2.80 g, 10.2 mmol, 32%) as a colourless oil. 
[α] =  - 1.57 (c = 4.35, dichloromethane) 1H NMR (400 MHz, CDCl3): δ 7.25 (1H, dd, J 
= 15.4, 11.3 Hz), 6.29 (1H, ddd, J = 15.2, 11.0, 0.7 Hz), 6.08 (1H, ddd, J = 15.2, 4.9, 
0.7 Hz), 5.84 (1H, d, J = 15.4 Hz), 4.38 (1H, dq, J = 12.23, 6.11 Hz), 3.70 (3H, s), 1.21 
(3H, d, J = 6.6 Hz), 0.87 (9H, s), 0.04 , 0.02 (6H, 2 x s) ppm. 13C NMR (100 MHz, 
CDCl3): δ 167.4 (Q), 147.1, 144.4, 125.7, 120.4, 68.4, 51.4, 25.8, 24.0, 18.2 (Q), -4.8, -
4.8 ppm . IR (thin film): ν = 2954, 2929, 2886, 2857 (C-H), 1723 (C=O), 1649, 
1618cm-1 (C=C). EIMS (70 eV) m/z (%): 213 (35) [M-C4H9]
+, 131 (100), 75 (95); 
HRMS: calcd for C10H17O3Si [M-C4H9]
+:213.0947; found: 213.0948.  
To a stirred solution of DIBAL-H (1.5 M solution in toluene, 10.22 mL, 15.3 mmol, 2.1 
equiv) at 0 ˚C under argon was added a solution of methyl (2E,4E,6S)-6-((tert-
butyldimethylsilyl)oxy)hepta-2,4-dienoate (1.97 g, 7.3 mmol, 1.0 equiv) in dry diethyl 
ether (3 mL). After 45 min the reaction mixture was added dropwise, via cannula, to a 
stirred solution of sodium potassium tartrate tetrahydrate (7.72g, 27.4 mmol, 3.75 
equiv) in ice/water (50 mL) and dichloromethane (20 mL). The emulsion was stirred at 
room temperature for 2 h. After separation of the phases the aqueous layer was 
extracted with ether (3  x 10 mL). The combined organic extracts were washed with sat. 
NaHCO3 (15 mL), sat. NaCl (15 mL) and dried (MgSO4). The filtered solution was then 
concentrated in vacuo to give (2E,4E,6S)-6-((tert-butyldimethylsilyl)oxy)hepta-2,4-
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dien-1-ol 94 (1.55 g, 6.3 mmol, 88%) as a colourless oil. [α] = +3.59 (c = 0.835, 
dichloromethane). 1H NMR (400 MHz, CDCl3): δ  6.23 (1H, ddt, J = 14.9, 10.5, 1.2 
Hz), 6.16 (1H, ddd, J = 14.4, 10.5, 1.0 Hz), 5.80 (1H, dt, J = 14.7, 5.9 Hz), 5.71 (1H, 
dd, J = 14.7, 5.6 Hz, 4.34 ( 1H, dq, J = 6.4, 6.4 Hz), 4.16 (2H, dd, J = 5.9, 1.2 Hz), 1.22 
(3H, d, J = 6.6 Hz), 0.89 (9H, s), 0.06, 0.05 (6H, 2 x s) ppm. 13C NMR (100 MHz, 
CDCl3): δ 138.9, 131.3, 131.3, 127.3, 68.9, 63.5, 26.0, 24.5, 18.4, -4.5, -4.7 ppm. IR 
(thin film): ν = 3331(OH), 2955, 2857 cm-1  (C-H). EIMS (70 eV) m/z (%): 224 (70), 
167 (60), 159 (100), 149 (65).  
 
7.2.2 The Ascorbate Series 
(2E,4E,6S,7S)-7,8-O-Isopropylidene-6-((tert-butyldimethylsilyl)oxy)-7,8-dihydroxy-
2,4-octadien-1-yl hydrogen maleate 96 
TBSO
O
O
O
O
CO2H
96  
The title compound was synthesised from (2S,3S,4E,6E)-1,2-O-isopropylidene-3-((tert-
butyldimethylsilyl)oxy)-4,6-octadien-1,2,8-triol 86 (124 mg, 0.38 mmol, 1.0 equiv) 
according to the procedure of Lilly to give (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl hydrogen maleate 96 (161 mg, 
0.38 mmol, 100%) as a pale yellow oil. 1H NMR data for this compound was consistent 
with that previously reported.216,217 
 
(2E,4E,6S,7S)-7,8-O-Isopropylidene-6,7,8-trihydroxy-2,4-octadien-1-yl methyl maleate 
78a 
HO
O
O
O
O
CO2Me
78a  
The title compound was synthesised from (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl hydrogen maleate 96 (161 mg, 
0.38 mmol, 1.0 equiv) according to the procedure of Lilly to give 78a (50 mg, 0.15 
mmol, 39%). 1H NMR data for this compound was consistent with that previously 
reported.216,217 
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(2E,4E,6S,7S)-7,8-O-Isopropylidene-6-((trimethylsilyl)oxy)-7,8-dihydroxy-2,4-
octadien-1-yl methyl maleate 78b 
TMSO
O
O
O
O
CO2Me
78b  
The title compound was synthesised from (2E,4E,6S,7S)-7,8-O-isopropylidene-6,7,8-
trihydroxy-2,4-octadien-1-yl methyl maleate 78a (12 mg, 0.04 mmol, 1.0 equiv) 
according to the procedure of Lilly to give (2E,4E,6S,7S)-7,8-O-isopropylidene-6-
((trimethylsilyl)oxy)-7,8-dihy-droxy-2,4-octadien-1-yl methyl maleate 78b (7.7 mg, 
0.02 mmol, 59%) as a colourless oil. 1H NMR data for this compound was consistent 
with that previously reported.216,217 
 
(2E,4E,6S,7S)-7,8-O-Isopropylidene-6-((tert-butyldimethylsilyl)oxy)-7,8-dihydroxy-
2,4-octadien-1-yl methyl maleate 78c 
TBSO
O
O
O
O
CO2Me
78c  
The title compound was synthesised form (2S,3S,4E,6E)-1,2-O-isopropylidene-3-((tert-
butyldimethylsilyl)oxy)-4,6-octadien-1,2,8-triol 86 (110 mg, 0.35 mmol, 1.0 equiv) 
according to the procedure of Lilly to give (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl methyl maleate 78c  (77 mg, 
0.17 mmol, 50%) as a pale yellow oil. 1H NMR data for this compound was consistent 
with that previously reported.216,217 
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(2E,4E,6S,7S)-7,8-O-Isopropylidene-6-((triisopropylsilyl)oxy)-7,8-dihydroxy-2,4-
octadien-1-yl methyl maleate 78d 
TIPSO
O
O
O
O
CO2Me
78d  
To a stirred solution of (2E,4E,6S,7S)-7,8-O-isopropylidene-6,7,8-trihydroxy-2,4-
octadien-1-yl methyl maleate 78a (15 mg, 0.05 mmol, 1.0 equiv) in dichloromethane (1 
mL) at 0 °C was added 2,6-lutidine (15 µL, 0.14 mmol, 3.0 equiv) and triisopropylsilyl 
trifluorometanesulphonate (22 µL, 0.08 mmol, 1.8 equiv). The reaction was warmed to 
rt and stirring was continued for 30 min. The reaction mixture was diluted with diethyl 
ether (20 mL) and portioned against sat. NaHCO3 (20 mL). The aqueous layer was 
extracted with diethyl ether (2 x10 mL) and the combined extracts were washed with 
sat. NaCl (10 mL), dried, filtered and concentrated in vacuo. After column 
chromatography on silica (hexanes/ethyl acetate 85:15) (2E,4E,6S,7S)-7,8-O-
isopropylidene-6-((triisopropylsilyl)oxy)-7,8-dihy-droxy-2,4-octadien-1-yl methyl 
maleate 78d (20 mg, 0.05 mmol, 91%) was obtained a colourless oil. 1H NMR data for 
this compound was consistent with that previously reported.216,217 
 
(2E,4E,6S,7S)-7,8-O-Isopropylidene-6-(4-nitrobenzoyloxy)-7,8-dihydroxy-2,4-
octadien-1-yl methyl maleate 78e 
PNBO
O
O
O
O
CO2Me
78e  
To a stirred solution of (2E,4E,6S,7S)-7,8-O-isopropylidene-6,7,8-trihydroxy-2,4-
octadien-1-yl methyl maleate 78a (33 mg, 0.10 mmol, 1.0 equiv) in dichloromethane (5 
mL) was added pyridine (82 µL, 1.01 mmol, 10.0 equiv), 4-nitrobenzoyl chloride (47 
mg, 0.25 mmol, 2.5 equiv) and DMAP (13 mg, 0.10 mmol, 1.0 equiv). The reaction 
mixture was stirred at rt for 18 h before being diluted with diethyl ether (20 mL) and 
portioned against 2M HCl (10 mL), water (10 mL) and brine (10 mL). The organic layer 
was then dried and concentrated in vacuo. After column chromatography 
(dichloromethane/ethyl acetate) 78e (37 mg, 0.08 mmol, 82%) was obtained as a 
colourless oil. 1H NMR (500 MHz, CDCl3): δ  8.28 (4H, m), 6.47 (1H, dd, J = 15.0, 
10.6 Hz), 6.32 (1H, m), 6.27 (1H, m), 5.89 (1H, dt, J = 15.0, 6.8 Hz), 5.76 (1H, dd, J = 
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15.0, 7.7 Hz), 5.60 (1H, t, J = 6.8 Hz), 4.73 (2H, d, J = 6.4 Hz), 4.38 (1H, q, J = 6.3 
Hz), 4.09 (1H, ddd, J = 8.7, 6.6, 1.0), 3.85 (1H, ddd, J = 8.9, 5.7, 0.9 Hz), 3.78 (3H, s), 
1.47 (3H, s), 1.38 (3H, s) ppm. 13C NMR (125 MHz, CDCl3): δ 165.7, 164.8, 163.9, 
150.7, 135.6, 134.7, 132.8, 130.9, 130.1, 129.6, 128.9, 127.5, 123.6, 110.4, 76.5, 76.4, 
65.8, 65.0, 52.3, 26.6, 25.3 ppm. IR (thin film): ν = 2989, 2953, 1728, 1647, 1608, 1529 
cm-1. EIMS (70 eV) m/z (%): 460 (40), 417 (15), 245 (35), 150 (100), 101 (75); HRMS: 
calcd for C22H22NO10 [M-CH3]: 460.1244; found: 460.1238 
 
(2E,4E,6S,7S)-7,8-O-Isopropylidene-6-((tert-butyldimethylsilyl)oxy)-7,8-dihydroxy-
2,4-octadien-1-yl methyl fumarate 78f 
TBSO
O
O
O
O
E
78f   E = CO2Me  
The title compound was synthesised from (2S,3S,4E,6E)-1,2-O-isopropylidene-3-((tert-
butyldimethylsilyl)oxy)-4,6-octadien-1,2,8-triol 86 (171 mg, 0.52 mmol, 1.0 equiv) 
according to the procedure of Lilly to give (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl methyl fumarate 78f (204 mg, 
0.46 mmol, 89%) as a colourless oil. 1H NMR data for this compound was consistent 
with that previously reported.216,217 
 
(2E,4E,6S,7S)-7,8-O-Isopropylidene-6-((tert-butyldimethylsilyl)oxy)-7,8-dihydroxy-
2,4-octadien-1-yl propiolate 78g 
TBSO
O
O
O
O
78g  
The title compound was synthesised from  (2S,3S,4E,6E)-1,2-O-isopropylidene-3-((tert-
butyldimethylsilyl)oxy)-4,6-octadien-1,2,8-triol 86 (27 mg, 0.08 mmol, 1.0 equiv) 
according to the procedure of Lilly to give (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl propiolate 78g (13 mg, 0.03 
mmol, 42%) as a colourless oil. 1H NMR data for this compound was consistent with 
that previously reported.216,217 
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7.2.2.1 IMDA reactions of 78 
IMDA reaction of (2E,4E,6S,7S)-7,8-O-isopropylidene-6,7,8-trihydroxy-2,4-octadien-1-
yl methyl maleate 78a 
O
O
O
OH O
CO2Me
H
H
H O
O
O
OH O
CO2Me
H
H
H
O
O
O
OH O
CO2Me
H
H
H O
O
O
OH O
CO2Me
H
H
H
+
PhMe 
reflux
++
79a trans, unlike 80a trans, like
98a cis, unlike 99a cis, like
H
H H
H
HO
O
O
O
O
CO2Me
78a
 
To a stirred solution of (2E,4E,6S,7S)-7,8-O-isopropylidene-6,7,8-trihydroxy-2,4-
octadien-1-yl methyl maleate 78a (522 mg, 1.60 mmol, 1.0 equiv) in toluene (320 mL) 
at rt under argon was added BHT (71 mg, 0.32 mmol, 0.2 equiv).  The solution was 
warmed to reflux and heating was continued for 5h. Chromatography of the crude 
residue (hexane:ethyl acetate 1:1) gave a mixture of the 4  IMDA adducts (79a, 80a, 
98a and 99a) (448 mg, 1.37 mmol, 86%, 79a:80a:98a:99a (56:32:8:4)). 
 
IMDA reaction of (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((trimethyl-silyl)oxy)-7,8-
dihydroxy-2,4-octadien-1-yl methyl maleate 78b 
O
O
O
TMSO O
CO2Me
H
H
H O
O
O
TMSO O
CO2Me
H
H
H
O
O
O
TMSO O
CO2Me
H
H
H O
O
O
TMSO O
CO2Me
H
H
H
+
PhMe 
reflux
++
79b trans, unlike 80b trans, like
98b cis, unlike 99b cis, like
H
H H
H
TMSO
O
O
O
O
CO2Me
78b
 
To a stirred solution of (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((trimethylsilyl)oxy)-7,8-
dihydroxy-2,4-octadien-1-yl methyl maleate 78b (45 mg, 0.11 mmol, 1.0 equiv) in 
toluene (28 mL) at rt under argon was added BHT (6 mg, 0.03 mmol, 0.2 equiv).  The 
solution was warmed to reflux and heating was continued for 12h.  Chromatography 
(hexane:ethyl acetate 4:1) gave the IMDA adducts (79b, 80b, 98b and 99b) (30 mg, 
0.08 mmol, 67%, 79b:80b:98b:99b (80:14:4:2)). 
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IMDA reaction of (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-butyldimethylsilyl)oxy)-
7,8-dihydroxy-2,4-octadien-1-yl methyl maleate 78c 
O
O
O
TBSO O
CO2Me
H
H
H O
O
O
TBSO O
CO2Me
H
H
H
O
O
O
TBSO O
CO2Me
H
H
H O
O
O
TBSO O
CO2Me
H
H
H
+
PhMe 
reflux
++
79c trans, unlike 80c trans, like
98c cis, unlike 99c cis, like
H
H H
H
TBSO
O
O
O
O
CO2Me
78c
 
To a stirred solution of (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl methyl maleate 78c (115 mg, 
2.6 mmol, 1.0 equiv) in toluene (52 mL) at rt under argon was added BHT (12 mg, 0.05 
mmol, 0.2 equiv).  The solution was warmed to reflux and heating was continued for 
15h. Chromatography (hexane:ethyl acetate 4:1) gave the IMDA adducts (79c, 80c, 98c 
and 99c) (92 mg, 0.21 mmol, 80%, 79c:80c:98c:99c (86:9:4:1)). 1H NMR data for 
these compounds were consistent with that previously reported.216,217 
 
IMDA reaction of (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((triiso-propylsilyl)oxy)-7,8-
dihydroxy-2,4-octadien-1-yl methyl maleate 78d 
O
O
O
TIPSO O
CO2Me
H
H
H O
O
O
TIPSO O
CO2Me
H
H
H
O
O
O
TIPSO O
CO2Me
H
H
H O
O
O
TIPSO O
CO2Me
H
H
H
+
PhMe 
reflux
++
79d trans, unlike 80d trans, like
98d cis, unlike 99d cis, like
H
H H
H
TIPSO
O
O
O
O
CO2Me
78d
 
To a stirred solution of (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((triisopropylsilyl)oxy)-
7,8-dihydroxy-2,4-octadien-1-yl methyl maleate 78d (37 mg, 0.08 mmol, 1.0 equiv) in 
toluene (15 mL) at rt under argon was added BHT (3 mg, 0.02 mmol, 0.2 equiv).  The 
solution was warmed to reflux and heating was continued for 18h.  Evaporation of the 
solvent gave the crude product. Chromatography (hexane:ethyl acetate 4:1) gave the 
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IMDA adducts (79d, 80d, 98d and 99d) (25.1mg, 0.052mmol, 68%, 79d:80d:98d:99d 
(92:7:1:0)).  
 
 IMDA reaction (2E,4E,6S,7S)-7,8-O-Isopropylidene-6-(4-nitrobenzoyloxy)-7,8-
dihydroxy-2,4-octadien-1-yl methyl maleate 78e 
O
O
O
PNBO O
CO2Me
H
H
H O
O
O
PNBO O
CO2Me
H
H
H
O
O
O
PNBO O
CO2Me
H
H
H O
O
O
PNBO O
CO2Me
H
H
H
+
PhMe 
reflux
++
79e trans, unlike 80e trans, like
98e cis, unlike 99e cis, like
H
H H
H
PNBO
O
O
O
O
CO2Me
78e
 
To a stirred solution of 78e (37 mg, 0.078 mmol, 1.0 equiv) in toluene (8 mL) was 
added BHT (3 mg, 0.015 mmol, 0.2 equiv), The solution was warmed to reflux and 
heating was continued for 12 h.  Evaporation of the solvent gave the crude product as a 
yellow oil.  Chromatographhy (hexane:ethyl acetate 1:1) gave the IMDA adducts (79e, 
80e, 98e and 99e) (25 mg, 0.052 mmol, 68%, 79e:80e:98e:99e (49:39:6:6). 
 
IMDA reaction of (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-butyldimethylsilyl)oxy)-
7,8-dihydroxy-2,4-octadien-1-yl methyl fumarate 78f 
O
O
O
TBSO O
H
H
H
H O
O
O
TBSO O
H
H
H
H
O
O
O
TBSO O
H
H
H
H O
O
O
TBSO O
H
H
H
H
+
PhCl
reflux
++
79f trans, unlike 80f trans, like
98f cis, unlike 99f cis, like
E
E E
E
TBSO
O
O
O
O
E
78f   E = CO2Me
 
To a stirred solution of  (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl methyl fumarate 78f (187 mg, 
0.42 mmol, 1.0 equiv) in chlorobenzene (85 mL) was added BHT (3 mg, 0.04 mmol, 
0.1 equiv). The solution was warmed to reflux and heating was continued for 53 h 
before the reaction mixture was concentrated in vacuo. Column chromatography on 
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silica (hexane/ethyl acetate 78:22) gave a mixture of the 4 IMDA adducts (79f, 80f, 98f 
and 99f) (116 mg, 0.26 mmol, 62%, 79f:80f:98f:99f (12:3:82:3).  
 
IMDA reaction of (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-butyldimethylsilyl)oxy)-
7,8-dihydroxy-2,4-octadien-1-yl propiolate 78g 
O
O
O
TBSO O
H
H O
O
O
TBSO O
H
H+
PhMe, 110 °C,
43 h, 92%
100 unlike 101 like
TBSO
O
O
O
O
78g
64:36  
 To a stirred solution of (2E,4E,6S,7S)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl propiolate 78g (13 mg, 0.03 
mmol) in toluene (3 mL) at rt under argon was added BHT (1 mg, 0.003 mmol, 0.1 
equiv).  The solution was warmed to reflux and heating was continued for 43h.  
Evaporation of the solvent gave the crude product as a yellow oil.  Chromatography 
(hexane:ethyl acetate 80:20) gave the IMDA adducts (100 and 101) (12 mg, 0.03 mmol, 
92% , 100:101 (64:36)). 1H NMR data for these compounds were consistent with that 
previously reported.216,217 
 
7.2.3 Isoascorbate and Malate series 
(2E,4E,6S,7R)-7,8-O-Isopropylidene-6-((tert-butyldimethylsilyl)oxy)-7,8-dihydroxy-
2,4-octadien-1-yl methyl maleate 81a 
TBSO
O
O
O
O
H
CO2Me
81a  
To a stirred solution of (2R,3S,4E,6E)-1,2-O-isopropylidene-3-((tert-
butyldimethylsilyl)oxy)-4,6-octadien-1,2,8-triol 89 (234 mg, 0.71 mmol, 1.0 equiv) in 
dichloromethane (5 mL) at 0 °C was added triethylamine (159 µL, 1.14 mmol, 1.6 
equiv), maleic anhydride (181 mg, 1.85 mmol, 2.6 equiv) and DMAP (10 mg, 0.08 
mmol, 0.12 equiv). The reaction was stirred at this temperature for 15 min before being 
diluted with diethyl ether (50 mL), washed with 2M HCl (25 ml), water (25 mL), dried 
and concencetrated in vacuo. Chromatography of the crude product on silica 
(hexane/ethyl acetate/ acetic acid 49:50:1) gave (2E,4E,6S,7R)-7,8-O-isopropylidene-6-
((tert-butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl hydrogen maleate (302 
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mg, 0.71 mmol, 100 %) as a colourless oil. To a stirred solution of (2E,4E,6S,7R)-7,8-
O-isopropylidene-6-((tert-butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl 
hydrogen maleate (215 mg, 0.50 mmol) in dichloromethane (5 mL) at – 78 °C was 
added an ethereal solution of diazomethane. After 15 min the reaction mixture was 
concentrated in vacuo. After column chromatography on silica (hexane/ethyl acetate 
5:1) (2E,4E,6S,7R)-7,8-O-isopropylidene-6-((tert-butyldimethylsilyl)oxy)-7,8-
dihydroxy-2,4-octadien-1-yl methyl maleate 81a (165 mg, 0.39 mmol, 74%) was 
obtained as a colourless oil. [α]D
25 = −5.88  (c= 0.26, chloroform). 1H NMR (500 MHz, 
CDCl3): δ 6.26 (2H, s), 6.26 (2H, m), 5.74 (2H, m), 4.71 (2H, d, J = 6.7 Hz), 4.15 (1H, 
t, J = 5.7 Hz), 3.99 – 3.84 (3H, m), 3.77 (3H, s), 1.40, 1.32 (6H, 2 x s), 0.88 (9H, s), 
0.07, 0.02 (6H, 2 x s)  ppm. 13C NMR (125 MHz, CDCl3): δ 165.7, 165.0, 135.3, 134.3, 
130.1, 129.9, 129.7, 126.0, 109.5, 79.1, 73.3, 66.2, 65.5, 52.3, 26.8, 25.9, 25.4, 18.2, -
4.1, -4.7 ppm . IR (thin film): ν = 2931, 2858, 1734, 1647 cm-1. EIMS (70 eV) m/z (%): 
425 (30), 409 (10), 101 (100); HRMS: calcd for C21H33O7 [M-CH3]: 425.1996; found: 
425.1992. 
 
(2E,4E,6S,7R)-7,8-O-Isopropylidene-6-((tert-butyldimethylsilyl)oxy)-7,8-dihydroxy-
2,4-octadien-1-yl methyl fumarate 81b 
TBSO
O
O
O
O
E
H
81b E = CO2Me  
To a stirred solution of (2R,3S,4E,6E)-1,2-O-isopropylidene-3-((tert-
butyldimethylsilyl)oxy)-4,6-octadien-1,2,8-triol 89 (239 mg, 0.73 mmol, 1.0 equiv) in 
diethyl ether (15 mL) at room temperature under nitrogen was added monomethyl 
fumarate (171 mg, 1.31 mmol, 1.8 equiv), DCC (300 mg, 1.45 mmol, 2.0 equiv) and 
DMAP (13 mg, 0.10 mmol, 0.15 equiv). Stirring was continued for 3 h. The reaction 
mixture was filtered and the filtrate was concentrated in vacuo.  Chromatography of the 
crude product on silica (hexanes/ethyl acetate 89:11) gave (2E,4E,6S,7R)-7,8-O-
isopropylidene-6-((tert-butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl methyl 
fumarate 81b (200 mg, 0.45 mmol, 62%) as a colourless oil. 1H NMR (500 MHz, 
CDCl3): δ 6.84 (2H, s), 6.25 (2H, m), 5.80-5.67 (2H, m), 4.69 (1H, d, J = 5.2 Hz), 4.13 
(1H, t, J = 5.2 Hz), 3.97-3.79 (3H, m), 3.77 (3H, s), 1.37, 1.29 (6H, 2 x s), 0.86 (9H, s), 
0.04, 0.00 (6H, 2 x s)  ppm. 13C NMR (125 MHz, CDCl3): δ 165.3, 164.6, 135.3, 134.1, 
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133.6, 133.5, 129.9, 125.9, 109.4, 78.9, 73.2, 66.1, 65.4, 52.3, 26.7, 25.8, 25.4, 18.4, -
4.2, -4.7 ppm . IR (thin film): ν = 2954, 2858, 1727 cm-1. EIMS (70 eV) m/z (%): 425 
(35), 383 (55), 101 (100); HRMS: calcd for C21H33O7Si [M-CH3]: 425.1996; found: 
425.1991. 
 
(2E,4E,7S)-7,8-O-Isopropylidene-7,8-dihydroxy-2,4-octadien-1-yl methyl maleate 82x 
O
O
O
O
CO2Me
82x  
The title compound was synthesised form (2S,4E,6E)-1,2-O-isopropylidene-4,6-
octdadiene-1,2,8-triol 92 (258 mg, 1.3 mmol, 1.0 equiv) according to the procedure of 
Lilly to give (2E,4E,7S)-7,8-O-isopropylidene-7,8-dihydroxy-2,4-octadien-1-yl methyl 
maleate 82x (226 mg, 0.73 mmol, 56%) as a colourless oil. 1H NMR data for this 
compound was consistent with that previously reported.216,217 
 
(2E,4E,7S)-7,8-O-Isopropylidene-7,8-dihydroxy-2,4-octadien-1-yl methyl fumarate 82y 
O
O
O
O
82y E = CO2Me
E
 
To a stirred solution of (2S,4E,6E)-1,2-O-isopropylidene-4,6-octdadiene-1,2,8-triol 92 
(210 mg, 1.06 mmol, 1.0 equiv) in diethyl ether (15 mL) was added monomethyl 
fumarate (248 mg, 1.91 mmol, 1.8 equiv), DCC (437 mg, 2.11 mmol, 2.0 equiv) and 
DMAP (19.4 mg, 0.16 mmol, 0.15 equiv). The reaction mixture was stirred for 16 h 
before being filtered. The filtrate was concentrated in vacuo. Chromatography of the 
crude product on silica (hexanes/ethyl acetate 75:25) gave (2E,4E,7S)-7,8-O-
isopropylidene-7,8-dihydroxy-2,4-octadien-1-yl methyl fumarate 82y  (243 mg, 0.78 
mmol, 74%) as a colourless oil. [α]D
25 =   +2.97 (c= 1.62, chloroform). 1H NMR (500 
MHz, CDCl3): δ 6.83 (2Η, m), 6.25 (1H, dd, J =15.0, 10.3 Hz), 6.10 (1H, dd, J =15.0, 
10.3 Hz), 5.69 (1H, m), 5.68 (1H, m), 4.68 (2H, d, J = 6.9 Hz), 4.12 (1H, dq, J = 6.3 6.3 
Hz), 4.01 (1H, dd, J  = 8.1, 6.1 Hz), 3.78 (3H,  s), 3.53 (1H, dd, J  = 8.2, 7.0 Hz), 2.39 
(1H, m), 2.32 (1H, m), 1.39 (3H, s), 1.32 (3H, s) ppm. 13C NMR (125 MHz, CDCl3): δ  
165.4, 164.6, 134.9, 133.6, 133.5, 131.7, 131.2, 124.5, 109.1, 75.2, 68.8, 65.6, 52.4, 
36.9, 26.9, 25.6 ppm. IR (thin film): ν =  2987, 2952, 2877, 1725, 1645 cm-1. EIMS (70 
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eV) m/z (%): 310 (2), 295 (30), 221 (10), 113 (40), 101 (100); HRMS: calcd for 
C16H22O6 [M]: 310.1416; found: 310.1419  
 
7.2.3.1 IMDA Reactions of 81 and 82 
IMDA reaction of (2E,4E,6S,7R)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl methyl maleate 81a 
O
O
O
O
O
O
O
TBSO O
CO2Me
H
H
H H O
O
O
TBSO O
CO2Me
H
H
H H
O
O
O
TBSO O
CO2Me
H
H
H H O
O
O
TBSO O
CO2Me
H
H
H H
+
PhMe
reflux
++
102a trans, unlike 103a trans, like
104a cis, unlike 105a cis, like
CO2Me
TBSO
81a
 
A solution of 81a (165 mg, 0.37 mmol, 1.0 equiv) and BHT (0.1 equiv) in toluene (37 
mL) was heated at reflux for 9.5 h. The solution was then cooled to room temperature 
and concentrated in vacuo. After column chromatography on silica (hexanes/ethyl 
acetate 85:15) a mixture of 4 products 102a:103a:104a:105a (141 mg, 0.32 mmol, 
86%) in a ratio of 78:16:4:2 was obtained. Normal phase HPLC (hexanes/ethyl acetate 
85:15) yielded compounds 102a and 103a. 
 
Methyl (3aS, 4R, 5S, 7aR)-5-((1S,2R)-2,3-O-isopropylidene-1-((tert-
butyldimethylsilyl)oxy)-2,3-dihydroxypropyl)-3-oxo-1,3,3a,4,5,7a-hexa-hydro-4-
isobenzofurancarboxylate 103a 
O
O
O
TBSO O
CO2Me
H
H
H H
103a trans, like  
[α]D
25 =  +60.34  (c= 0.29, chloroform). 1H NMR (500 MHz, CDCl3): δ 6.04 (1H, dt, J 
= 10.3, 2.4 Hz), 5.81 (1H, dt, J = 9.8, 2.9 Hz), 4.55 (1H, t, J = 7.6 Hz), 4.08-4.00 (2H, 
m), 3.85 (1H, dd, J = 11.7, 8.3 Hz), 3.82-3.76 (2H, m), 3.72 (3H, s), 3.38 (1H, dd, J = 
4.4, 1.5 Hz), 3.27 (1H, m), 2.95 (1H, m), 2.61 (1H, dd, J = 13.4, 4.4 Hz), 1.39, 1.30 
(6H, 2 x s), 0.87 (9H, s), 0.11, 0.07 (6H, 2 x s) ppm. 13C NMR (125 MHz, CDCl3): δ  
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174.8, 173.3, 130.1, 126.7, 109.6, 76.6, 76.4, 70.5, 67.9, 52.2, 43.9, 43.0, 37.0, 36.2, 
26.8, 25.8, 25.5, 18.0, -3.5, -4.6 ppm. IR (thin film): ν = 2955, 2931, 2893, 2858, 1788, 
1736 cm-1. EIMS (70 eV) m/z (%): 425 (10), 383 (15), 339 (10), 325 (20), 310 (55), 265 
(100), 101 (40); HRMS: calcd for C21H33O7Si [M
+-CH3]: 425.1996; found: 425.1996. 
 
Methyl (3aR, 4S, 5R, 7aS)-5-((1S,2R)-2,3-O-isopropylidene-1-((tert-
butyldimethylsilyl)oxy)-2,3-dihydroxypropyl)-3-oxo-1,3,3a,4,5,7a-hexa-hydro-4-
isobenzofurancarboxylate 102a 
O
O
O
TBSO O
CO2Me
H
H
H H
102a trans, unlike  
[α]D
25 =  −23.44  (c= 0.32, chloroform). 1H NMR (500 MHz, CDCl3): δ 5.88 (1H, dm, J 
= 9.3 Hz), 5.76 (1H, dt, J = 9.8, 2.6 Hz), 4.53 (1H, dd, J = 7.4, 7.4 Hz), 4.06-3.99 (2H, 
m), 3.87-3.80 (2H, m), 3.70 (3H, s), 3.32 (1H, d, J = 4.5 Hz), 3.20 (1H, m), 3.02 (1H, 
m), 2.57 (1H, dd, J = 13.5, 4.7 Hz), 1.37, 1.29 (6H, s), 0.87 (9H, s), 0.11, 0.10 (6H, 2 x 
s) ppm. 13C NMR (125 MHz, CDCl3): δ 174.7, 172.9, 129.9, 124.6, 109.3, 76.6, 75.6, 
70.6, 67.4, 52.2, 43.9, 42.8, 37.5, 36.5, 27.5, 26.7, 25.8, 18.1, -3.9, -4.3 ppm. IR (thin 
film): ν = 2986, 2892, 2858, 1788, 1735 cm-1. EIMS (70 eV) m/z (%): 425 (20), 383 
(50), 339 (10), 310 (55), 187 (60), 101 (50), 73 (100); HRMS: calcd for C21H33O7Si 
[M+-CH3]: 425.1996; found:425.1991 
 
IMDA reaction of (2E,4E,6S,7R)-7,8-O-isopropylidene-6-((tert-
butyldimethylsilyl)oxy)-7,8-dihydroxy-2,4-octadien-1-yl methyl fumarate 81b 
O
O
O
O
O
O
O
TBSO O
H
H
H
H E O
O
O
TBSO O
H
H
H
H E
O
O
O
TBSO O
H
H
H
H E O
O
O
TBSO O
H
H
H
H E
+
PhMe
reflux
++
102b trans, unlike 103b trans, like
104b cis, unlike 105b cis, like
TBSO
E
E = CO2Me
81b
 
A solution of 2b (330 mg, 0.75 mmol, 1.0 equiv) and BHT (0.1 equiv) in chlorobenzene 
(75 ml) was heated at reflux for 72 h. The reaction mixture was cooled to rt and 
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concentrated in vacuo. After column chromatography on silica (hexanes/ethyl acetate 
80:20) a mixture of 4 products (295 mg, 0.67 mmol, 89%) was obtained. Normal phase 
HPLC (hexanes/ethyl acetate 85:15) yielded compounds 102b, 103b, 104b and 105b in 
a ratio of 9:6:66:19. 
 
Methyl (3aR, 4R, 5S, 7aR)-5-((1S,2R)-2,3-O-isopropylidene-1-((tert-
butyldimethylsilyl)oxy)-2,3-dihydroxypropyl)-3-oxo-1,3,3a,4,5,7a-hexa-hydro-4-
isobenzofurancarboxylate 105b 
O
O
O
TBSO O
H
H
H
H E
105b cis, like  
             E = CO2Me 
[α]D
25 =  −149.59  (c= 0.903, chloroform). 1H NMR (500 MHz, CDCl3): δ 5.90 (2H, s), 
4.44 (1H, dd, J = 8.2, 7.0 Hz), 4.09 (1H, q, J = 5.8 Hz), 4.03 (1H, dd, J = 7.0, 5.8 Hz), 
3.88 (1H, dd, J = 11.5, 7.9 hz), 3.77 (3H, s), 3.77 (1H, dd, J = 8.3, 5.2 Hz), 3.72 (1H, 
dd, J = 5.9, 2.2 Hz), 3.09 (1H, m), 3.01 (2H, m), 2.78 (1H, m), 1.38 (3H, s), 1.31 (3H, 
s), 0.86 (9H, s), 0.13, 0.09 (6H, 2 x s) ppm. 13C NMR (125 MHz, CDCl3): δ 174.2, 
171.5, 130.5, 123.7, 109.4, 77.8, 74.3, 70.4, 67.3, 51.9, 43.5, 41.5, 41.5, 40.5, 26.7, 
26.1, 25.1, 18.6, -3.5, -4.2 ppm. IR (thin film): ν = 2954, 2931, 2896, 2857, 1790, 1742 
cm-1. EIMS (70 eV) m/z (%): 425 (15), 383 (100), 339 (85), 325 (50), 73 (95); HRMS: 
calcd for C21H33O7Si [M-CH3]: 425.1996; found: 425.1997 
 
Methyl (3aR, 4R, 5R, 7aS)-5-((1S,2R)-2,3-O-isopropylidene-1-((tert-
butyldimethylsilyl)oxy)-2,3-dihydroxypropyl)-3-oxo-1,3,3a,4,5,7a-hexa-hydro-4-
isobenzofurancarboxylate 102b 
O
O
O
TBSO O
H
H
H
H E
102b trans, unlike  
        E = CO2Me 
[α]D
25 = +75.73  (c= 0.780, chloroform). 1H NMR (500 MHz, CDCl3): δ 6.04 (1H, dt, J 
= 10.8, 2.0 Hz), 5.76 (1H, dt, J = 9.9, 3.2 Hz), 4.49 (1H, dd, J = 8.3, 8.3 Hz), 4.02-3.96 
(2H, m), 3.93 (1H, dd, J = 8.3, 8.3 Hz), 3.75 (3H, s), 3.75 (1H, dd, J = 12.6, 7.1 Hz), 
3.70 (1H, dd, J = 6.5, 3.6 Hz), 3.18 (1H, m), 3.12 (1H, dd, J = 10.8 Hz), 2.86 (1H, dd, J 
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= 10.8, 7.4 Hz), 2.78 (1H, m), 1.35, 1.30 (6H, 2 x s), 0.88 (9H, s), 0.10, 0.08 (6H, 2 x s) 
ppm. 13C NMR (125 MHz, CDCl3): δ 176.6, 174.1, 128.7, 123.6, 109.5, 76.0, 73.1, 
71.8, 67.8, 52.2, 43.5, 41.3, 39.0, 36.2, 29.8, 26.4, 25.8, 18.0, -4.3, -4.7 ppm. IR (thin 
film): ν = 2954, 2930, 2858, 1782, 1736 cm-1. EIMS (70 eV) m/z (%): 425 (10), 383 
(15), 339 (40), 325 (40), 105 (100); HRMS: calcd for C21H33O7Si [M-CH3]: 425.1996; 
found: 425.1997. 
 
Methyl (3aS, 4S, 5R, 7aS)-5-((1S,2R)-2,3-O-isopropylidene-1-((tert-
butyldimethylsilyl)oxy)-2,3-dihydroxypropyl)-3-oxo-1,3,3a,4,5,7a-hexa-hydro-4-
isobenzofurancarboxylate 104b 
O
O
O
TBSO O
H
H
H
H E
104b cis, unlike  
          E = CO2Me 
[α]D
25 =  −49.06  (c= 1.27, chloroform). 1H NMR (500 MHz, CDCl3): δ 5.96 (1H, dt, J 
= 11.0, 2.0 Hz), 5.66 (1H, ddd, J = 10.4, 3.8, 2.1 Hz), 4.48 (1H, dd, J = 8.8, 7.8 Hz), 
4.14 (1H, q, J = 5.9 Hz), 4.05 (1H, dd, J = 8.0, 6.2 Hz), 3.91 (1H, dd, J = 8.5, 8.5 Hz), 
3.84 (1H, dd, J = 8.2, 6.3 Hz), 3.75 (3H, s), 3.69 (1H, dd, J = 6.0, 2.1 Hz), 3.18 (1H, m), 
3.07 (1H, m), 2.83 (2H, m), 1.38, 1.32 (6H, 2 x s), 0.85 (9H, s), 0.07, 0.06 (6H, 2 xs) 
ppm. 13C NMR (125 MHz, CDCl3): δ 176.8, 173.6, 129.6, 123.2, 109.3, 76.9, 73.6, 
71.7, 66.9, 52.3, 40.6, 40.5, 40.3, 34.9, 26.7, 26.0, 25.3, 18.3, -4.0, -4.2 ppm. IR (thin 
film): ν = 2954, 2931, 2897, 2858, 1780, 1741 cm-1. EIMS (70 eV) m/z (%):425 (10), 
409 (5), 383 (15), 339 (85), 73 (100); HRMS: calcd for C21H33O7Si [M-CH3]: 425.1996; 
found: 425.1996. 
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Methyl (3aS, 4S, 5S, 7aR)-5-((1S,2R)-2,3-O-isopropylidene-1-((tert-
butyldimethylsilyl)oxy)-2,3-dihydroxypropyl)-3-oxo-1,3,3a,4,5,7a-hexa-hydro-4-
isobenzofurancarboxylate 103b 
O
O
O
TBSO O
H
H
H
H E
103b trans, like  
          E = CO2Me 
[α]D
25 =  +157.09  (c= 1.24, chloroform). 1H NMR (500 MHz, C6D6): δ 5.64 (1H, dt, J 
= 10.0, 3.1 Hz), 5.12 (1H, dt, J = 10.3, 2.0 Hz), 4.30 (1H, ddd, J = 8.3, 6.3, 2.5 Hz), 
4.00 (1H, t, J = 3.0 Hz), 3.85 (1H, m), 3.81 (1H, m), 3.56 (1H, dd, J = 8.3, 6.9 Hz), 3.46 
(3H, s), 2.95 (1H, dd, J = 12.0, 8.5 Hz), 2.75 (1H, m), 2.71 (1H, dd, J = 12.0, 9.4 Hz), 
2.37 (1H, dd, J = 13.2, 12.2 Hz), 1.88 (1H, m), 1.42, 1.35 (6H, 2 x s), 0.93 (9H, s), 0.14, 
0.09 (6H, 2 xs) ppm. 13C NMR (125 MHz, C6D6): δ  173.1, 170.8, 129.0, 125.1, 107.8, 
77.5, 73.3, 69.4, 65.0, 51.6, 43.3, 42.1, 41.9, 40.5, 26.9, 26.1, 26.0, 18.3, -4.3, -4.9 ppm. 
IR (thin film): ν = 2986, 2954, 2929, 2857, 1790, 1743 cm-1. EIMS (70 eV) m/z 
(%):425 (5), 383 (10), 325 (25), 310 (15), 105 (100); HRMS: calcd for C21H33O7Si [M-
CH3]: 425.1996; found: 425.1991. 
 
(3aS,5aR,6S,7R,9aS,9bS)-3,3a,6,7-Tetrahydro-6-[(tert-butyldimethyllsilyl)oxy]-7-
(hydroxymethyl)-5aH-furo[3,4-h]isochromene-1,9(9aH,9bH)-dione 106 
O
O
H
H
H H
106
O O
HO
TBSO
48
 
To a stirred solution of 104b (22 mg, 0.05 mmol, 1.0 equiv) in dichloromethane (500 
µL) was added trifluoroacteic acid (195 µL, 2.50 mmol, 50 equiv). Stirring was 
continued for 4 h 40 min. Evaporation of the solvent gave the crude product as a 
colourless oil. Chromatography of this material on silica (hexane/ethyl acetate 70:30) 
gave 106 (10 mg, 0.03 mmol, 56%) as a colourless solid. [α]D
25 =  + 4.18 (c= 0.335, 
chloroform). 1H NMR (500 MHz, CDCl3): δ  6.12 (1H, dt, J = 9.9, 2.4 Hz), 5.85 (1H, 
dt, J = 9.7, 2.7 Hz), 4.49 (dd, J = 9.3, 7.0 Hz), 4.28 (1H, ddd, J = 9.8, 6.4, 3.2 Hz), 4.25 
(1H, dd, J = 9.2, 3.1 Hz), 4.05 (1H, dd, J = 10.4, 6.5 Hz), 3.95 (1H, dd, J = 12.3, 2.4 
Hz), 3.80 (1H, dd, J = 12.6, 3.5 Hz), 3.57 (1H, dd, J = 8.3, 7.3 Hz), 3.07 (1H, m), 2.61 
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(1H, dd, J = 12.8, 7.4 Hz), 2.38 (1H, ddd, J = 10.1, 2.3, 2.3 Hz), 1.63 (1H, bs), 0.92 
(9H, s), 0.17 (3H, s), 0.15 (3H, s) ppm. 13C NMR (100 MHz, CDCl3): δ  177.8, 171.5, 
130.8, 129.6, 86.3, 71.8, 69.7, 62.3, 39.4, 39.3, 38.8, 35.4, 25.8, 18.1, -3.9, -3.9 ppm. IR 
(thin film): ν = 3468, 2957, 2918, 2851, 1769, 1647 cm-1. EIMS (70 eV) m/z (%): 368 
(30), 311 (30), 293 (35), 219 (45), 75 (100); HRMS: calcd for C18H28O6Si [M]: 
368.1655; found: 368.1656. 
 
IMDA reaction of (2E,4E,7S)-7,8-O-isopropylidene-7,8-dihydroxy-2,4-octadien-1-yl 
methyl maleate 82x 
O
O
O
O
O
O
O
O
CO2Me
H
H
H H O
O
O
O
CO2Me
H
H
H H
O
O
O
O
CO2Me
H
H
H H O
O
O
O
CO2Me
H
H
H H
+
PhMe
reflux
++
102x trans, unlike 103x trans, like
104x cis, unlike 105x cis, like
CO2Me
82x
 
To a stirred solution of (2E,4E,7S)-7,8-O-isopropylidene-7,8-dihydroxy-2,4-octadien-1-
yl methyl maleate 82x (200 mg, 0.64 mmol, 1.0 equiv) in toluene (65 mL) at rt under 
argon was added BHT (5 mg, 0.13 mmol, 0.2eq).  The solution was warmed to reflux 
and heating was continued for 18h.  Evaporation of the solvent gave the crude product  
as a yellow oil.  Chromatography (hexane:ethyl acetate 2:1) gave the IMDA adducts 
(102x, 103x, 104x and 105x, 41:39:11:9) (86 mg, 0.28 mmol, 43%). 
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IMDA reaction of (2E,4E,7S)-7,8-O-isopropylidene-7,8-dihydroxy-2,4-octadien-1-yl 
methyl fumarate 82y 
O
O
O
O
O
O
O
O
H
H
H
H E O
O
O
O
H
H
H
H E
O
O
O
O
H
H
H
H E O
O
O
O
H
H
H
H E
+
PhMe
reflux
++
102y trans, unlike 103y trans, like
104y cis, unlike 105y cis, like
E
E = CO2Me
82y
 
To a stirred solution of 82y (179 mg, 0.58 mmol, 1.0 equiv) in toluene (65mL) at rt 
under argon was added BHT (2 mg, 0.06 mmol, 0.1eq).  The solution was warmed to 
reflux and heating was continued for 43h.  Evaporation of the solvent gave the crude 
product as a yellow oil.  Chromatography of this material on silica with hexane:ethyl 
acetate (60:40) gave the ETDA adducts (102y, 103y, 104y, 105y) (160 mg, 0.52 mmol, 
89%, 102y:103y:104y:105y (32:33:18:17)) as a mixture.  
 
Methyl (3aS, 4S, 5R, 7aS)-5-((2S)-2,3-O-isopropylidene-2,3-dihydroxypropyl)-3-oxo-
1,3,3a,4,5,7a-hexahydro-4-isobenzofurancarboxylate 104y 
O
O
O
O
H
H
H
H E
104y cis, unlike  
             E = CO2Me 
1H NMR (500 MHz, CDCl3): δ 5.94 (1H, ddd, J = 10.1, 3.9, 1.8 Hz), 5.62 (1H, dt, J = 
10.1, 2.6 Hz), 4.45 (1H, dd, J = 9.0, 7.2 Hz), 4.24 (1H, dq, J = 7.2, 5.3 Hz), 4.07 (2H, 
m), 3.76 (3H, s), 3.50 (1H, t, J = 7.9 Hz), 3.22 (1H, m), 3.19 (1H, dd, J = 8.3, 4.3 Hz), 
3.08 (1H, t, J = 4.3 Hz), 2.79 (1H, m), 1.61 (2H, m), 1.40 (3H, s), 1.35 (3H, s) ppm. 13C 
NMR (125 MHz, C6D6): δ 176.8, 173.9, 132.6, 124.5, 109.2, 74.5, 71.1, 69.8, 51.9, 
41.1, 39.3, 38.8, 33.9, 33.8, 27.3, 26.0  ppm. IR (thin film): ν =  2925, 1769, 1734 cm-1. 
EIMS (70 eV) m/z (%): 295 (80), 279 (5), 105 (100); HRMS: calcd for C15H19O6 [M-
CH3]: 295.1182; found: 295.1182. 
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Methyl (3aR, 4R, 5S, 7aR)-5-((2S)-2,3-O-isopropylidene-2,3-dihydroxypropyl)-3-oxo-
1,3,3a,4,5,7a-hexahydro-4-isobenzofurancar-boxylate 105y 
O
O
O
O
H
H
H
H E
105y cis, like  
               E = CO2Me 
[α]D
25 =  -48.75 (c = 0.08, chloroform). 1H NMR (500 MHz, CDCl3): δ 5.97 (1H, ddd, J 
= 10.4, 4.2, 1.7 Hz), 5.67 (1H, dt, J = 10.4, 2.2 Hz), 4.45 (1H, dd, J = 9.0, 6.9 Hz), 4.19 
(1H, m), 4.08 (1H, dd, J = 9.0, 3.0 Hz), 4.04 (1H, dd, J = 8.0, 5.7 Hz), 3.75 (3H, s), 3.52 
(1H, t, J = 6.7 Hz), 3.22 (2H, m), 3.01 (1H, t, J = 4.1 Hz), 2.87 (1H, m), 1.79 (1H, m), 
1.54 (1H, m), 1.42 (3H, s), 1.35 (3H, s) ppm. 13C NMR (125 MHz, CDCl3): δ 177.4, 
173.9, 131.3, 124.9, 109.2, 73.5, 71.7, 69.6, 52.5, 42.6, 39.4, 39.2, 33.9, 32.6, 27.1, 25.9 
ppm. IR (thin film): ν = 2923, 1772, 1734 cm-1. EIMS (70 eV) m/z (%):310 (1), 295 
(100); HRMS: calcd for C16H22O6 [M]: 310.1416; found: 310.1414. 
 
Methyl (3aR, 4R, 5R, 7aS)-5-((2S)-2,3-O-isopropylidene-2,3-dihydroxypropyl)-3-oxo-
1,3,3a,4,5,7a-hexahydro-4-isobenzofurancar-boxylate 102y 
O
O
O
O
H
H
H
H E
102y trans, unlike  
            E = CO2Me 
[α]D
25 =  +  130.37 (c= 0.135, chloroform). 1H NMR (500 MHz, CDCl3): δ  5.86 (2H, 
m), 4.46 (1H, dd, J = 8.2, 6.8 Hz), 4.02 (2H, m), 3.94 (1H, dd, J = 11.9, 8.7 Hz), 3.77 
(3H, s), 3.45 (1H, m), 2.99 (1H, dd, J = 12.4, 7.3 Hz), 2.81 (2H, m), 2.56 (1H, dd, J = 
14.2, 11.6 Hz), 1.64 (2H, m), 1.39 (3H, s), 1.34 (3H, s) ppm. 13C NMR (125 MHz, 
CDCl3): δ 174.1, 171.7, 134.1, 123.0, 109.3, 74.7, 70.3, 69.6, 52.0, 43.2, 41.7, 41.1, 
36.1, 35.9, 27.1, 25.9 ppm. IR (thin film): ν = 2925, 1785, 1735 cm-1. EIMS (70 eV) 
m/z (%): 310 (1), 295 (95), 43 (100); HRMS: calcd for C16H22O6 [M]: 310.1416; found: 
310.1414. 
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Methyl (3aS, 4S, 5S, 7aR)-5-((2S)-2,3-O-isopropylidene-2,3-dihydroxypropyl)-3-oxo-
1,3,3a,4,5,7a-hexahydro-4-isobenzofurancarboxylate 103y 
O
O
O
O
H
H
H
H E
103y trans, like  
               E = CO2Me 
[α]D
25 =  + 78.4 (c = 0.31, chloroform). 1H NMR (500 MHz, CDCl3): δ 5.96 (1H, dt, J = 
10.1, 3.3 Hz), 5.87 (1H, d, J = 9.8 Hz), 4.46 (1H, dd, J = 8.0, 6.6 Hz), 4.18 (1H, m), 
4.04 (1H, dd, J = 8.0, 6.0 Hz), 3.93 (1H, dd, J = 11.2, 8.0 Hz), 3.79 (3H, s), 3.51 (1H, 
dd, J = 7.8, 6.3 Hz), 3.01 (2H, m), 2.84 (1H, m), 2.56 (1H, dd, J = 13.4, 11.3 Hz), 1.51 
(2H, m), 1.39 (3H, s), 1.34 (3H, s) ppm. 13C NMR (125 MHz, CDCl3): δ 174.1, 171.5, 
132.5, 123.7, 109.4, 73.1, 70.3, 69.9, 52.0, 43.5, 41.5, 41.3, 36.6, 34.4, 27.2, 25.6 ppm. 
IR (thin film): ν = 2925, 1785, 1734 cm-1. EIMS (70 eV) m/z (%): 295 (80), 279 (15), 
105 (100); HRMS: calcd for C15H19O6 [M-CH3]: 295.1182; found:295.1178. 
 
7.2.4 Lactate series 
 (2Z)-4-[[(2E,4E,6S)-6-((tert-Butyldimethylsilyl)oxy)hepta-2,4-dienyl]oxy]-4- oxobut-
2-enoic acid 107 
TBSO
O
O
CO2H
107  
To a stirred solution of 94 (1.11 g, 4.58 mmol, 1.0 equiv) in dichloromethane (30 mL) at 
0 ˚C under argon was added triethylamine (1.02 mL, 7.33 mmol, 1.6 equiv), maleic 
anhydride (1.26 g, 12.82 mmol, 2.8 equiv) and DMAP (61 mg, 0.5 mmol, 0.1 equiv). 
The reaction mixture was stirred at this temperature for 15 min before being diluted 
with diethyl ether (110 mL), washed with 2M HCl (55 mL), water (55 mL), dried 
(MgSO4) and concentrated in vacuo. Chromatography of the crude product on silica 
(hexane/ethyl acetate/methanol/acetic acid 20:20:1:1) gave 107 (1.16 g, 3.4 mmol, 
75%). [α] = +4.54 (c = 0.573, dichloromethane). 1H NMR (300 MHz, CDCl3): δ 6.47-
6.28 (3H, m), 6.17 (1H, ddd, J  = 15.0, 10.6, 1.5 Hz), 5.80 (1H, dd, J = 15.0, 5.5 Hz), 
5.73 (1H, dt, J = 15.0, 6.6 Hz),  4.78 (2H, d, J = 7.0 Hz), 4.35 (1H, dq, J = 11.7, 5.5 
Hz), 1.22 (3H, d, J =  6.6 Hz), 0.89 (9H, s), 0.06, 0.05 (6H, 2 x s). 13C NMR (100 MHz, 
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CDCl3): δ 167.3, 165.2, 141.2, 136.2, 135.8, 129.5, 126.5, 123.6, 68.6, 67.3, 25.9, 24.3, 
18.3, -4.6, -4.7 ppm.  IR (thin film): ν = 2955, 2929, 2886, 2857 (C-H), 1769, 1738, 
1732, 1713, 1682, 1651, 1633 cm-1. ESIMS (positive ion) m/z (%): 341 (100). HRMS: 
calcd for C17H29SiO5 [M + H]
+: 341.1786; found 341.1782  
 
 (2E,4E,6S)-6-((tert-Butyldimethylsilyl)oxy)hepta-2,4-dienyl methyl-(2Z)-but-2-
enedioate 83c 
TBSO
O
O
CO2Me
83c  
To a stirred solution of dienol 94 (307 mg, 1.26 mmol, 1.0 equiv) in dichloromethane 
(8.5 mL) at 0 ˚C was added triethylamine (281 µL, 2.02 mmol, 1.6 equiv), maleic 
anhydride (347 mg, 3.54 mmol, 2.8 equiv) and DMAP (15 mg, 0.12 mmol, 0.1 equiv). 
The reaction mixture was stirred at this temperature for 20 min. The mixture was diluted 
with diethyl ether (30 mL) and washed with 2M HCl (15 mL), water (15 mL), dried 
(MgSO4) and concentrated in vacuo. The residue was dissolved in dichloromethane (15 
mL) and an ethereal solution of diazomethane was added dropwise at –78 ˚C. The  
reaction mixture was concentrated in vacuo. After column chromatography on silica 
(hexane/ethyl acetate 88:12) the triene 83c (384 mg, 1.10 mmol, 87%) was obtained as a 
colourless oil.  [α] = +2.21 (c = 1.27, dichloromethane). 1H NMR (400 MHz, CDCl3): δ  
6.29 (1H, dd, J = 14.9, 10.8 Hz), 6.25 (2H, m), 6.16 (1H, ddd, J = 15.2, 10.8, 1.2 Hz), 
5.76 (1H, dd, J = 15.2, 5.4 Hz), 5.73 (1H, dt, J = 14.9, 6.6 Hz), 4.70 (2H, dd, J = 6.6, 
1.0 Hz), 4.34 (1H, dq, J = 12.2, 5.6 Hz), 3.77 (3H, s), 1.20 (3H, d, J = 6.4 Hz), 0.89 
(9H, s), 0.05, 0.04 (6H, 2 x s) ppm . 13C NMR (100 MHz, CDCl3): δ 165.7, 165.0, 
140.3, 134.9, 129.9, 129.7, 126.8, 125.0, 68.7, 65.7, 52.3, 25.9, 24.4, 18.3, -4.6, -4.7 
ppm. IR (thin film): ν =2954, 2886, 2856 (C-H), 1732 (C=O), 1644 cm-1  (C=C). 
ESIMS (positive ion) m/z (%): 377 (100) HRMS: calcd for C18H30O5SiNa [M + Na]
+: 
377.1755; found 377.1756 
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 (2E,4E,6S)-6-Hydroxyhepta-2,4-dienyl methyl (2Z)-but-2-enedioate 83a 
HO
O
O
CO2Me
83a  
To a stirred solution of 107 (54  mg, 0.16 mmol, 1.0 equiv) in tetrahydrofuran (2 mL) 
under argon at 0 ˚C was added tetrabutyl ammonium fluoride (0.50 mL, 0.50 mmol, 3.1 
equiv) The reaction mixture was warmed to rt and stirring was continued for 23 h. The 
reaction mixture was diluted with diethyl ether (20 mL) and partitioned against sat. 
NH4Cl (10 mL). The aqueous layer was extracted with ethyl acetate (3 x 10 mL). The 
combined organic layers were dried (MgSO4) and concentrated in vacuo. The residue 
was then diluted in dichloromethane (3 mL) and an ethereal solution of diazomethane 
was added dropwise at –78 oC. The mixture was then concentrated in vacuo. 
Chromatography of the crude product on silica (hexane/ethyl acetate 60:40) gave 83a 
(17 mg, 0.07 mmol, 44%) as a colourless oil. [α] = +5.82 (c = 0.75, dichloromethane). 
1H NMR (400 MHz, CDCl3): δ 6.31 (1H, dd, J  = 15.2, 10.5 Hz), 6.27 (2H, m), 6.22 
(1H, dd, J = 14.9, 10.5 Hz), 5.81 (1H, dd, J = 13.7, 6.6 Hz), 5.79 (1H, dt, J = 14.0, 6.6 
Hz), 4.72 (2H, d, J = 6.6 Hz), 4.37 (1H, dq, J = 12.7, 6.6 Hz), 3.79 (3H, d, J = 0.5 Hz), 
1.80 (1H, s), 1.29 (3H, d, J = 6.36 Hz) ppm. 13C NMR (100 MHz, CDCl3): δ 165.8, 
164.9, 139.2, 134.3, 130.0, 129.7, 128.1, 126.0, 68.3, 65.5, 52.3, 23.3 ppm. IR (thin 
film): ν =. 3437 (OH), 2971, 2875 (C-C), 1738, 1731, 1720 (C=O), 1660, 1651, 1633 
(C=C). ESIMS (positive ion) m/z (%): 263 (100). HRMS: calcd for C15H16O5Na [M + 
Na]+: 263.0896; found 263.0899 
 
 (2E,4E,6S)-6-((Trimethylsilyl)oxy)hepta-2,4-dienyl methyl-(2Z)-but-2-enedioate 83b 
TMSO
O
O
CO2Me
83b  
To a stirred solution of 83a (24.8 mg, 0.10 mmol, 1.0 equiv) in dichloromethane (2 mL) 
at 0 °C under argon was added 2,6-lutidine (36 µL, 0.31 mmol, 3.0 equiv) and 
trimethylsilyl triflouromethanesulphonate (35 µL, 0.18 mmol, 1.8 equiv). On 
completion of addition the solution was warmed to rt and stirred for 15 min. The 
reaction mixture was diluted with diethyl ether (10 mL) and partitioned against sat. 
NaHCO3 (10 mL). The aqueous layer was extracted with diethyl ether (2 x 5 mL). The 
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combined organic layers were washed with NaCl (5 mL), dried (MgSO4) and 
concentrated in vacuo. After column chromatography on silica (hexane/ethyl acetate 
90:10) 83b (27.5 mg, 0.09 mmol, 88%) was obtained as a colouless oil. [α] = +8.24 (c = 
0.17, dichloromethane). 1H NMR (400 MHz, CDCl3): δ 6.29 (1H, dd, J = 15.2, 10.8 
Hz), 6.25 (2H, m), 6.14 (1H, ddd, J = 15.2, 10.8, 1.0 Hz), 5.75 (2H, dt, J = 15.2, 5.9 
Hz),  4.70 (2H, d, J  = 6.4 Hz), 4.33 (1H, dq, J = 12.2, 5.9 Hz), 3.77 (3H, s), 1.23 (3H, 
d, J = 6.4 Hz), 0.11 (9H, s) ppm. 13C NMR (100 MHz, CDCl3): δ 165.7, 165.0, 140.0, 
134.7, 130.0, 129.7, 127.7, 127.2, 125.3, 120.0, 68.6, 65.6, 52.3, 24.3, 0.2 ppm. IR (thin 
film) ν = 2955 (C-H), 1732, 1644. ESIMS (positive ion) m/z (%): 647 (14), 335 (100), 
263 (24). HRMS: calcd for C14H21O5Si [M-CH3]:  297.1158;  found 297.1166. 
 
(2E,4E,6S)-6-((Trimethylsilyl)oxy)hepta-2,4-dienyl methyl-(2Z)-but-2-enedioate 83d 
TIPSO
O
O
CO2Me
83d  
To a stirred solution of 83a (41 mg, 0.17 mmol, 1.0 equiv) in dichloromethane (5 mL) 
at 0 °C under argon was added 2,6-lutidine (56 µL, 0.51 mmol, 3.0 equiv) and 
triisopropylsilyl trifluoromethanesulphonate (83 µL, 0.31 mmol, 1.8 equiv). On 
completion of addition the solution was warmed to rt and the stirring was continued for 
1.5 h. The reaction mixture was diluted with diethyl ether (20 mL) and partioned against 
sat. NaHCO3 (20 mL). The aqueous layer was extracted with diethyl ether (2 x 10 mL) 
and the combined extracts were washed with NaCl (10 mL), dried (MgSO4), filtered and 
concentrated in vacuo. After column chromatography on silica (hexanes/ethyl acetate 
85:15) 83d (53 mg, 0.13 mmol, 78%) was obtained as a colourless oil. [α] = +5.96 (c = 
0.94, dichloromethane). 1H NMR (400 MHz, CDCl3): δ 6.30 (1H, dd, J = 14.9, 10.3 
Hz), 6.26 (2H, m), 6.18 (1H, dd, J = 15.2, 10.8 Hz), 5.79 (1H, dd, J = 14.9, 5.6 Hz), 
5.73 (1H, dt, J = 15.2, 6.6 Hz),  4.71 (2H, d, J = 6.6 Hz), 4.44 (1H, dq, J = 6.2, 6.2 Hz), 
3.77 (3H, s), 1.24 (3H, d, J = 6.2 Hz), 1.12-0.99 (21H, m) ppm. 13C NMR (100 MHz, 
CDCl3): δ 165.8, 165.0, 140.8, 135.0, 139.9, 129.8, 126.7, 124.9, 68.8, 65.8, 52.3, 24.9, 
18.1, 12.4 ppm. IR (thin film) ν = 2944, 2866, 1732, 1645, 1463, 1437, 1396, 1368 cm-
1. ESIMS (positive ion) m/z (%): 419 (100), 815 (10). HRMS: calcd for C21H36NaSiO5 
[M + Na]+: 419.2230; found 419.2228.  
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(2E,4E,6S)-6-((tert-Butyldimethylsilyl)oxy)hepta-2,4-dienyl methyl-(2E)-but-2-
enedioate 83e 
O
O
MeO2C
TBSO
83e  
To a stirred solution of 94 (162 mg, 0.60 mmol, 1.0 equiv) in diethyl ether (5 mL) at 
room temperature under nitrogen was added monomethyl fumarate (140.4 mg, 1.08 
mmol, 1.8 eqiuv), DCC (247 mg, 1.20 mmol, 2.0 equiv) and DMAP (11 mg, 0.09 
mmol, 0.15 equiv). Stirring was continued for 3 h. The reaction mixture was filtered and 
the filtrate was concentrated in vacuo. Chromatography of the crude product on silica 
(hexanes/ethyl acetate 97:3) gave (2E,4E,6S)-6-((tert-butyldimethylsilyl)oxy)hepta-2,4-
dienyl methyl-(2E)-but-2-enedioate 83e (182.2 mg, 0.53 mmol, 89%) as a colourless 
oil. [α]D
25 =  +21.47  (c= 0.340, chloroform). 1H NMR (500 MHz, CDCl3): δ 6.85 (2H, 
s), 6.28 (1H, dd, J = 15.5, 10.4 Hz), 6.14 (1H, ddd, J = 14.8, 10.5, 1.4 Hz), 5.75 (1H, dd, 
J = 15.0, 5.1 Hz), 5.70 (1H, dd, J = 14.9, 6.6 Hz), 4.09 (2H, d, J = 7.0 Hz), 4.33 (1H, 
dq, J = 11.3, 6.0 Hz), 3.79 (3H, s), 1.19 (3H, d, J = 7.4 Hz), 0.88 (9H, s), 0.04, 0.03 
(6H, 2 x s) ppm. 13C NMR (100 MHz, CDCl3): δ 165.4, 164.7, 140.3, 134.8, 133.7, 
133.5, 126.7, 124.9, 68.6, 65.6, 52.3, 25.9, 24.3, 18.3, -4.7, -4.8 ppm . IR (thin film): ν 
= 2955, 2930, 2887, 2857, 1727, 1662 cm-1. EIMS (70 eV) m/z (%): 339 (2), 297 (30), 
224 (35), 187 (100), 113 (50), 75 (65); HRMS: calcd for C17H27O5Si [M
+-CH3-
]:339.1628; found: 339.1624.  
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7.2.4.1 IMDA reactions of 83 
Thermal IMDA reaction of  (2E,4E,6S)-6-((tert-butyldimethylsilyl)oxy)hepta-2,4-dienyl 
methyl-(2Z)-but-2-enedioate 83c 
TBSO
O
O
CO2Me
83c
O
TBSO O
CO2Me
H
H
H HO
TBSO O
CO2Me
H
H
H H
O
TBSO O
CO2Me
H
H
H HO
TBSO O
CO2Me
H
H
H H
+
++
109c trans, unlike 110c trans, like
111c cis, unlike 112c cis, like
PhMe
reflux
 
A solution of 83c (238 mg, 0.67 mmol, 1.0 equiv) and BHT (15 mg, 0.07 mmol, 0.1 
equiv) in toluene (85 mL) was heated at reflux for 7 h and 25 min. The reaction mixture 
was concentrated in vacuo. After column chromatography on silica (hexanes/ethyl 
acetate 80:20) a mixture of 4 products  (229 mg, 0.65 mmol, 96%) was obtained. 
Normal phase HPLC (hexanes/ethyl acetate 85:15) yielded compounds 111c as a white 
solid and 112c as a colourless oil, as well as a mixture of compounds 109c and 110c. 
Reverse phase HPLC (methanol/water 80:20) of this mixture yielded compound 109c  
as a white solid and 110c as a colourless oil.  
 
Methyl (3aR,4S,5R,7aS)-5-[(1S)-1-(tert-butyldimethylsilyl)oxyethyl]-3-oxo-
1,3,3a,4,5,7a-hexahydro-2-benzofuran-4-carboxylate 110c 
O
TBSO O
CO2Me
H
H
H H
110c trans, like  
 [α] = +53.90 (c = 0.590, dichloromethane). 1H NMR (400 MHz, MeOD): δ 6.01 (1H, 
ddd, J = 10.0, 2.2, 2.2 Hz), 5.74 (1H, ddd, J = 10.0, 3.2, 3.2 Hz), 4.56 (1H, dd, J =  8.1, 
7.1 Hz), 4.04 (1H, dq, J = 6.1, 3.9 Hz), 3.84 (1H, dd, J = 11.5, 8.1 Hz), 3.69 (3H, s), 
3.35 (1H, d, J  = 3.7 Hz), 3.2 (1H, m), 2.67 (1H, dd, J = 13.5, 3.9 Hz), 2.63 (1H, m), 
1.28 (3H, d, J  = 6.1 Hz), 0.89 (9H, s), 0.10, 0.07 (6H, 2 x s) ppm. 13C NMR (100 MHz, 
MeOD): δ 177.6, 174.6, 132.6, 127.0, 72.3, 72.3, 52.5, 48.0, 44.0, 37.5, 37.2, 26.3, 22.2, 
18.8, -4.3, -4.5 ppm. IR (thin film): ν =2953 (C-H), 1790, 1731 (C=O) cm-1. EIMS (70 
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eV) m/z (%): 339 (7), 323 (15), 310 (55), 297 (100), 159 (85), 73 (85)  HRMS: calcd for 
C17H27O5Si [M – CH3]
+: 339.1628; found 339.1629.  
 
Methyl (3aS,4R,5S,7aR)-5-[(1S)-1-(tert-butyldimethylsilyl)oxyethyl]-3-oxo-
1,3,3a,4,5,7a-hexahydro-2-benzofuran-4-carboxylate 109c 
O
TBSO O
CO2Me
H
H
H H
109c trans, unlike  
m.p. 54-56 oC. [α] = +84.0 (c = 0.300, dichloromethane). 1H NMR (400 MHz, CDCl3): 
δ 5.96 (1H, ddd, J = 10.0, 2.2, 2.2 Hz,), 5.74 (1H, ddd, J = 10.0, 3.0, 3.0 Hz), 4.52 (1H, 
dd, J = 7.8, 7.8 Hz), 4.00 (1H, dq, J = 6.4, 4.7 Hz), 3.83 (1H, dd, J = 11.5, 7.8 Hz), 3.68 
(3H, s), 3.31 (1H, d, J = 3.9 Hz), 3.24 (1H, m), 2.78 (1H, m), 2.50 (1H, dd, J = 13.5, 4.2 
Hz), 1.16 (3H, d, J = 6.4), 0.87 (9H, s), 0.07, 0.06 (6H, 2 x s) ppm.  13C NMR (100 
MHz, CDCl3): δ 174.6, 173.2, 129.4, 125.9, 71.3, 70.6, 52.1, 46.1, 43.1, 38.0, 36.4, 
25.8, 20.9, 18.1, -4.4, -4.9 ppm. IR (KBr disc): ν =2950, 2929, 2857, 2350 (C-H), 1780, 
1731 (C=O) cm-1. EIMS (70 eV) m/z (%): 339 (30), 310 (30), 297 (100), 159 (65), 73 
(70).  HRMS: calcd for C17H27O5Si [M – CH3]
+: 339.1628; found 339.1626. 
 
Methyl (3aS,4R,5R,7aS)-5-[(1S)-1-(tert-butyldimethylsilyl)oxyethyl]-3-oxo-
1,3,3a,4,5,7a-hexahydro-2-benzofuran-4-carboxylate 112c 
O
TBSO O
CO2Me
H
H
H H
112c cis, like  
 [α] = +23.53 (c = 0.136, dichloromethane). 1H NMR (400 MHz, CDCl3): δ  5.96 (1H, 
ddd, J = 10.0, 2.5, 2.5 Hz), 5.68 (1H, ddd, J = 10.0, 2.7, 2.7 Hz), 4.53 (1H, dd, J= 9.5, 
8.3 Hz), 4.09 ( 1H, dd, J = 9.8, 8.1 Hz), 3.84 (1H, dq, J = 9.8, 5.9 Hz), 3.64 (3H, s), 
3.36 (1H, dd, J = 5.6, 4.2 Hz), 3.21 (1H, m, C7a-H), 2.95 (1H, dd, J = 11.3, 6.1 Hz), 
2.24 (1H, m), 1.29 (3H, d, J = 5.9 Hz), 0.89 (9H, s), 0.09, 0.08 (6H, 2 x s)  ppm.  13C 
NMR (100 MHz, CDCl3): δ  177.9, 172.3, 129.1, 125.0, 72.0, 69.4, 51.9, 46.7, 41.3, 
40.5, 34.0, 25.9, 22.1, 18.2, -3.8, -4.6 ppm. IR (thin film): ν =2958, 2856, 2358 (C-H), 
1770, 1731 (C=O) cm-1. EIMS (70 eV) m/z (%): 355 (5), 339 (35), 297 (100), 159 (30), 
73 (80). HRMS: calcd for C17H27O5Si [M – CH3]
+: 339.1628; found 339.1629. 
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Methyl (3aR,4S,5S,7aR)-5-[(1S)-1-(tert-butyldimethylsilyl)oxyethyl]-3-oxo-
1,3,3a,4,5,7a-hexahydro-2-benzofuran-4-carboxylate 111c 
O
TBSO O
CO2Me
H
H
H H
111c cis, unlike  
 m.p. 95-98 oC [α] = -20.44 (c = 0.450, dichloromethane). 1H NMR (400 MHz, CDCl3): 
δ  5.67 (2H, m), 4.50 (1H, dd, J = 9.5, 8.1 Hz), 4.06 (1H, dq, J = 9.3, 6.1 Hz), 4.00 ( 
1H, dd, J  = 10.3, 8.3 Hz), 3.62 (3H, s), 3.60 (1H, dd, J = 6.1, 3.9 Hz), 3.20 (1H, m), 
2.95 (1H, dd, J = 10.8, 6.4), 2.24 (1H, m), 1.24 (3H, d, J = 5.9 Hz), 0.87 (9H, s), 0.07, 
0.03 (6H, 2 x s) ppm.  13C NMR (100 MHz, CDCl3): δ  177.6, 172.3, 128.2, 125.7, 71.6, 
68.6, 51.6, 47.0, 41.6, 39.5, 34.6, 26.0, 22.3, 18.1, -3.9, -4.9 ppm. IR (KBr disc): ν = 
2931, 2857 (C-H), 1760, 1737 (C=O) cm-1. EIMS (70 eV) m/z (%): 339 (40), 297 (100), 
159 (30), 89 (80), 73 (85). HRMS calcd for C17H27O5Si [M – CH3]
+: 339.1628; found 
339.1627. 
 
Thermal IMDA reaction of  (2E,4E,6S)-6-hydroxyhepta-2,4-dienyl methyl (2Z)-but-2-
enedioate 83a 
HO
O
O
CO2Me
83a
O
HO O
CO2Me
H
H
H HO
HO O
CO2Me
H
H
H H
O
HO O
CO2Me
H
H
H HO
HO O
CO2Me
H
H
H H
+
++
109a trans, unlike 110a trans, like
111a cis, unlike 112a cis, like
PhMe
reflux
 
A solution of 83a (35 mg, 0.15 mmol, 1.0 equiv) and BHT (4 mg, 0.02 mmol, 0.1 
equiv) in toluene (15 mL) was heated at reflux for 4.5 h. The reaction mixture was 
concentrated in vacuo. After column chromatography on silica (hexanes/ethyl acetate 
40:60) a mixture of 4 products 109a:110a:111a:112a (31 mg, 0.13 mmol, 88%) was 
obtained. 
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Thermal IMDA reaction of  (2E,4E,6S)-6-((trimethylsilyl)oxy)hepta-2,4-dienyl methyl-
(2Z)-but-2-enedioate 83b 
TMSO
O
O
CO2Me
83b
O
TMSO O
CO2Me
H
H
H HO
TMSO O
CO2Me
H
H
H H
O
TMSO O
CO2Me
H
H
H HO
TMSO O
CO2Me
H
H
H H
+
++
109b trans, unlike 110b trans, like
111b cis, unlike 112b cis, like
PhMe
reflux
 
A solution of 83b (99 mg, 0.32 mmol, 1.0 equiv) and BHT (7 mg, 0.03 mmol, 0.1 
equiv) in toluene (32 mL) was heated at reflux for 6.5 h. The reaction mixture was 
concentrated in vacuo. After column chromatography on silica (hexanes/ethyl acetate 
60:40) a mixture of 4 products 109b, 110b, 111b, and 112b (82  mg, 0.27 mmol, 83%) 
was obtained. 
 
Thermal IMDA reaction of  (2E,4E,6S)-6-((trimethylsilyl)oxy)hepta-2,4-dienyl methyl-
(2Z)-but-2-enedioate 83d 
TIPSO
O
O
CO2Me
83d
O
TIPSO O
CO2Me
H
H
H HO
TIPSO O
CO2Me
H
H
H H
O
TIPSO O
CO2Me
H
H
H HO
TIPSO O
CO2Me
H
H
H H
+
++
109d trans, unlike 110d trans, like
111d cis, unlike 112d cis, like
PhMe
reflux
 
A solution of 83d (53 mg, 0.13 mmol, 1.0 equiv) and BHT (3 mg, 0.01 mmol, 0.1 
equiv) in toluene (13 mL) was heated at reflux for 8.25 h. The reaction mixture was 
concentrated in vacuo. After column chromatography on silica (hexanes/ethyl acetate 
85:15) a mixture of 4 products 109d, 110d, 111d and 112d (45 mg, 0.11 mmol, 85%) 
was obtained. 
 
 
 
 194
IMDA reaction of (2E,4E,6S)-6-((tert-butyldimethylsilyl)oxy)hepta-2,4-dienyl methyl-
(2E)-but-2-enedioate 83e 
O
O
MeO2C
TBSO
83e
O
TBSO O
H
H
H
H EO
TBSO O
H
H
H
H E
O
TBSO O
H
H
H
H EO
TBSO O
H
H
H
H E
+
++
109e trans, unlike 110e trans, like
111e cis, unlike 112e cis, like
PhCl
reflux
E = CO2Me  
A solution of 83e (173 mg, 0.51 mmol, 1.0 equiv) and BHT (0.05 equiv) in 
chlorobenzene (102 mL) was heated at reflux for 43 h. The solution was cooled to room 
temperature and concentrated in vacuo. After column chromatography on silica 
(hexanes/ethyl acetate 80:20) a mixture of 4 products (130 mg, 0.38 mmol, 75%) was 
obtained. Normal phase HPLC of the mixture yielded compounds 109e, 110e, 111e and 
112e in a ratio of 8:28:40:24. 
 
Methyl (3aS,4S,5S,7aR)-5-[(1S)-1-(tert-butyldimethylsilyl)oxyethyl]-3-oxo-
1,3,3a,4,5,7a-hexahydro-2-benzofuran-4-carboxylate 109e 
O
TBSO O
H
H
H
H E
109e trans, unlike  
   E = CO2Me 
[α]D
25 = −164.52  (c= 0.420, chloroform). 1H NMR (500 MHz, CDCl3): δ 6.00 (2H, m), 
4.46 (1H, t, J = 7.4 Hz), 3.95 (1H, dd, J = 11.5, 8.4 Hz), 3.77 (3H, s), 3.68 (1H, m), 3.03 
(1H, dd, J = 12.3, 9.0 Hz), 2.93 (1H, m), 2.57 (1H,t, J = 12.7 Hz), 1.10 (3H, d, J = 6.4 
Hz), 0.86 (9H, s), 0.04, 0.04 (6H, 2 x s). ppm. 13C NMR (125 MHz, CDCl3): δ 174.2, 
171.3, 129.9, 124.5, 70.5, 68.9, 51.8, 44.7, 41.7, 41.5, 41.2, 25.8, 20.7, 18.1, -4.7, -5.0 
ppm. IR (thin film): ν = 3032, 2954, 2930, 1788, 1735 cm-1. EIMS (70 eV) m/z (%): 
339 (4), 310 (20), 297 (90), 159 (55), 73 (100); HRMS: calcd for C17H27O5Si [M
+-CH3-
]:339.1628; found: 339.1625. 
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Methyl (3aS,4S,5R,7aS)-5-[(1S)-1-(tert-butyldimethylsilyl)oxyethyl]-3-oxo-
1,3,3a,4,5,7a-hexahydro-2-benzofuran-4-carboxylate 112e 
O
TBSO O
H
H
H
H E
112e cis, like  
          E = CO2Me 
[α]D
25 = +191.98  (c= 0.424, chloroform). 1H NMR (500 MHz, CDCl3): δ 5.94 (1H, 
ddd, J = 10.3, 1.9, 1.9 Hz), 5.87 (1H, ddd, J = 9.9, 3.3, 3.3 Hz), 4.43 (1H, dd, J = 8.0, 
6.7 Hz), 3.90 (1H, dq, J = 6.6, 2.7 Hz), 3.88 (1H, dd, J = 11.3, 7.8 Hz), 3.77 (3H, s), 
3.14 (1H, dd, J = 14.4, 12.0 Hz), 2.95 (1H, dd, J = 11.1, 7.4 Hz), 2.78 (1H, m), 2.64 
(1H, m), 1.24 (3H, d, J = 6.4 Hz), 0.90 (9H, s), 0.07, 0.04 (6H, 2 x s). 13C NMR (125 
MHz, CDCl3): δ 174.3, 171.5, 129.5, 124.5, 70.3, 69.4, 51.8, 45.4, 43.8, 41.6, 41.3, 
26.0, 23.0, 18.2, -3.7, -4.8 ppm. IR (thin film): ν = 3015, 2951, 2929, 2904, 2882, 1783, 
1748 cm-1. EIMS (70 eV) m/z (%):310 (15), 297 (100), 159 (35), 75 (65); HRMS: calcd 
for C14H21O5Si [M
+-C4H9]:297.1158; found: 297.1157. 
 
Methyl (3aR,4R,5R,7aS)-5-[(1S)-1-(tert-butyldimethylsilyl)oxyethyl]-3-oxo-
1,3,3a,4,5,7a-hexahydro-2-benzofuran-4-carboxylate 110e 
O
TBSO O
H
H
H
H E
110e trans, like  
       E = CO2Me 
[α]D
25 =  −44.88  (c= 0.205, chloroform). 1H NMR (500 MHz, CDCl3): δ 5.94 (1H, ddd, 
J = 10.4, 2.3, 2.3 Hz), 5.70 (1H, ddd, J = 10.4, 2.9, 2.9 Hz), 4.45 (1H, dd, J = 8.9, 7.5 
Hz), 3.98 (1H, dd, J = 8.8, 6.0 Hz), 3.75 (1H, dq, J = 12.3, 6.3 Hz), 3.75 (3H, s), 3.20 
(1H, m), 3.10 (1H, dd, J = 7.7, 7.7 Hz), 2.99 (1H, dd, J = 6.6, 6.6 Hz), 2.58 (1H, m), 
1.09 (3H, d, J = 6.5 Hz), 0.90 (9H, s), 0.10, 0.06 (6H, 2 x s). 13C NMR (125 MHz, 
CDCl3): δ 177.0, 174.4, 129.3, 125.0, 71.7, 69.0, 52.4, 44.6, 39.9, 39.0, 34.7, 25.9, 20.2, 
18.1, -4.3, -4.8 ppm. IR (thin film): ν = 2930, 2847, 1778, 1735 cm-1. EIMS (70 eV) m/z 
(%):339 (5), 297 (100), 159 (55), 73 (75); HRMS: calcd for C14H21O5Si [M
+-C4H9-
]:297.1158; found: 297.1158. 
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Methyl (3aR,4R,5S,7aR)-5-[(1S)-1-(tert-butyldimethylsilyl)oxyethyl]-3-oxo-
1,3,3a,4,5,7a-hexahydro-2-benzofuran-4-carboxylate 111e 
O
TBSO O
H
H
H
H E
111e cis, unlike  
       E = CO2Me 
[α]D
25 = +92.86  (c= 0.868,). 1H NMR (500 MHz, CDCl3): δ 5.96 (1H, ddd, J = 10.5, 
3.2, 2.1 Hz), 5.66 (1H, ddd, J = 10.4, 3.3, 2.6 Hz), 4.45 (1H, dd, J = 8.9, 7.5 Hz), 3.97, 
(1H, dd, J = 9.3, 6.5 Hz), 3.76 (1H, dq, J = 11.9, 6.0 Hz), 3.73 (3H, s), 3.20 (1H, m), 
3.07 (1H, dd, J = 8.0, 8.0 Hz), 2.93 (1H, dd, J = 7.5, 6.1 Hz), 2.52 (1H, m), 1.25 (3H, d, 
J = 6.4 Hz), 0.87 (9H, s), 0.02, 0.00 (6H, 2 x s) ppm. 13C NMR (125 MHz, CDCl3): δ 
177.3, 174.3, 130.3, 123.9, 71.9, 69.8, 52.3, 44.4, 40.0, 39.3, 34.6, 25.9, 21.6, 18.1, -4.2, 
-5.1 ppm. IR (thin film): ν = 2929, 2856, 1788, 1735 cm-1. EIMS (70 eV) m/z (%): 339 
(4), 310 (15), 297 (100), 159 (50), 73 (70); HRMS: calcd for C17H27O5Si [M
+-CH3]: 
339.1628; found: 339.1629. 
 
Methyl (3aS,4R,5S,7aR)-5-[(1S)-1-hydroxyethyl]-3-oxo-1,3,3a,4,5,7a-hexahydro-2-
benzofuran-4-carboxylate 109a 
109a trans, unlike
O
HO O
CO2Me
H
H
H H
 
To a stirred solution of 109c (40 mg, 0.11 mmol, 1.0 equiv) in CDCl3 (500 µL) was 
added trifluoroacetic acid (348 µL, 4.5 mmol, 40 equiv). After 2.5 h the mixture was 
concentrated in vacuo. Chromatography of the crude product on silica (hexane/ethyl 
acetate 50:50) gave 109a (26 mg, 0.11 mmol, 95%) as a colourless oil. 
[α]D
25 =  +3.20  (c= 0.625, chloroform). 1H NMR (500 MHz, CDCl3): δ 6.06 (1H, dt, J 
= 10.0, 2.1 Hz), 5.82 (1H, dt, J = 10.1, 3.1 Hz), 4.55 (1H, t, J = 8.3 Hz), 4.05 (1H, dq, J 
= 6.5, 4.2 Hz), 3.89 (1H, dd, J = 11.5, 8.2 Hz), 3.73 (3H, s), 3.31 (1H, d, J = 4.3 Hz), 
3.24 (1H, m), 2.80 (1H, m), 2.64 (1H, dd, J = 13.6, 4.3 Hz), 1.97 (1H, bs), 1.30 (3H, d, 
J = 6.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): δ 174.8, 172.9, 128.0, 127.1, 71.4, 70.6, 
52.3, 45.4, 42.8, 39.4, 36.4, 21.2 ppm. IR (thin film): ν = 3462, 2962, 2902, 1781, 1730 
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cm-1. EIMS (70 eV) m/z (%): 209 (15), 196 (35), 136 (70), 119 (75), 91 (100) ; HRMS: 
calcd for C11H13O4 [M-OMe]: 209.0814; found: 209.0815. 
 
Methyl (3aR,4S,5R,7aS)-5-[(1S)-1-hydroxyethyl]-3-oxo-1,3,3a,4,5,7a-hexahydro-2-
benzofuran-4-carboxylate 110a 
O
HO O
CO2Me
H
H
H H
110a trans, like  
To a stirred solution of 110c (15 mg, 0.04 mmol, 1.0 equiv) in CDCl3 (300 µL) was 
added trifluoroacetic acid (132 µL, 1.8 mmol, 40 equiv). After 5 h the mixture was 
concentrated in vacuo. Chromatography of the crude product on silica (hexane/ethyl 
acetate 50:50) gave 110a (10 mg, 0.04 mmol, 98%) as colourless crystals. [α]D
25 =   -
20.57 (c = 0.125, chloroform). m.p 128 oC.  1 H NMR (500 MHz, CDCl3): δ 6.03 (1H, 
dt, J = 10.0, 1.8 Hz), 5.72 (1H, dt, J = 9.8, 3.1 Hz), 4.55 (1H, t, J = 7.9 Hz), 3.94 (1H, 
dq, J = 6.4, 4.8 Hz), 3.87 (1H, dd, J = 11.4, 8.1 Hz), 3.71 (3H, s), 3.49 (1H, d, J = 4.3 
Hz), 3.28 (1H, m), 2.67 (1H, m), 2.49 (1H, dd, J = 13.6, 4.1 Hz), 1.56 (1H, bs), 1.35 
(3H, d, J = 6.2 Hz) ppm. 13C NMR (125 MHz, CDCl3): δ 174.8, 173.0, 130.9, 126.8, 
70.6, 70.2, 52.4, 46.5, 42.8, 36.3, 36.2, 21.5 ppm. IR (thin film): ν = 3469, 2917, 1780, 
1730 cm-1. EIMS (70 eV) m/z (%): 209 (20), 196 (35), 150 (45), 136 (70), 119 (70), 91 
(100); HRMS: calcd for C11H13O4 [M-OMe]: 209.0814; found: 209.0814. 
 
(3S,3aR,5aS,8aS,8bR)-3-Methyl-3,3a,5a,6,8a,8b-hexahydrofuro[3,4-e][2]benzo-furan-
1,8-dione 113 
O
O
H
H
H H
O
O
113  
To a stirred solution of 111c (31 mg, 0.09 mmol, 1.0 equiv) in CDCl3 (300 µL) was 
added trifluoroacetic acid (250 µL, 3.20 mmol, 36 equiv). The mixture was stirred at 
room temperature for 2.25 h before being concentrated in vacuo. After column 
chromatography on silica (hexane/ethyl acetate 15:85) 113 (13 mg, 0.06 mmol, 66%) 
was obtained as a colourless crystalline solid. m.p 90 oC  1H NMR (400 MHz, CDCl3): δ 
5.89 (1H, ddd, J = 10.3, 3.4, 2.0 Hz), 5.80 (1H, ddd, J = 10.3, 2.0, 2.0 Hz), 4.37 (1H, 
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dd, J  = 9.3, 6.4 Hz), 4.24 (1H, dq, J = 8.3, 6.4 Hz), 4.13 (1H, dd, J = 9.3, 2.9 Hz), 3.24 
(1H, dd, J = 6.9, 6.9 Hz), 3.19-3.11 (2H, m), 2.68 (1H, m), 1.47 (3H, d, J = 6.4 Hz) 
ppm. 13C NMR (100 MHz, CDCl3): δ 175.8, 175.7, 127.9, 126.9, 80.4, 71.4, 41.7, 37.4, 
37.2, 35.6, 19.4 ppm . IR (KBr disc): ν  2989, 2878, 2359, 2339, 1764 cm-1 . EIMS (70 
eV) m/z (%): 209 (30), 164 (47), 149 (20), 136 (70), 92 (100). HRMS: calcd for 
C11H13O4 [M + H]
+: 209.0814; found 209.0813.   
 
(3S,3aS,5aR,8aR,8bS)-3-Methyl-3,3a,5a,6,8a,8b-hexahydrofuro[3,4-e][2]benzo-furan-
1,8-dione 114. 
O
O
H
H
H H
O
O
114  
To a stirred solution of 112c (10 mg, 0.03 mmol, 1.0 equiv) in CDCl3 (300 µL) at room 
temperature was added trifluoroacteic acid (89 µL, 1.15 mmol, 40 equiv). The mixture 
was stirred at room temperature for 3 h before being concentrated in vacuo. 
Recrystalisation from TBME gave (3S,3aS,5aR,8aR,8bS)-3-methyl-3,3a,5a,6,8a,8b-
hexahydrofuro[3,4-e][2]benzo-furan-1,8-dione 114 (5mg, 0.02 mmol, 85%) as a 
colourless crystalline solid. [α]D
25 =   -1.19 (c = 0.23, chloroform). m.p 139 oC 1H NMR 
(500 MHz, CDCl3): δ   5.91 (2H, m), 4.71 (1H, dq, J = 6.4, 5.3 Hz ) 4.51 (1H, t, J = 8.6 
Hz), 3.90 (1H, dd, J = 10.2, 8.5 Hz), 3.39 (1H, t, J = 6.6 Hz), 3.20 (1H, m), 3.06 (1H, 
m), 2.97 (1H, dd, J = 9.5, 6.8 Hz), 1.46 (3H, d, J = 6.4 Hz) 13C NMR (125 MHz, 
CDCl3): δ 179.8, 175.3, 147.8, 127.8, 124.0, 71.6, 39.9, 39.3, 35.9, 34.6, 29.8, 16.0 
ppm. IR (thin film): ν =  3749, 2916, 1768 cm-1 . EIMS (70 eV) m/z (%): 208 (10), 164 
(40), 149 (15), 136 (75), 91 (100). HRMS: calcd for C11H12O4 [M]
+: 208.0736; found 
208.0730. 
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(3S,3aS,5aR,8aS,8bS)-3-Methyl-3,3a,5a,6,8a,8b-hexahydrofuro[3,4-e][2]benzo-furan-
1,8-dione 115 
O
O
H
H
H H
O
O
115  
To a stirred solution of 110e (6 mg, 0.02 mmol, 1.0 equiv) in CDCl3 (300 µL) at room 
temperature was added trifluoroacteic acid (55 µL). The mixture was stirred at room 
temperature for 3 h before being concentrated in vacuo. Recrystalisation from TBME 
gave 115 (3mg, 0.01 mmol, 81%) as a colourless crystalline solid. [α]D
25 =   -59.13 (c = 
0.12, chloroform). m.p 170 oC  1H NMR (500 MHz, CDCl3): δ 6.05 (1H, dt, J = 9.8, 2.1 
Hz), 5.80 (1H, dt, J = 9.8, 3.3 Hz), 4.55 (1H, dd, J = 8.4, 7.1 Hz), 4.34 (1H, dq, J = 8.6, 
6.1 Hz), 4.00 (1H, dd, J = 10.5, 7.7 Hz), 3.13 (1H, dd, J = 12.2, 8.8 Hz), 2.99-2.79 (2H, 
m), 2.43 (1H, t, J = 13.2 Hz), 1.51 (3H, d, J = 6.3 Hz). 13C NMR (125 MHz, CDCl3): δ 
173.5, 172.4, 127.7, 126.6, 79.9, 70.0, 45.2, 40.7, 40.4, 39.7, 20.0 ppm. IR (thin film): ν 
=  3749, 2973, 2917, 2851, 1788 cm-1. EIMS (70 eV) m/z (%): 208 (10), 164 (35), 149 
(20), 136 (80), 91 (100). HRMS: calcd for C11H12O4 [M]
+: 208.0736; found 208.0730. 
 
Methyl (3aR,4R,5S,7aR)-5-[(1S)-1-hydroxyethyl]-3-oxo-1,3,3a,4,5,7a-hexahydro-2-
benzofuran-4-carboxylate 116 
O
OH O
CO2Me
H
H
H
116  
To a stirred solution of 111e (21 mg, 0.09 mmol, 1.0 equiv) in dichloromethane (1 mL) 
was added trifluoroacetic acid (183 µL, 3.75 mmol, 40 equiv). After 5 h the mixture 
was concentrated in vacuo. Chromatography of the crude product on silica 
(hexane/ethyl acetate 50:50) gave 116 (12 mg, 0.06 mmol, 85%) as colourless crystals. 
[α]D
25 =  + 83.85 (c= 0.390, chloroform). m.p 90 oC 1H NMR (500 MHz, CDCl3): 
δ 5.99 (1H, ddd, J = 10.2, 3.1, 1.9 Hz), 5.78 (1H, dt, J = 10.2, 2.8 Hz), 4.50 (1H, dd, J = 
8.7, 7.5 Hz), 4.08 (1H, dd, J = 8.7, 5.0 Hz), 3.90 (1H, dq, J = 11.8, 6.0 Hz), 3.77 (3H, s), 
3.24 (1H, m), 3.18 (1H, t, J = 6.4 Hz), 3.04 (1H, t, J = 6.0 Hz), 2.62 (1H, m), 1.66 (1H, 
bs), 1.33 (3H, d, J = 6.3 Hz) ppm. 13C NMR (125 MHz, CDCl3): δ 177.7, 174.3, 128.2, 
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126.1, 71.8, 69.8, 52.6, 43.4, 40.2, 39.7, 34.3, 21.1 ppm. IR (thin film): ν =  3503, 2956, 
2917, 1770, 1733 cm-1. EIMS (70 eV) m/z (%): 209 (4), 196 (80), 164 (35), 136 (65), 
105 (40), 92 (100); HRMS: calcd for C11H13O4 [M-OMe]: 209.0814; found: 209.0817. 
 
7.3 Chapter 3 
1,1-Dibromo[(3S)-(tert-butyldimethylsilyl)oxy]-1-butene 139 
OTBSBr
Br
139  
This compound was prepared according to modified literature procedures.91,219,220 To a 
stirred solution of triphenyl phospine (56.9 g, 217 mmol, 4.0 equiv) in dichloromethane 
(200 mL) at 0 oC under argon, was added a solution of carbon tetrabromide (35.98 g, 
108 mmol, 2 equiv) in dichloromethane (80 mL) over 45 min, via cannula. The reaction 
mixture was stirred at rt for 30 min before being cooled to 0 oC. A solution of aldehyde 
9391,219,220 (10.22 g, 54 mmol, 1.0 equiv) in dichloromethane (40 mL) was added 
dropwise. The reaction mixture was warmed to rt and stirring continued for a further 30 
min. To the reaction mixture was added hexanes and the resulting precipitate was 
filtered. The filtrate was then concentrated under reduced pressure. After column 
chromatography (hexanes) 139 (14.15 g, 41 mmol, 76%) was obtained as a colourless 
oil. 1H NMR data was consistent with that reported in the literature.91,219,220 
 
(2S, 3Z)-4-Bromo[(tert-butyldimethylsilyl)oxy]-hexa-3,5-diene 140 
Br
OTBS
140  
This compound was prepared according to modified literature procedures.85 To a stirred 
solution of 139 (1.0 g, 2.9 mmol, 1.0 equiv) and  tributyl(vinyl)tin (970 mg, 3.05 mmol, 
1.05 equiv) in tetrahydrofuran (16 mL) was added triphenyl arsine (89 mg, 0.29 mmol, 
0.10 equiv) and tris(dibenzylideneacetone)dipalladium (0) (33 mg, 0.04 mmol, 0.013 
equiv). The mixture was freeze/thaw degassed (x 2) then heated to 50 oC and stirred for 
20 h. The mixture was diluted with diethyl ether (80 mL) and filtered through a short 
pad of silica. The filtrate was washed with aq. ammonia solution (20 mL x 3), dried and 
concentrated in vacuo. Column chromatography (hexanes/ethyl acetate 98:2) gave 140 
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(638 mg, 2.2 mmol, 76%). 1H NMR data was consistent with that reported in the 
literature.85 
 
(2S, 3Z)-4-Bromohexa-3,5-dien-2-ol 138 
Br
OH
138  
To a stirred solution of 140 (230 mg, 0.78 mmol, 1.0 equiv) in tetrahydrofuran (10 mL) 
at 0 oC was added tetrabutyl ammonium fluoride (1.0 M sol, 1.58 mL, 1.58 mmol, 2.0 
equiv). The mixture was warmed to rt and stirring was continued for 4 h. The reaction 
mixture was diluted with diethyl ether (20 mL) and partitioned against sat. NH4Cl (10 
mL). The aqueous layer was extracted with ethyl acetate (3 x 10 mL). The combined 
organic layers were dried (MgSO4) and concentrated in vacuo. Column chromatography 
(hexanes/ethyl acetate 90:10) gave 138 (88 mg, 0.50 mmol, 64%) as a colourless oil. 1H 
NMR data was consistent with that reported in the literature.85 
 
Methyl (1S,2E)-3-Bromo-1-methylpenta-2,4-dien-1-yl Maleate 43Z 
O
O
CO2Me
Br
43Z  
Triethylamine (52 µL, 0.37 mmol, 1.6 equiv), maleic anhydride (64 mg, 0.65 mmol, 2.8 
equiv) and DMAP (3 mg, 0.03 mmol, 0.12 equiv) were added to a stirred solution of 
alcohol 141 (41 mg, 0.23 mmol, 1.0 equiv) in dichloromethane (2 mL) at 0 oC. The 
mixture was stirred at this temperature for 2.5 h. The solution was allowed to warm to rt 
before being diluted with diethyl ether (20 mL). The mixture was washed with 2M HCl 
(10 mL), sat. aq. NaHCO3 (10 mL), brine (10 mL), dried (Na2SO4) and concentrated in 
vacuo. The crude material was diluted with tetrahydrofuran (5 mL) and cooled to -78 oC 
with stirring. An ethereal solution of diazomethane was added dropwise until tlc 
confirmed the reaction had gone to completion. Excess diazomethane was removed by 
bubbling N2 gas through the solution. The solution was concentrated in vacuo and 
subjected to column chromatography on silica (hexanes/ethyl acetate 90:10) to give 
maleate 43Z (27 mg, 0.09 mmol, 40 %) as a colourless oil. [α] =  +37.4 (c = 0.42, 
chloroform). 1H NMR (300 MHz, C6D6): δ   6.03 (1H, dq, J = 7.7, 6.3 Hz), 5.90 (1H, 
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ddd, J = 16.3, 10.3, 0.8 Hz), 5.79 (1H, dd, J = 7.7, 0.7 Hz), 5.68 (2H, d, J = 3.2 Hz), 
5.58 (1H, dt, J = 16.3, 0.7 Hz), 4.94 (1H, d, J = 10.5 Hz), 3.31 (3H, s), 1.23 (3H, d, J = 
6.5 Hz) ppm. 13C NMR (125 MHz, C6D6): δ 164.9, 163.7, 134.9, 133.4, 129.9, 129.0, 
126.2, 119.5, 71.4, 51.1, 18.8  ppm . IR (thin film): ν 2918, 1788, 1731 cm-1. EIMS (70 
eV) m/z (%): 290 (2), 288 (2), 175 (15), 113 (100). HRMS: calcd for C11H13O4
79Br 
[M]+: 287.9997; found: 288.0003. 
 
Methyl (1S,2E)-3-bromo-1-methylpenta-2,4-dien-1-yl Fumarate 43E 
O
O
CH3
MeO2C
Br
43E  
To a stirred solution of alcohol 141 (54 mg, 0.31 mmol, 1.0 equiv) in diethyl ether (1.5 
mL) at room temperature was added (E)-3-methoxycarbonylacrylic acid (72 mg, 0.5 
mmol, 1.8 equiv), DCC (127 mg, 0.61 mmol, 2.0 equiv) and DMAP (6 mg, 0.05 mmol, 
0.15 equiv). Stirring was continued for 3 h. The reaction mixture was filtered through 
celite and concentrated in vacuo. The crude residue was subjected to column 
chromatography on silica (hexanes/ethyl acetate 9:1) to give fumarate 43E (56 mg, 0.19 
mmol, 63%) as a colourless oil. [α] =  + 94.0 (c = 0.92, chloroform). 1H NMR (300 
MHz, CDCl3): δ   6.85 (2H, s), 6.29 (1H, dd, J = 16.3, 10.4 Hz), 6.03 (1H, d, J = 7.9 
Hz), 5.88 (1H, dq, J = 6.6, 6.3 Hz), 5.68 (1H, d, J = 16.3 Hz), 5.32 (1H, d, J = 10.5 Hz), 
3.80 (3H, s), 1.42 (3H, d, J = 6.4 Hz) ppm. 13C NMR (75 MHz, CDCl3): δ 165.5, 164.0, 
134.9, 133.8, 133.6, 132.6, 126.8, 120.6, 72.0, 52.4, 19.5 ppm . IR (thin film): ν  2953, 
2849, 1723, 1645 cm-1 . EIMS (70 eV) m/z (%): 290 (18), 288 (20), 209 (25), 159 (50), 
113 (95), 85 (80), 79 (90), 59 (75), 53 (100). HRMS: calcd for C11H13O4
79Br [M]+: 
287.9997; found: 288.0003. 
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IMDA Reaction of Maleate 43Z in Toluene at 110 oC 
trans,lk-142Z
O
O
H
H
MeO2C
Br
O
O
CO2Me
Br
43Z  
A solution of maleate 43Z  (12 mg, 42 µmol, 1.0 equiv) and BHT (1 mg, 4.5 µmol, 0.1 
equiv) in toluene (4.2 mL) was stirred at 110 °C for 40 min. The reaction mixture was 
concentrated in vacuo. After column chromatography cycloadduct 142Z (10 mg, 35 
µmol, 83%) was obtained as a single isomer. 
 
Methyl (3S,3aR,7R,7aS)-4-bromo-3-methyl-1-oxo-3,3a,6,7,7a-hexahydro-7-
isobenzofurancarboxylate 142Z  
White crystalline solid after recrystallistaion from hexane/dichloromethane. m.p. 86-88 
°C [α] =  - 42.0 (c = 0.82, chloroform). 1H NMR (500 MHz, CDCl3): δ   6.05 (1H, m), 
4.36 (1H, dq, J = 9.7, 5.9 Hz), 3.74 (3H, s), 3.35 (1H, dd, J = 8.3, 3.8 Hz), 3.11 (1H, m), 
2.77 (1H, m), 2.71 (1H, dd, J = 13.2, 3.5 Hz), 2.58 (1H, ddt, J = 19.1, 8.0, 3.7 Hz), 1.69 
(1H, d, J = 6.1 Hz) ppm. 13C NMR (75 MHz, CDCl3): δ 172.3, 172.0, 130.0, 116.4, 
79.8, 52.6, 47.3, 47.3, 35.0, 31.2, 19.9 ppm . IR (thin film): ν  2920, 1787, 1732 cm-1 . 
EIMS (70 eV) m/z (%): 290 (2), 244 (30), 228 (15), 105 (100), 77 (95).  HRMS: calcd 
for C11H14O4
81Br [M+H]+: 289.0075; found: 289.0082. 
 
IMDA Reaction of Fumarate 43E in Toluene at 110 oC 
O
OMeO2C
Br
43E trans,lk-142E
O
O
H
H
MeO2C
Br
 
 A solution of fumarate 43E  (15 mg, 50 µmol, 1.0 equiv) and BHT (1 mg, 4.5 µmol, 
0.1 equiv) in toluene (5 mL) was stirred at 110 °C for 9 h 50 min. The reaction mixture 
was concentrated in vacuo. After column chromatography cycloadduct 142E (10 mg, 36 
µmol, 71%) was obtained as a single isomer.  
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Methyl (3S,3aR,7S,7aS)-4-bromo-3-methyl-1-oxo-3,3a,6,7,7a-hexahydro-7-
isobenzofurancarboxylate 142E  
White crystalline solid after recrystallisation from hepatane/dichloromethane. m.p. 181-
182 °C. [α] =  + 88.7 (c = 0.94, chloroform). 1H NMR (500 MHz, CDCl3): δ   6.09 (1H, 
q, J = 3.4 Hz), 4.41 (1H, dq, J = 10.0, 6.2 Hz), 3.78 (3H,s), 3.00 (1H, dd, J = 12.5, 11.7 
Hz), 2.77 (1H, ddd, J = 11.7, 10.3, 7.0 Hz), 2.66 (1H, m), 2.53 (1H, dddd, J = 18.4, 6.8, 
4.5, 2.7 Hz) 2.44 (1H, ddt, J = 18.4, 10.1, 3.7 Hz), 1.66 (3H, d, J = 6.2 Hz) ppm. 13C 
NMR (125 MHz, CDCl3): δ 173.2, 172.0, 130.3, 115.6, 79.7, 52.5, 50.8, 47.6, 39.0, 
32.7, 19.8 ppm . IR (thin film): ν  2990, 2937, 1779, 1743 cm-1 . EIMS (70 eV) m/z (%): 
288 (20), 230 (25), 213 (60), 105 (98), 77 (100). HRMS: calcd for C11H14O4
81Br 
[M+H]+: 289.0075; found: 289.0081. 
 
Reductive debromination of methyl (3S,3aR,7R,7aS)-4-bromo-3-methyl-1-oxo-
3,3a,6,7,7a-hexahydro-7-isobenzofurancarboxylate 142Z 
O
O
H
H
MeO2C
trans,lk-142Z
Br
O
O
H
H
MeO2C
trans,lk-39Z  
To a solution of cycloadduct 142Z (10 mg, 30 µmol, 1.0 equiv) in toluene (500 µL) at 
room temperature was added tributyltin hydride (27 µL, 0.10 mmol, 2.9 equiv) and 
AIBN (1.0 mg, 6 µmol, 0.2 equiv) before warming to 80 °C for 3 h 50 min. The 
reaction mixture was then concentrated in vacuo. The crude product was passed through 
a short pad of silica (dichloromethane) to give 39Z (4 mg, 18 mmol, 59%), 
spectroscopically identical to the major product obtained upon IMDA reaction of 38Z. 
1H NMR data was consistent with that reported in the literature.112 
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Reductive debromination of methyl (3S,3aR,7S,7aS)-4-bromo-3-methyl-1-oxo-
3,3a,6,7,7a-hexahydro-7-isobenzofurancarboxylate 142E 
trans,lk-142E
O
O
H
H
MeO2C
Br
trans,lk-39E
O
O
H
H
MeO2C
 
To a solution of cycloadduct 142E (10 mg, 30 µmol, 1.0 equiv) in toluene (500 µL) at rt 
was added tributyltin hydride (27 µL, 0.10 mmol, 2.9 equiv) and AIBN (1 mg, 6 µmol, 
0.2 equiv) before warming to 80 °C for 2 h 40 min. The reaction mixture was then 
concentrated in vacuo. The crude product was passed through a short pad of silica 
(dichloromethane) to give 39E (4 mg, 18 µmol, 59%), spectroscopically identical to the 
major product obtained upon IMDA reaction of 38E 
 
“Mix and Heat” Procedure for (S,Z)-4-bromohexa-3,5-dien-2-ol 138  
cis,lk-143Z
O
O
H
H
MeO2C
O
O
O
+
OH
138
1. mix/heat, PhMe, 
reflux
2. CH2N2, THF
O
O
H
H
MeO2C
+
trans,lk-142Z
Br
Br Br
 
To a solution of 138 (22 mg, 0.13 mmol, 1.0 equiv) in toluene (1mL) was added maleic 
anhydride (18 mg, 0.18 mmol, 1.5 equiv). The mixture was heated at reflux for 5 h 30 
min then concentrated in vacuo. The crude material was diluted with tetrahydrofuran (5 
mL) and cooled to -78 oC with stirring. An ethereal solution of diazomethane was added 
dropwise until tlc confirmed the reaction had gone to completion. Excess diazomethane 
was removed by bubbling N2 gas through the solution. The solution was concentrated in 
vacuo and subjected to column chromatography on silica (hexanes/ethyl acetate 88:12) 
to give a mixture of 142Z and 143Z 13:87 (21 mg, 0.08 mmol, 58%). 
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“Mix and Heat” Procedure for ((S,Z)-4-bromohexa-3,5-dien-2-yloxy)(tert-
butyl)dimethylsilane 140  
cis,lk-143Z
O
O
H
H
MeO2C
O
O
O
+
OTBS
140
1. mix/heat, PhMe, 
reflux
2. CF3CO2H, CH2Cl2
3. CH2N2, THF
Br
Br
 
To a solution of 140 (30 mg, 0.10 mmol, 1.0 equiv) in toluene (1 mL) was added maleic 
anhydride (11 mg, 0.11 mmol, 1.1 equiv). The mixture was heated at reflux for 74 h 
then concentrated in vacuo. The crude material was dissolved in dichloromethane (2 
mL) and trifluoroacetic acid (250 µL) was added the reaction mixture was stirred at rt 
for 18h then concentrated in vacuo. The crude material was diluted with tetrahydrofuran 
(5 mL) and cooled to -78 oC with stirring. An ethereal solution of diazomethane was 
added dropwise until tlc confirmed the reaction had gone to completion. Excess 
diazomethane was removed by bubbling N2 gas through the solution. The solution was 
concentrated in vacuo and subjected to column chromatography on silica (hexanes/ethyl 
acetate 88:12) to give 143Z (17 mg, 0.06 mmol, 58%). [α] = +64.6  (c = 1.4, 
chloroform). 1H NMR (500 MHz, CDCl3): δ   6.25 (1H, m), 4.84 (1H, q, J = 6.8 Hz), 
3.80 (3H,s), 3.74 (1H, ddd, J = 8.3, 4.4, 1.0 Hz), 3.07 (1H, dd, J = 8.3, 1.5 Hz), 2.83 
(1H, m), 2.50-2.35 (3H, m), 1.48 (3H, d, J = 6.8 Hz) ppm. 13C NMR (125 MHz, 
CDCl3): δ 174.7, 171.9, 131.2, 121.7, 79.6, 52.5, 49.6, 41.3, 36.3, 25.5, 20.6 ppm . IR 
(thin film): ν  2929, 1771, 1735 cm-1 . ESIMS (positive ion) m/z (%): 313 (90), 311 
(95), 289 (100). HRMS: calcd for C11H13O4Br Na [M+Na]
+: 310.9895; found: 
310.9897. 
 
Reductive debromination of methyl (3S,3aR,7S,7aR)- 4-bromo-3-methyl-1-oxo-
3,3a,6,7,7a-hexahydro-7-isobenzofurancarboxylate 143Z  
cis,lk-143Z
O
O
H
H
MeO2C
Br
cis,lk-40Z
O
O
H
H
MeO2C
 
To a solution of cycloadduct 143Z (6  mg, 19 µmol, 1.0 equiv) in toluene (500 µL) at rt  
was added tributyltin hydride (15 µL, 0.06 mmol, 2.9 equiv) and AIBN (1 mg, 6 µmol, 
0.32 equiv) before warming to 80 °C for 3h. The reaction mixture was then 
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concentrated in vacuo. The crude product was passed through a short pad of silica 
(dichloromethane) to give 40Z (3 mg, 14 µmol, 72%). 1H NMR data was consistent 
with that reported in the literature.112 
 
7.4 Chapter 4 
7.4.1 Substituted Chiral Dendralenes 
(2S)-2-(tert-Butyldimethylsilyl)oxy-4-vinylhexa-3,5-diene 265 by indium-mediated 
coupling 
OTBS
O OTBS
OH
OTBS
93
264
265
 
To a stirred solution of aldehyde 93 (500 mg, 2.7 mmol, 1.0 equiv) and (E)-1-
bromobuta-1,3-diene  (463 mg, 3.2, mmol, 1.2 equiv) in dry DMF (1.5 mL) was added 
indium metal (336 mg, 2.9 mmol, 1.1 equiv). The reaction mixture was stirred at room 
temperature for 16 h. The reaction was quenched with sat. NH4Cl solution (5 mL) and 
extracted with ethyl acetate (3 x 20 mL). The combined organics were washed with 
brine (20 mL), dried and concentrated in vacuo. Column chromatography 
(hexanes/ethyl acetate 96:4) gave 264 (366 mg, 1.4 mmol, 54%) as a 1:1 mixture of 
diastereomers.  
To a stirred solution of 264 (143 mg, 0.56 mmol, 1.0 equiv) in tetrahydrofuran (3 mL) 
was added triphenyl phosphine (293 mg, 1.12 mmol, 2.0 equiv) and DEAD (176 µL, 
1.12 mmol, 2.0 equiv). The mixture was heated at 60 ºC for 3.25 h before being 
concentrated in vacuo. Column chromatography (hexanes/ethyl acetate 99:1) gave 265 
(61 mg, 0.26 mmol, 46%) as a colourless oil. [α] = -24.3 (c = 0.77, dichloromethane). 
1H NMR (400 MHz, C6D6): δ  6.36 (1H, dd, J = 17.6, 11.3 Hz), 6.30 (1H, dd, J = 17.1, 
10.8 Hz), 5.67 (1H, d, J = 8.8 Hz), 5.29 (1H, dd, J = 17.6, 2.0 Hz), 5.17 (1H, dd, J  = 
17.2, 2.0 Hz,), 5.13 (1H, dd, J = 10.3, 2.0 Hz), 4.97 (1H, dd, J = 10.3, 1.5 Hz), 4.73 
(1H, dq, J = 8.8, 6.4 Hz), 1.22 (3H, d, J = 6.4 Hz), 0.96 (9H, s), 0.06 (3H, s), 0.05 (3H, 
s)  ppm. 13C NMR (100 MHz, CDCl3): δ 137.8, 136.8, 135.1, 131.9, 118.4, 115.1, 65.7, 
26.0, 24.7, 18.3, -4.3, -4.6  ppm . IR (thin film): ν  2956, 2928, 2894, 2857cm-1 . EIMS 
(70 eV) m/z (%):  181 (40), 75 (100).  HRMS: calcd for C10H17OSi [M-C4H9]
+: 
181.1049; found 181.1048 
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 (2S)-2-(tert-Butyldimethylsilyl)oxy-4-vinylhexa-3,5-diene 265 by Stille coupling 
 To a stirred solution of dibromoalkene 13991,219,220 (1.0 g, 2.9 mmol, 1.0 equiv) and 
tributyl(vinyl)tin  (2.54 g, 7.3 mmol, 2.5 equiv) in acetonitrile (10 mL) under argon was 
added palladium (II) acetate (33 mg, 5 mol%) and triphenyl phosphine (76 mg, 10 
mol%). The mixture was stirred at 60 ºC for 20 h before the addition of a further 
amount of palladium (II) acetate (15 mg, 2.5 mol%) and triphenyl phosphine (40 mg, 5 
mol%). The reaction mixture was stirred at 60 ºC for a further 5 h. The mixture was 
diluted with diethyl ether (100 mL) and partitioned against aqueous ammonia solution 
(30 %v/v, 2 x 80 mL). The organic layer was washed with brine (100 mL), dried and 
concentrated in vacuo. After column chromatography on silica (hexanes) 265 (419 mg, 
1.76 mmol, 61%) was obtained as a colourless oil. 
 
(2S)-2-(tert-Butyldimethylsilyl)oxy-4-vinylhexa-3,5-diene 265 by Negishi coupling 
To a stirred solution of vinyl magnesium bromide (1.0 M sol. in THF, 14.5 mL, 14.5 
mmol, 3.33 equiv) in tetrahyrdofuran (5 mL) at 0 oC was added zinc bromide (3.4 g, 15 
mmol, 3.47 equiv). After 5 min a solution of 139 (1.5 g, 4.4 mmol, 1.0 equiv) and 
tetrakis(triphenylphosphine)palladium(0)  (161 mg, 0.1 mmol, 0.032 equiv) in 
tetrahyrdofuran (8 mL) was added dropwise via canula. Stirring was continued for 2 h 
before the mixture was diluted with hexane and filtered. The filtrate was concentrated in 
vacuo. After column chromatography (hexanes) 265 (693 mg, 2.9 mmol, 67%) was 
obtained as a colourless oil. 
 
(2S)-4-Vinylhexa-3,5-dien-2-ol 44 
OH
44  
To a stirred solution of 265 (863 mg, 3.62 mmol, 1.0 equiv) in tetrahydrofuran at 0 ºC 
under argon, was added TBAF (1M solution in tetrahydrofuran, 7.25 mL, 7.25 mmol, 
2.0 equiv).  Stirring was continued at this temperature for 10 min before being warmed 
to rt. After 2.5 h the reaction mixture was diluted in diethyl ether (50 mL) and 
partitioned against sat. NH4Cl (25 mL). The aqueous layer was extracted with ethyl 
acetate (3 x 20 mL). The combined organic layers were dried and concentrated in 
vacuo. After column chromatography on silica (hexanes/ethyl acetate 85:15) the title 
compound 44 (389 mg, 3.13 mmol, 86%) was obtained as a colourless oil. [α] = -31.2 
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(c = 1.65, dichloromethane) 1H NMR (400 MHz, C6D6): δ 6.34 (1H, dd, J = 17.7, 11.4 
Hz), 6.31 (1H, dd, J = 10.9, 17.2 Hz), 5.54 (1H, d, J = 8.8 Hz), 5.30 (1H, dd, J = 17.1, 
1.5 Hz), 5.20 (1H, dd, J = 17.6, 1.5 Hz), 5.11 (1H, dd, J = 10.8, 1.5 Hz), 4.99 (1H, dd, J 
= 10.8, 1.5 Hz), 4.55 (1H, dq, J = 8.8, 6.4 Hz), 1.76 (1H, s), 1.14 (3H, d, J = 6.4 Hz) 
ppm. 13C NMR (100 MHz, C6D6): δ 138.0, 137.3, 136.2, 132.1, 118.6, 115.5, 64.4, 23.7 
ppm. IR (thin film): ν  3329 (OH), 3088, 2972, 1603, 1452, 1424, 1368, 1293 cm-1 . 
EIMS (70 eV) m/z (%):  124 (10), 109 (20), 43 (100).  HRMS: calcd for C8H12O [M]
+: 
124.0888; found 124.0892. 
 
(2S)-2-(tert-Butyldimethylsilyl)oxy-5-methyl-4-(prop-1-en-2-yl)hexa-3,5-diene 266 
OTBS
266  
To a stirred solution of zinc bromide (360 mg, 1.60 mmol, 5.5 equiv) in tetrahydrofuran 
(2 mL) was added a solution of isopropenyl magnesium bromide (3.8 mL of a 0.38 M 
solution in tetrahydrofuran, 1.45 mmol, 5.0 equiv). After 30 min the solution was 
cooled to -78 oC and a solution of 139 (100 mg, 0.29 mmol, 1.0 equiv) and 
tetrakis(triphenylphosphine)palladium(0)  (17 mg, 0.015 mmol, 0.05 equiv) in 
tetrahydrofuran (2 mL) was added dropwise via canula. Stirring was continued at rt for 
18 h before the mixture was diluted with hexane and filtered. The filtrate was 
concentrated in vacuo. After column chromatography (hexanes) 266 (64 mg, 0.24 
mmol, 83%) was obtained as a colourless oil. [α]D
25 = - 70.5  (c = 2.46, chloroform). 1H 
NMR (300 MHz, CDCl3): δ  5.49 (1H, d, J = 8.4 Hz), 5.13 (1H, bs), 4.99 (2H, m), 4.69 
(1H, bs), 4.53 (1H, dq, J = 8.4, 6.3 Hz), 1.89 (3H, bs), 1.82 (3H, bs), 1.21 (3H, d, J = 
6.2 Hz), 0.87 (9H, s), 0.03 (3H, s), 0.02 (3H, s) ppm. 13C NMR (100 MHz, CDCl3): δ 
142.7, 142.1, 141.8, 131.5, 115.6, 114.7, 67.2, 26.0, 25.5, 23.5, 20.6, 18.2, -4.2, -4.5 
ppm. IR (thin film): ν = 3080, 2956, 2929, 2894, 2857 cm-1. EIMS (70 eV) m/z (%): 
245 (35), 209 (50), 171 (20), 135 (22), 75 (100); HRMS: calcd for C12H21OSi [M-
C4H9]: 209.1362; found: 209.1362.  
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(2S, 3Z)-2-(tert-Butyldimethylsilyl)oxy-4-(1,1-dioxo-2,5-dihydrothiene-3-yl)hexa-3,5-
diene 267 
OTBS
O2S
267  
To a stirred solution of 140 (172 mg, 0.59 mmol, 1.0 equiv) and 3-(tributylstannyl)-3-
sulfolene (289 mg, 0.71 mmol, 1.02 equiv) in acetonitrile (5 mL) under argon was 
added palladium (II) acetate (4 mg, 0.02 mmol, 5 mol%) and triphenyl phosphine (9 
mg, 0.03 mmol, 10 mol%). The reaction mixture was stirred at 60 °C for 48 h. The 
mixture was diluted in diethyl ether (50 mL) and partitioned against aqueous ammonia 
solution (30 %v/v, 2 x 40 mL). The organic layer was washed with brine (40 mL), dried 
and concentrated in vacuo. After column chromatography on silica (hexanes/ethyl 
acetate 90:10) 267 (174 mg, 0.53 mmol, 90%) was obtained as a colourless oil. 
[α]D
25 =  − 45.1 (c = 3.4, chloroform). 1H NMR (500 MHz, CDCl3): δ  6.31 (1H, dd, J = 
18.0, 11.3 Hz), 5.94 (1H, m), 5.46 (1H, ddd, J = 11.2, 1.7, 0.7 Hz), 5.44 (1H, d, J = 8.3 
Hz), 5.21 (1H, dd, J = 17.7, 1.6 Hz), 4.65 (1H, dq, J = 8.3, 6.2 Hz), 3.93-3.84 (4H, m), 
1.23 (3H, d, J = 6.5 Hz), 0.86 (9H, s), 0.02 (3H, s), 0.00 (3H, s) ppm. 13C NMR (125 
MHz, CDCl3): δ  137.7, 136.9, 132.2, 130.7, 121.3, 120.0, 65.8, 57.5, 56.3, 25.9, 24.6, 
18.2, -4.4, -4.6 ppm. IR (thin film): ν = 2955, 2928, 2856 cm-1. EIMS (70 eV) m/z (%): 
271 (20), 207 (100), 133 (70), 75 (95); HRMS: calcd for C12H19O3SiS [M-C4H9]: 
271.0824; found: 271.0824.  
 
(2S, 3E)-2-(tert-Butyldimethylsilyl)oxy-5-methylene-4-vinylhepta-3,6-diene 268 
OTBS
268  
A solution of (2S, 3Z)-4-bromo-2-(tert-butyldimethylsilyl)oxy-hexa-3,5-diene 267 (34 
mg, 0.10 mmol, 1.0 equiv) in chlorobenzene (10 mL) was heated at reflux for 1.5 h 
before being concentrated in vacuo. After column chromatography (hexanes/ethyl 
acetate 98:2) 268 (19 mg, 0.07 mmol, 69%) was obtained as a colourless oil. 
[α]D
25 = + 14.3  (c = 0.86, chloroform). 1H NMR (500 MHz, C6D6): δ  6.60 (1H, dd, J = 
17.5, 11.2 Hz), 6.34 (1H, dd, J = 17.3, 10.3 Hz), 5.63 (1H, d, J = 8.4 Hz), 5.30 (2H, 
ddd, J = 17.4, 11.9, 1.7 Hz), 5.11-5.02 (4H, m), 4.80 (1H, dq, J = 8.3, 6.4 Hz), 1.24 (3H, 
d, J = 6.4 Hz), 0.98 (9H, s), 0.10 (3H, s), 0.09 (3H, s) ppm. 13C NMR (125 MHz, C6D6): 
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δ 147.9, 138.8, 137.5, 136.2, 131.7, 118.1, 118.0, 116.6, 65.3, 26.1, 25.0, 18.3, -4.2, -4.5  
ppm. IR (thin film): ν = 2957, 2929, 2857 cm-1. EIMS (70 eV) m/z (%): 264 (2), 207 
(60), 159 (15), 75 (100); HRMS: calcd for C16H28OSi [M]: 264.1909; found: 264.1905. 
 
(2S, 3Z)-4-Bromo-2-(tert-butyldimethylsilyl)oxy-4-(1,1-dioxo-2,5-dihydrothiene-3-
yl)but-3-ene 269 
OTBS
O2S
Br
269  
To a stirred solution of 139 (1.50 g, 4.36 mmol, 1.0 equiv) and 3-(tributylstannyl)-3-
sulfolene (1.80 g, 4.40 mmol, 1.0 equiv) in toluene (40 mL) was added 
tris(dibenzylideneacetone)dipalladium (0) (99 mg, 0.11 mmol, 2.5 mol%) and tri(2-
furyl)phosphine (151 mg, 0.65 mmol, 15 mol%). The reaction mixture was heated at 55 
oC for 16 h before cooling to rt and diluting with diethyl ether (50 mL). The organic 
layer was treated with ammonia solution (2 x 50 mL), washed with brine (50 mL) and 
concentrated in vacuo. After column chromatography (hexanes/ethyl acetate 90:10) 269 
(895 mg, 2.34 mmol, 54%) was obtained as a yellow oil.  [α]D
25 =  +1.28 (c= 1.8, 
chloroform). 1H NMR (500 MHz, CDCl3): δ 6.39 (1H, m), 5.92 (1H, d, J = 6.9 Hz), 
4.76 (1H, dq, J = 6.6, 6.6 Hz), 4.02-3.94 (4H, m), 1.26 (3H, d, J = 6.4 Hz), 0.88 (9H, s), 
0.08 (3H, s), 0.05 (3H, s)  ppm. 13C NMR (125 MHz, CDCl3): δ  139.9, 133.9, 123.6, 
117.2, 69.4, 57.6, 56.4, 25.9, 23.0, 18.2, -4.5, -4.7 ppm. IR (thin film): ν = 2955, 2929, 
2887, 2857 cm-1. EIMS (70 eV) m/z (%): 325 (5), 323 (6), 281 (55), 279 (53), 261 (60), 
259 (65), 181 (100); HRMS: calcd for C10H16O3SiS
81Br [M-C4H9]: 324.9752; found: 
324.9736.  
 
(2S, 3E)-2-(tert-Butyldimethylsilyl)oxy-4-(1,1-dioxo-2,5-dihydrothiene-3-yl)hexa-3,5-
diene 270 
OTBS
O2S
270  
A solution of 269 (78 mg, 0.2 mmol, 1.0 equiv) and tributyl(vinyl)tin (107 mg, 0.41 
mmol, 2.0  equiv) in acetonitrile (2 mL) was degassed by the freeze/thaw method (x 2). 
To the resulting solution was added palladium (II) acetate (2 mg, 0.01 mmol, 5 mol%) 
and triphenyl phosphine (5 mg, 0.02 mmol, 10 mol%). The solution was then heated at 
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60 oC for 4 h before cooling to RT and dilution with diethyl ether (50 mL). The organic 
layer was treated with ammonia solution (2 x 50 mL), washed with brine (50 mL) and 
concentrated in vacuo. After column chromatography (hexanes/ethyl acetate 90:10) 270 
(62 mg, 0.19 mmol, 92%) was obtained as a colourless oil.  [α]D
25 = −10.7  (c = 2.9, 
chloroform). 1H NMR (500 MHz, CDCl3): δ  6.27 (1H, dd, J = 17.7, 10.7 Hz), 5.82 
(1H, m), 5.66 (1H, d, J = 8.8 Hz), 5.14 (1H, d, J = 10.8, 5.1 Hz), 5.10 (1H, d, J = 17.4 
Hz), 4.45 (1H, dq, J = 8.6, 6.3 Hz), 3.93 (2H, m), 3.77 (2H, dq, J = 16.6, 1.6 Hz), 1.22 
(3H, d, J = 6.3 Hz), 0.86 (9H, s), 0.03 (3H, s), 0.01 (3H, s) ppm. 13C NMR (125 MHz, 
CDCl3): δ 139.6, 136.9, 134.3, 133.0, 122.9, 116.2, 66.1, 57.5, 56.6, 25.8, 25.2, 18.2, -
4.3, -4.4  ppm. IR (thin film): ν = 2956, 2929, 2857 cm-1. EIMS (70 eV) m/z (%): 271 
(70), 208 (40), 207 (100), 133 (50); HRMS: calcd for C12H19O3SiS [M-C4H9]: 
271.0824; found: 271.0818.  
 
(2S, 3Z)-2-(tert-Butyldimethylsilyl)oxy-5-methylene-4-vinylhepta-3,6-diene 271 
OTBS
271  
A solution of 270 (29 mg, 0.088 mmol, 1.0 equiv) in chlorobenzene (10 mL) was heated 
at reflux for 1.5 h before being concentrated in vacuo. After column chromatography 
(hexanes/ethyl acetate 98:2) 271 (21 mg, 0.079 mmol, 90%) was obtained as a 
colourless oil. [α]D
25 =  −10.7  (c = 0.97, chloroform). 1H NMR (500 MHz, CDCl3): δ  
6.30 (1H, ddd, J = 17.1, 10.4, 0.6 Hz), 6.27 (1H, dd, J = 16.6, 10.4 Hz), 5.72 (1H, d, J = 
8.3 Hz), 5.22 (1H, ddd, J = 5.1, 1.5, 0.5 Hz), 5.18 (1H, ddd, J = 5.4, 1.5, 0.7 Hz), 5.16 
(1H, m), 4.99 (1H, dm, J = 10.5 Hz), 4.96 (1H, ddd, J = 10.5, 1.5, 0.7 Hz), 4.92 (1H, 
m), 4.50 (1H, dq, J = 8.4, 6.3 Hz), 1.23 (3H, d, J = 6.4 Hz), 0.99 (9H, s), 0.08 (3H, s), 
0.06 (3H, s) ppm. 13C NMR (125 MHz, C6D6): δ 144.3, 139.0, 138.3, 137.5, 137.1, 
119.2, 117.2, 115.4, 67.0, 26.1, 25.1, 18.3, -4.0, -4.3 ppm. IR (thin film): ν = 2958, 
2857 cm-1. EIMS (70 eV) m/z (%): 221 (20), 207 (35), 159 (34), 75 (100); HRMS: calcd 
for C12H19OSi [M-C4H9]: 207.1205; found: 207.1203.  
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7.4.2 DTDA reactions 
(1S,3aR,4S,7aS)-1-Methyl-3-oxo-7-vinyl-1,3,3a,4,5,7a-hexahydro-2-benzofuran-4-
carboxylic acid 279 
O
O
H
H
HO2C
279  
To a solution of [3] dendralene 44 (45 mg, 0.36 mmol, 1.0 equiv) in d6-benzene (1.2 
mL) was added maleic anhydride (35 mg, 0.36 mmol, 1.0 equiv). The mixture was left 
at rt for 48 h. The product was filtered to give 279 (67 mg, 0.30 mmol, 83%) as a white 
solid. m.p. 163 – 165 °C. [α] = + 150  (c = 0.88, methanol). 1H NMR (400 MHz, d6-
acetone): δ  6.35 (1H, dd, J = 18.1, 11.3 Hz), 5.97 (1H, dd, J = 6.4, 2.5 Hz), 5.08 (1H, 
d, J = 11.3 Hz), 5.02 (1H, d, J = 18.1 Hz), 4.50 (1H, q, J = 6.4 Hz), 3.87 (1H, ddd, J = 
8.3, 3.9, 1.0 Hz), 3.29 (1H, dm, J = 8.3 Hz), 2.72 (1H, ddd, J = 11.7, 5.4, 3.9 Hz), 2.49-
2.30 (2H, m), 1.49 (3H, d, J = 6.9 Hz) ppm. 13C NMR (100 MHz, d6- acetone): δ 176.3, 
173.4, 138.4, 136.4, 131.4, 115.2, 80.5, 42.4, 39.7, 37.3, 24.3, 20.5 ppm. IR (KBr disc): 
ν 2993, 1770, 1700, 1644, 1452, 1419 cm-1. ESIMS (positive ion) m/z (%): 467 (100), 
246 (87), 224 (55). HRMS: calcd for C12H14O4 [M]
+: 222.0892; found 222.0891. 
 
Tetracycle 280 
O
O
H
H
HO2C
O
O
O
H
H
H
280  
To a solution of 44 (27 mg, 0.22 mmol, 1.0 equiv) in deuterated acetonitrile (1 mL) was 
added maleic anhydride (43 mg, 0.44 mmol, 2.0 equiv). The mixture was left at rt for 60 
h before being concentrated in vacuo to give 280 (70 mg, 0.22 mmol, 100%) as a 
colourless solid of approximately 90 % purity. [α]D
25 =  − 4.34  (c= 1.66, chloroform). 
1H NMR (500 MHz, CD3CN): δ  5.88 (1H, m), 4.49 (1H, dq, J = 6.4, 6.2 Hz), 3.55-3.48 
(2H, m), 3.26 (1H, m), 3.15 (1H, dd, J = 12.2, 6.4 Hz), 2.98 (1H, m), 2.66 (1H, dd, J = 
15.1, 7.0 Hz), 2.49 (1H, m), 2.38 (1H, ddd, J = 14.1, 11.2, 3.4 Hz), 2.29-2.15 (2H, m), 
1.49 (3H, d, J = 6.4 Hz) ppm. 13C NMR (125 MHz, CD3CN): δ  178.1, 175.8, 174.7, 
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174.1, 132.7, 123.0, 83.2, 45.4, 43.1, 41.9, 41.8, 39.9, 32.8, 26.3, 25.36, 22.5 ppm. IR 
(thin film): ν =  2926, 2855, 1846, 1773, 1712, 1630 cm-1. EIMS (70 eV) m/z (%): 320 
(10), 230 (100); HRMS: calcd for C16H16O7 [M]
+: 320.0896; found: 320.0895.  
 
Methyl (1S,3aR,4S,7aS)-1-methyl-3-oxo-7-vinyl-1,3,3a,4,5,7a-hexahydro-2-benzofuran-
4-carboxylate 281 
O
O
H
H
MeO2C
281  
To a stirred solution of 279 (29 mg, 0.13 mmol, 1.0 equiv) in tetrahydrofuran (3 mL) at 
–78 °C was added a solution of diazomethane. After 15 min the reaction mixture was 
concentrated in vacuo. Purification by column chromatography on silica (hexanes/ethyl 
acetate 85:15) gave 281 (21 mg, 0.09 mmol, 70%) was obtained as a colourless solid. 
m.p. 74-75 oC. [α] = +120.0 (c = 0.20, dichloromethane) 1H NMR (400 MHz, CDCl3): 
δ 6.29 (1H, dd, J = 17.9, 11.0 Hz), 5.94 (1H, dd, J = 5.9, 2.9 Hz), 5.06 (1H, d, J = 11.0 
Hz), 4.91 (1H, d, J = 17.9 Hz), 4.56 (1H, q, J = 6.6 Hz), 3.79 (3H, s), 3.17 (1H, d, J = 
8.4 Hz), 2.66 (1H, ddd, J = 11.0, 5.9, 4.0 Hz), 2.49-2.37 (2H, m), 1.49 (3H, d, J = 6.6 
Hz) ppm. . 13C NMR (100 MHz, CDCl3): δ 175.9, 172.6, 137.4, 134.9, 130.7, 112.0, 
80.1, 52.2, 41.6, 39.2, 37.1, 23.4, 20.6 ppm. IR (KBr disc): ν  2359, 1772, 1726, 1644, 
1432 cm-1 . EIMS (70 eV) m/z (%):  236 (45), 176 (70), 131 (50), 117 (80), 105 (100), 
91 (35), 77 (40).  HRMS: calcd for C13H16O4 [M]
+: 236.1049; found 236.1048. 
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Tetracycle 282 
O
O
H
H
MeO2C
O
O
O
H
H
H
282  
To a solution of 281 (18  mg, 0.07 mmol, 1.0 equiv) in deuterated benzene (1 mL) was 
added maleic anhydride (7 mg, 0.07mmol, 1.0 equiv). The mixture was heated at reflux 
for 3.5 h before additional maleic anhydride (4 mg, 0.04 mmol 0.5 equiv) was added. 
The mixture was heated at reflux for a further 14 h. The mixture was cooled to rt and 
the product was filtered to give 282 (17  mg, 0.05 mmol, 67%) as a white solid. The 
product was recrystallised from heptane/dichloromethane to give coulourless crystals. 
m.p.176-179 oC. [α] = − 11.72 (c = 0.51, methanol).  1H NMR (400 MHz, CDCl3): 
δ  5.86-5.81 (1H, m), 4.55 (1H, q, J = 6.4 Hz), 3.69 (3H, s), 3.48-3.44 (2H, m), 3.11 
(1H, dd, J = 12.2, 6.4 Hz), 2.99-2.90 (1H, m), 2.80 (1H, ddd, J = 15.7, 7.3, 1.5 Hz), 
2.50 (1H, ddd, J = 13.2, 10.8, 3.4), 2.41-2.32 (1H, m), 2.32-2.16 (2H, m), 1.54 (3H, d, J 
= 6.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): δ 176.7, 173.5, 173.1, 172.0, 139.6, 
122.4, 82.5, 52.4, 44.6, 42.6, 41.1, 40.8, 39.3, 32.4, 25.9, 24.9, 22.6 ppm. IR (KBr disc): 
ν  2988, 2360, 2339, 1772, 1717 cm-1 . EIMS (70 eV) m/z (%): 334 (20), 302 (40), 230 
(95), 157 (70), 129 (100).  HRMS: calcd for C17H18O7 [M]
+: 334.1052; found 334.1055.  
 
Tetracycle 284 
O
OTBS
O
O
H
H
HO
O
O
H
H
H
284  
To a solution of 265 (44 mg, 0.18 mmol, 1.0 equiv) in deuterated benzene (1 mL) at rt 
was added maleic anhydride (39 mg, 0.37 mmol, 1.0 equiv). After 115 h the reaction 
mixture was concentrated in vacuo to give 284 (78 mg, 0.18 mmol, 97%) as a colourless 
solid. m.p. 80-83 oC. [α]D
25 = +21.9  (c = 0.77, chloroform). 1H NMR (500 MHz, 
CDCl3): δ  5.72 (1H, m), 4.36 (1H, dq, J = 9.9, 5.5 Hz), 4.01 (1H, dd, J = 10.6, 4.8 Hz), 
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3.58 (1H, ddd, J = 11.0, 6.4, 2.2 Hz), 3.43 (1H, ddd, J = 9.5, 7.4, 1.7 Hz), 3.38 (1H, dd, 
J = 9.6, 5.4 Hz), 2.84 (1H, dd, J = 15.7, 7.7 Hz), 2.73 (1H, ddd, J = 13.8, 13.8, 6.1 Hz), 
2.43 (1H, m), 2.33 (1H, ddd, J = 14.4, 4.6, 1.9 Hz), 2.18 (2H, m), 1.23 (3H, d, J = 5.8 
Hz), 0.88 (9 H, s), 0.15 (3H, s), 0.11 (3H, s) ppm. 13C NMR (100 MHz, CDCl3): δ  
174.4, 173.3, 171.3, 171.0, 138.2, 123.4, 65.4, 46.5, 44.0, 40.4, 40.0, 34.1, 26.0, 25.0, 
23.8, 23.5, 18.1, -4.0, -4.9 ppm. IR (thin film): ν = 2930, 1850, 1777 cm-1. EIMS (70 
eV) m/z (%): 419 (10), 377 (100), 75 (80); HRMS: calcd for C18H21O7Si [M-C4H7]: 
377.1057; found: 377.1056. Anal. Calcd for C22H30O7Si: C, 60.81; H, 6.96. Found: C, 
60.98; H, 7.09. 
Conversion of tetracycle 284 to tetracycle 282 
O
O
H
H
MeO2C
O
O
O
H
H
H
O
OTBS
O
O
H
H
HO
O
O
H
H
H
284 282  
To a stirred solution of 284 (47 mg, 0.11 mmol, 1.0 equiv) in dichloromethane (2 mL) 
was added trifluoroacetic acid (250 µL, 3.20 mmol, 30 equiv). Stirring was continued 
for 16 h before the reaction mixture was concentrated in vacuo. The crude residue was 
dissolved in tetrahydrofuran (5 mL) and cooled to -78 oC with stirring. An ethereal 
solution of diazomethane was added dropwise until tlc confirmed the reaction had gone 
to completion. Excess diazomethane was removed by bubbling N2 gas through the 
solution. The solution was concentrated in vacuo. Recrystallisation from 
heptane/dichloromethane gave 282 (30 mg, 0.09 mmol, 81%) as colourless crystals. 
 
(S)-5-(Methoxymethoxy)-3-vinylhexa-1,3-diene 285 
OMOM
285  
To a stirred solution of 44 (25 mg, 0.20 mmol, 1.0 equiv) in dichloromethane (2 mL) 
was added iPr2NEt (346 µL, 1.98 mmol, 10.0 equiv) and MOM-Cl (79 µL, 0.99 mmol, 
5.0 equiv). Stirring was continued for 18 h before the reaction was quenched with sat. 
NaHCO3 (5 mL). Ethyl acetate (10 mL) was added and the organic layer was washed 
with 2 M HCl (5 mL), NaHCO3 (5 mL) and brine (5 mL) before being dried and 
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concentrated in vacuo. Column chromatography of the crude material (hexane/ethyl 
acetate 96:4) yielded 285 (20 mg, 0.11 mmol, 55%) as a colourless oil. 
[α]D
25 =  −166.8  (c = 0.61, chloroform). 1H NMR (300 MHz, CDCl3): δ 6.49 (1H, dd, J 
= 17.8, 11.6 Hz), 6.39 (1H, ddd, J = 17.3, 10.7, 0.9 Hz), 5.48 (1H, d, J = 9.7 Hz), 5.36 
(1H, m), 5.33-5.24 (2H, m), 5.12 (1H, dd, J = 10.8, 1.9 Hz), 4.67 (1H, dq, J = 9.2, 6.4 
Hz), 4.63 (1H, d, J = 6.5 Hz), 4.53 (1H, d, J = 6.5 Hz), 3.36 (3H, s), 1.29 (3H, d, J = 6.5 
Hz) ppm. 13C NMR (100 MHz, CDCl3): δ 139.0, 137.3, 132.6, 131.6, 118.9, 115.9, 
93.8, 67.8, 55.3, 21.5 ppm. IR (thin film): ν = 2919, 2850, 1996 cm-1. EIMS (70 eV) 
m/z (%): 167.0 (28), 149 (100), 57 (92); HRMS: calcd for C10H16O2 [M]
+: 168.1150; 
found: 168.1143. 
 
Tetracycle 287 
O
OMOM
O
O
H
H
HO
O
O
H
H
H
287  
To a stirred solution of 285 (12 mg, 0.07 mmol, 1.0 equiv) in deutereated benzene (1 
mL) was added maleic anhydride (14 mg, 0.14 mmol, 2.0 equiv). The reaction mixture 
was allowed to stand at rt for 48 h before being concentrated in vacuo. Recrystalisation 
from benzene/dichloromethane yielded 287 (26 mg, 0.07 mmol, 100%) as colourless 
crystals. m.p. 194-195 oC. [α]D
25 = -48.1  (c = 0.185, chloroform). 1H NMR (500 MHz, 
CDCl3): δ 5.74 (1H, m), 4.87 (1H, d, J = 6.7 Hz), 4.74 (1 H, d, J = 6.7 Hz), 4.13 (1H, 
dq, J = 6.0, 4.2 Hz), 4.05 (1H, dd, J = 10.8, 5.0 Hz), 3.58 (1H, ddd, J = 10.7, 6.3, 2.3 
Hz), 3.45 (1H, ddd, J = 9.4, 7.4, 1.5 Hz), 3.40 (3H, s), 3.38 (1H, dd, J = 9.7, 5.3 Hz), 
2.86 (1H, dd, J = 15.9, 7.7 Hz), 2.72 (1H, dt, J = 13.9, 6.5 Hz), 2.53 (1H, m), 2.35 (1H, 
ddd, J = 14.4, 4.6, 2.6 Hz), 2.24-2.14 (2H, m), 1.30 (3H, d, J = 6.0 Hz) ppm. 13C NMR 
(125 MHz, CDCl3): δ  174.2, 173.2, 171.4, 171.3, 137.9, 123.6, 96.9, 71.2, 56.0, 45.1, 
44.1, 40.4, 40.2, 39.9, 34.0, 25.0, 23.7, 20.9 ppm. IR (thin film): ν = 2956, 1845, 1774 
cm-1. EIMS (70 eV) m/z (%): 364 (1), 333 (10), 319 (15), 302 (20), 45 (100); HRMS: 
calcd for C18H20O8 [M]
+: 364.1158; found: 364.1154. 
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Tetracycle 289 
O
O
OH
OH
H
MeO2C
H
H
289  
To a solution of 281 (51 mg, 0.22 mmol, 1.0 equiv) in deuterated benzene (1mL) was 
added benzoquinone (23 mg, 0.22 mmol, 1.0 equiv). The mixture was heated at reflux 
for 48 h before being cooled to RT and concentrated in vacuo. After column 
chromatography on silica gel (hexanes/ethyl acetate 60:40) 289 (52 mg, 0.15 mmol, 
70%) was obtained as an off white solid. m.p. 127 – 130 °C. [α] =  + 62.3 (c = 0.26, 
methanol). 1H NMR (400 MHz, acetone): δ 7.77 (1H, s), 7.62 (1H, s), 6.56 (2H, dd, J = 
8.3, 2.0 Hz), 5.85 (1H, m), 4.68 (1H, dq, J = 7.8, 6.4 Hz), 3.67 (3H, s), 3.57-3.47 (1H, 
m), 3.30-3.24 (2H, m), 3.24-3.16 (2H, m), 3.00 (1H, dd, J = 9.8, 7.8 Hz), 2.91-2.84 
(1H, m), 1.58 (1H, ddd, J = 13.2, 11.3, 5.9 Hz), 1.39 (3H, d, J = 6.4 Hz) ppm. 13C NMR 
(100 MHz, acetone): δ  177.6, 174.7, 148.5, 148.2, 125.4, 122.0, 121.7, 113.4, 113.2, 
79.6, 52.1, 51.7, 42.4, 41.0, 35.1, 28.4, 25.9, 19.9  ppm. IR (KBr disc): ν  3200, 2973, 
1743, 1490  cm-1 . EIMS (70 eV) m/z 344 (100), 312 (90), 284 (55), 239 (50), 211 (90); 
HRMS: calcd for C19H20O6 [M]
+: 344.1260; found: 344.1262. 
 
Tetracycle 45 
O
O
O
O
H
H
MeO2C
H
H
45  
To a stirred solution of 281 (30 mg, 0.13 mmol, 1.0 equiv) in deutereated toluene (1 
mL) was added 2,5-dimethyl benzoquinone (21 mg, 0.15 mmol, 1.2 equiv). The mixture 
was heated to reflux for 125 h before being cooled to RT and concentrated in vacuo. 
HPLC of the crude material (hexane/ethyl acetate, 55:45) yielded 45 (37 mg, 0.10 
mmol, 78%) as a yellow oil. [α]D
25 = +78.4  (c = 0.37, chloroform). 1H NMR (500 
MHz, CDCl3): δ 6.54 (1H, m), 5.65 (1H, m), 4.49 (1H, dq, J = 8.1, 6.0 Hz), 3.71 (3H, 
s), 3.16 (1H, dt, J = 7.6, 6.0 Hz), 3.08 (1H, dd, J = 10.6, 7.6 Hz), 2.90 (1H, dd, J = 6.6, 
3.3 Hz), 2.81-2.73 (2H, m), 2.15 (1H, ddt, J = 18.5, 6.8, 2.5 Hz), 2.07 (1H, m), 2.02 
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(3H, d, J = 1.5 Hz), 1.89 (1H, dt, J = 13.8, 5.4 Hz), 1.55 (1H, ddd, J = 13.8, 11.6, 5.9 
Hz), 1.39 (3H, d, J = 6.3 Hz), 1.38 (3H, s) ppm. 13C NMR (100 MHz, CDCl3): δ 201.7, 
199.7, 176.9, 173.3, 150.1, 137.2, 132.6, 122.1, 79.5, 52.5, 51.0, 50.8, 50.6, 41.7, 40.2, 
39.2, 30.1, 24.2, 21.1, 19.8, 16.3 ppm. IR (thin film): ν = 2931, 1766, 1735, 1676, 1625 
cm-1. EIMS (70 eV) m/z (%): 372 (30), 341 (10), 312 (10), 32 (100); HRMS: calcd for 
C21H24O6 [M]
+: 372.1573; found: 372.1573. 
 
Tetracycle 290 
O
O
O
O
H
H
MeO2C
H
H
290  
To a stirred solution of 281 (47 mg, 0.20 mmol, 1.0 equiv) in deuterated toluene (1 mL) 
was added 2,6-dimethylbenzoquinone (33 mg, 0.23 mmol, 1.2 equiv). The reaction 
mixture was heated to reflux for 109 h before being cooled to rt and concentrated in 
vacuo. After column chromatography (hexane/ethyl acetate, 55:45) 290 (56 mg, 0.15 
mmol, 76%) was obtained as a yellow oil. [α]D
25 = +72.0  (c = 0.35, chloroform). 1H 
NMR (500 MHz, CDCl3): δ 6.59 (1H, dd, J = 3.0, 1.5 Hz), 5.62 (1H, m), 4.45 (1H, dq, 
J = 7.8, 6.3 Hz), 3.71 (3H, s), 3.17 (1H, dt, J = 6.9, 5.9 Hz), 3.10 (1H, dd, J = 10.3, 7.3 
Hz), 2.88 (1H, dd, J = 6.6, 4.2 Hz), 2.79 (1H, dd, J = 10.1, 7.9 Hz), 2.72 (1H, ddt, J = 
18.5, 4.8, 1.8 Hz), 2.15 (1H, m), 2.08 (1H, m), 2.01 (3H, d, J = 1.4 Hz), 1.78(1H, dt, J = 
13.6, 5.6 Hz), 1.69 (1H, ddd, J = 13.6, 11.0, 5.6 Hz), 1.40 (3H, s), 1.38 (3H, d, J = 6.3 
Hz) ppm. 13C NMR (125 MHz, CDCl3): δ  202.3, 198.8, 176.8, 173.2, 149.9, 136.6, 
132.8, 122.2, 79.7, 52.5, 51.6, 50.6, 50.4, 41.7, 40.1, 39.4, 29.5, 24.3, 22.5, 19.9, 16.6 
ppm. IR (thin film): ν = 2930, 1769, 1735, 1678 cm-1. EIMS (70 eV) m/z (%): 372 
(100), 340 (40), 312 (45); HRMS: calcd for C21H24O6 [M]
+: 372.1573; found: 372.1570.  
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Tetracycle 292 
O
O
O
O
H
MeO2C
H
H
H
292  
To a stirred solution of 45 (10 mg, 0.03 mmol, 1.0 equiv) in chloroform (4 ml) was 
added dry silica (2.5 g). Stirring was continued for 8 h before the reaction mixture was 
filtered. The silica was rinsed with ethyl acetate (2 x 10 mL) and the filtrate 
concentrated in vacuo to give 292 (10 mg, 0.03 mmol, 100%). Recrystallisation 
(heptane/dichloromethane/chloroform) gave colourless needles. m.p. 110-112 oC. 
[α]D
25 = +132.4  (c = 0.18, chloroform). 1H NMR (500 MHz, CDCl3): δ 6.48 (1H, q, J = 
1.4 Hz), 5.66 (1H, d, J = 4.9 Hz), 4.43 (1H, dq, J = 6.4, 3.8 Hz), 3.77 (3H, s), 3.48 (1H, 
dd, J = 10.4, 5.0 Hz), 2.89 (1H, dd, J = 8.3, 5.3 Hz), 2.87 (1H, dd, J = 6.1, 3.3 Hz), 2.74 
(1H, dd, J = 7.4, 4.8 Hz), 2.73 (1H, dd, J = 7.4, 5.2 Hz), 2.50 (1H, m), 2.47-2.38 (2H, 
m), 2.33 (1H, ddt, J = 18.5, 11.0, 1.9 Hz), 2.01 (3H, d, J = 1.5 Hz), 1.41 (3H, d, J = 6.4 
Hz), 1.37 (1H, m), 1.08 (3H, s) ppm. 13C NMR (100 MHz, CDCl3): δ 201.0, 200.3, 
176.3, 173.1, 150.3, 136.2, 135.8, 121.7, 79.9, 52.4, 51.0, 50.5, 45.7, 41.2, 38.8, 37.1, 
29.0, 22.1, 21.7, 21.5, 16.2 ppm. IR (thin film): ν = 2927, 1766, 1736, 1674 cm-1. EIMS 
(70 eV) m/z (%): 372 (50), 312 (60), 69 (100); HRMS: calcd for C21H24O6 [M]
+: 
372.1573; found: 372.1577 
 
Tetracycle 291 
O
O
O
O
H
MeO2C
H
H
H
291  
To a stirred solution of 290 (8 mg, 0.02 mmol, 1.0 equiv) in chloroform (4 mL) was 
added dry silica (2 g). Stirring was continued for 4 h before the reaction mixture was 
filtered. The silica was rinsed with ethyl acetate (15 mL x 2) to give 291 (8 mg, 0.02 
mmol, 100%). Recrystalisation (heptane/ethyl acetate) gave colourless needles. m.p. 
180-182 oC. [α]D
25 = +214.0  (c = 0.83, chloroform). 1H NMR (500 MHz, CDCl3): 
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δ 6.64 (1H, ddd, J = 2.8, 1.5, 1.5 Hz), 5.68 (1H, dd, J = 5.0, 1.7 Hz), 4.44 (1H, dq, J = 
6.4, 3.5 Hz), 3.79 (3H, s), 3.51 (1H, dd, J = 10.3, 4.6 Hz), 2.92 (1H, m), 2.88 (1H, m), 
2.74 (1H, ddd, J = 9.8, 7.3, 4.8 Hz), 2.61-2.40 (2H, m), 2.30 (1H, ddt, J = 2.0,m 11.0, 
19 Hz), 2.01 (3H, d, J = 1.5 Hz), 1.43 (3H, d, J = 6.4 Hz), 1.36 (1H, m), 1.10 (3H, s) 
ppm. 13C NMR (100 MHz, CDCl3): δ  201.1, 199.3, 176.2, 173.0, 148.4, 137.1, 135.9, 
121.7, 79.9, 52.4, 50.7, 50.5, 45.7, 41.1, 38.7, 37.0, 28.9, 22.1, 21.8, 21.5, 16.5 ppm. IR 
(thin film): ν = 2933, 1764, 1737, 1680, 1628 cm-1. EIMS (70 eV) m/z (%): 372 (100), 
341 (25), 312 (80); HRMS: calcd for: C21H24O6 [M]
+: 372.1573; found: 372.1576. 
 
Heptacycle 293 
O O
O
O
OO
H
H
CO2Me
H
H
H
MeO2C
H
H
H
293  
To a solution of 281 (160 mg, 0.68 mmol, 1.0 equiv) in dichloromethane (3 mL) was 
added 2,6-dimethylbenzoquinone (46 mg, 0.34 mmol, 0.5 equiv). The reaction mixture 
was compressed at 19 kbar for 72 h then concentrated in vacuo. After column 
chromatography 293 (176 mg, 0.29, 85%) was obtained. Recrystallisation 
(heptane/dichloromethane) gave colourless needles. m.p.  132-135 oC. [α]D
25 = +4.24  (c 
= 0.66, chloroform). 1H NMR (500 MHz, C6D6): δ  5.17 (2H, m), 4.47 (2H, dq, J = 8.8, 
6.2 Hz), 3.31 (6 H, s), 2.97 (2H, m), 2.88 (2H, dd, J = 17.6, 6.1 Hz), 2.50 (2H, dd, J = 
10.7, 7.8 Hz), 2.24 (2H, d, J = 5.9 Hz), 2.19 (2H, t, J = 9.6 Hz), 2.00 (2H, d, J = 12.2 
Hz), 1.84 (2H, dt, J = 12.5, 4.1 Hz), 1.68 (2H, dd, J = 17.3, 6.6 Hz), 1.11 (6H, s), 1.04 
(6H, d, J = 6.2 Hz), 1.06-0.09 (2H, m) ppm. 13C NMR (125 MHz, C6D6): δ  215.8, 
208.0, 175.8, 173.1, 133.9, 122.4, 79.2, 52.1, 49.8, 49.6, 49.0, 41.7, 41.1, 40.17, 31.9, 
26.3, 22.5, 19.7 ppm. IR (thin film): ν = 2974, 2892, 1768, 1734, 1701 cm-1. EIMS (70 
eV) m/z (%): 608 (100), 576 (50), 372 (40), 277 (45), 243 (70), 171 (95); HRMS: calcd 
for: C34H40O10 [M]
+: 608.2621; found: 608.2624. 
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7.5 Chapter 5 
7.5.1 Syntheses of Substituted Dendralenes 
3,3-Dibromo-1-[(tert-butyldimethylsilyl)oxy]-prop-2-ene 362 
OTBSBr
Br
362  
The title compound was prepared according to modified literature procedures.85 To a 
stirred solution of triphenyl phoshpine (11.0 g, 40 mmol, 4.0 equiv) in dichloromethane 
(35 mL) at 0 oC under argon, was added a solution of carbon tetrabromide (7.0 g, 20 
mmol, 2.0 equiv) in dichloromethane (15 mL) over 45 min, via cannula. The reaction 
mixture was stirred at rt for 30 min, NEt3 (1.46 mL, 10 mmol, 1.0 equiv) was added 
before the mixture was cooled to 0 oC. A solution of [(tert-
butyldimethylsilyl)oxy]acetaldehyde91,169 (1.83 g, 10 mmol, 1.0 equiv) in 
dichloromethane (5 mL) was added dropwise. The reaction mixture was warmed to rt 
and stirring continued for a further 30 min. To the reaction mixture was added hexanes 
and the resulting precipitate was filtered. The filtrate was then concentrated under 
reduced pressure. After column chromatography (hexanes/diethyl ether 97:3) 362 (1.98 
g, 6 mmol, 57 %) was obtained as a colourless oil. 1H NMR data was consistent with 
that reported in the literature.85 
 
(2Z)-3-Bromo-1-[(tert-butyldimethylsilyl)oxy]-penta-2,4-diene 363 
OTBS
Br
363  
The title compound was prepared according to modified literature procedures.85 To a 
stirred solution of 362 (750 mg, 2.27 mmol, 1.0 equiv) and tributyl(vinyl)tin (756 mg, 
2.38 mmol, 1.05 equiv) in tetrahydrofuran (12 mL) was added 
tris(dibenzylideneacetone)dipalladium (0) (26 mg, 0.03 mmol, 0.0125 equiv) and 
triphenyl arsine (70 mg, 0.23 mmol, 0.1 equiv). The mixture was freeze thaw degassed 
(x 2). The mixture was heated to 55 oC and stirring was continued for 18 h. The mixture 
was cooled and diluted with diethyl ether (50 mL), washed with aq NH3 (20 mL x 2). 
The aqueous layer was extracted with diethyl ether (50 mL). The combined organic 
layers were washed with brine, dried and concentrated in vacuo. Column 
chromatography gave 363 (436 mg, 1.49 mmol, 66%) as a colourless oil. 1H NMR data 
was consistent with that reported in the literature.85 
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Stille reaction of  (2Z)-3-bromo-1-[(tert-butyldimethylsilyl)oxy]-penta-2,4-diene 363 
with tributyl(prop-1-en-2-yl)stannane. 
OTBS
Br
363
OTBS
365
OTBS
364
+
 
Method A 
To a stirred solution of 363 (200 mg, 0.69 mmol, 1.0 equiv) and tributyl(prop-1-en-2-
yl)stannane (250 mg, 0.76 mmol, 1.1 equiv) in acetonitrile (4 mL) was added palladium 
acetate (8 mg, 0.03 mmol, 0.05 equiv) and triphenyl phosphine (18 mg, 0.06 mmol, 0.1 
equiv). The mixture was freeze/thaw degassed (x 2) then heated to 60 oC for 18 h. The 
mixture was diluted with diethyl ether (20 mL) and washed with aq. NH3 (2 x 20 mL). 
The aqueous layer was extracted with diethyl ether (2 x 20 ml). The combined organic 
layers were washed with brine, dried and concentrated in vacuo. Column 
chromatography gave 364 and 365 as an inseprable mixture (1:1, 70 mg, 0.29 mmol, 
42%). 
Method B 
To a stirred solution of 363 (51 mg, 0.18 mmol, 1.0 equiv) and tributyl(prop-1-en-2-
yl)stannane (122 mg, 0.37 mmol, 2.0 equiv) in DMF (200 µL) was added CsF (56 mg, 
0.37 mmol, 2.0 equiv). The mixture was freeze/thaw degassed (x 2). CuI (4 mg, 0.02 
mmol, 0.12 equiv), palladium chloride (2 mg, 0.01 mmol, 0.06 equiv) and PtBu3 (6 mg, 
0.02 mmol, 0.12 equiv) were added and the mixture was heated to 45 oC for 18 h. The 
mixture was filtered through a pad of celite with dichloromethane (50 mL). The filtrate 
was washed with brine, dried and concentrated in vacuo. Column chromatography 
(hexanes/dichloromethane 90:10) gave 364 and 365 as an inseparable mixture (1:1, 22 
mg, 0.09 mmol, 44%). 
 
Deprotection of 364 and 365 
OTBS
365
OTBS
364
+
OH
51
OH
540
+
 
To a stirred solution of 364 and 365 (1:1, 70 mg, 0.29 mmol, 1.0 equiv) in 
tetrahydrofuran (4 mL) was added TBAF (1.0 M sol, 590 µL, 0.59 mmol, 2.0 equiv). 
Stirring was continued for 30 min before the mixture was diluted with diethyl ether (20 
mL). The mixture was washed with sat. aqueous NH4Cl (20 mL), brine (20 mL), dried 
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and concentrated in vacuo. Column chromatography gave 540 and 51 as an inseparable 
mixture (1:1, 16 mg, 0.12 mmol, 43%). 
 
(2Z)-3-Bromo-1-[(tert-butyldimethylsilyl)oxy]-4-methylpenta-2,4-diene 366 
Br
OTBS
366  
To a stirred solution of zinc bromide (1.12 g, 5.0 mmol, 1.1 equiv) in tetrahydrofuran (5 
mL) at 0 oC was added a solution of isopropenyl magnesium bromide (0.26 M solution 
in tetrahydrofuran, 17.5 mL, 4.5 mmol, equiv). The resulting mixture was warmed to rt 
before the dropwise addition of a solution of 362 (1.5 g, 4.5 mmol, 1.0 equiv) and 
tetrakis(triphenylphosphine)palladium(0) (263 mg, 0.23 mmol, 0.05 equiv) in 
tetrahydrofuran (15 mL). The reaction mixture was stirred at rt for 45 min before being 
diluted with hexane (100 mL) and filtered. The filtrate was concentraed in vacuo and 
after column chromatography (hexane/ethyl acetate 99:1) 366 (1.03 g, 3.5 mmol, 78%) 
was obtained as a colourless oil. 1H NMR (300 MHz, CDCl3): δ 6.16 (1H, t, J  = 5.1 
Hz), 5.49 (1H, m), 5.13 (1H, m), 4.43 (2H, d, J  = 5.1 Hz), 2.00 (3H, m), 0.92 (9H, s), 
0.10 (3H, s) ppm. 13C NMR (100 MHz, CDCl3): δ 140.2, 131.8, 125.3, 118.4, 64.6, 
26.0, 20.8, 18.4, -5.1 ppm . IR (thin film): ν = 2955, 2930, 2886, 2858, 1609 cm-1. 
EIMS (70 eV) m/z (%): 290 (20), 249 (30), 235 (28), 115 (50), 75 (100); HRMS: calcd 
for C8H14OSiBr [M]: 232.9997; found: 232.9994.  
 
Stille reaction of (2Z)-3-bromo-1-[(tert-butyldimethylsilyl)oxy]-4-methylpenta-2,4-
diene 366 and tributyl(vinyl)tin 
 
Br
OTBS OTBS
+
OTBS
366 365 364  
Method A 
To a stirred solution of 366 (84 mg, 0.29 mmol, 1.0 equiv) and tributyl(vinyl)tin (110 
mg, 0.34 mmol, 1.2 equiv) in DMF (500 µL) was added CsF (87 mg, 0.58 mmol, 2.0 
equiv). The mixture was freeze/thaw degassed (x 2). CuI (4 mg, 0.02 mmol, 0.08 
equiv), palladium chloride (2 mg, 0.01 mmol, 0.04 equiv) and PtBu3 (5 mg, 0.02 mmol, 
0.08 equiv) were added and the mixture was heated to 45 oC for 18 h. The mixture was 
filtered through a pad of celite with dichloromethane (50 mL). The filtrate was washed 
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with brine, dried and concentrated in vacuo. Column chromatography (hexanes/ethyl 
acetate 99:1) gave 366, 364 and 365 (50% conversion, 28 mg of 366 and 34 mg of 364 
and 365 (91:9), 69% based on recovered s.m). Column chromatography of this mixture 
(hexanes/dichloromethane 90:10) gave 364 and 365 (91:9). 
 
(2Z)- 1-[(tert-Butyldimethylsilyl)oxy]-4-methyl-3-vinylpenta-2,4-diene 365 
1H NMR (300 MHz, CDCl3): δ  6.31 (1H, dd, J = 17.4, 10.5 Hz), 5.55 (1H, t, J = 6.4 
Hz), 5.16 (1H, bs), 5.15 (1H, d, J = 17.4 Hz), 5.07 (1H, d, J = 10.5 Hz), 4.72 (1H, bs), 
4.26 (2H, d, J = 6.4 Hz), 1.85 (3H, s), 0.91 (9H, s), 0.08 (6H, s) ppm. 13C NMR (125 
MHz, CDCl3): δ 143.4, 141.1, 138.0, 130.3, 115.7, 114.9, 60.9, 26.1, 23.0, 18.5, -5.0 
ppm. IR (thin film): ν =  2957, 2929, 2857 cm-1. EIMS (70 eV) m/z (%): 238 (2), 223 
(2), 181 (55), 75 (100); HRMS: calcd for C10H17OSi [M-C4H9]: 181.1049; found: 
181.1050. 
 
Method B 
A solution of 366 (300 mg, 1.03 mmol, 1.0 equiv) and tributyl(vinyl)tin (448 mg, 2.06 
mmol, 2.0 equiv) in acetonitrile (4 mL) was freeze/thaw degassed (x 2). Triphenyl 
phosphine  (24 mg, 0.10 mmol, 0.10 equiv) and palladium acetate (14 mg, 0.05 mmol, 
0.05 equiv) were added and the mixture was heated to 60 oC for 18 h. The mixture was 
diluted with diethyl ether (20 mL) and washed with aq. NH3 (2 x 20 mL). The aqueous 
layer was extracted with diethyl ether (2 x 20 ml). The combined organic layers were 
washed with brine, dried and concentrated in vacuo. Column chromatography gave 364 
and 365 as an inseprable mixture (72:28, 113 mg, 0.47 mmol, 46%). 
 
Deprotection of 364 and 365 
OTBS
365
OTBS
364
+
OH
51
OH
540
+
 
To a stirred solution of 364 and 365 (91:9, 10 mg, 0.04 mmol, 1.0 equiv) in 
tetrahydrofuran (2 mL) was added tetrabutyl ammonium fluoride (1.0 M sol, 140 µL, 
0.14 mmol, 3.3 equiv). Stirring was continued for 2 h before the mixture was diluted 
with diethyl ether (20 mL). The mixture was washed with sat. NH4Cl sol (20 mL), brine 
(20 mL), dried and concentrated in vacuo. Column chromatography (dichloromethane) 
gave 540 and 51 as an inseparable mixture (91:9, 4 mg, 0.03 mmol, 77%). 
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(2Z)-4-Methyl-3-vinylpenta-2,4-dien-1-ol 540 
1H NMR (300 MHz, CDCl3): δ 6.30 (1H, dd, J = 17.4, 10.5 Hz), 5.60 (1H, t, J = 6.7 
Hz), 5.24-5.08 (3H, m), 4.74 (1H, bs), 4.22 (2H, d, J = 6.7 Hz), 1.86 (3H, s), 1.54 (1H, 
bs, OH) ppm. 13C NMR (100 MHz, CDCl3): δ  145.5, 141.1, 137.7, 128.7, 115.9, 60.2, 
31.0, 23.4 ppm. IR (thin film): ν = 3361, 2921, 2851 cm-1. EIMS (70 eV) m/z (%):124 
(5), 123 (7), 95 (100); HRMS: calcd for C8H11O [M-H]: 123.0810; found:123.0810. 
7.5.2 Synthesis of the Bicyclic Intermediate  
(±)-(3aS,7aS)-3,3a,7,7a-Tetrahydro-5-methyl-4-vinylisobenzofuran-1(6H)-one 49 
O
O
H
H
49  
To a stirred solution of 365 and 364 (72:28, 113 mg, 0.47 mmol, 1.0 equiv) in 
tetrahydrofuran (5 mL) was added tetrabutyl ammonium fluoride (1.0 M sol, 2.5 mL, 
2.5 mmol, 5.2 equiv). Stirring was continued for 2 h before the mixture was diluted with 
diethyl ether (20 mL). The mixture was washed with sat NH4Cl sol (20 mL), brine (20 
mL), dried and concentrated in vacuo. Column chromatography (dichloromethane) gave 
51 and 540 as an inseparable mixture (72:28). Toluene (2 mL) and methyl acrylate (2 
mL) were added and the mixture was heated in a sealed tube for 18 h. Concentration in 
vacuo followed by column chromatography (hexanes/ethyl acetate 75:25) gave 49 (18 
mg, 0.10 mmol, 30%). 1H NMR (300 MHz, CDCl3): δ 6.74 91H, dd, J = 17.7, 11.3 Hz), 
5.04 (1H, d, J = 11.3 Hz), 4.95 (1H, d, J = 17.8 Hz), 4.52 (1H, dd, J = 9.0, 7.5 Hz), 4.06 
(1H, dd, J = 9.0, 4.9 Hz), 3.42 (1H, m), 2.86 (1H, m), 2.23-1.90 (3H, m), 1.81 (3H, s), 
1.77 (1H, m) ppm. 13C NMR (75 MHz, CDCl3): δ  179.3, 136.8, 133.2, 126.5, 111.8, 
72.5, 38.3, 34.8, 29.6, 20.5, 19.9 ppm . IR (thin film): ν = 3087, 2919, 1772 cm-1. EIMS 
(70 eV) m/z (%): 178 (65), 163 (15), 134 (28), 105 (100); HRMS: calcd for C11H14O2: 
178.0994; found: 178.0999. 
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 (2Z)-3-Bromo-4-methylpenta-2,4-dien-1-ol 377  
Br
OH
377  
To a stirred solution of 366 (174 mg, 0.59 mmol, 1.0 equiv) in tetrahydrofuran (4 mL) 
at 0 oC was added tetrabutyl ammonium fluoride (1M in tetrahydrofuran, 1.19 mL, 1.19 
mmol, 2.0 equiv). The resulting solution was warmed to rt  and stirred for 30 min before 
being quenched with sat. aq. NH4Cl. The aqueous layer was extracted with diethyl ether 
(2 x 20 mL), and the combined organic layers were washed with brine, dried and 
concentrated in vacuo. After column chromatography 377 (94 mg, 0.52 mmol, 88%) 
was obtained as a colourless oil. 1H NMR (300 MHz, CDCl3): δ 6.22 (1H, t, J = 5.7 
Hz), 5.52 (1H, m), 5.16 (1H, m), 4.41 (2H, d, J = 5.7 H), 2.19 (1H, s), 2.00 (3H, m) 
ppm. 13C NMR (100 MHz, CDCl3): δ 140.1, 129.9, 127.7, 119.2, 63.3, 20.7 ppm . IR 
(thin film): ν = 3325, 2952, 2925, 1608 cm-1. EIMS (70 eV) m/z (%): 178 (5), 149 (20), 
97 (70), 41 (100); HRMS: calcd for C6H9O
81Br: 177.9811; found: 177.9816.  
 
(2Z)-3-Bromo-4-methylpenta-2,4-dienyl acrylate 378  
O
Br
O
378  
To a stirred solution of 377 (91 mg, 0.51 mmol, 1.0 equiv) in dichloromethane (5 mL) 
at 0 oC was added triethylamine (150 µL, 1.08 mmol, 2.1 equiv) and acryloyl chloride 
(63 µL, 0.77 mmol, 1.5 equiv). Stirring was continued at this temperature for 1.5 h 
before warming to rt and quenching with sat. NaHCO3 (15 mL). The aqueous layer was 
extracted with diethyl ether (3 x 15 mL) and the combined organic layers were dried 
and concentrated in vacuo. After column chromatography (hexanes/ethyl acetate 85:15) 
378 (81 mg, 0.35 mmol, 69%) was obtained as a colourless oil. 1H NMR (300 MHz, 
CDCl3): δ  6.40 (1H, dd, J = 17.3, 1.5 Hz), 6.17 (1H, t, J  = 5.7 Hz), 6.13 (1H, dd, J = 
17.2, 10.3 Hz), 5.85 (1H, dd, J = 10.3, 1.5 Hz), 5.55 (1H, m), 5.18 (1H, m), 4.91 (2H, d, 
J  = 5.7 Hz), 1.99 (3H, dd, J = 1.4, 0.6 Hz) ppm. 13C NMR (100 MHz, CDCl3): δ 165.9, 
140.0, 131.4, 129.5, 128.0, 125.0, 119.7, 64.9, 20.6 ppm . IR (thin film): ν = 2954, 
2927, 1728, 1634, 1611 cm-1. EIMS (70 eV) m/z (%): 232.0 (2), 230.0 (2), 151 (12), 79 
(20), 55 (100); HRMS: calcd for     C9H11O2
79Br [M]: 229.9942; found: 229.9931.  
 228
 
(±)-(3aR,7aS)-4-Bromo-3,3a,7,7a-tetrahydro-5-methylisobenzofuran-1(6H)-one 379 
O
Br
O
H
H
379  
A solution of 378 (284 mg, 1.23 mmol, 1.0 equiv) and BHT (14 mg, 0.06 mmol, 0.05 
equiv) in dichlorobenzene (90 mL) was heated at reflux for 72 h. The solvent was 
distilled under reduced pressure. The crude residue was dissolved in dichloromethane 
(15 mL) and DBU (202 µL, 1.35 mmol, 1.1 equiv) was added. The mixture was heated 
to reflux for 2.5 h then cooled to rt. The mixture was diluted with ether (50 mL), 
washed with 1 M HCl (20 ml), water (20 mL) and brine (20 mL). The organic layer was 
dried and concentrated in vacuo. After column chromatography (hexanes/ethyl acetate 
85:15) 379  (113 mg, 0.53 mmol, 40%) was obtained as a colourless oil. 1H NMR (300 
MHz, CDCl3): δ  4.41 (1H, dd, J = 9.4, 2.9 Hz), 4.35 (1H, ddd, J = 9.4, 6.5, 0.8 Hz), 
3.36 (1H, bs), 2.91 (1H, m), 2.23-2.04 (3H, m), 1.86 (1H, m), 1.84 (3H, s) ppm. 13C 
NMR (125 MHz, CDCl3): δ 177.7, 137.0, 117.3, 71.8, 44.3, 40.5, 29.3, 24.0, 20.3 ppm . 
IR (thin film): ν = 2918, 1773  cm-1. EIMS (70 eV) m/z (%): 232 (28), 230 (30), 187 
(48), 185 (50), 172 (20), 93 (100); HRMS: calcd for C9H11O2
79Br [M]: 229.9942; 
found: 229.9935.  
 
(±)-(3aS,7aS)-3,3a,7,7a-Tetrahydro-5-methyl-4-vinylisobenzofuran-1(6H)-one 49 
O
O
H
H
49  
A solution of 378  (29 mg, 0.13 mmol, 1.0 equiv) and tributyl(vinyl)tin  (80 mg, 0.25 
mmol, 2.0 equiv) in DMF (1 mL) was freeze/thaw degassed (x 2). 
bis(acetonitrile)palladium dichloride (3.2 mg, 0.01 mmol, 0.10 equiv) was added and 
the mixture heated to 100 oC for 6 d. Concentration in vacuo followed by column 
chromatography (hexanes/ethyl acetate 85:15) gave 49 (8 mg, 0.05 mmol, 36%). 
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2-Methylbut-1-en-3-yne 381 
381  
2-Methylbut-1-en-3-yne 381 was prepared following a modified procedure of 
Brandsma.212 A mixture of acetic anhydride (50 mL, 530 mmol, 1.5 equiv) and p-
toluenesulphonic acid (3.5 g, 20 mmol, 0.06 equiv) were placed in a two-necked flask 
fitted to a distillation apparatus. The mixture was cooled to 0 oC and 2-methylbut-3-yn-
2-ol (33 mL, 350 mmol, 1.0 equiv) was added. The mixture was gradually heated in a 
oil bath and the product was distilled. The crude product was washed with cold KOH 
solution and dried (MgSO4). Distillation through a short column afforded 2-methylbut-
1-en-3-yne 381 (11.5 g, 170 mmol, 50%). 
 
4-Methylpent-4-en-2-yn-1-ol 382 
OH
382  
The title compound was prepared according to modified literature procedures.173 To a 
solution of ethyl magnesium bromide (1.25 M in tetrahydrofuran, 140 mL, 170 mmol, 
1.0 equiv) at 0 oC was added 2-methylbut-1-en-3-yne 381(11.5 g, 170 mmol, 1.0 equiv) 
and paraformaldehyde (10 g). The mixture was stirred at rt for 1 h then heated to reflux 
for 6 h. The reaction was cooled to rt and aq. NH4Cl (100 mL) was added. The mixture 
was extacted with ether (200 mL), dried and concentrated in vacuo. Distillation afforded 
382 (9.25 g, 96 mmol, 55%). 
 
(2Z)-3-Iodo-4-methylpenta-2,4-dien-1-ol 383 and (2E)-3-Iodo-4-methylpenta-2,4-dien-
1-ol 384 
I
OH
I
OH
+
383 384  
The title compounds were prepared according to modified literature procedures.174 To a 
suspension of lithium aluminium hydride (1.81g, 48 mmol, 1.2 equiv) in diethyl ether 
(40 mL) at 0 oC was added a solution of 382 (3.82 g, 40 mmol, 1.0 equiv) in diethyl 
ether (8 mL). The mixture was stirred at rt for 1 h then cooled to 0 oC. Ethyl acetate (4.7 
mL, 48 mmol, 1.2 equiv) was added dropwise and stirring was continued at this 
temperature for 1 h. The mixture was cooled to -78 oC and solid I2 (20 g, 79 mmol, 2.0 
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equiv) was added in portions. The reaction was stirred at -78 oC for 1 h, 0 oC for 1 h 
then warmed to rt. Sodium thiosulphate solution (50 mL) was added and the mixture 
was filtered. The mixture was extracted with ether (2 x 100 mL). The combined organic 
layers were washed with sodium thiosulphate solution (50 mL), brine (50 mL) and 
dried. Concentration in vacuo followed by column chromatography (hexanes/ethyl 
acetate 85:15) gave 383 and 384 (3.79 g, 17 mmol, 42%) as a 2.75:1 ratio of E/Z 
isomers. 
 
(±)-(3aR,7aS)-3,3a,7,7a-Tetrahydro-4-iodo-5-methylisobenzofuran-1(6H)-one 385 
O
O
I
H
H
385  
A solution of 383 and 384 (2.75:1 mixture of E/Z isomers, 3.79 g, 17 mmol, 1.0 equiv) 
in methyl acrylate (15 mL) and toluene (10 mL) was heated at 100 oC for 18 h. The 
mixture was concentrated in vacuo and the crude residue was dissolved in CH2Cl2 (15 
mL). Imidazole (1.73 g, 25 mmol, 1.5 equiv), tert-butyldimethylsilyl chloride (2.55 g, 
17 mmol, 1.0 equiv) and DMAP (378 mg, 3.4 mmol, 0.2 equiv) were added. Stirring 
was continued for 4 h. Water (20 mL) was added and the mixture was extracted with 
ether (100 mL). The organic layer was washed with brine, dried and concentrated in 
vacuo. Column chromatography (hexanes/ethyl acetate 85:15) gave 385 (2.10 g, 7.6 
mmol, 61%). 1H NMR (500 MHz, CDCl3): δ  4.38 (1H, ddd, J = 9.4, 6.5, 1.4 Hz), 4.32 
(1H, ddd, J = 9.4, 3.7, 1.2 Hz), 3.47 (1H, bs), 2.81 (1H, dd, J = 12.4, 5.4 Hz), 2.27-2.06 
(3H, m), 1.90 (3H, s), 1.90 (1H, m) ppm. 13C NMR (125 MHz, CDCl3): δ 177.9, 142.7, 
97.0, 73.5, 47.6, 40.7, 30.0, 29.3, 26.9, 20.7 ppm . IR (thin film): ν = 2917, 1769, 1646  
cm-1. EIMS (70 eV) m/z (%): 278 (95), 233 (30), 220 (28), 151 (12), 93 (100); HRMS: 
calcd for C9H11O2
127I: 277.9804; found: 277.9803. 
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(±)-(3aS,7aS)-3,3a,7,7a-Tetrahydro-5-methyl-4-vinylisobenzofuran-1(6H)-one 49 
O
O
H
H
49  
A solution of 385 (500 mg, 1.79 mmol, 1.0 equiv) and tributyl(vinyl)tin (1.14 g, 3.60 
mmol, 2.0 equiv) in toluene (10 mL) was freeze/thaw degassed (x 2). 
tris(dibenzylideneacetone)dipalladium (0) (41 mg, 0.04 mmol, 2.5 mol%) and tri-2-
furylphosphine (63 mg, 0.27 mmol, 15 mol%) were added and the mixture was heated 
to 60 oC for 24 h. The mixture was diluted with diethyl ether (20 mL) and washed with 
aq. ammonia solution (50 mL). The aqueous layer was extracted with diethyl ether (20 
mL). The combined organic layers were washed with brine, dried and concentrated in 
vacuo. Column chromatography (hexanes to hexanes/ethyl acetate 85:15) gave 49 (277 
mg, 1.55 mmol, 86%). 
 
3-Iodo-2-methanol-4-methyl(2,5-dihydrothiphene-1,1-dioxide) 386 
S
O2
I
OH
386  
To a solution of 383/384 (1:1 mixture of E/Z isomers, 3.24 g, 14 mmol, 1.0 equiv) in 
methanol/ether (1:1, 8 mL) in a sealable tube was added quinol (5 mg). The mixture was 
cooled to -78 oC and liquid SO2 (20 mL) was added and the tube was sealed. The 
mixture was stirred at rt for 4 d. Concentration in vacuo followed by column 
chromatography (hexanes/ethyl acetate 60:40) gave 386 (2.13 g, 7.4 mmol, 51%). 1H 
NMR (500 MHz, CDCl3): δ  4.20 (1H, ddd, J = 12.7, 2.4, 0.7 Hz), 4.02 (1H, dd, J = 
12.7, 5.7 Hz), 3.86 (1H, m), 3.83 (1H, d, J = 17.4 Hz), 3.73 (1H, d, J = 15.7 Hz), 1.99 
(3H, s) ppm. 13C NMR (75 MHz, CDCl3): δ  138.8, 87.5, 74.6, 60.0, 59.9, 22.7 ppm . IR 
(thin film): ν = 3503, 2923, 1307, 1126 cm-1. EIMS (70 eV) m/z (%): 289 (76), 258 
(95), 41 (100); HRMS: calcd for C6H9O3S
127I [M]: 287.9317; found: 287.9312. 
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2-Methanol-4-methyl-3-vinyl(2,5-dihydrothiphene-1,1-dioxide) 387 
S
O2 OH
387  
To a solution of 386 (200 mg, 0.69 mmol, 1.0 equiv) in DMF (1 mL) was added 
tributyl(vinyl)tin (440 mg, 1.39 mmol, 2.0 equiv) and bis(acetonitrile)palladium 
dichloride (18 mg, 0.07 mmol, 10 mol%). The mixture was freeze/thaw degassed (x 2) 
and heated to 100 oC for 22 h. The solvent was removed under reduced pressure. 
Column chromatography (hexanes/ethyl acetate 60:40) gave 387 (98 mg, 0.52 mmol, 
75%). 1H NMR (500 MHz, CDCl3): δ  6.63 (1H, dd, J = 18.0, 11.5 Hz), 5.37 (1H, d, J = 
11.5 Hz), 5.26 (1H, d, J = 18.0 Hz), 4.10 (1H, dd, J = 12.7, 3.1 Hz), 4.05 (1H, d, J = 7.9 
Hz), 3.96 (1H, d, J = 16.9 Hz), 3.94 (1H, dd, J = 12.5, 7.1 Hz), 3.72 (1H, d, J = 16.9 
Hz), 1.97 (3H, s) ppm. 13C NMR (125 MHz, CDCl3): δ 131.1, 129.6, 128.1, 117.7, 67.1, 
60.3, 60.1, 15.2 ppm . IR (thin film): ν =  3503, 2922, 1298, 1109 cm-1. EIMS (70 eV) 
m/z (%): 188 (25), 158 (75), 123 (30), 95 (100); HRMS: calcd for C8H12O3S: 188.0507; 
found: 188.0506. 
 
(2E)-3-(Prop-1-en-2-yl)penta-2,4-dien-1-ol 51 
OH
51  
387 (61 mg, 0.32 mmol, 1.0 equiv) was heated to 240 oC under reduced pressure (85 
mm). The distillate was purified by column chromatography (dichloromethane) to give 
51 (4 mg, 0.03 mmol, 10%) as a colourless oil. 1H NMR (500 MHz, CDCl3): δ  6.40 
(1H, dd, J = 17.5, 10.9 Hz), 5.74 (1H, t, J = 6.7 Hz), 5.36 (1H, ddd, J = 10.9, 2.1, 0.8 
Hz), 5.15 (1H, dd, J = 17.5, 2.1 Hz), 5.03 (1H, bs), 5.01 (1H, bs), 4.35 (2H, d, J = 6.7 
Hz), 1.92 (3H, s) ppm. 13C NMR (100 MHz, CDCl3): δ  143.4, 142.6, 132.5, 127.2, 
119.5, 115.2, 60.1, 21.5 ppm. IR (thin film): ν = 3395, 2918, 2849 cm-1. EIMS (70 eV) 
m/z (%): 124 (7), 123 (10), 43 (100); HRMS: calcd for C8H11O [M-H]: 123.0810; 
found: 123.0810. 
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(±)-(3aS,7aS)-3,3a,7,7a-Tetrahydro-5-methyl-4-vinylisobenzofuran-1(6H)-one 49 
O
O
H
H
49  
To a stirred solution of 51 (12 mg, 0.096 mmol, 1.0 equiv) in methanol/water (95:5, 100 
µL) was added acrolein (65 µL, 0.96 mmol, 10.0 equiv). Stirring was continued for 18 
h. Concentration in vacuo and column chromatography (hexanes/ethyl acetate 85:15) 
gave 351 (5.1 mg, 0.028 mmol, 29%). 
To a stirred solution of 351 (9.1 mg, 0.05 mmol, 1.0 equiv) in dichloromethane (1 mL) 
was added celite (20 mg), PCC (22 mg, 0.10 mmol, 2.0 equiv), NaOAc (7 mg, 0.05 
mmol, 1.0 equiv) and NaHCO3 (4 mg, 0.05 mmol, 1.0 equiv). Stirring was continued for 
18 h. The mixture was dilted with diethyl ether (20 mL), filtered and concentrated in 
vacuo. Column chromatography (hexanes/ethyl acetate 85:15) gave 49 (8.4 mg, 0.05 
mmol, 93%). 
 
 (±)-(3aR,7aS)-3,3a,7,7a-Tetrahydro-4-iodo-5-methylisobenzofuran-1(6H)-one 385 
O
OH
I
O
O
I
I
OH
H
H
H
H
383
389 385  
To a stirred solution of 383 and 384 (1:1, 100 mg, 0.36 mmol, 1.0 equiv) in 
methanol/water (95:5, 360 µL) was added acrolein (240 µL, 3.6 mmol, 10.0 equiv). The 
mixture was stirred at rt for 6 d. Concentration in vacuo and column chromatography 
(hexanes/ethyl acetate 80:20) gave 389 (41 mg, 0.15 mmol, 83%). 
To a stirred solution of 389 (41 mg, 0.15 mmol, 1.0 equiv) in dichloromethane (5 mL) 
was added celite (100 mg), PCC (63 mg, 0.30 mmol, 2.0 equiv), NaOAc (20 mg, 0.15 
mmol, 1.0 equiv) and NaHCO3 (12 mg, 0.15 mmol, 1.0 equiv). The mixture was stirred 
at rt for 18 h before being diluted with diethyl ether (20 mL). The mixture was filtered 
and concentrated in vacuo. Column chromatography (hexanes/ethyl acetate 85:15) gave 
385 (34 mg, 0.12 mmol, 82%). 
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7.5.3 Completion of the Synthesis 
Diels-Alder reaction between diene 49 and quinone 50 
O
O
H
H
49
+
O
O
50
 
A solution of 49 (890 mg, 4.99 mmol, 1.0 equiv) and quinone 50177 (1.10 g, 7.32 mmol, 
1.5 equiv) in dichloromethane (3 mL) was compressed at 19 kbar for 7 days. The 
mixture was concentrated in vacuo. After column chromatography 48 (819 mg, 2.49 
mmol, 50%) was obtained. Further elution gave 394 as a minor product. 
 
(±)-(3aS,5aR,9aR,9bR,11aS)-3,3a,5,5a,9b,10,11,11a-Octahydro-7-isopropyl-9b-
methylphenanthro[2,1-c]furan-1,6,9(9aH)-trione 48 
O
H
H
H
H
O
O
O
48  
Recrystalisation from heptane/dichloromethane gave colourless crystals. m.p. 167-170 
oC. 1H NMR (500 MHz, CDCl3): δ  6.42 (1H, s), 5.42 (1H, t, J = 3.7 Hz), 4.30 (1H, t, J 
= 9.2 Hz), 4.09 (1H, dd, J = 11.2, 9.2 Hz), 3.54 (1H, ddd, J = 10.5, 7.2, 4.9 Hz), 3.29 
(1H, dd, J = 19.0, 8.8 Hz), 3.03 (1H, d, J = 4.8 Hz), 2.92 (1H, dsept. J = 6.8, 1.0), 2.77 
(1H, ddd, J = 12.4, 8.1, 6.1 Hz), 2.63 (1H, dt, J = 13.3, 3.5 Hz), 2.36 (1H, ddd, J = 19.0, 
7.2, 3.9 Hz), 2.09 (1H, ddd, J = 19.0, 10.5, 3.5 Hz), 2.05 (1H, m), 1.81 (1H, ddd, J = 
26.6, 13.3, 3.5 Hz), 1.29 (1H, dt, J = 13.3, 3.7 Hz), 1.26 (3H, s), 1.10 (3H, d, J = 6.8 
Hz), 1.06 (3H, d, J = 6.8 Hz) ppm. 13C NMR (125 MHz, CDCl3): δ 200.1, 199.3, 179.3, 
155.1, 136.7, 135.5, 123.2, 71.6, 58.1, 45.6, 41.8, 40.2, 35.0, 31.2, 28.3, 26.6, 21.3, 
20.9, 20.0 ppm. IR (thin film): ν =  2962, 1768, 1673 cm-1. EIMS (70 eV) m/z (%): 328 
(80), 285 (19), 177 (24), 152 (100); HRMS: calcd for C20H24O4: 328.1675; 
found:328.1682. 
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(±)-(3aS,5aR,9aR,9bR,11aS)-3,3a,5,5a,9b,10,11,11a-Octahydro-8-isopropyl-9b-
methylphenanthro[2,1-c]furan-1,6,9(9aH)-trione 394 
O
H
H
H
H
O
O
O
394  
1H NMR (500 MHz, CDCl3): δ  6.21 (1H, s), 5.38 (1H, t, J = 4.1 Hz), 4.28 (1H, t, J = 
9.2 Hz), 4.07 (1H, dd, J = 11.1, 9.2 Hz), 3.46 (1H, dddd, J = 12.1, 6.7, 5.1, 1.3 Hz), 3.30 
(1H, dd, J = 19.3, 8.9 Hz), 3.04 (1H, d, J = 4.8 Hz), 2.91 (1H, dsept. J = 6.9, 1.0), 2.74 
(1H, ddd, J = 12.6, 8.3, 6.2 Hz), 2.47 (1H, dt, J = 13.0, 3.4 Hz), 2.37 (1H, ddd, J = 19.2, 
7.1, 3.6 Hz), 2.08-1.92 (2H, m), 1.80 (1H, ddd, J = 26.6, 13.4, 3.6 Hz), 1.27 (1H, m), 
1.22 (3H, s), 1.09 (3H, d, J = 6.9 Hz), 1.02 (3H, d, J = 6.9 Hz) ppm. 13C NMR (125 
MHz, CDCl3): δ 200.6, 199.9, 179.2, 162.3, 136.2, 129.8, 122.9, 71.6, 59.2, 45.1, 41.7, 
40.2, 34.6, 31.0, 28.2, 26.7, 21.3, 20.5, 19.9 ppm. IR (thin film): ν =  2969, 2928, 1776, 
1796, 1674 cm-1. EIMS (70 eV) m/z (%): 328 (70), 285 (10), 177 (5), 152 (40), 84 
(100); HRMS: calcd for C20H24O4: 328.1675; found:328.1676. 
 
(±)- (3aS,5aR,6R,9aR,9bR,11aS)-3,3a,5a,6,9b,10,11,11a-Octahydro-6-hydroxy-7-
isopropyl-9b-methylphenanthro[2,1-c]furan-1,9(5H,9aH)-dione 397 
O
H
H
H
H
O
O
OH
397  
To a stirred solution of 48 (270 mg, 0.83 mmol, 1.0 equiv) in tetrahydrofuran (14 mL) 
at 0 oC was added a solution of NaBH4 (25 mg, 0.66 mmol, 0.8 equiv) in water (2 mL). 
Stirring was continued for 30 min before the reaction was quenched by the addition of 
sat NH4Cl. (20 mL). The mixture was extracted with ethyl acetate (20 mL x 2). The 
combined organics were dried and concentrated in vacuo to give 397 (270 mg, 0.83 
mmol, 100%). Recrystalisation gave 397 as colourless crystals. m.p. 176-178 oC.  1H 
NMR (500 MHz, CDCl3): δ  5.70 (1H, bs), 5.36 (1H, t, J = 3.2 Hz), 4.88 (1H, d, J = 3.2 
Hz), 4.28 (1H, t, J = 9.2 Hz), 4.06 (1H, dd, J = 11.1, 9.2 Hz), 3.25 (1H, q, J = 8.8 Hz), 
3.19 (1H, m), 2.98 (1H, dt, J = 13.7, 3.9 Hz), 2.78 (1H, sept., J = 6.9 Hz), 2.75 (1H, 
ddd, J = 12.6, 8.0, 5.9 Hz), 2.41 (1H, d, J = 3.9 Hz), 2.18 (1H, ddd, J = 19.2, 6.3, 4.7 
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Hz), 2.01-1.97 (2H, m), 1.78 (1H, dq, J = 13.4, 3.6 Hz), 1.28-1.23 (1H, m), 1.26 (3H, s), 
1.14 (3H, d, J = 6.9 Hz), 1.09 (3H, d, J = 6.9 Hz) ppm. 13C NMR (125 MHz, CDCl3): δ 
199.5, 180.0, 165.7, 136.6, 124.3, 123.9, 71.9, 71.6, 56.9, 41.8, 40.3, 38.5, 35.8, 31.3, 
29.1, 29.0, 23.1, 22.0, 20.4, 20.0 ppm . IR (thin film): ν = 3469, 2965, 2872, 1762, 1668 
cm-1. EIMS (70 eV) m/z (%): 330 (12), 178 (54), 150 (50), 111 (100); HRMS: calcd for 
C20H26O4: 330.1831; found: 330.1834. 
 
(±)- (3aS,5aR,6R,9aR,9bR,11aS)-3,3a,5a,6,9b,10,11,11a-Octahydro-7-isopropyl-6-
methoxy-9b-methylphenanthro[2,1-c]furan-1,9(5H,9aH)-dione 398 
O
H
H
H
H
O
O
OMe
398  
A solution of 397 (40 mg, 0.12 mmol, 1.0 equiv) and Ag2O (280 mg, 1.21 mmol, 10 
equiv) in methyl iodide (5 mL) was heated to reflux for 18 h. The solution was diluted 
with dichloromethane (20 mL), filtered through celite and concentrated in vacuo. After 
column chromatography (hexanes/ethyl acetate 70:30) gave 398 (41 mg, 0.12 mmol, 
99%). Recrysatalisation (heptane/dichloromethane) gave colourless needles. m.p. 88-90 
oC 1H NMR (500 MHz, CDCl3): δ  5.68 (1H, bs), 5.36 (1H, t, J = 3.7 Hz), 4.30 (1H, dd, 
J = 4.7, 2.1 Hz), 4.27 (1H, t, J = 9.1 Hz), 4.06 (1H, dd, J = 11.2, 9.1 Hz), 3.49 (3H, s), 
3.37 (1H, m), 3.25 (1H, q, J = 8.7 Hz), 3.00 (1H, dt, J = 13.0, 3.6 Hz), 2.79-2.72 (2H, 
m), 2.34 (1 H, d, J = 3.8 Hz), 2.09 – 1.95 (3H, m), 1.79 (1H, dq, J = 13.3, 3.8 Hz), 1.29 
(3H, s), 1.27 (1H, dt, J = 13.3, 3.8 Hz), 1.07 (3H, d, J = 6.7 Hz), 1.05 (3H, d, J = 6.7 
Hz) ppm. 13C NMR (125 MHz, CDCl3): δ 199.4, 179.8, 165.0, 136.6, 124.5, 123.9, 
80.3, 71.8, 57.1, 56.3, 41.9, 40.3, 36.0, 33.6, 31.4, 29.1, 29.0, 23.0, 21.8, 20.3, 20.1 ppm 
. IR (thin film): ν = 2925, 1778, 1672 cm-1. EIMS (70 eV) m/z (%): 344 (9), 312 (25), 
178 (45), 125 (100); HRMS: calcd for C21H28O4: 344.1988; found: 344.1996. Anal. 
Calcd for  C21H28O4: C, 73.23; H, 8.19. Found: C, 73.12; H, 7.97. 
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Reaction of (±)- (3aS,5aR,6R,9aR,9bR,11aS)-3,3a,5a,6,9b,10,11,11a-octahydro-7-
isopropyl-6-methoxy-9b-methylphenanthro[2,1-c]furan-1,9(5H,9aH)-dione 398 with 
triflic anhydride  
O
H
H
O
O
O
O
OMe
O
H
H
H
H
O
O
OMe
H
H
+
44% 17%
398 355 400
 
To a stirred solution of 398 (133 mg, 0.39 mmol, 1.0 equiv) in dichloromethane (2 mL) 
at -78 oC was added 2,6-ditertbutyl-4-methyl pyridine (95 mg, 0.46 mmol, 1.2 equiv) 
and triflic anhydride (71 µL, 0.42 mmol, 1.1 equiv). The mixture was gradually warmed 
to rt and stirring was continued for 72 h. The mixture was diluted with dichloromethane 
(20 mL) and washed with sat. aq. NaHCO3 (10 mL). The aqueous layer was extracted 
with dichloromethane (10 mL). The combined organic layers were washed with brine 
(10 mL), dried and concentrated in vacuo. Column chromatography (heaxanes/diethyl 
ether 60:40) gave 355 (55 mg, 0.17 mmol, 43%) and 400 (21 mg, 0.07 mmol, 17%). 
 
(±)- (3aS,9bS,11aS)-3,3a,9b,10,11,11a-Hexahydro-7-isopropyl-6-methoxy-9b-
methylphenanthro[2,1-c]furan-1(5H)-one 355 
O
H
H
O
OMe
355  
1H NMR (500 MHz, CDCl3): δ  7.16 (1H, d, J = 8.4 Hz), 7.10 (1H, d, J = 8.4 Hz), 5.95 
(1H, dd, J = 6.4, 2.3 Hz), 4.43 (1H, t, J = 9.3 Hz), 4.27 (1H, dd, J = 11.7, 9.3 Hz), 3.75 
(3H, s), 3.64 (1H, dd, J = 21.6, 6.1 Hz), 3.45 (1H, q, J = 9.2 Hz), 3.32 (1H, sept., J = 6.8 
Hz), 3.14 (1H, d, J = 21.1 Hz), 2.57 (1H, m), 2.35 (1H, ddd, J = 13.4, 4.2, 3.1 Hz), 2.13 
(1H, m), 1.88 (1H, ddd, J = 26.3, 13.4, 2.7 Hz), 1.75 (1H, dt, J = 13.3, 2.7 Hz), 1.30 
(3H, s), 1.26 (3H, d, J = 6.8 Hz), 1.20 (3H, d, J = 6.8 Hz)  ppm. 13C NMR (125 MHz, 
CDCl3): δ 179.5, 154.2, 144.4, 138.8, 136.2, 127.6, 126.2, 124.8, 119.8, 72.0, 61.1, 
42.3, 40.2, 37.5, 34.9, 29.1, 26.3, 24.5, 24.2, 23.7, 20.5 ppm. IR (thin film): ν = 2961, 
2868, 2823, 1777 cm-1. EIMS (70 eV) m/z (%): 326 (35), 311 (55), 269 (100); HRMS: 
calcd for C21H26O3: 326.1882; found: 326.1883. 
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Rearranged product 400 
O
H
H
O
O400  
1H NMR (500 MHz, CDCl3): δ  6.56 (1H, dd, J = 6.7, 1.0 Hz), 5.09 (1H, s), 4.57 (1H, 
s), 4.38 (1H, dd, J = 9.6, 7.7 Hz), 4.30 (1H, dd, J = 9.6, 2.1 Hz), 3.20 (1H, ddd, J = 10.0, 
8.4, 6.2 Hz), 3.02-2.97 (2H, m), 2.84 (1H, d, J = 6.4 Hz), 2.74 (1H, sept., J = 6.8 Hz), 
2.56 (1H, d, J = 7.4 Hz), 2.09-2.03 (3H, m), 1.93 (1H, ddd, J = 13.1, 14.9, 7.6 Hz), 1.75 
(1H, ddd, J = 19.8, 13.4, 6.7 Hz), 1.61 (1H, dd, J = 14.0, 7.9 Hz), 1.49 (1H, ddd, J = 
14.0, 5.0, 1.7 Hz), 1.01 (3H, d, J = 6.8 Hz), 0.96 (3H, d, J = 6.8 Hz) ppm. 13C NMR 
(125 MHz, CDCl3): δ  201.6, 180.2, 154.2, 144.5, 139.4, 108.1, 69.8, 62.3, 60.3, 51.8, 
50.8, 46.0, 46.0, 42.0, 27.3, 27.0, 26.1, 21.6, 21.6 ppm . IR (thin film): ν = 2959, 1771, 
1675  cm-1. EIMS (70 eV) m/z (%): 312 (100), 297 (39), 269 (44); HRMS: calcd for C-
20H24O3: 312.1725; found: 312.1719. 
 
4,5,6,7-Tetrahydroisobenzofuran-1(3H)-one 410 
O
O
O
O
H
H
408 410  
To a stirred solution of 408 (36.6 mg, 0.26 mmol, 1.0 equiv) in dichloromethane (2 mL) 
at 0 oC was added triethylamine (110 µL, 0.79 mmol, 3.0 equiv) and triispropysilyl 
triflouromethansulphonate (142 µL, 0.53 mmol, 2.0 equiv). Stirring was continued for 
30 min before the addition of PhSeCl (151 mg, 0.79 mmol, 3.0 equiv). Stirring was 
continued for 30 min before the mixture was diluted with dichloromethane (10 mL). 
The mixture was washed with sat aq. NaHCO3 (10 mL) and brine (10 mL). The organic 
layer was dried and concentrated in vacuo. The crude residue was dissolved in 
dichloromethane (5 mL) and cooled to 0 oC. 30% H2O2 (1 mL) was added and the 
mixture stirred for 1.5 h. The mixture was diluted with dichloromethane (10 mL) and 
washed with water (10 mL) and brine (10 mL), dried and concentrated in vacuo. 
Column chromatography (hexanes/ethyl acetate 80:20) gave 410 (24 mg, 0.17 mmol, 
66%). Data for this compound was constistant with that reported in the literature.221 
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(±)- (9bS)-10,11-Dihydro-7-isopropyl-6-methoxy-9b-methylphenanthro[2,1-c]furan-
1(3H,5H,9bH)-one 47 
O
O
OMe
47
 
To a solution of 355 (7.5 mg, 0.02 mmol, 1.0 equiv) in CD2Cl2 (500 µL) at 0 
oC was 
added triethylamine (13 µL, 0.08 mmol, 4.0 equiv) and triispropysilyl 
triflouromethansulphonate (19 µL, 0.06 mmol, 3.0 equiv). After 15 min triethylamine 
(13 µL, 0.08 mmol, 4.0 equiv) and triispropysilyl triflouromethansulphonate (19 µL, 
0.06 mmol, 3.0 equiv) were added again.  After 30 min PhSeCl (70 mg, 0.16 mmol, 8.0 
equiv) was added. After 30 min the solution was diluted with dichloromethane (10 mL) 
and washed with sat. aq. NaHCO3 (5 mL). The solution was dired and concentrated in 
vacuo. The crude residue was dissolved in dichloromethane (10 mL) and cooled to 0 oC. 
H2O2 (30% solution, 2 mL) was added and the mixture stirred for 2 h. The organic layer 
was collected, dried and concentrated in vacuo. NMR of the crude mixture showed 50% 
conversion of 355 to 47. Column chromatography (hexanes/dethyl ether 60:40) gave 47.  
1H NMR (500 MHz, CDCl3): δ  7.20 (2H, s), 6.17 (1H, dd, J = 5.6, 2.3 Hz), 5.02 (1H, 
dt, J = 16.0, 2.6 Hz), 4.93 (1H, dd, J = 16.0, 3.1 Hz), 3.81 (1H, dd, J = 23.0, 5.5 Hz), 
3.77 (3H, s), 3.39 (1H, d, J = 23.0 Hz), 3.32 (1H, sept., J = 7.1 Hz), 2.64-2.44 (2H, m), 
1.80 (1H, m), 1.27 (3H, d, J = 7.1 Hz), 1.21 (3H, d, J = 7.1 Hz), 1.19 (3H, s) ppm. 13C 
NMR (125 MHz, CDCl3): δ 174.2, 154.9, 154.5, 142.4, 139.2, 135.3, 126.3, 125.9, 
125.2, 123.8, 120.6, 69.2, 61.1, 37.0, 32.9, 27.3, 26.3, 25.0, 24.2, 23.7, 18.0  ppm . IR 
(thin film): ν =  2962, 2869, 1755 cm-1. EIMS (70 eV) m/z (%): 324 (40), 309 (35), 281 
(20), 267 (65), 43 (100); HRMS: calcd for C21H24O3: 324.1725; found: 324.1728. All 
data was consistent with that reported in the literature.160 The 1H NMR data in the 
literature is incomplete. 
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7.6 Chapter 6 
7.6.1 Synthesis of a Terminally-Substituted [3]Dendralene 
((2S, 3E)-5-Methylenehepta-3,6-dien-2-yloxy)(tert-butyl)dimethylsilane via indium 
mediated coupling 
OTBS
OBr +
OTBS OTBS
500
93
OH
501 499  
To a stirred solution of 500207,222 (279 mg, 1.91 mmol, 1.1 equiv) and 93 (327 mg, 1.74 
mmol, 1.0 equiv) in DMF (1 mL) was added indium metal (219 mg, 1.91 mmol, 1.1 
equiv). The reaction mixture was stirred at rt for 16 h. The reaction was quenched with 
sat. NH4Cl solution (5 mL) and extracted with ethyl acetate (3 x 20 mL). The combined 
organics were washed with brine (20 mL), dried and concentrated in vacuo. Column 
chromatography (hexanes/ethyl acetate 96:4) gave 501 (259 mg, 1.01 mmol, 58 %) as a 
1:1 mixture of diastereomers.  
To a stirred solution of 501 (130 mg, 0.51 mmol, 1.0 equiv) in tetrahydrofuran (5 mL) 
was added triphenyl phosphine (266 mg, 1.01 mmol, 2.0 equiv) and DEAD (160 µL, 
1.01 mmol, 2.0 equiv). The mixture was heated at 63 ºC for 5 h before being 
concentrated in vacuo. Column chromatography (hexanes/ethyl acetate 95:5) gave 499 
(31 mg, 0.13 mmol, 26%) as a colourless oil. 1H NMR (500 MHz, CDCl3): δ  6.44 (1H, 
dd, J = 17.4, 11.0 Hz), 6.26 (1H, d, J = 15.9 Hz), 5.88 (1H, dd, J = 15.9, 5.5 Hz), 5.38 
(1H, d, J = 17.4 Hz), 5.13 (1H, d, J = 11.0 Hz), 5.11 (1H, s), 5.10 (1H, s), 4.38 (1H, dq, 
J = 6.2, 6.2 Hz), 1.25 (3H, d, J = 6.2 Hz), 0.91 (9H, s), 0.08 (3H, s), 0.07 (3H, s) ppm. 
13C NMR (100 MHz, CDCl3): δ  144.0, 136.6, 136.4, 126.6, 115.5, 115.0, 69.2, 26.0, 
24.6, 18.4, -4.5, -4.7ppm. IR (thin film): ν =  2956, 2929, 2857cm-1. EIMS (70 eV) m/z 
(%): 181 (20), 159 (10), 75 (100); HRMS: calcd for C10H17OSi [M-C4H9]: 181.1049; 
found: 181.1048. 
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((2S, 3E)-5-Methylenehepta-3,6-dien-2-yloxy)(tert-butyl)dimethylsilane 499 via Wittig 
reaction 
OTBS
OPPh3Br +
OTBS
OTBS
+
502 93
499 503  
To a stirred solution of 502 (391 mg, 0.96 mmol, 1.2 equiv) in tetrahydrofuran (5 mL) 
at -78 oC was added n-butyllithium (1.56 M in hexanes, 511 µL, 0.80 mmol, 1.0 equiv). 
The mixture was warmed to -40 oC and stirring was continued for 45 min. A solution of 
93 (150 mg, 0.80 mmol, 1.0 equiv) in tetrahydrofuran (2 mL) was added dropwise via 
cannula. The mixture was stirred at this temperature for 45 min before being warmed to 
rt. Stirring was continued for 1.5 h. The mixture was diluted with diethyl ether (20 mL) 
and washed with sat. aq. NH4Cl (10 mL). The aqueous layer was extracted with diethyl 
ether (10 mL)). The combined organic extracts were washed with brine (10 mL), dried 
and concentrated in vacuo. Column chromatography (hexanes/ethyl acetate 197:3) gave 
499/503 (E/Z 70:30, 71 mg, 0.30 mmol, 37%) as a colourless oil. 
 
Allenyldiphenylphosphine oxide 510 
C
P(Ph)2
O
510  
The title compound was prepared according to a modified literature procedure.172 To a 
stirred solution of propargyl alcohol (17.46 mL, 0.30 mol, 1.0 equiv) and triethylamine 
(46 mL, 0.33 mol, 1.1 equiv) in dichloromethane (300 mL) at -80 oC was added a 
solution of Ph2PCl (27 mL, 0.15 mol, 0.5 mmol) in dichloromethane (225 mL) at such a 
rate to maintain the temperature. The mixture was warmed to -10 oC then poured into a 
solution of HCl (7.5 mL) in water (300 mL). The aqueous layer was extracted with 
dichloromethane (100 mL x 2). The combined organic layers were washed with water 
(200 mL x 2), dried and concentrated in vacuo to give allenyldiphenylphosphine oxide 
510 (33 g, 0.14 mmol, 92%). 
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2-Iodo-2-propenyl diphenyl phosphine oxide 511 
P(Ph)2
O
I
511  
The title compound was prepared according to a modified literature procedure.213 To a 
stirred solution of allenyldiphenylphosphine oxide 510 (8.87 g, 34 mmol, 1.0 equiv) in 
acetic acid (40 mL) was added LiI.H2O (6.26 g, 41 mmol, 1.2 equiv). The mixture was 
heated at 100 oC for 18h. After cooling to rt water (50 mL) was added and the mixture 
was extracted with ethyl acetate (5 x 50 mL). The combined organic layers were washed 
with 5% aq Na2S2O3 (100 mL) and sat. aq. NH4Cl (100 mL), dried then concentrated in 
vacuo. Column chromatography (hexanes/ethyl acetate 20:80) gave 2-iodo-2-propenyl 
diphenyl phosphine oxide 511 (10.1 g, 27 mmol, 81%). 
 
2-Propenyl-2-vinyldiphenyl phosphine oxide 512 
P(Ph)2
O
512  
A solution of 2-iodo-2-propenyl diphenyl phosphine oxide 511 (500 mg, 1.36 mmol, 1.0 
equiv) and tributyl(vinyl)tin (517 mg, 1.63 mmol, 1.2 equiv) in dry DMF (8 mL) was 
freeze/thaw degassed (x2). To this solution was added bis(acetonitrile)palladium 
dichloride (18 mg, 0.07 mmol, 5 mol%). The reaction mixture was stirred at rt for 3 h 
before being diluted with diethyl ether (50 mL) and washed with aqueous ammonia 
solution (2 x 50 mL). The organic layer was washed with brine (50 mL), dried and 
concentrated in vacuo. Column chromatography (hexanes/ethyl acetate 20:80) gave 
phosphine oxide 512 (262 mg, 0.98 mmol, 72%) as a white soild. 1H NMR (300 MHz, 
CDCl3): δ  7.80-7.70 (4H, m), 7.53-7.40 (6H, m), 6.32 (1H, dd, J = 18.0, 11.6 Hz), 5.24 
(1H, s), 5.18 (1H, s), 5.14 (1H, dd, J = 17.5, 3.9 Hz), 5.03 (1H, d, J = 10.7 Hz), 3.26 
(2H, dd, J = 13.9, 0.9 Hz) ppm. 13C NMR (100 MHz, CDCl3): δ 138.5 (J = 0.54 ppm), 
136.4 (J = 0.11 ppm), 132.8 (J = 1.32 ppm), 131.8 (J = 0.4 ppm), 131.1 (J = 0.12 ppm), 
128.5 (J = 0.16 ppm), 120.8 (J = 0.11 ppm), 114.9, 32.7 (J = 0.90 ppm). IR (thin film): 
ν = 3055, 2916, 1437, 1189, 1119cm-1. EIMS (70 eV) m/z (%):268 (75), 201 (100); 
HRMS: calcd for C17H17OP: 268.1017; found: 268.1011. 
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((2S, 3E)-5-Methylenehepta-3,6-dien-2-yloxy)(tert-butyl)dimethylsilane via Horner-
Emmons type reaction 
+P(Ph)2
O
OTBS
O
OTBS
512 93 499  
To a stirred solution of phosphine oxide 512 (121 mg, 0.45 mmol, 1.2 equiv) in 
tetrahydrofuran (2 mL) and HMPA (157 µL, 0.90 mmol, 2.4 equiv) at -78 °C was added 
n-butyllithium (1.60 M in hexanes, 280 µL, 1.2 equiv). The reaction mixtrure was 
stirred at this temperature for 15 min before the dropwise addition of a solution of 
aldehyde 93 (71 mg, 0.38 mmol, 1.0 equiv) in tetrahydrofuran (2 mL). The mixture was 
stirred at -78 °C for 30 min, 0 °C for 1 h and finally at rt for 2 h. The reaction mixture 
was quenched with ice cold 1M aqueous HCl (20 mL) and extracted with diethyl ether 
(3 x 20 mL). The combined organic layers were washed with water (20 mL) and brine 
(20 mL) dried and concentrated. Column chromatography (hexanes/diethyl ether 98:2) 
gave dendralene  499 (49 mg, 0.20 mmol, 55%) as a colourless oil. 
 
7.6.2 Formation of the Tetracyclic Framework 
(Cyclohex-3-enyl)methyl benzoate 498 
OBz
498  
To a stirred solution of lithium aluminium hydride (3.34 g, 88 mmol, 1.0 equiv) in 
diethyl ether (200 mL) at 0 oC was added a solution of 520 (9.7 g, 88 mmol, 1.0 equiv) 
in diethyl ether (20 mL). Stirring was continued at rt for 30 min. 30% sodium sulfate 
solution (40 mL) was added dropwise at 0 oC. The mixture was stirred for 30 min, 
filtered, dried and concentrated in vacuo to give 541 (9.88 g, 88 mmol, 100%) as a 
colourless oil. 
To a stirred solution of alcohol 541 (8.0 g, 71 mmol, 1.0 equiv) in dichloromethane (500 
mL) at 0 oC was added triethylamine (11.93 mL, 86 mmol, 1.2 equiv) and benzoyl 
chloride (9.93 mL, 86 mmol, 1.2 equiv). Stirring was continued for 18 h. The mixture 
was washed with 1M HCl (200 mL), sat. NaHCO3 (200 mL) and brine (200 mL). The 
organic layer was dried and concentrated in vacuo. Distillation 128-132 oC at 1.5 
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mm/Hg) gave 498 (13.0 g, 60 mmol, 84%) as a colourless oil. Data was consistant with 
that reported in the literature. 
 
3-(Benzyloxy)methyl-1,6-di[(tert-butyldimethylsilyl)oxy]hexane 513  
TBSO
OTBS
OBz
513  
Ozone was bubbled through a stirred solution of 498 (1.27 g, 5.9 mmol, 1.0 equiv) in 
dichloromethane (25 mL) and methanol (5 mL) at -78 oC. After the mixture turned blue 
nitrogen was bubbled through the mixture for 30 min. NaBH4 (222 mg, 5.9 mmol, 1.0 
equiv) was added and the reaction was warmed to rt. A second portion of NaBH4 (222 
mg, 5.9 mmol, 1.0 equiv) was added and the mixture was stirred for 18 h. A solution of 
NH4Cl (20 ml) was added. The mixture was extracted with ethyl acetate (50 mL x 5). 
The combined organic layers were washed with brine (100 mL), dried and concentrated 
in vacuo. The crude product was dissolved in DMF (8 mL) and cooled to 0 oC. 
Imidazole (1.17 g, 17.2 mmol, 2.9 equiv) and tert-butyldimethylsilyl chloride (2.16 g, 
14.3 mmol, 2.4 equiv) were added. The mixture was warmed to rt and stirring was 
continued for 1.5 h. The mixture was diluted with diethyl ether (20 mL) and washed 
with water (20 mL). The aqueous layer was extracted with diethyl ether (20 mL x 2). 
The combined organic layers were washed with brine, dried and concentrated in vacuo. 
After column chromatography (hexanes/diethyl ether 96.5:3.5) 513 (2.27 g, 4.72 mmol, 
80%) as a colourless oil. 1H NMR (500 MHz, CDCl3): δ  8.04 (2H, dd, J = 8.1, 1.5 Hz), 
7.55 (1H, dt, J = 7.4, 1.4 Hz), 7.43 (2H, t, J = 7.9 Hz), 4.27 (4H, d, J = 5.5 Hz), 3.72 
(2H, t, J = 6.6 Hz), 3.62 (2H, t, J = 6.6 Hz), 1.98 (1H, sept. 6.2 Hz), 1.72-1.44 (7H, m), 
0.89 (9H, s), 0.88 (9H, s), 0.05 (6H, s), 0.04 (6H, s) ppm. 13C NMR (125 MHz, CDCl3): 
δ  166.7, 132.9, 130.5, 129.6, 128.4, 67.5, 63.3, 61.0, 34.7, 34.4, 30.1, 27.8, 26.0 (2 
coincident peaks), 18.4, 18.4, -5.2 (2 coincident peaks) ppm . IR (thin film): ν = 2953, 
2929, 2894, 2857, 1722 cm-1. EIMS (70 eV) m/z (%): 423 (72), 179 (98), 95 (100); 
HRMS: calcd for C22H39O4Si2 [M-C4H9]: 423.2387; found: 423.2385. 
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1,6-Di[(tert-butyldimethylsilyl)oxy]-3-methanolhexane 521  
TBSO
OTBS
OH
521  
To 513 (2.5 g, 5.2 mmol, 1.0 equiv) was added a methanolic solution of NaOH (196 mL 
of a 0.18 M solution). The mixture was stirred for 8 h then concentrated in vacuo. Water 
(100 mL) and diethyl ether (100 mL) were added. The organic layer was washed with 
brine (50 mL), dried and concentrated in vacuo. After column chromatography 521 
(1.51 g, 4.0 mmol, 77%) was obtained as a colourless oil. 1H NMR (300 MHz, CDCl3): 
δ   3.76 (1H, ddd, J = 10.5, 6.2, 4.0 Hz), 3.70-3.54 (4H, m), 3.45 (1H, dd, J = 11.1, 6.5 
Hz), 1.73-1.46 (5H, m), 1.42-1.23 (2H, m), 0.89 (9H, s), 0.85 (9H, s), 0.07 (6H, s), 0.04 
(6H, s)ppm. 13C NMR (100 MHz, CDCl3): δ  66.1, 63.4, 61.9, 39.5, 35.7, 30.4, 27.9, 
26.0, 25.9, 18.4 (2 coincident peaks), -5.2, -5.4 ppm . IR (thin film): ν = 3339, 2929, 
2885, 2858 cm-1. EIMS (70 eV) m/z (%): 319 (40), 115 (50), 57 (100); HRMS: calcd for 
C15H35O3Si2 [M-C4H9]: 319.2125; found: 319.2130. 
 
1,6-Di[(tert-butyldimethylsilyl)oxy]-3-formylhexane 497 
TBSO
OTBS
O
497  
To a solution of oxalyl chloride (419 µL, 4.8 mmol, 1.2 equiv) in dichloromethane (50 
mL) at -78 oC was added dimethyl sulfoxide (568 µL, 8.0 mmol, 2.0 equiv). After 10 
min a solution of 521 (1.51 g, 4.0 mmol, 1.0 equiv) in dichloromethane (25 mL) was 
added. Stirring was continued for 1.5 h before the addition of triethylamine (2.23 mL, 
16 mmol, 4.0 equiv). The mixture was gradually allowed to warm to rt. The mixture 
was washed with water (50 mL). The aqueous layer was extracted with diethyl ether (20 
mL x 2). The combined organic layers were washed with brine, dried and concentrated 
in vacuo. Column chromatography (hexanes/diethyl ether 95:5) gave 497 (1.14 g, 3.0 
mmol, 76%) as a colourless oil. 1H NMR (500 MHz, CDCl3): δ  9.59 (1H, d, J = 2.62 
Hz), 3.67-3.55 (4H, m), 2.44-2.32 (1H, m), 1.96-1.46 (6H, m), 0.87 (9H, s), 0.86 (9H, 
s), 0.03 (6H, s), 0.01 (6H, s) ppm. 13C NMR (125 MHz, CDCl3): δ  205.0, 62.8, 60.6, 
 246
48.9, 32.3, 30.1, 26.0, 25.9, 24.9, 18.4, 18.3, -5.3, -5.4 ppm. IR (thin film): ν =   2929, 
2886, 1728, 1708 cm-1. EIMS (70 eV) m/z (%): 317 (25), 259 (5), 75 (100); HRMS: 
calcd for C15H33O3Si2 [M-C4H9]: 317.1968; found: 317.1964. 
 
(5E)-1-[(tert-Butyldimethylsilyl)oxy]-4-[(tert-butyldimethylsilyl)oxyethyl]-7-
methylenenona-5,8-diene 514 
OTBS
TBSO
514  
To a stirred solution of phosphine oxide 512 (478 mg, 1.78 mmol, 1.2 equiv) in 
tetrahydrofuran (20 mL) at -78 oC was added n-butyllithium (1.6 M sol. in hexanes, 
1.02 mL, 1.1 equiv). After 15 min a solution of aldehyde 497 (556 mg, 1.48 mmol, 1.0 
equiv) in tetrahydrofuran (10 mL) was added. The mixture was stirred at -78 oC for 1 h, 
0 oC for 1 h and rt for 2.5 h. The mixture was washed with 1M HCl solution (10 mL). 
The aqueous layer was extracted with diethyl ether (20 mL x 3). The combined organic 
layers were washed with water (20 mL) and brine (20 mL) then dried and concentrated 
in vacuo. Column chromatography (hexanes/diethyl ether 96:4) gave 514 (545 mg, 1.28 
mmol, 86%). 1H NMR (500 MHz, CDCl3): δ 6.43 (1H, dd, J = 17.4, 10.8 Hz), 6.07 (1H, 
d, J = 15.5 Hz), 5.58 (1H, dd, J = 15.5, 9.1 Hz), 5.37 (1H, dd, J = 17.5, 1.4 Hz), 5.12 
(1H, d, J = 10.6 Hz), 5.04 (2H, s), 3.65-3.53 (4H, m), 2.20 (1H, m), 1.70-1.41 (5H, m), 
1.35-1.27 (1H, m), 0.9 (18 H, s), 0.04 (6H, s), 0.03 (6H, s) ppm. 13C NMR (125 MHz, 
CDCl3): δ  144.4, 136.8, 136.5, 129.0, 115.4, 114.0, 63.3, 61.2, 39.5, 38.4, 31.6, 30.6, 
26.1, 26.1, 18.5, 18.4, -5.2 (2 coincident peaks) ppm. IR (thin film): ν =  2954, 2929, 
2896, 2857 cm-1. EIMS (70 eV) m/z (%): 367 (55), 292 (20), 235 (100); HRMS: calcd 
for C20H39O2Si2 [M-C4H9]: 367.2489; found: 367.2484. 
 
3-((E)-3-Methylenepenta-1,4-dienyl)hexane-1,6-diol 522 
OH
HO
522  
To a stirred solution of 514 (525 mg, 1.24 mmol, 1.0 equiv) in tetrahydrofuran (33 mL) 
at 0 oC was added tetrabutyl ammonium fluoride (1.0 M sol in tetrahydrofuran, 3.71 
mL, 3.71 mmol, 3.0 equiv). Stirring was continued at rt for 2.5 h before the addition of a 
 247 
solution of NH4Cl (10 mL). The mixture was extracted with diethyl ether (10 mL) and 
ethyl acetate (10 mL x 2). The combined organic layers were washed with brine (20 
mL), dried and concentrated in vacuo. Column chromatography (hexane/ethyl acetate 
10:90) gave 522 (185 mg, 0.94 mmol, 76%). 1H NMR (500 MHz, C6D6): δ  6.46 (1H, 
dd, J = 17.6, 10.8 Hz), 6.16 (1H, d, J = 15.7 Hz), 5.63 (1H, dd, J = 15.7, 9.1 Hz), 5.40 
(1H, dd, J = 17.3, 1.4 Hz), 5.16 (1H, d, J = 10.8 Hz), 5.10 (2H, s), 3.74-3.57 (4H, m), 
2.29 (1H, m), 1.80-1.27 (6H, m) ppm. 13C NMR (125 MHz, C6D6): δ   144.9, 137.1, 
136.9, 129.7, 115.7, 114.5, 62.4, 60.6, 39.8, 38.5, 31.7, 30.7ppm . IR (thin film): ν =  
3306, 2953, 2923, 2854 cm-1. EIMS (70 eV) m/z (%): 196 (1), 91 (100), 79 (70); 
HRMS: calcd for C12H20O2: 196.1463; found: 196.1472. 
 
Tetracycle 524 
O
O
H
H
H
H
H
524  
To a solution of oxalyl chloride (102 µL, 1.17 mmol, 2.4 equiv) in dichloromethane (20 
mL) at -78 oC was added dimethyl sulfoxide (139 µL, 1.96 mmol, 4.0 equiv). After 10 
min a solution of 522 (96 mg, 0.049 mmol, 1.0 equiv) in dichloromethane (10 mL) was 
added. Stirring was continued for 1.5 h before the addition of triethylamine (545 µL, 
3.91 mmol, 8.0 equiv). The mixture was gradually allowed to warm to rt. The mixture 
was washed with water (50 mL). The aqueous layer was extracted with diethyl ether (20 
mL x 2). The combined organic layers were washed with brine, dried and concentrated 
in vacuo. The crude reside was dissolved in tetrahydrofuran (15 mL) and cooled to 0 oC. 
Vinyl magnesium bromide (1.0 M sol. in tetrahydrofuran, 2.5 mL, 2.5 mmol, 5.1 equiv) 
was added and the mixture stirred for 1 h. Sat. NH4Cl (10 mL) was added and the 
mixture extracted with ethyl acetate (2 x 20 mL). The combined organic layers were 
washed with brine (20 mL), dried and concentrated in vacuo. The crude diol 523 was 
dissolved in dichloromethane (10 mL).  
To a solution of oxalyl chloride (102 µL, 1.17 mmol, 2.4 equiv) in dichloromethane (20 
mL) at -78 oC was added dimethyl sulfoxide (139 µL, 1.96 mmol, 4.0 equiv). After 10 
min a solution of crude diol 523 in dichloromethane (10 mL) was added. Stirring was 
continued for 1.5 h before the addition of triethylamine (545 µL, 3.91 mmol, 8.0 equiv). 
The mixture was gradually allowed to warm to rt. The mixture was washed with water 
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(50 mL). The aqueous layer was extracted with diethyl ether (20 mL x 2). The 
combined organic layers were washed with brine, dried and concentrated in vacuo. The 
residue was dissolved in CDCl3 (1.5 mL) and TFA (70 µL) was added. The mixture was 
stood at rt for 48 h before being concentrated in vacuo. HPLC gave 524 (4 mg, 1.6 µm, 
3%). 
1H NMR (800 MHz, CDCl3): δ  5.51 (1H, dd, J = 3.5, 2.5 Hz), 2.85 (1H, m), 2.64 (1H, 
ddd, J = 13.1, 3.7, 1.4 Hz), 2.56 (1H, dt, J = 14.4, 6.6 Hz), 2.53 (1H, m), 2.48 (1H, dd, J 
= 14.4, 3.7 Hz), 2.35 (1H, ddd, J = 14.6, 4.4, 2.2 Hz), 2.31-2.14 (5H, m), 2.11 (1H, t, J 
= 13.7 Hz), 2.06-2.00 (2H, m), 1.84 (1H, d, J = 18.1 Hz), 1.78 (1H, dq, J = 13.2, 4.4 
Hz), 1.66 (1H, m), 1.46 (1H, m), 1.32 (1H, m) ppm. 13C NMR (125 MHz, CDCl3): δ 
213.7, 209.8, 133.1, 124.4, 53.0, 47.8, 45.9, 44.9, 42.2, 36.8, 33.8, 33.6, 30.8, 26.0, 
22.2, 21.5 ppm. EIMS (70 eV) m/z (%): 244 (100); HRMS: calcd for C16H20O2: 
244.1463; found: 244.1463. 
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Appendix 
 
X-Ray crystallography reports for compounds 110a, 113, 114, 115, 116, 282, 287, 291, 
292, 293, 48, 397, 398, 355, 400 and 524 are provided on the CD on the inside back 
cover of this thesis. Single crystal X-Ray analyses were performed by Dr Anthony 
Willis, Dr Alison Edwards and Dr Peter Turner. 
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